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Abstract 
 
 
One key principle of protein regulation is post-translational modification such as 
methylation or phosphorylation, which can alter activity, substrate interaction and subcellular 
localization of proteins. Protein phosphorylation is one of the key regulatory events driving 
cell growth and division, metabolism, and motility. Also many signal transduction processes 
require the activity of protein kinases and phosphatases. These enzymes catalyse the transfer 
of phosphate moieties from adenosine triphosphate as to specific amino acid side chains to 
form phosphoric acid esters, anhydrides, or phospho-amidates and thereby creating a negative 
charge at the amino acid side chain. Addition of the phospho-moiety requires physical 
interaction of kinase and target protein, which makes this modification an important marker 
for protein-protein interactions. Technical improvements of the sample preparation such as 
specific enrichment techniques as well as novel detection methods for mass spectrometry 
provide easier access to protein phosphorylation data and even allow quantitative analysis. 
Physico-chemical properties of the different phospho-modifications on amino acids 
require different experimental strategies for detection by mass spectrometry. Therefore two 
strategies for phosphopeptide analysis are presented in individual sections of the thesis. The 
first part deals with the problem of peptides with multiple phosphorylations, which are quite 
often underrepresented in phospho-proteomic datasets. Furthermore, such peptides have often 
underlying combinatorial complexity, which is caused by the distribution of the phospho-
moieties onto different putative acceptors. In the second section I report the first identification 
of a protein-arginine kinase as a fundamental signal transducer in bacteria. Further, I 
established a protocol which allows detection of this arginine modification by proteomic 
methods.     
With regard to the first part, one of the problems for reliable detection of peptides with 
multiple phosphorylation sites by mass spectrometry is their low stoichiometry in comparison 
to unphosphorylated and singly phosphorylated peptides. Chemical properties which give rise 
to multiple charged isoforms, due to similar pKa values of the phospho-moieties, require 
specific separation conditions in chromatography and optimized mass spectrometric detection. 
Our protocol combines the previously reported titanium dioxide enrichment procedure with 
separation of phospho-peptides using a monolithic column followed by matrix-assisted laser 
desorption/ionization mass spectrometry. Using this method, we are able to localize the 
phosphorylated amino acid in peptide sequences with 3 or more phospho-moieties reliably.  
The second part of the thesis is focused on phosphorylation of histidines and arginines 
in peptides and proteins. Detection of this modification has been challenging because of its 
low stability under acidic conditions. Nevertheless, recently developed methods in mass 
spectrometry allow unambiguous identification of such phosphorylated amino acids. We 
developed a protocol which preserves the modification during sample preparation, thereby 
allowing us to detect arginine phosphorylation on a bacterial translation factor CtsR after in 
vitro phosphorylation with McsB. Using synthethic peptides we demonstrate the specificity of 
the arginine kinase McsB that is expressed in some Gram-positive bacteria.  
Further, we optimized our protocol to purify arginine and histidine phosphorylated 
peptides from in vitro phosphorylation samples. Using these purified model peptides we 
monitored the hydrolysis at different temperatures and pH values, allowing us to estimate the 
limits of acidic treatment. To improve mass spectrometric detection, we applied different 
fragmentation conditions in collision-induced and electron-induced dissociation methods. 
Under collision-induced dissociation processes, the fragmentation behaviour of phospho-
arginine containing peptides differs significantly from that of serine or threonine 
phosphorylated peptides, although all modifications show extensive elimination of phosphoric 
acid.   
Based on the stability experiments, an enrichment procedure was established which 
allows purification of peptides with nitrogen-bound phosphorylations. Furthermore, we 
studied the influence of analysis method and search parameters on identification of the correct 
phospho-amino acid. This protocol confirmed the arginine phosphorylation of the bacterial 
protein CtsR and revealed a high similarity between the phosphorylation patterns of this 
protein from B. subtilis and B. stearothermophilus after in vitro phosphorylation. The 
developed protocol will also help to study these modifications in cell lysates of other bacteria 
and eukaryotic cells. 
Zusammenfassung 
 
In Zellen gibt es unzählige, chemische Prozesse, wie z.B. Zellteilung oder Wachstum, 
welche ausschließlich von Proteinen gesteuert werden und strikter Regulierung bedürfen. 
Einen sehr wichtigen Beitrag zur Regulierung von Proteinaktivitäten liefern post-
translationale Modifikationen, welche in Form von reversiblen, an Aminosäureseitenketten 
gekoppelte Molekülen, wie bei der Acetylierung oder Phosphorylierung, oder als irreversible 
Änderungen auftreten können, z.B. bei der Abspaltung eines Signalpeptids. Die Protein-
Phosphorylierung stellt zum jetzigen Zeitpunkt die am besten untersuchte post-translationale 
Modifikation dar und spielt eine sehr wichtige Rolle für den Ablauf der Zellteilung sowie in 
fast allen Signaltransduktionswegen innerhalb der Zellen. Die Phosphorylierung wird von der 
Enzymfamilie der Proteinkinasen übertragen, welche einen Phospho-Ester an den 
Seitenketten der Aminosäuren Serin, Threonin, Tyrosin, ein Phospho-Anhydrid an Aspartat 
oder ein Phospho-Amidat an Stickstoff-Atomen von Histidin, Lysin oder Arginin 
synthetisieren. Dabei wird an vorher positiv geladenen oder ungeladenen Seitenketten eine 
negative Ladung angebracht, welche die Interaktion zu benachbarten Aminosäuren 
beeinflusst. Die Wichtigkeit dieser Modifikation für zelluläre Prozesse und die 
schwerwiegenden Effekte, die durch eine Missregulation entstehen, machen ein 
umfangreiches Verständnis dieser Modifikation erforderlich. 
Durch Entwicklung neuer Methoden, die spezifisch auf die Anreicherung und 
Detektion post-translationaler Modifikationen ausgelegt sind, ist die Massenspektrometrie zu 
einer Standardmethode zum Nachweis von Proteinphosphorylierungen geworden. Aufgrund 
der Eigenschaften der verschiedenen phosphorylierten Aminosäuren müssen unterschiedliche 
experimentelle Bedingungen für die Bestimmung angewendet werden. Die Dissertation 
behandelt die Analyse von mehrfach phosphorylierten Peptiden und die Detektion von 
Stickstoff-gebundenen Phosphorylierungen in Peptiden in zwei Teilen. Im ersten Teil wird ein 
Protokoll vorgestellt mit dem Phosphorylierungsstellen in Peptiden besser identifiziert 
werden, wenn mehrere dieser Modifikationen in der Peptidsequenz vorhanden sind. Die 
Analyse von Stickstoff-gebundenen Phosphorylierungen ist im zweiten Teil detailliert 
beschrieben.    
Peptide mit drei oder mehr Phosphorylierungen sind in den meisten Studien oft 
unterrepräsentiert, da sie einerseits nur zu einem geringen Prozentsatz vorhanden sind und 
andererseits aufgrund ihrer physikalisch-chemischen Eigenschaften oft nicht detektiert 
werden. Zur Verbesserung der Analyse solcher vielfach phosphorylierter Peptide haben wir 
ein Protokoll entwickelt, welches Metalloxid-Affinitätschromatographie an Titandioxid mit 
der Sensitivität von Matrix-unterstützter Laser Desorption/Ionisations Massenspektrometrie 
verbindet. Dabei werden Phosphopeptide im ersten Schritt nach der enzymatischen Spaltung 
mittels Titanoxid angereichert. Aufgrund des ungenügenden Trennungsverhaltens vielfach 
phosphorylierter Peptide auf herkömmlichen "reversed phase" Chromatographiesäulen wurde 
die Elutionsmischung auf einer monolithischen Säule getrennt. Detektion und Identifikation 
erfolgt mittels Matrix-unterstützte Laser Desorption/Ionisations-Massenspektrometrie, wobei 
aufgrund des besonderen Fragmentationsverhaltens der einfach geladenen Peptidionen oft 
eine hohe Sequenzabdeckung und genaue Lokalisation der Phosphorylierungsstelle erreicht 
werden kann. Als Modellsystem haben wir die mehrfach phosphorylierten Peptide von 
Osteopontin und ß-Casein analysiert und das neue Protokoll mit den etablierten Methoden 
"multi-stage activation" kollisionsaktivierter Dissoziation und Elektronentransferdissoziation 
verglichen. 
Bereits in den frühen 1970er Jahren wurden Phosphorylierungen an Seitenketten von 
Histidin, Lysin oder Arginin beschrieben und mittels Radioaktivitätsassays nachgewiesen, 
allerdings sind nur sehr wenige Phosphorylierungstellen bekannt. Im Allgemeinen werden N-
Phosphorylierungen mit der Domäne der Prokaryonten verbunden und gelten als evolutionär 
früheste Form der Protein-Phosphorylierung. Über die Funktion von Stickstoff-gebundenen 
Phosphorylierungen (N-Phosphorylierungen) auf Proteinen ist bisher nur wenig bekannt, da 
diese Modifikation durch die Probenvorbereitung oft verloren geht. Werden Bakterien Stress-
Situationen ausgesetzt, wie z.B. erhöhter Temperatur oder hohen Salzkonzentrationen, 
müssen sie sich schnell an die Bedingungen anpassen und eventuelle Schäden, wie 
Proteinaggregation oder Denaturierung, beheben.  
Aufgrund der Stickstoff-Phosphor-Bindung, welche signifikant reaktiver ist als die 
Sauerstoff-Phosphor-Bindung in den Phosphoestern von Serin oder Threonin, kann diese 
Modifikation sehr leicht unter sauren Bedingungen abgespalten werden. Daher wurde die 
Probenvorbereitung für die Analyse dieser Modifikation verändert um sie einer 
massenspektrometrischen Detektion zugänglich zu machen. Bei der Analyse solcher 
Verbindungen wird die Phosphorylierung als Phosphorsäure abgespalten, was oft zu 
Fehlinterpretationen führt. Um die Analyse von N-Phosphorylierungen zu verbessern, haben 
wir ein Anreicherungsprotokoll für die Metalloxid-Affinitätschromatographie sowie 
Trennbedingungen für die Umkehrphasen-Chromatographie optimiert. Das verbesserte 
Protokoll wurde im Folgenden zur Detektion der Phosphorylierungsstellen in verschiedenen 
bakteriellen Proteinen angewandt. Im Fall der Arginin-Phosphorylierung ist nicht nur die 
Probenvorbereitung von großer Wichtigkeit, sondern aufgrund des speziellen 
Fragmentationsverhaltens im Massenspektrometer wird auch die Interpretation der Daten 
erschwert. Um diese Modifikation zuverlässig von anderen Protein-Phosphorylierungen zu 
unterscheiden haben wir die Fragmentierung verschiedener Modellpeptide untersucht.  
In dieser Dissertation werden zwei wichtige Probleme aktueller Phospho-Proteomstudien 
untersucht, die Analyse mehrfach phosphorylierter Peptide und die Eigenschaften von 
Arginin-gebundenen Proteinphosphorylierungen. Die Entdeckung der Arginin-
Phosphorylierung lieferte aufschlussreiche Details zur Adaption von Bakterien an 
Stressbedingungen. Mit Hilfe einer optimierten Probenvorbereitung und Dateninterpretation 
kann eine Analyse Stickstoff-gebundener Proteinphosphorylierungen auch mit komplexen 
Proben wie Proteinkomplexen und Zell-Lysaten möglich werden. 
 Structure of the PhD thesis - Novel Protocols for the Identification of Protein Phosphorylation Sites on 
Multiply Phosphorylated Domains and Acid-Labile Phosphorylations of Histidine and Arginine in 
Proteins 
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Introduction Part 1 
 
A Phosphorylation Processes in Cells 
 
 I  Abundance, Properties and Function 
 
All cellular processes rely on protein activity, which makes these molecules 
indispensable for live. To adapt to environmental changes, cells require fast and reliable 
regulatory systems, which are often based on networks of interacting proteins. Since 
expression and degradation of proteins are long lasting processes, cells use enzyme-catalyzed, 
reversible, post-translational modifications such as phosphorylation, acetylation, methylation, 
and others to directly modify protein activity. Thereby, protein phosphorylation represents a 
key activator of protein activity in all kingdoms of live and has been shown to be the key 
regulator in cell division and signal transduction processes. On the other side, mis-regulation 
of protein phosphorylation can severely affect cellular processes and thereby lead to 
oncogenic transformation (Blume-Jensen P. and HunterT., 2001; Rush J. et al., 2005). 
Recently, a plethora of protein phosphorylation sites has been reported in several large scale 
studies, which led to the estimate that up to 30% of all eukaryotic proteins encounter this 
modification during their lifetime (Hunter T., 2000). This makes phosphorylation the most 
widespread protein modification in eukaryotic cells. Phosphorylation is not only limited to 
proteins but also sugars, lipids, DNA and RNA are phosphorylated by kinases or 
phosphorylases (Voet D., 2002). A well studied example for sugar phosphorylation is that of 
glucose to glucose-6-phosphate, an initiation step of sugar metabolism. Furthermore, also the 
repair of DNA breaks requires specific phosphorylation to reconnect both strands.   
In proteins, phosphorylation is often attached in the form of phospho-esters to the OH-
moieties in the side chains of the amino acids serine (Ser), threonine (Thr) or tyrosine (Tyr) 
(figure A_01; Hunter T., 2000). To a significantly lower extend histidine (His), arginine 
(Arg), aspartate (Asp), cysteine (Cys), and lysine (Lys) residues can also be phosphorylated. 
These five amino acid modifications are highly labile under acidic pH conditions that they are 
often lost durinsample preparation. Furthermore, most of these modifications are reported to 
be present in bacteria and plants, while their existence in eukaryotes is only assumed. Of the 
acid-labile phosphorylations, histidine and aspartate phosphorylation have been intensely 
studied, since they occur in conjunction in the so called two-component signalling systems 
(Mitrophanov A.Y. and Groisman E.A., 2008). Protein kinases for Arg, Lys, and Cys are 
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rarely reported (Besant P.G. et al., 2009, Attwood P.V. et al., 2007). The phosphorylations of 
Ser, Thr and Tyr are quite stable during the chemical treatment most of the common sample 
preparation methods but can easily be removed by phosphatases, both in vivo and in vitro. 
Since both hydrogen atoms in the applied phospho-moiety are acidic, this modification adopts 
a doubly negative charge state under physiological pH conditions. Such a strong negative 
charge has powerful influence on the binding of other proteins, which could either be 
impaired or promoted. For instance 14-3-3 proteins or proteins with polo box domains 
specifically bind to phosphorylated peptide sequences (Thomas D. et al., 2005; Lowery D.M. 
et al., 2004). Not only protein-protein interactions are altered upon phosphorylation events, 
but also structural changes within the phospho-protein itself have been observed which might 
be re-localization of an inhibitory domain to allow access to the active centre, e.g. activation 
of calmodulin-dependent kinases.  
Protein phosphorylation has important functions in every cell compartment from the 
transcriptional machinery in the nucleus to secreted proteins in the extra-cellular matrix 
(Hunter T., 2000). Interestingly, while eukaryotes have a very complex network of  
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Fig. A-01 Phosphorylated amino acids in proteins 
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recent data show that this 
modification is only 
rudimentary present in 
bacteria (Macek B. et al., 
2007, Miller M.L. et al., 
2009). In eukaryotes, signal 
transduction from the cell 
membrane to the nucleus is 
meditated by many protein 
phosphory-lation events 
which lead to activation of 
other kinases and can 
thereby form 
phosphorylation cascades.
Prominent members of 
such cascades are the  
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receptor tyrosine kinases (figure A_02) and members of MAP-kinase pathways (mitogen-
activated   protein    kinase) which mediate signal transduction from the cell surface to the 
transcription machinery (Hunter T., 2000). While the former Tyr-kinases are important to 
sense growth factors and other extra-cellular signals, the latter MAP-kinases are messengers 
within the cell which activate transcription factors and thereby regulate gene expression. 
Phosphorylation cascades consists of several kinases, for instance MAP-kinase, MAP-kinase-
kinase, and MAP-kinase-kinase-kinase, which are activated upon phosphorylation and 
subsequently phosphorylate the next downstream kinase (Teis D. et al., 2002).  Also cell 
division processes depend on the activity of different protein kinases and the appropiate 
phosphorylation state of key proteins (King R. et al., 1994; Nigg E.A., 2001). As consequence 
of these essential roles in maintaining the viability of cells, misregulation and inactivation of 
protein kinases can lead to neoplastic transformation or the promotion of tumor growth, as 
demonstrated for receptor tyrosine kinases and several members of the MAP kinase family 
(Blume-Jensen P. and Hunter T., 2001). 
Protein phosphorylation is not only able to mediate protein-protein-interactions, it is 
also a good indicator of kinase-substrate interactions as demonstrated by the signalling 
cascades. Studying protein phosphorylation can help to explain different states of protein 
activity at the molecular level, and also enlucidate the pathways behind such important 
processes like cell division and oncogenic transformation. 
      
Figure A_02 Schematic 
Phosphorylation Cascade in 
Eukaryotic Cells.  
Interaction with an extra-cellular 
signal leads to receptor
dimerization and activates the Tyr-
kinase activity. Both receptors
auto-phosphorylate each other in 
their intra-cellular domains and 
thereby become active for docking 
of other proteins. These effector 
proteins are phosphorylated by the 
kinase domain and thereby initiate 
MAP kinase cascades, to transduct
the signal to effector proteins,
altering gene expression. 
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II Protein Kinases 
 
Protein kinases are enzymes that catalyze the transfer of the γ-phosphoryl moiety from 
an adenosyl triphosphate (ATP) molecule onto a specific amino acid in a target protein (figure 
A_03). Three domains are ubiquitously found in protein kinases: the ATP binding domain, the 
active centre, and the target protein recognition domain, which can be extended by a 
regulatory domain. These domains have often evolutionarily conserved amino acid sequences. 
Since the chemical natures of Ser, Thr, Tyr, and His differ significantly from each other, 
various classes of kinases have evolved. Furthermore, kinases are normally not able to modify 
just any putative target amino acid in a protein sequence, for instance serines and threonines. 
Often only a specific peptide strands or even specific amino acids become phosphorylated. 
For some kinases these strands have developed specific recognition sequences with certain 
amino acids at fixed positions close to the target site for phosphorylation. The yeast MAP 
kinases, for example, require a proline residue C-terminal to the Ser or Thr, but also more 
complex motifs have been described recently, for instance for protein kinase A or polo-like 
kinase (Nakajima H. et al., 2003). The aim of this diversity is a tight control over kinase 
activity which allows the activation of specific cellular pathways. In human cells 518 different 
kinases are encoded by the DNA and assumed to be expressed (Linding R. et al., 2008). Many 
of them have been proposed based on their amino acid sequences, but not all of these proteins 
have been detected by biochemical methods. The biochemical data are still required to 
demonstrate catalytic activity. A different approach for kinase identification uses specific 
kinase inhibitors, which are often structurally related to ATP, to immobilize kinases onto a 
solid phase. The bound proteins are identified by mass spectrometry and can be tested by 
other biochemical techniques to reveal the kinase activity (Bantscheff M. et al., 2007). 
 
 
 
Figure A_03 Protein Phosphorylation by Kinases and Dephosphorylation by 
Phosphatases Are Antagonistic Processes in Cells. Kinases belong to the enzyme class of 
transferases, protein phosphatases are hydrolases. 
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III Protein Phosphatases 
 
Similar to the protein kinase family, protein phosphatases have evolved, to generate 
high diversity for tight control of phosphorylation processes. Nevertheless, some 
phosphatases have a more general activity and are therefore able to dephosphorylate many 
different substrates. Since one of the substrates is water, these enzymes belong to the 
hydrolase family and they are classified by the type of amino acid that becomes 
dephosphorylated (figure A-03, Theodosiou A. and Ashworth A., 2002). Up to now 4 classes 
have been described, the Ser/Thr phosphatases, the Tyr phosphatases and the His 
phosphatases, which act on the individual phospho-amino acids, respectively. The fourth class 
are dual-specificity phosphatases, which are able to hydrolyze the phospho-ester bond on 
phosphorylated Ser, Thr, and Tyr (Keyse S.M., 1995). In cells, phosphatases are the 
antagonists of kinases, and their function is to shut the kinase-activated pathways off when the 
signal is no longer required. To allow a rapid kinase signalling as required in case of stress, 
the general phosphatase activity in cells has to be slightly higher than the kinase activity to 
maintain the supply of kinase substrates.  
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B Analysis of Protein Phosphorylation by Mass Spectrometry 
 
Incorporation of radioactive phosphorous 32P is still the most prominent technique for 
visualizing kinase activity (Wålinder O. et al., 1969). Unfortunately, this method is not able to 
determine the phosphorylated amino acid and has to be combined with mutational studies 
where putatively phosphorylated amino acids are exchange to such which cannot be modified. 
Despite the sensitivity of detection systems for radioactive markers other methods have been 
established to study protein phosphorylation, since radioactive radiation is ionizing and can 
cause health damage, when working with it over long time. Specific antibodies for 
phosphotyrosine (phospho-Tyr) can be used in Western Blot experiments to detect proteins 
with this modification. Phosphoserine (phospho-Ser) and phosphothreonine (phospho-Thr) 
can be detected by phosphorylation specific stainings, since available antibodies cannot 
universally detect this modification. Other antibodies have to be generated to detect specific 
phosphorylated peptide strands in selected proteins.  
Recently, technological advances and novel enrichment methods made mass 
spectrometry (MS) a highly important tool for phospho-protein research. This technique 
provides the ability to observe multiple phosphorylation events on many proteins within a 
single experiment and is therefore often faster than mutating specific amino acids. The 
introduction of label-free or isotope-based relative quantification methods even allows 
distinction of the phosphorylation state of a protein in different cell states or at different 
timepoints (Agrawal G.K. and Thelen J.J., 2006; Villen, J. et al., 2007). 
  
 I  Protein Identification by Mass Spectrometry 
 
Currently, protein identification by mass spectrometry (MS) is a routine method in 
biochemistry. Individual proteins of interest or complex mixtures of proteins and cell lysates 
are enzymatically cleaved into short peptide fragments see figure A_04A. Prior to the 
digestion step, proteins are denatured and disulfide bonds that stabilize the three-dimensional 
structure are reduced to sulfhydryls and modified by alkylation, for instance with 
iodoacetamide. Then a protease, which hydrolyses amide bonds at specific positions within 
the amino acid sequence, is added to the mixture. A commonly-used protease is trypsin, 
which cleaves C-terminally to Arg and Lys and thereby produces a distinct peptide pattern. 
The resulting peptide mixture is further fractionated by chromatography steps; usually 
“reversed-phase” liquid chromatography (RP-LC) is the last chromatography step prior to 
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mass spectrometric detection of the peptides. Nowadays, nano-scale high performance liquid 
chromatography (HPLC) systems are directly linked to the inlet of the mass spectrometer 
which allows on-line-detection and analysis of peptides even from quite complex mixtures. In 
the late 1980s two major ionization techniques have been invented, electro-spray ionization 
and matrix-assisted laser desorption/ionization. Both are so-called soft ionization techniques 
because relatively labile biomolecules can be transferred into the gas-phase without 
undergoing extensive fractionation, which was observed with other ionization techniques 
(Karas M. and Hillenkamp F., 1988; Fenn J.B. et al., 1989). Upon ESI, dissolved analytes are 
sprayed from the tip of a capillary, connected to an electrode, towards the entrance of the 
mass spectrometer, which is the counter electrode. During this process the solvent evaporates 
and in case of peptides leaves often multiply-charged analyte ions. The MALDI process 
requires co-crystallization of the sample with an excess of matrix, which is a substance that 
can be irradiated by UV lasers. The energy uptake upon laser exposure leads to a local 
temperature increase and evaporation of matrix molecules, also transferring analytes into the 
gas phase. Application of an electric field accelerates the analyte ions into direction of the 
mass analyzer. Whereas ESI is easily coupled to an HPLC system, MALDI sample 
preparation requires a spotting device that fractionates the sample onto the sample plate. 
 Following ionization, the analyte ions are separated by the mass analyzer and finally 
detected. The principles of mass analyzers are based on the behaviour of ions in electric or 
magnetic fields or the flight time through a fieldless tube. These processes are combined into 
computer software, allowing automatic acquisition of multiple MS spectra during HPLC 
separation. For protein identification, acquired mass spectra are typically compared to a 
database that contains all expected protein sequences. According to the specificity of the 
proteolytic enzyme, a list of theoretically observable peptides is generated and matched to the 
experimental data. If a high number of theoretical peptides is found in the MS data, the 
protein is more reliably identified. Due to the fact that the protein sequence is reconstructed 
from its peptides this method is called bottom-up approach and a scheme is shown in figure 
A_04A. 
With growing knowledge of the proteome, it became obvious that identification of a 
protein based on the peptide masses from the enzymatic cleavage is not accurate enough, 
since it determines only the amino acid composition. This is often fulfilled by several peptides 
of different proteins. Higher assurance for the peptide identity is provided, if each amino acid 
can be localized within the sequence (Arnott D. et al., 1993). To gain this information, 
peptides have to be sequenced within the mass spectrometer, which is achieved by 
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dissociation of an amide bond in the peptide backbone in tandem MS experiments (MS/MS). 
Special fragmentation methods have been introduced for this purpose, which either increase 
the internal energy of the peptide, for instance by collisions with gas molecules (collision-
induced dissociation, CID) or infrared radiation (infrared multi-photon dissociation, IRMPD), 
or induce radical dissociations by uptake of low-energy electrons (Hunt D.F. et al., 1986; 
Stensballe A. et al., 2000). Methods which increase the internal energy of the precursor ion to 
induce fragmentations are “so-called” thermal activation methods and lead to dissociation of 
the weakest bond in the molecule (see figure A_04B), which is the peptide bond in case of 
unmodified peptides (Hunt D.F. et al., 1986). This fragmentation type predominantly leads to 
formation of “so-called” b- and y-type ions and it became the standard method in proteomics 
(Roepstorff P. and Fohlman J., 1984). It is available in every mass spectrometer, easily 
implemented into the analysis program and delivers highly reliable peptide identifications. 
Obtained MS/MS data are also searched against a database but now each peptide is validated 
individually so that peptides with equal amino acid composition but different sequence can be 
distinguished. Identification of amino acid sequences reduced the number of false positive 
identifications dramatically.  
To circumvent the laborious digestion step and to reveal the mass of the intact protein, 
a different methodology is available, top-down analysis (see figure A_04C, Reid G.E. et al., 
2001; Ge Y. et al., 2002). Although intact proteins can be analyzed with almost all instrument 
types, this technique is routinely applied on Fourier-transform (FT) mass spectrometers, 
which possess highest mass accuracy and highest resolution. Top down MS approaches were 
also demonstrated for ion trapping and quadrupole-TOF (qToF) instruments. Mass differences 
of measured and calculated protein mass provide hints for putative amino acid modifications 
and cleavage of signal peptides. Fragmentation of the whole protein leads to localization of 
the modification site within the protein sequence (Ge Y. et al., 2003). Due to the physical 
parameters for the ion transfer into the mass analyzer the protein size is limited to 
approximately 50 kDa for commercially available instruments; custom built mass 
spectrometers are able to analyze much larger proteins. 
QTOF instruments have an almost unlimited mass range but lack the resolution and 
accuracy. The high mass range provides analysis of intact protein complexes (Rostom A.A. 
and Robinson C.V., 1999; Ruotolo B.V. and Robinson C.V., 2006). Upon CID activation, 
individual subunits of the complex can be released, elucidating specific protein-protein 
interactions and the structural association of the complex. 
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Figure A_04 Protein Analysis by Mass Spectrometry. A. Schematic representation of 
“bottom up”-proteomics approach. After enzymatic cleavage of the protein, peptides are 
separated by chromatographic methods and detected in the mass spectrometer. Proteins are 
identified by their respective peptides. B. Fragmentation of oligopeptides in tandem MS 
processes leads to breaking of the peptide backbone, resulting in characteristic fragment ions 
(daughter ions). Small characters represent the nomenclature of peptide fragment ions. C. 
Analysis of full-length proteins by top down mass spectrometry is applied to identify protein 
sequences and modifications, but requires purified protein samples.  
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II Phosphopeptide Enrichment Techniques  
 
Protein phosphorylation in cells is not a stoichiometric process but more often this 
modification is applied to only a small fraction of the observed protein. Furthermore, sample 
preparation for mass spectrometry requires enzymatic cleavage of the proteins to small 
peptide fragments. Since only specific amino acids are phosphorylated in a protein molecule, 
a large fraction of the peptide mixture forms a biological background, which interferes with 
the analysis of phosphorylated peptides. This background of non-phosphorylated peptides 
influences the analysis by reducing the ionization efficiency for phosphopeptides and the 
chance to select phosphopeptide ions for MS/MS analysis (Janek K. et al., 2001; Steen H. et 
al., 2006). 
To reduce this biological background and improve phosphopeptide detection, special 
enrichment protocols have been developed recently. The aim of each experimental setup is to 
physically isolate phosphopeptides from all other peptides. Chromatographic techniques that 
rely on a specific affinity of the phospho-moiety to the solid phase have been successfully 
applied to enrich phosphopeptides from highly complex samples and become standard 
techniques in phosphoproteomics (Thingholm T.E. et al., 2009). Other techniques such as 
isoelectric focussing, thin-layer chromatography, phospho-amidate chemistry, or calcium 
hydroxide precipitation have not been widely used but also proved good enrichment results 
(Xu C.F. et al., 2007; Kochin V. et al., 2006; Bodenmiller B. et al., 2007, Zhang X. et al., 
2007).  
Phospho-tyrosine has also an outstanding position, since it is the only phosphorylation 
that can be isolated by antibody-affinity chromatography, routinely (Rush J. et al., 2005). 
Therefore, anti-phosphotyrosine antibodies are immobilized on a chromatographic resin such 
as modified silica and this material can then be mixed with the sample. Under specific elution 
conditions the antibody releases the peptide, which is further analyzed by mass spectrometry.  
 
Strong Cation Exchange (SCX) and Electrostatic-Repulsion Hydrophilic-Interaction 
(ERLIC) Chromatography 
Due to the negative charge of the phospho-moiety even at low pH, interaction with the 
already negatively charged strong-cation exchange chromatography resin is impaired, and 
furthermore repulsion of the peptide could be observed as schematically demonstrated in 
figure A_05A (Trinidad J.C. et al., 2006). Other peptides adopt a positive charge, since 
carboxylic acids and amine functions are protonated and are therefore retained on the column. 
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This method allows partial enrichment of phosphopeptides within the flow-through and the 
first fractions. Phosphopeptides with more than one positively charged amino acid in their 
sequence are also retained and might elute together with unphosphorylated peptides.  
A sophisticated procedure which uses ion pairing is electrostatic-repulsion hydrophilic-
interaction chromatography (ERLIC) which introduces the idea of competitive binding of 
small organic acids to a weak anion exchange column (WAX) to prevent unphosphorylated 
peptides from interaction with the stationary phase (see figure A_05B, Alpert A.J., 2008). 
Ammonium formiate and ammonium methylphosphonate have been depicted as masking 
reagents because they have a lower affinity towards the stationary phase than the phospho-
moiety and guarantee stable pH conditions in the range of pH 2-3. Elution of the peptides can 
be achieved with a gradient of increasing phosphate concentration which outcompetes the 
phosphopeptides for the binding sites and allows even a separation due to the number of 
phospho-moieties on the peptide. Since establishing this method is quite laborious, the 
potency of this method is yet not fully explored. 
 
Immobilized-Metal Ion Affinity Chromatography (IMAC) 
Since phospho-moieties are negatively charged down to very low pH values (the first 
pKa of the phospho-moiety is about 1.2) they can form salt bridges to positively charged 
metal ions. A particularly high affinity was thereby observed for three-valent metal ions such 
as iron Fe3+, gallium Ga3+ and aluminium Al3+ (Ficarro S.B. et al, 2002). This interaction 
requires only two free ligand binding sites on the metal ion, so that the other sites can be used 
to immobilize the metal ion on a chromatographic resin. Under acidic loading conditions, 
phosphopeptides occupy the positively charged binding sites much stronger than peptides 
without phosphorylated amino acids. In contrast, these peptides compete with the buffer 
molecules for residual free binding sites due to their low affinity and can be washed from the 
column with few column volumes of loading buffer. Afterwards, phosphopeptides are 
selectively eluted with a sodium phosphate solution at neutral or basic pH. To reconstitute the 
column material, the respective metal salt solution is applied under loading conditions. The 
carrier for the metal ion is an organic molecule with several coordination sites, which 
chemical nature could be carboxylic acids or nitrogen atoms. The structure of that ligand is 
similar to that of chelating reagents in solution as for instance imido-diacetic acid derivatives 
(Ficarro S.B. et al, 2002). The carboxylic acids of this chelate are still sensitive towards 
protonation at very low pH, thereby allowing an application of the IMAC method only at pH 
values above 3.5. The pH limitation causes a partial deprotonation of acidic amino acids, 
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aspartate and glutamate, which then become able to interact with the positively charged metal 
ions on the resin and enrich highly acidic peptides (Ficarro S.B. et al, 2002).  
Later on, an effective method to avoid binding of unphosphorylated peptides was 
introduced by Ficarro et al.; modification of the carboxylic acid side chains in peptides by a 
methyl ester prior to the enrichment step (Ficarro S.B. et al, 2005). Using this protocol 13000 
phosphorylation sites have been identified in the mouse brain (Villen J. and Gygi S.P., 2008). 
Since the elution solvent contains a high salt concentration and the polymeric stationary phase 
is sensitive to high pressure, this method is predominantly applied in batch mode on the bench 
and not in automated HPLC systems. Nevertheless, it is difficult to adopt this method to 
varying sample amounts. A schematic illustration of the phosphopeptide binding is 
demonstrated in figure A_05C. 
 
 
Figure A-05 Enrichment Techniques for Phosphopeptides. While SCX (A) 
chromatography elutes phosphopeptides earlier than unphosphorylated peptides, ERLIC (B), 
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IMAC (C), and MOAC-based (D) methods retain phosphorylated peptides on the column. 
Phosphopeptides stay attached to the resin under loading and washing conditions and are 
eluted with a specific elution buffer. Masking substances as buffer components competitively 
remove unphosphorylated peptides during loading and washing steps in ERLIC, IMAC, and 
MOAC-based protocols. 
 
 
Metal oxide-affinity chromatography (MOAC) on titanium dioxide TiO2, zirconium 
dioxide ZrO2, and tin oxide SnO2  
The enrichment procedure with the highest impact in the recent years was metal oxide-
affinity chromatography (MOAC) on spheres of metal oxides from Ti, Zr, or Sn. Theroretical 
arguments and affinity experiments of inorganic and organic ions (Cl-, SO42-, NO3-, CO32-, 
acetate, formiate, PO43-) towards these metal oxides revealed that only phosphate was strongly 
adsorbed on the surface and every other anion could be released by washing with a phosphate 
solution (Kweon H.K. and Hakansson K., 2006). Since phosphopeptides represent the 
monoesters of phosphoric acid, these molecules should also be able to attach to the surface of 
these metal oxides with high affinity, which provides a good method to separate these 
analytes from the majority of unphosphorylated peptides (Cantin G.T. et al.,  2007).  
While the first protocols achieved only slight depletion of unmodified peptide due to 
the fact that carboxylic acid can also bind to these materials, introduction of masking reagents 
such as acetic acid, oxalic acid, pthalic acid, dihydroxybenzoic acid, or lactic acid resulted in 
almost complete depletion of unmodified peptides with high recovery of phosphopeptides 
(Pinkse M.W. et al., 2004, Larsen M.R. et al., 2005). Currently, the binding mode of the 
phosphoryl group is heavily discussed; one theory states that two oxygen atoms of the 
phospho-moiety are able to act as a bi-dentate ligand which coordinates two binding sites on  
Ti-ions while carboxylic acids occupy only a single coordination site (Larsen M.R. et al., 
2005). Masking reagents bind competitively to the same sites, which can be occupied by 
unmodified peptides and the excess of these additives shifts the equilibrium towards release of 
unmodified peptides. The phosphate-metal ion complex has a higher stability so that 
enrichment of phosphopeptides is not disturbed. Another theory suggests the binding towards 
binding sites with different chemical nature, so that the masking reagents can successfully 
block the binding sites for COOH-moieties, while the phospho-binding sites are not affected 
(Larsen M.R. et al., 2005). The binding mode is schematically drawn in figure A_05D. 
Interestingly, this procedure requires a high amount of organic solvent for sample loading to 
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impair undesired hydrophobic interactions of unphosphorylated peptides and to increase the 
solubility of peptides. Detergents and other hydrophobic sample additives stay also in the 
mobile phase during sample washing which allows further purification of phosphopeptides 
from these substances (Jensen S.S. and Larsen M.R., 2007). Low pH conditions also improve 
the binding, since the affinity of the carboxylate towards TiO2 is dramatically decreased by 
protonation. Phosphopeptides are eluted by a pH shift from acidic to alkaline, which induces 
dissociation of the surface OH-groups and electrostatic repulsion of the phosphopeptides. 
Recent protocols for TiO2 based phosphopeptide enrichment demonstrated that even 
enzymatic digests of cell lysates can be pepared with this method. This enrichment effect 
could not be demonstrated with the earlier protocols, since highly acidic, unphosphorylated 
peptides were not depleted without effective masking reagents (Pinske M.W. et al., 2008). 
Another remaining question was, if highly acidic phosphopeptides and peptides with multiple 
phosphorylations are partially lost on the surface of the metal oxide due to irreversible 
binding. This observation might result from the elution conditions, since most early protocols 
suggested 10% ammonia for phosphopeptide elution (Jensen S.S. and Larsen M.R., 2007). 
We and others could show that elution with ammonium phosphate also releases such peptides 
quantitatively, so that nowadays metal-oxide enrichment of phosphopeptides is a standard 
method next to the IMAC procedure. It was further shown that a combination of both methods 
even increased the phosphopeptide yield due to a better fractionation of phosphopeptides with 
different number of phospho-moieties (Thingholm T.E. et al., 2008).  
 
 III Identification by Mass Spectrometry     
 
Identification of phosphorylation sites of a protein by proteomic methods is still a 
challenging task, because phosphopeptides behave differently from unmodified ones. Not 
only the chromatographic behaviour is significantly altered but most importantly the 
ionization efficiency is significantly reduced, especially if peptides without phospho-moieties 
are present (Steen H. et al., 2006; Nabetani T. et al., 2006; Gao Y. and Wang Y., 2007). Due 
to the chemical nature of the phospho-ester of Ser and Thr and the phospho-amidate bond of 
His, these covalent bonds dissociate more effectively upon thermal activation than the peptide 
bonds between the individual amino acids. As shown in figure A_06A, CID-MSMS 
fragmentation of phosphopeptides leads to dissociation in the phosphorylated side chain. The 
majority of the phosphopeptide ions undergoes a neutral loss of phosphoric acid in positive 
ionization mode (Schlosser A. et al., 2001; Boersema P.J. et al., 2009). Several mechanisms 
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have been proposed for this reaction, which in case of Ser and Thr is based on parallel 
elimination of bi-phosphate and the hydrogen atom in β-position, thereby forming a double 
bond (Boersema P.J. et al., 2009). For His this mechanism is not yet fully understood, but 
might involve a transfer of the phospho-moiety onto an OH group on another amino acid 
(Medzihradszky K.F. et al., 1997; Zu X.L. et al., 2007) Excessive loss of H3PO4 causes a low 
number and intensity of fragment ion signals, so that spectra yield only little sequence 
information. The aromatic system in side chain of tyrosine impairs the β-elimination process 
of the phenolic C-O bond and thereby increases the stability of such phospho-esters. 
Therefore tandem MS analysis of Tyr-phosphorylated peptides leads mainly to dissociation of 
amid bonds between the amino acids (Steen H. et al., 2001). Several adaptations have been 
introduced recently to improve fragmention phosphorylated peptides, which led to broad 
application and discovery of numerous novel phosphorylation sites. 
 
Phosphatase treatment 
A quite simple method to detect phosphopeptides is to compare mass spectra of the 
enzymatically cleaved sample with a sample treated with an unspecific phosphatase (figure 
A_06B). Due to the enzymatic activity, phosphoryl groups are removed from the 
phosphopeptides and the mass of the peptide ion is decreased by the mass of the phosphoryl 
group (80 Da) (Raggiaschi R. et al., 2006). Furthermore, the dephosphorylated peptide can 
easily be sequenced by tandem MS, thereby revealing their amino acid sequence. Since this 
process requires the comparison of two different samples a mass spectrometer with good mass 
accuracy and resolution is required to determine both peptide forms correctly. Unfortunately, 
the information of the location of the modified amino acid is lost during the hydrolysis. 
 
Neutral Loss and Immonium Ion Screening 
The occurring neutral losses of the phospho-moiety can also be used to find 
phosphopeptides in mixture with unmodified peptides (figure A_06C). Precursor ion scanning 
methods on triple quadrupole mass spectrometers are applied to detect the loss of H3PO4 upon 
CID activation in positive ionization mode or the formation of the HPO3-ion in negative mode 
(Schlosser A. et al., 2001). This method is also valuable for detection of peptides with Tyr-
phosphorylation, but instead of neutral loss ions, the immonium ion of phosphotyrosine at 
216.11 Da is detected (Steen H. et al., 2001). Unfortunately, peptide sequence and the 
location of the phosphorylated amino acid remains unkown without further analyses. 
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Similarly, switching the ionization mode from positive to negative ionization was 
reported to result in significantly higher signal intensities for phosphorylated peptides (Janek 
K. et al., 2006; Nabetani T. et al., 2006). Comparison of MS data of both ionization 
conditions further helps to validate the phosphorylation state of a peptide.  
 
 
 
Figure A_06 Mass Spectrometry of Phosphorylated Peptides. A. Tandem MS analysis by 
thermal activation methods of most phosphopeptides results in extensive elimination of 
phosphoric acid, thereby impairing detection of backbone fragment ions and identification of 
the amino acid sequence. B. Phosphatase treatment can identify the number of 
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phosphorylations and the phosphorylated sequence, but the information of the phosphorylated 
amino acid is lost. C. Precursor scanning methods specifically identify phosphopeptides, but 
require a combination with standard tandem MS analysis to reveal the amino acid sequence. 
D. A second fragmentation step is introduced in MS3 and pseudo-MS3 methods in which the 
dephosphorylated peptide ion (shown in A) is selected for further fragmentation to reveal the 
amino acid sequence. E. Higher fragmentation energies induce backbone cleavages with 
higher frequency than low-energy methods. Therefore backbone fragments gain higher signal 
intensities, but also different neutral loss pathways can be activated. F Electron-induced 
fragmentations preserve the phospho-moiety on the fragment ions which makes this method 
mostly suited for phosphopeptide analysis.  
 
 MSn and pseudo-MSn 
Despite their low mass resolution and accuracy, ion trapping mass spectrometers have 
the unique opportunity to perform multiple stages of fragmentation which allows very specific 
investigation of peptide sequences or reliable MS/MS spectra of peptides with labile 
modifications (figure A_06D) (Beausoleil S.A. et al., 2004). While MSn methods require the 
detection of fragmentation products after each fragmentation step to select the ion of choice, 
pseudo-MSn activates putative product ions without isolation of the respective ion (Kalkum 
M. et al., 2003; Chang E.J. et al., 2004). In comparison to real MSn, pseudo- MSn is faster 
because it does not require refilling of the ion trap after the first fragmentation step, but the 
obtained mass spectra show fragment products of each fragmentation step which makes data 
interpretation more difficult. In real MSn methods the obtained mass spectrum consists only of 
the fragment ions of the respective precursor ion. A special method for phosphopeptide 
research is the neutral loss-triggered MS3 method which acquires MS3 spectra of 
phosphopeptides only when they exhibit a strong loss of H3PO4 in the MS/MS step. This 
could also save time since not every peptide has to be fragmented in two adjacent steps 
(Chang E.J. et al., 2004). 
These methods are the standard techniques in phosphoproteomics, since the neutral 
loss species are further fragmented and their amino acid sequence is accessible. In contrast to 
phosphatase treatment and neutral loss scanning only a single MS experiment is required. β-
elimination of H3PO4 in Ser and Thr residues nominally leads to a loss of water in comparison 
to the unmodified amino acid, which allows localization of the phospho-amino acid in an MSn 
spectrum (Claverol S. et al., 2003). Since water losses can also occur from other residues the 
specificity of these signals is currently discussed (Palumbo A.M. and Reid G.E., 2009). 
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Pseudo-MSn spectra contain also fragment ions with intact modifications which remain from 
the first fragmentation step and often allow reliable identification of the modified amino acid.    
Another benefit of the MSn techniques is easy implementation into any HPLC-MS 
method without data analysis to find putative phosphopeptides from the pre-screen. This 
facilitates database search and identification of the phosphopeptides.  
 
Higher energy collision-induced dissociation (HE-CID) 
In comparison to the collisional activation in ion trapping instruments, mass 
spectrometers with multi-polar mass analyzers like quadrupoles deliver significantly higher 
collision energy in a relatively short activation time (figure A_06E, Chang E.J. et al., 2004). 
The energy uptake is high enough to induce dissociation of bonds, which require more energy 
than a break at the amide bond, for instance in amino aid side chains, or to trigger dissociation 
of multiple bonds (Chang E.J. et al., 2004). Mass spectra which are acquired under these 
conditions have a high diversity of fragment ions; in case of phosphopeptides also fragments 
with intact phosphorylation sites can be identified. Peptide ion signals with neutral loss of 
modifications occur with reduced intensity compared to ion trap MS/MS spectra as the result 
of a more average dissociation of covalent bonds due to the high energy (Olsen J.V. et al., 
2007). 
Similarly, fragmentation of peptide ions in MALDI instruments also depends on the 
uptake of high amounts of energy during the ionization which leads to formation of multiple 
different fragment ion types in post-source decay (PSD) (Annan R.S. and Carr S.A., 1996; 
Schmidt A. et al., 2008). Phosphopeptides undergo also tremendous neutral loss of 
phosphoric acid in MALDI-PSD-MS, but at low intensities sequence specific fragment ions 
can be found.  
Another method for thermal activation uses infrared radiation, which increases the 
internal energy and leads to fragmentations similar to that observed in CID processes (Flora 
J.W. and Muddiman D.C., 2001). Since the implementation of infrared multi-photon 
dissociation (IRMPD) requires an external IR-laser as source and special geometry of the 
mass spectrometer, it is almost exclusively applied to FT-ICR mass spectrometers.   
 
Electron-induced fragmentations  
Electron-induced fragmentation procedures follow completely different fragmentation 
rules. In positive ionization mode a peptide acts as acceptor of low energy electrons, which 
are caught by positively charge side chains like lysine and arginine. Free, emitted electrons in 
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electron-capture dissociation (ECD) or chemically ionized polyaromatic anions such as 
fluoranthen in electron-transfer dissociation (ETD) act as electron donors (Stensballe A. et al., 
2000; Syka J.E. et al., 2003; Gunawardena H.P. et al., 2006). After translocation of the 
electron to the peptide bond, radical rearrangement results in dissociation of the N-Cα-bond 
and thereby forms c and z ions (see figure A_04B and figure A_06F) (Stensballe A. et al., 
2000). This type of fragmentation requires no increase of internal energy and does not rely on 
the dissociation energy of a specific bond, which is demonstrated in average signal intensities 
as well as integrity of almost all labile peptide modifications such as phosphorylation or 
glycosylation (Sleno L. and Vollmer D.A., 2004). In comparison to ECD, which is almost 
exclusively available in FT-ion cyclotron resonance (ICR) MS instruments, ETD is applied in 
ion trap mass spectrometers and has higher fragmentation efficiency, due to the cation-anion 
interaction (Syka J.E. et al., 2003). 
Unfortunately, these methods are not as robust as the MSn technique and they have 
significantly lower fragmentation efficiency. Furthermore, singly charged ions are completely 
excluded from fragmentation analysis because they lose their charge upon the electron uptake. 
Fragmentation of doubly charged peptides often results in low sequence information. 
However, electron-induced fragmentation methods are highly efficient to study large peptides 
or small proteins in top down experiments.  
Studies of electron transfer and detachment in negative ionization mode have been 
conducted, but so far no common mechanism has been reported (Gunawardena H.P. et al., 
2006; Kleinijenhuis A.J. et al., 2008). With regard to phosphopeptide analysis, electron-
detachment dissociation (EDD) delivered high quality fragment ion spectra that allowed 
identification of the modified amino acid in almost all cases. Only the negative ionization 
mode, which is seldomly used in common proteomic protocols, prevents a wider application 
of this technique. 
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 C Properties of Peptides with Multiple Phosphorylation 
 
RP chromatography of multi-phosphorylated peptides 
Chromatographic separation of peptides with multiple phosphate moieties under 
standard nanoRP-HPLC-MS conditions is often very difficult because such peptides tend to 
elute over a broad time window, even if relatively short gradients are applied (see figure 
A_07A, Choi H. et al., 2008). This “smearing” is caused by undesired hydrophilic interaction 
with the silica material, especially enclosed metal atoms, as well as the abundance of different 
“charge isoforms” of the same peptide. These isoforms are a result from dissociation of the 
phosphate moieties, since the phospho-ester moiety is a stronger acid than formic acid. The 
first pKa of the phosphorylation is at 1.2 and the second at 4.6. Separation conditions for RP-
HPLC prior to MS of peptides often include 0.1% formic acid and a low percentage of 
acetonitrile which has a pH of approx. 2.6 and lies between the first and the second pKa value 
of the phosphoester. Increase of the organic modifier during the gradient elution will raise the 
pH by approximately 0.5 to one unit. Since pH conditions of the separation are near to the 
first equivalence point each phospho-moiety is mainly present in the singly de-protonated 
state, but could also adopt full protonation at the beginning of the gradient. At high percentage 
of organic solvent, singly or doubly negative charged forms occur, since the pH is slightly 
raised. High amounts of organic modifier in the solvent reduce the protonation state of all 
charge groups. Solvation by the liquid phase is limited due to the lower amount of water, 
thereby impairing further deprotonation and establishing of a doubly negative charge. The 
increased pH on the other side promotes deprotonation, especially since the phospho-moiety 
represents the stronger acid. A further effect of the organic solvent is increased stability of 
electrostatic interactions of the phospho-moiety with the silica surface which results in a 
prolonged retention of phosphopeptides. Therefore, pH conditions during chromatography 
allow the phosphate moieties to adopt a fully protonated, singly deprotonated, as well as 
doubly deprotonated state.  
As an example, figure A_07B shows uncharged to fourtimes-negatively charged 
peptide isoforms for a fourtimes phosphorylated peptide, when only fully protonated and 
singly deprotonated forms of phosphate moieties are considered. All putative charge states of 
such a peptide are shown in a simplified version in figure A_07C where 0 represents fully 
protonated state; - and -- denote singly and doubly negative charged phospho-groups, 
respectively. As the table shows, 69 different charge isoforms are possible under standard 
chromatographic conditions of which most have slightly different retention effects. 
 20
Uncharged and singly negative charged molecules have higher hydrophobicity than highly 
charged molecules, whereas these molecules interact intensely with hydrophilic or charged 
surfaces, as for instance the fused silica material and especially metal ions, which can be 
found in low concentration in almost all stationary phases. Even different charge distributions 
will cause a difference in retention times.  
Since peak broadening reduces the peak height, subsequent ESI-MS analysis of these 
peptide species is often not achieved. As demonstrated in figure A_07A, while unmodified 
and singly phosphorylated peptides elute in a sharp peak, elution profiles for higher 
phosphorylated forms become very broad. Guessing from the individual peak heights only, 
the monophosphorylated peptide seems to represent the most abundant species, whereas the 
peak area clearly shows that the fourtimes phosphorylated form has the highest abundance. 
During MS acquisition in data-dependent manner, the instrument is not able to identify such 
broad elution profiles thereby resulting either in missed identification due to low intensity or a 
multiple selection for MS/MS of the same peptide and increased undersampling of other 
peptides. The fourtimes phosphorylated peptide shown in figure A_07A was selected for 
MS/MS analysis at least 19 times over the whole elution profile. Similar retention behaviour 
was observed also for other multiply phosphorylated peptides. Since peptides with multiple 
phosphorylations have a very strong negative charge, it was believed, that they bind 
irreversibly to specific surfaces, such as TiO2 (Larsen M.R. et al., 2005). Such effects would 
limit the applicability of specific enrichment protocols tremendously. 
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with only a single charge on each phosphosite. C. A fourtimes phosphorylated peptide has 69 
different  charge isoforms under standard conditions. (symbols 0 = uncharged, - = singly 
negative charged, -- = double negative charge. 
 
Mass spectrometry of peptides with multiple phosphorylations 
Mass spectrometry of peptides with multiple phosphorylations has two major 
bottlenecks: First, often the peptides undergo parallel, multiple neutral losses of phosphoric 
acid, which cannot be triggered individually and suppress formation of sequence specific 
fragments. Second, due to the low quality of MS/MS spectra, pinpointing of all individual 
phosphosites is often not achieved.  
With regard to the first problem, all techniques applied for detection of mono-
phosphopeptides described in 1.B.III can also be applied for the analysis of peptides with 
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B Figure A_07. 
Dissociation of Phospho-
Moieties in HPLC-
Separation. A. Growing 
number of phospho-sites
on the peptide 
LPVKPTSSGSSEEK 
results in broader elution 
profiles. While 
unphosphorylated and 
monophosphorylated  
peptides elute as sharp 
peaks, the fully 
phosphorylated form is 
distributed over the whole 
gradient and was selected 
19 times for MS/MS 
analysis. B. Partial 
dissociation of a fourtimes 
phosphorylated peptide 
from uncharged to to 
fourfold negative charge
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multiple phosphorylations but they require adaptations. Upon phosphatase treatment the 
number of phospho-moieties, which are removed, is higher, thereby increasing the mass 
difference between unphosphorylated and phosphorylated peptide. MSn methods have to 
apply more fragmentation steps to remove all phosphorylations efficiently, which requires 
longer analysis time. Therefore, the intensity of MSn fragment ion spectra is often very low, 
since other fragmentation processes and neutral loss of water molecules reduce the number of 
ions that are available for each fragmentation process. This behaviour results in fragment ion 
spectra with only little sequence information. In pseudo-MSn spectra often signals of multiple 
eliminations of phosphoric acid or combination of phosphoric acid and water are observed 
with high intensity, which impair fragment ion detection in this spectral region. Multiple 
activation processes of this technique induce formation of fragment ions with varying 
phosphorylation state, which requires a complex data interpretation. 
Most important, higher phosphorylation states reduce the occupation of higher charge 
states even for large peptides, therefore impairing the application of electron-induced 
fragmentation methods for exact pinpointing of each phosphorylated amino acid.   
An origin of the second challenge, impaired identification of the phosphorylated amino 
acids, is that excessive phosphorylation affects enzymatic protein cleavage, therefore leading 
to larger peptide fragments. Next to the traditional handicaps of HPLC-MS analysis of large 
peptides, such peptides have often more putatively phosphorylated amino acid residues (STY) 
than phosphorylation sites, which results in a combinatorial complexity. Assignment of a 
fragment ion spectrum to a distinct isoform of a multiphosphorylated peptide is therefore 
often impossible for MSn and pseudo-MSn fragment ion mass spectra, because not all possible 
fragment ions are detected. Another problem is the low mass accuracy of ion tap mass spectra 
which often causes multiple assignments of a single signal to different fragment ions. Most 
reliable are spectra with intact phosphorylated fragments, which can be achieved by MALDI-
MS/MS and electron-induced dissociation methods, since extensive elimination of the 
phosphate moiety is impaired under both fragmentation conditions. Moreover, both methods 
predominantly form singly charged fragment ions, thereby reducing the complexity of the 
obtained tandem MS spectrum.    
Results  
Part 1  Enrichment of Multiply Phosphorylated Peptides Using Metal Affinity 
Chromatography on Titanium Dioxide       
 
a Optimization of MALDI MS Detection and Identification 
Identification of phosphopeptides by MALDI-MS has been described in some 
publications, but there is still no protocol that allows reliable detection of such peptides. The 
initial step in establishing the protocol was to test various, recently described MALDI 
matrices on their potency to ionize phosphopeptides from a phosphopeptide mixture and from 
a sample which also included unmodified peptides. Further, crystallization conditions should 
be optimized with focus on the connection to HPLC separation. In the second step, tandem 
MS conditions were screened for the individual matrix substances, since identification should 
be achieved by high-energy fragmentation in the MALDI mass spectrometer.  
For optimization of the MALDI-MS protocol I tested two well-known MALDI 
matrices: α-cyano-4-hydroxycinnamic (CHCA) acid and 2,5-dihydroxybenzoic acid (gentisic 
acid, DHB), which have been described to give good results also for phosphopeptides. 
Furthermore, two other substances were described in single studies, which focussed on 
phosphopeptide identification. These matrices were indolylacrylic acid and 2,5-
hydroxyacetophenone. While sample preparation has been widely studied and optimized for 
CHCA, significantly less is known for the optimal conditions for the other three substances, 
apart from the fact that they are applied in significantly higher concentrations. For both 2,5-
hydroxyacetophenone and DHB, 20 mg/ml have been described recently as optimal 
concentration, indolylacrylic acid should be used at 5 to 25 mg/ml. In comparison, a CHCA 
concentration of 2 to 5 mg/ml is suggested for the newest type of MALDI mass 
spectrometers. Since our studies were carried out on the recently introduced MALDI 
TOF/TOF mass spectrometer 4800 MALDI TOF/TOF Analyzer (Applied Biosystems, 
Darmstadt, Germany, now LifeTech) optimization of the crystallization conditions was 
necessary. The crystal formation and incorporation of the analyte is very important for the 
MALDI process, while CHCA forms very small crystals, the other matrices aggregate to 
significantly larger assemblies.  
Two phosphopeptide mixtures, which consisted of peptides 1-14 (mix A) from table 
TA_1 and 15-23 (mix B) were used in 50 nM concentration to test which matrix was able to 
ionize the phosphopeptides also at low concentrations. To simulate a sample with biolocical 
background, a tryptic digest of cytochrome C was added to mixture A in an equimolar ratio. 
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1µl of the sample was crystallized with 1µl matrix. The matrices DHB, indolylacrylic acid, 
and 2,5-hydroxyacetophenone were prepared in concentrations of 2, 5, 10, 15, 20, and 50 
mg/ml, CHCA was used in 2 and 5 mg/ml concentrations. All matrix substances were 
dissolved in 70% ACN with 0.2% TFA. For MS analysis 4000 shots were acquired per spot. 
For each matrix, signal intensities of the individual peptide ions were monitored from 10 
different spots. Good ionization was only achieved by CHCA and DHB, whereas 2,5-
hydroxyacetophenone (mass spectrum not shown) and indolylacrylic acid gave only very poor 
signal intensities at all matrix concentrations (figure A_08A). The optimization was focussed 
on DHB and CHCA, since these matrices performed significantly better. Initial experiments 
with indolylacrylic acid revealed good ionization at higher concentrations of phosphopeptides, 
but working with this matrix had the severe side effect, that after few laser shots the intensity 
dropped dramatically due to formation of a polymer and loss of the crystalline properties. 
Polymerization also impaired automated MS/MS analysis, since fragment ion spectra are 
acquired from the same sample spots that were used for MS analysis before. 
DHB had very good results in the range between 5 and 20 mg/ml and CHCA gave high 
intensities for both preparations. Low concentrations of DHB (2-5 mg/ml) poorly crystallized 
on the MALDI sample plate and led to large spot areas with few, sparse crystals. The MALDI 
spectra of DHB (10 mg/ml) clearly showed higher ionization efficiency for all 
phosphopeptides in comparison to CHCA (5 mg/ml) (figure A_08B). Moreover only DHB 
was able to ionize the multiply phosphorylated peptides TwoP_1 and ThreeP_1. 
Unfortunately, the second triphosphorylated peptide ThreeP_2 was never observed at this low 
concentrations. Mixtures of both matrices were reported to even improve phosphopeptide 
detection, but this was not observed for the described phosphopeptide/cytochrome C sample 
(Laugensen S. and Roepsdorff P., 2003). Based on these data, we selected DHB at 10 mg/ml 
as optimal concentration for MALDI-MS analysis of multiphosphorylated peptides. 
Kjellström and Jensen demonstrated that addition of phosphoric acid to the matrix 
solution up to 1% v/v increases phosphopeptide ion signals by masking the metal ions on the 
surface of the stainless steel MALDI target and thereby impairing adsorption of 
phosphopeptides (Kjellström S. and Jensen O.N., 2004). The composition of the matrix 
solution was therefore again optimized and contained finally 80% ACN (v/v), 1% TFA (v/v), 
and 0.2% H3PO4 (v/v), since higher concentrations of H3PO4 showed clusters of phosphate in 
the lower mass range. 
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Figure A_08 MALDI TOF-MS Analysis of Phosphopeptides. A. Only DHB and CHCA are 
able to ionize low amounts of phosphopeptides efficiently. However, peptides with multiple 
phosphosites are suppressed by CHCA (red). B. Individual phosphopeptides have higher 
signal intensity in DHB crystallized samples (red bars) in comparison to CHCA (gray bars) 
when using optimized ionization conditions. C. The relative signal intensity of peptides with 
multiple phosphorylations does not depend on the ionization mode. Singly modified peptides 
have the highest signal intensity in positive and negative ionization, but amino acids with high 
proton affinity seem to suppress negative ionization. Signals with multiple negative charges 
were not observed, even for the fourtimes phosphorylated forms. 
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Table TA_1 Synthetic Phosphopeptides for Optimization of MALDI-TOF/TOF-Analysis 
of Protein Phosphorylations. Mix A consist of peptides 1 to 14, mix B contains peptides 15-
23. 
 
 
As reported by Janek et al., ionization of phosphopeptides is improved in negative 
ionization mode in comparison to unmodified peptides (Janek K., et al., 2001). Negative 
ionization was tested with both previously mentioned phosphopeptide mixtures and a sample 
containing solely peptides 16-22 in 100 nMol concentration. For both standard peptide 
mixtures, negative ionization mass spectra did not differ dramatically from that acquired in 
positive ionization mode. All spectra were acquired from the same sample spots. And 
increased signal intensity for phosphorylated peptides was not obvious.  
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Interestingly, signal intensities for peptides 16-22 significantly depended on the 
number of phospho-moieties. In both ionization modes monophosphorylated peptides had the 
most intense signals, while multiphosphorylated forms were strongly suppressed, although 
they share the same sequence background. By comparison of mass spectra from positive and 
negative mode, it was obvious that multiply phosphorylated peptides do not gain signal 
intensity in negative ionization mode, as demonstrated in Figure A_08C. The s/n ratios for the 
two least intense signals, FourP_1 and FourP_2 in positive ionization mode and ThreeP_3 and 
FourP_2 in negative ionization mode, were in average approx. 20-30 for both ionization 
modes. This result was unexpected, since higher phosphorylation should improve negative 
ionization. Interestingly, also peptide ions with higher negative charge states were completely 
absent. In negative ionization the peptide with the longer sequence is significantly suppressed 
even for the monophosphorylated form. Since both sequences differ only in a single histidine 
residue, we assume that the high proton affinity of this residue might suppress the formation 
of negatively charged peptide ions. Similar to the positive ionization mode, PSD 
fragmentation in negative ionization led to extensive elimination of phosphoric acid and only 
few peptide fragment ions. The masses of these fragments corresponded to singly negatively 
charged b- and y-type fragments. Comparison of positive and negative ionization MS/MS 
spectra showed always higher number of sequence related ions for the positive ionization 
mode. Since negative ionization showed significant disadvantages in acquisition and 
interpretation of tandem MS spectra, we optimized the MALDI protocol for positive 
ionization.   
The second important aspect of the project was fragmentation of the phosphopeptide 
for identification of the amino acid sequence and localization of the phosphate moiety. For 
this purpose, tandem MS methods were optimized with focus on fragment ion intensity and 
s/n ratio for CHCA and DHB matrix preparations. Both matrices performed similarly well, 
whereas signal intensities were slightly higher for DHB. Neutral loss of H3PO4 was observed 
in almost all phosphopeptide spectra, except for tyrosine phosphorylated peptides. 
Interestingly, the number of phosphorylated Ser and Thr residues could be estimated by the 
neutral loss ions, since multiple losses of phosphoric acid were also observed. Figure A_09 
shows an example spectrum for the Ser-phosphorylated peptide FQSEEQQQTEDELQDK 
from β-casein (aa 48-63) after tryptic digestion, which was crystallized with 10 mg/ml DHB. 
Interestingly, the b-ion series completely lost the phosphorylation due to β-elimination, while 
the y-ions exhibited the intact phospho-amino acid on fragments y 14 and y15. 
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A_09 MS/MS Spectrum of the Singly Phosphorylated Peptide (aa 33–48) from 
Tryptically Digested β-casein. While the b-ion series was observed in dephosphorylated 
form (-98Da for b4-b8 blue), y ions (red) 14 and 15 had intact phospho-moieties.  
 
Since spotting should be automated and connected to a RP-HPLC system, the matrix 
composition was also optimized with regard to these special conditions. Therefore the matrix 
should be mixed with the column eluent in a micro-T flow path before deposition on the 
sample carrier and it should crystallize rapidly in small spots after deposition. We optimized 
the matrix flow rate for different time steps, since the spotting device was operated to 
fractionate the sample every 4-20 seconds. For this purpose, we evaluated crystallization by 
eye and tested the MS ionization efficiency for different conditions. Again the matrix solution 
with 10 mg/ml DHB dissolved in 80% ACN (v/v), 1%TFA (v/v), and 0.1% H3PO4 (v/v) gave 
excellent results and was further used to prepare the LC-MALDI MS samples.  
 
b Development of an Enrichment Procedure 
As MALDI MS spectra demonstrated, ionization of multiply phosphorylated peptides 
is dramatically reduced in the presence of unmodified peptides and peptides with one 
phospho-moiety. Based on the protocols by Mazanek and Larsen, we optimized an offline 
TiO2 enrichment procedure that allows analysis of multiphosphorylated peptides. The 
workflow is schematically drawn in figure A_10 (Mazanek M. et al., 2007; Larsen M.R. et 
al., 2005). TiO2 enrichment was performed on 5µm TiO2 microspheres from Glygen 
(Columbia, USA) which were packed into top tips. 
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Our data demonstrate that sample loading onto TiO2 with a loading buffer which 
consists of 200 mg/mL DHB, 35 mM OcSNa (octylsulfonate sodium salt), 23% acetic acid 
(AcOH), 40% ACN and 0.1 % heptafluorobutyric acid (HFBA) showed the best removal of 
unmodified peptides and is compatible with MALDI ionization. Peptide samples were first 
diluted with 50% ACN, containing 10% AcOH, to ensure a high amount of organic solvent, to 
promote phosphopeptide binding to TiO2 and in a second step with 300 mg/mL DHB, 50 mM 
OcSNa in 40% AcOH, 40% ACN, 0.2% HBFA in a 1:2 v/v (sample/buffer) ratio. This 
mixture was rinsed through the TiO2 tip slowly over a time span of 15-30 min to allow 
efficient adsorption of phosphopeptides. Unmodified peptides were removed by washing with 
200 mg/mL DHB, 35 mM OcSNa, 23% AcOH, 40% ACN and 0.1 % HFBA and additionally 
with 100 mL of 70% ACN containing 0.2% HFBA to remove components of the loading 
buffer, which might interfere with the adjacent LC-MS analysis.  
 
      
 
Figure A_10 
Strategy for 
Phosphopeptide 
Identification by 
Off-line TiO2-
MOAC Enrichment 
and Subsequent
HPLC-MS/MS 
Analysis.  
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Effective elution of peptides with multiple phosphorylations could not be achieved 
with ammonia alone, therefore we used 50 mM (NH4)2HPO4 (pH 11 with ammonia), which 
introduces phosphate as competitive binder to TiO2. Elution time and volume of elution buffer 
were optimized in several experiments, resulting in a minimal volume of 25µl of buffer to 
release the phosphopeptides in a minimal time span of 10 min. 
Since previous publications mentioned irreversible binding of peptides with multiple 
phosphosites to the TiO2 surface, we tested the recovery of these peptides by quantitative 
mass spectrometry. For this purpose we labelled the peptides OneP_5, OneP_8, OneP_9, 
TwoP_1, TwoP_3, ThreeP_1, ThreeP_4, and FourP_1 with iTRAQ (isobaric tag for relative 
and absolute quantification) reagents 114 and 115. Peptides with the 115 label were enriched 
on TiO2 and afterwards the same amount of iTRAQ-114 labelled peptides was added to the 
eluted phosphopeptides. MS/MS experiments were performed for all peptides and the 
intensity of the respective reporter ions was extracted from the raw data. Tandem MS analysis 
of the identified peptides demonstrates almost quantitative recovery for most of the 
phosphopeptides (Fig A_11A). Peptides with very hydrophobic nature, for instance peptide 
OneP_8 (THILLFLPKSVSDYEGK, peptide C), have a higher solubility in the loading 
solvent and might be lost partially in the loading and washing steps.  
The efficiency of this method is demonstrated in figure A_11B which shows the mass 
spectra for two phosphoprotein digests before (spectra AI and BI) and after applying the 
enrichment protocol (spectra AII and BII). 2 pMol tryptically digested β-casein (A) and 
osteopontin (B) were treated according to the protocol and a fraction of 300 fMol was 
crystallized per spot on a MALDI target. Osteopontin is a secreted protein which is involved 
in bone cell differentiation and it has many phosphorylation sites spread over the whole 
protein sequence (Sørensen E.S. et al., 1995). The majority of the phosphorylation sites are 
applied by the casein kinase 2 and have the respective recognition sequence with an acidic 
amino acid two residues C-terminal from the observed phosphorylation site. 
Although the same amount of the untreated protein digest was spotted, mass spectra 
before and after enrichment were strikingly different for both proteins. Apart from the 
monophosphorylated peptide FCSEEQQQTEDELQDK (amino acids 33–48, m/z 2061.83) 
which was just above detection limit, no phosphopeptides were identified in the untreated 
protein digests (AI and BI). After TiO2 enrichment (AII) this peptide became base peak of the 
β-casein sample and the fourtimes phosphorylated, N-terminal peptide RELEELNVP-
GEIVESLSSSEESITR (aa 1-25, m/z 3122.26) was detected with more than 30% relative 
intensity. This sample also demonstrated that trypsin rarely cleaves the N-terminal arginine 
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residue of β-casein as demonstrated by the low intensity of the peptide 2-25 (m/z 2966.16), 
which is just above detection limit.  
A similar enrichment effect was observed for osteopontin where only two peptides 
with multiple sodium adducts were detected in the untreated sample. Extraction of 
phosphopeptides from this sample leads to the detection of at least 10 multiphosphorylated 
peptides (Fig A-11B_BII), which are formed upon tryptic cleavage. The most abundant signal 
stems from the triply phosphorylated C-terminal peptide IRISHELDSASSEVN at 1896.72 
m/z. Most of the observed peptide signals belong to phosphorylated peptides of osteopontin, 
as subsequent MS/MS analysis and comparison with theoretical cleavage products reveals.  
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Figure A_11 Results of Optimized TiO2-Enrichment Procedure for MALDI-MS/MS 
Analysis. A. TiO2 enrichment provides high recovery rates for phosphopeptides with 
different number of phosphorylations (OneP_5 (A), OneP_9 (B), OneP_8 (C), TwoP_1 (D), 
TwoP_3 (E), ThreeP_1 (F) ThreeP_4 (G) FourP_1 (H)). Hydrophobic peptides are partially 
soluble under washing conditions, resulting in lower recovery as demonstrated by peptide C. 
B. Phosphopeptides with various number of phosphorylation sites are efficiently enriched 
from tryptic digests of β-casein (A) and osteopontin (B) by the TiO2 procedure, thereby 
allowing reliable detection of various phosphorylation products. ○  monophosphorylated, ●  
multiphosphorylated; AI, BI digests before enrichment; AII, BII after enrichment 
 
 
c Reversed-Phase Separation of Multiple Phosphorylated Peptides  
As demonstrated in figure A_7A, one major problem of phosphopeptide analysis 
results from the retention behaviour in standard RP chromatography. To determine the 
influence of unspecific binding to hydrophilic surfaces during chromatographic fractionation, 
we first added phosphoric acid instead of TFA or formic acid to the HPLC solvents. This 
addition should impair interaction with metal ions in the silica material. Since our protocol is 
designed for MALDI-MS detection, low amounts of phosphoric acid do not interfere with the 
ionization process. Other reports mention even enhanced ionization of phosphopeptides by 
addition of phosphoric acid and suppression of matrix clusters. In contrast, phosphate is able 
to form large cluster ions during ESI ionization, thereby resulting in huge signals in the lower 
m/z range. In comparison to formic acid and TFA, phosphoric acid has a lower UV absorption 
at the wavelength of 214 nm. Therefore, detection of phosphopeptides during LC separation is 
even possible at low concentrations.  
To test the influence of the acidic modifier, mix_A and a fraction of TiO2 purified 
phosphopeptides from osteopontin were HPLC separated on a 25 cm C18 column (Dionex, 
PepMapC18, 25cmx75µmx3µm, 100A) using solvents with TFA and phosphoric acid, 
respectively. Individual fractions were placed onto the MALDI sample plate together with 
DHB matrix every 15 seconds. Signal intensity and peak shape of phosphopeptides were 
determined from MALDI-MS spectra. Upon phosphoric acid addition, elution profiles of 
phosphopeptides improved slightly in comparison to TFA-containing buffers, but the signal 
intensity was quite low as demonstrated in figure A_12A. Interestingly, peptides with higher 
phosphorylation states have a stronger hydrophobic nature under these separation conditions 
than peptides with single or double phosphorylations, since multiphosphorylated peptides are 
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detected in later fractions. Introduction of phosphoric acid improved the chromatographic 
separation, but could not solve the charge-related distribution over a broad elution window. 
Peak broadening becomes more severe with increased gradient times, which are often used to 
achieve better chromatographic separation.  
In comparison to nano-scale columns with silica stationary phase, the earlier 
mentioned monolithic columns require significantly less analysis time to separate peptide 
mixtures (Schley C. et al., 2006; Yoo C. et al., 2007). Unfortunately these columns are not 
able to fractionate samples with high complexity such as digests of whole cells, due to the 
reduced resolving power. Furthermore, they have only limited capacity, which interferes with 
trace analysis of complex samples. To optimize separation on monolithic columns, a mixture 
of synthetic phospho-peptides (see table TA_1, peptides 1-14) each 500 fMol was separated 
using different gradient conditions. Thereby, the sample was directly injected onto the 
separation column. A monolithic trapping column was not used, because the hydrophobic 
nature of the styrole-divinylbenzole monolith is significantly weaker than that of C18-resins, 
so that hydrophilic peptides might be lost (Schley C. et al., 2006). For comparison with the 
C18 column, equal amounts of mix_A and osteopontin digest were also applied to monolithic 
separation. We observed sharp elution profiles for all phosphopeptides as demonstrated in 
figure A12_B. Moreover, monolithic separation resulted in dramatically increased peptide 
intensities for almost all observed phosphopeptides. Especially phosphopeptides of the 
osteopontin digest (lower traces) exhibited strong signals and amino acid sequence and 
phosphorylation sites were identified with high reliability from the obtained tandem MS 
spectra. Interestingly, if a peptide sequence exists in different phosphorylation states, first 
eluting the form with the highest number of phospho-moieties, while monophosphorylated 
and unphosphorylated forms are stronger retained. 
Although monolithic separation leads to improved detection of highly phosphorylated 
peptides, a further problem, separation of regio-isomeres, where phospho-moieties are located 
on different amino acids, was seldomly observed. Due to the timely-limited chromatography 
and the rather large fractions applied by the spotting device, regio-isomeric, multiply 
phosphorylated peptides, which differ only in the localization of a single phosphorylation are 
not separated. Therefore, such peptides cannot be distinguished reliably and might result in 
mixed fragment ion spectra that contain fragments of both species. 
 34
 
 
Figure A_12 Optimized Chromatographic Conditions for Phosphopeptide Separation on 
RP Columns. A. Replacing the acidic solvent modifier by phosphoric acid improves 
phosphopeptide elution, but peptides with multiple phosphorylations are still strongly 
retained. B. Observed phosphopeptide signals are significantly higher after monolithic 
chromatography and highly phosphorylated peptide forms elute first. Some peptides which 
could not be detected by C18-RPC were identified by separation on monolithic columns. 
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d Comparison to other methods for phosphopeptide analysis 
 
Figure A_09 shows that MALDI TOF/TOF tandem MS is able to produce sequence 
specific fragment ions, which allow both identification of the peptide sequence and 
localization of the phosphorylated amino acid. The low intensity of these fragments is mainly 
caused by extensive loss of H3PO4 from the phosphorylated peptide, which often represented 
the dominant ion in the corresponding fragment mass spectra of peptides with Ser or Thr 
phosphorylation. This fragmentation behaviour was also observed for peptides with multiple 
phosphorylations, but significantly more neutral loss species occurred in the upper mass 
region, because of multiple eliminations of H3PO4. Furthermore, under the applied 
fragmentation conditions not only β-elimination mechanisms (-H3PO4, -98 Da) played a role, 
but also the loss of HPO3 (-80 Da) could be observed with relatively high intensity. Signals, 
stemming from multiple eliminations of phospho-moieties, often occupied the complete high 
mass region of fragment ion spectra of highly phosphorylated peptides and could be used to 
estimate the minimal number of phosphorylations. Here, also combinations of H3PO4 and 
HPO3 loss were observed. In case of Tyr-phosphorylation, neutral loss signals have 
significantly lower intensity compared to other fragment ions and did not interfere with 
peptide sequence identification. 
Another important observation was the formation of fragment ions which had lost the 
phospho-moiety. These fragment ions can further help to confirm the amino acid sequence but 
their intensity varied strongly with the amino acid composition of the peptide.    
 
Optimization of database searching parameters and comparison to standard HPLC-
ESI-pseudoMSn analysis 
In contrast to ESI-MS/MS analysis, fragmentation of singly charged peptides in 
MALDI mass spectrometry locates peptide ions, which result from neutral loss of H3PO4, to 
the upper mass range, while most backbone fragments are found at lower masses. To improve 
data interpretation, we tested, if automatic interpretation of these spectra is improved by 
reduction of signal intensities of neutral loss peaks by a factor of 100 or complete deletion of 
these signals from the peak list. Neutral loss signals yield no sequence information, so 
database search algorithms are not able to identify them correctly. Since these signals cannot 
be explained by standard peptide fragmentation rules, they reduce the overall peptide score by 
not matching to the proposed amino acid sequence. Extracted MS/MS data from synthetic 
phosphopeptides were searched with altered NL-ion intensities and the corresponding 
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MASCOT scores were compared. As table TA_2 shows, reduction of intensities or even 
deletion of the neutral loss ions significantly enhanced sequence annotation by MASCOT 
(www.matrixscience.org). Application of this data interpretation step into the analysis of 
phosphopeptides from β-casein and osteopontin, resulted in significantly increased MASCOT 
scores for all observed peptides. 
 
Table TA_2 
Deletion of Neutral Loss 
Peaks Increases the 
MASCOT Score.  
High signals from neutral 
loss of H3PO4 in the upper 
mass area impair 
phosphopeptide identi-
fication by database search 
algorithms. Reduction of 
this peak area by factor 
100 increases the score 
slightly (Column B), 
complete deletion gives 
the best identification 
scores (Column C).  
 
 
To test the efficiency of the new protocol, we performed a comparison to the standard 
phosphopeptide analysis method in our laboratory, which is carried out by nanoC18RP-
HPLC/nanoESI pseudo-MSn. Therefore, either 1 or 3 pMol tryptic digest of osteopontin were 
enriched for phosphopeptides on TiO2 and 1/3 of the sample (300 fMol and 1 pMol, 
respectively) was injected on each separation system, nanoC18RP-HPLC or monolithic HPLC 
with optimized buffer conditions. MALDI MS/MS identified the same number of 
phosphorylation sites (see figure A_13), but required only one third of the sample amount 
injected onto the separation system. All phosphopeptides identified by MALDI were from 300 
fMol osteopontin digest, while ESI MS/MS experiments at this concentration did not identify 
peptides with multiple phosphorylations. Nevertheless, some singly phosphorylated peptides 
were observed, which corresponded to peptide sequences that were expected in higher 
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phosphorylation states. Therefore, 1 pMol of osteopontin was analyzed by “in house” 
standard protocol.  
MALDI data delivered one additional fourtimes phosphorylated peptide 
(LPVKPTSSGSSEEK) of which only the doubly modified form was identified by the ESI 
method. One doubly phosphorylated peptide was additionally found in the ESI dataset which 
could not be detected by MALDI MS/MS. Both methods identified 15 out of 28 proposed 
phosphorylation sites of osteopontin, but many putative phospho-amino acids could not be 
identified due to the peptide size produced by tryptic cleavage. The amino acid sequence 
between S62 and R136 does not have a Lys or Arg residue, so that this region with 8 proposed 
phosphorylation sites could not be cut down to smaller peptides. For ESI data, peptides with 
MASCOT scores above 20 were inspected and accepted, MALDI results were manually 
validated for scores above 30.  
 
 
Figure A_13 Identified Phosphorylation Sites of Osteopontin After Tryptic Cleavage. 
Phosphorylated amino acids in red were identified by both types of analysis, MALDI-
TOF/TOF and ESI-CID pseudoMSn analysis. Phosphorylation sites with black triangles were 
exclusively found by the ESI method, while MALDI was able to identify the fourtimes 
phosphorylated N-terminus which was found only doubly modified in ESI. 
 
Further, we compared the localization of phospho-moieties within the highest scoring 
peptide sequence with the proposed phospho-amino acids on the swissprot database entry 
(Sørensen E.S. et al., 1995). Distinct localization of a phospho-site is indicated by the 
difference of the MASCOT scores for individual isoforms of a peptide, where larger 
differences stand for higher localization confidence. It was obvious, that MALDI data not 
only resulted in higher peptide scores, but at the same time allowed more accurate 
identification of the phospho-sites, if multiple Ser, Thr, and Tyr residues are present (Schmidt 
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A. et al., 2008). As demonstrated in table TA_3, most isoforms of the phosphopeptides 
assigned in the MALDI dataset have the expected phospho-site distribution, while ESI data 
often point to other distributions of phospho-sites within the peptide sequence. The correct 
phosphopeptide sequence (high-lighted in gray) received highest scores from MALDI data 
and was often unequivocally distinguished from all other putative phospho-isoforms. One 
explanation for the poor performance of the ESI tandem MS protocol is the bigger mass 
difference used for data interpretation of MS/MS spectra, thereby causing false positive 
annotation of fragment ions from noisy spectra. Interestingly, many phosphopeptides which 
were additionally identified from the ESI dataset missed one or two phosphorylations 
compared to the database entry. 
  
 
Table TA_3 MALDI 
Data Allow 
Localization of 
Phosphorylation Sites 
with Higher 
Confidence. 
Phosphorylated amino 
acids of osteopontin 
are localized to the
expected phosphosites 
of the database entry
only from the MALDI 
data. ESI-MS/MS data 
point often to different 
distributions of the 
phosphosites within 
the peptide sequence. 
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Comparison to Electron-Transfer-Dissociation 
Recently, novel tandem MS fragmentation techniques boosted phosphopeptide 
research and one of the most promising techniques is electron-transfer dissociation (ETD). 
Fragment ions (c- and z-type ions) formed by this process result from a cleavage of the N-Cα 
bond of the amide backbone and are therefore complementary to the b-and y-ion series of CID 
fragmentation (Syka J.E. et al., 2003). Moreover, the fragmentation process is not due to an 
increase of the internal energy of the molecule, but involves radical rearrangements which 
leave fragment ions with intact phosphoester modifications. Upon electron uptake, the charge 
of the peptide is reduced by one which limits the application of this technique to peptide ions 
with charge states of 3+ or higher. Nevertheless, the implementation into ion trapping 
instruments makes this technique a sensitive and powerful tool for phosphopeptide research.  
To compare both fragmentation techniques we prepared the peptide 
HWWGSGPSGSGGSGGGKR (FourP_1) with four phosphoserines in the sequence and 
crystallized 100 fMol with DHB matrix for the MALDI MS/MS experiment. 8000–12000 
subspectra were summed up for the MS/MS spectrum and peaks were exported using the 
PEAKStoMASCOT tool from the 4000 Explorer Software (Applied Biosystems). The upper 
mass region starting from 1720 m/z, where exclusively neutral loss ions were observed, was 
removed from the mgf-file prior to database search. For ESI-ETD fragmentation a 2.5 µM 
solution was directly injected into the LTQ ETD mass spectrometer (Thermo-Fisher, 
Bremen). ETD fragmentation was performed on the doubly and triply charged precursor with 
the optimized activation time of 90 ms. 
As demonstrated by figure A_14 both methods deliver high sequence coverage and 
provide identification of all phospho-sites by the respective fragment ions. The main signal of 
the MALDI spectrum stems from the elimination of one phosphoric acid molecule and neutral 
losses are also observed in the upper mass region. The localization of the positive charge in 
MALDI MS/MS leads mainly to intense y-ions, which can be observed from y1-y16 with a 
maximal mass error of 0.2 Da. The only b-ion which could be identified was b2.  
ETD MS/MS data were obtained by fragmentation of the triply charged precursor ion 
([M+3H]3+), since the doubly charged precursor delivered almost no fragment ions. 
Interestingly, upon ETD activation sequence related fragment ions were found at lower 
intensities (max. 7%) compared to MALDI (12 %). The base peak of this analysis was the 
doubly charged radical peptide ion, which is formed upon electron uptake and a large fraction 
of the precursor ion was also present. This fragmentation did not result in a dominant ion 
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series like MALDI-MS/MS, but the identified c- and z-type fragment ions formed a 
complementary series so that all amino acid residues were covered by fragment ions. 
 Nevertheless, identification of all fragments required a mass window of 0.8 Da which 
is significantly larger than that of the MALDI spectrum (0.2 Da). Overall, both methods were 
able to map the complete peptide sequence and identify all phosphorylation sites. MALDI 
MS/MS has the higher mass accuracy, lower noise level and parallel fragment ion series 
which are formed upon neutral loss of a modification, this makes the MALDI analysis at least 
equal to ETD fragmentation, for the analysis of multiply phosphorylated peptides. Higher 
scores from database searching tools were observed for MALDI data which is due to the long 
y-ion series which receives an extra-score since the sequence is confirmed much better than 
by dispersed c- and z-fragments. 
 
 
 
 
 
 
 
Next page: 
Figure A_14 Comparison of MALDI-TOF/TOF MS/MS and ESI-ETD MS/MS Analysis. 
The fourtimes phosphorylated peptide HWWGSGPSGSGGSGGGKR was fragmented by 
both methods. A. Fragment ion spectra of both fragmentation principles result in high 
sequence coverage and all phosphorylation sites are covered by the identified fragment ions. 
The neutral loss region above 1750 m/z was truncated in the MALDI spectrum, because there 
were only peptide ion signals which resulted from neutral loss of phospho-moieties. MALDI 
fragmentation results in a second fragment ion series with a neutral loss of H3PO4. Both 
spectra are displayed with expanded view (MALDI 12% relative intensity, ETD 7%) on the 
identified fragment ions, since fragment ions were identified at low intensity. Fragment ions 
of the MALDI-TOF/TOF MS/MS spectrum fall into a 0.2 Da window, whereas 0.8 Da have 
to be applied to identify fragment signals of the ETD spectrum (symbols indicate loss of 
phosphoric acid: ▲ 1x, ●○ 2x, ■ 3x) B. MASCOT identification results for both 
fragmentation experiments and table of annotated fragment ions (red). Interestingly, many y-
ions (blue) are observed in the ETD spectrum which were not expected from the proposed 
fragmentation mechanism. 
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Discussion – Part 1 
 
Despite technological and methodical novelties for LC-MS/MS-based 
phosphoproteomics increased the number of known phosphorylation sites, multi-
phosphorylated peptides are still underrepresented. I optimized a protocol to overcome 
difficulties of their analysis, caused by their special physico-chemical properties and 
fragmentation behaviour. For instance, poor HPLC separation of such peptides under standard 
conditions was often underestimated in many phosphoproteomic studies. Further, the low 
ionization efficiency often requires a special inclusion list or exclusion of tandem MS 
precursor signal in a second LC-MS/MS experiment to acquire spectra of 
multiphosphorylated peptides. 
To deplete unmodified peptides from the sample, I established a phosphopeptide 
enrichment protocol on titanium dioxide, which is compatible with subsequent HPLC 
separation of phosphopeptides and either electro-spray ionization or matrix-assisted laser 
desorption/ionization. The method is highly robust and does not require further modification 
of unmodified peptides by esterification of the carboxylic acid moieties, thereby allowing a 
more general application. Further, this protocol can also be applied to samples with 
detergents, since the high percentage of organic modifier will remove these buffer additives in 
the loading and washing steps of the titanium enrichment.  
Often the most critical step is separation of the peptides by RP-chromatography before 
mass spectrometric analysis. To improve this step, I implemented separation on monolithic 
columns resulting in shorter elution fractions of less than five seconds at high resolution and 
allows direct deposition of the eluting peptides on a MALDI sample plate. Peptides with 
different number of phospho-sites were reliably separated with the highest phosphorylated 
form eluting first.   
Further we developed a robust MALDI detection protocol with DHB as optimal matrix 
for ionization of phosphopeptides. Using this protocol, multiply phosphorylated peptides 
could be detected down to 20 fMol on the spot. Improved identification of phosphorylated 
peptides was achieved by elimination of neutral loss peptide ions in the upper mass range that 
often dominate tandem MS spectra of multi-phosphorylated peptides. This step is not 
available for ESI MS/MS spectra, since the multiply charged precursor ions form a region of 
neutral loss peaks in the central mass range, thereby overlapping with many fragment ions. In 
comparison to standard protein phosphorylation analysis peptides with higher phosphorylation 
were identified and the phosphorylation sites were assigned with increased accuracy. ESI-CID 
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MS/MS was not able to identify the same phosphopeptides at low concentration, but the 
recently introduced ETD fragmentation technique was as efficient as the MALDI method.  
Although direct analysis of phosphopeptides from complete cell lysates cannot be 
provided by the presented procedure, it is able to detect phosphopeptides reliably after further 
reduction of the sample complexity as for instance by purification of protein complexes with 
immuno-precipitation. Interestingly, only one third of the sample amount used for ESI-
MS/MS analysis was required to identify the major phosphopeptides. The residual amount 
could be used to evaluate the findings in experimental repeats or to obtain MS/MS data for 
peptides that have not been identified in this step.  
A further problem, which comes more into focus of phosphoproteomics, is comparison 
of the phosphorylation state of a selected protein from different samples or under different 
conditions. Direct comparison of two individually analyzed samples shows significant 
shortcomings such as differences of sample amounts, separation conditions, or peptide 
ionization and detection conditions. Next to these technical problems, data interpretation plays 
a crucial role for the comparison of two different samples. Therefore, not only the 
identification score, which is provided by the search algorithm, is important for identification 
of the respective peptide sequence in both samples. Moreover, reliable localization of the 
peptide modification within the sequence improves the comparison. MALDI-MS/MS analysis 
addressed both questions, due to the separation of neutral loss ions and sequence specific 
fragments by the analysis of singly charged peptides and increased mass accuracy of fragment 
ions. To address such quantitative question by mass spectrometry, diverse isotope dilution 
methods have become quite popular in recent years. The presented protocol allows 
implementation of any of the published isotope labeling strategies such as SILAC (Ong S.E. 
et al., 2002), ICPL (Schmidt A. et al., 2005), and iTRAQ (Ross P.L. et al., 2004).     
 
PART B  ANALYSIS OF ACID LABILE PROTEIN 
PHOSPHORYLATIONS 
 
Protein purification, mutation studies of CtsR, and x-ray structural analysis of the 
transcription factor CtsR-DNA complex were carried out by J. Fuhrmann in the Group of T. 
Clausen at the IMP Vienna. To demonstrate the importance of the identified protein arginine 
phosphorylation in its biological context, these data are shortly described in the results 
section. Initial protein full mass determination and protein fragmentation experiments were 
performed by C. Stingl a former member of the Protein Chemistry Facility at the IMP Vienna. 
These data clearly demonstrate the phosphorylation state and are highly consistent with the 
data from the analysis of protein digests. NMR measurements were carried out at the NMR 
facility by Dr. L. Brecker of the Department for Organic Chemistry at the University of 
Vienna. 
 
 
General Introduction  
 
Nitrogen-bound Protein Phosphorylation Processes in Cells 
 
The methodology for mass spectrometry based identification of protein phosphorylations has 
improved significantly by the introduction of enrichment techniques. Nevertheless, only few 
studies report on phosphorylation events in bacteria, since many phosphorylations in these 
organisms are attached to other amino acid side chains. Unlike eucaryotic cells, 
phosphorylation on serine, threonine or tyrosine is mostly absent in bacteria (Miller M.L. et 
al., 2009). This observation is mainly due to a different set of protein kinases and 
phosphatases, which are expressed in bacteria and couple phospho-moieties to nitrogen atoms 
of histidine or arginine side chains (figure B_01).  
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Figure B_01 Nitrogen-Bound Phosphorylations in Living Cells. Phosphohistidine is highly 
important for bacteria to sense molecules in the extra-cellular medium. Phospholysine is 
seldomly observed as reaction intermediate of phospho-transfer catalyzing enzymes. 
Phosphoarginine (invertebrates) and phosphocreatine (vertebrates) are important in energy 
homeostasis, since they buffer high ATP levels. Arginine phosphorylation in proteins was 
suggested in earlier studies.  
 
A major part of known bacterial phospho-signalling is based on histidine and aspartate 
phosphorylation in two component signalling systems or phospho-relays (figure B_02A) 
(Mitrophanov A.Y. and Groisman E.A., 2008, Hoch J.A. and Silhavy T.J., 2005). Since 
bacteria inhabit precarious environments they need reliable detection systems for humidity, 
acidity, nutrients, temperature, or osmolarity, which are in majority based on two-component 
systems (Hoch J.A. and Silhavy T.J., 2005, p. 9). Further, these protein systems are also 
involved in chemotaxis by which bacteria detect different toxins in their environment and are 
able to move to the most fortunate place to grow (Parkinson J.S. and Kofoid E.C., 1992). 
Another very important task of two component signalling system is to report detected changes 
in the environment, to allow adaptation to altered growth conditions, for instance if density of 
bacteria becomes very high (Freeman J.A. et al., 2000, Gov Y. et al., 2004). Furthermore, two 
component signalling systems can also be found in plants where they developed a diverse 
protein class that has multiple functions (Mizuno T., 2005). Both systems, from bacteria and 
plant, consist of an often membrane-associated receptor that has the primary protein histidine 
kinase domain in its cytoplasmic domain (figureB_02B). Upon sensing of substrate molecules 
two receptor proteins dimerize and the structure of the intra-cellular kinase domain is altered, 
thereby enabling the kinase to autophosphorylate on a histidine, which is often conserved 
throughout different species. Similar to receptor tyrosine kinases in mammalian cells, the 
histidine residue of one receptor subunit is always phosphorylated by the active kinase 
domain of the second subunit and not by autophosphorylation within a single receptor 
molecule (Laub M.T. and Goulian M., 2007). This reaction product, phospho-histidine, is then 
the substrate for phosphorylation of a highly conserved aspartate residue in the response 
regulator protein. To demonstrate that the histidine phosphorylation is not the signalling 
molecule in this process, it was shown that the response regulator protein is phosphorylated 
by incubation with small phosphor-His analogues such as phosphoramidate or imidazol-N-
phosphate (Hoch J.A. and Silhavy T.J., 2005, p18f.). Since the phospho-acceptor is 
responsible for the transfer step, the recognition of the dimerization domain of the receptor 
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histidine kinase by the response regulator must be highly specific to exclude activation of 
other phosphorylation pathways. Upon aspartate phosphorylation, the associated acceptor 
protein is able to interact with the flagellum system to change the direction of movement or it 
is a transcription factor and regulates expression of specific proteins.  
The “so called” phospho-relay systems are a special form of the two-component 
response systems that involve multiple phospho-transfer reaction between histidine and 
aspartate in different proteins. The increased complexity of such systems allows a better 
regulation of the signal transduction process. This process is similar to the mammalian 
receptor tyrosine kinase systems, which are involved in sensing of growth factors and 
therefore are often associated with cancers (Blume-Jensen P. and Hunter T., 2001). Often, 
histidine kinases of two-component response systems are not only required to transfer the 
phosphate group onto the histidine, but many of them also have phosphatase activity that 
removes the modification to silence the signalling process (Laub M.T. and Goulian M., 2007). 
 
Figure B_02 Receptor 
Histidine Kinases in 
Bacteria and Plants. A. 
Two forms of receptor 
histidine kinases have 
evolved; two-component 
systems provide direct 
activation of the 
transcription factor after 
autophosphorylation of the 
receptor kinase. Phospho-
relays include three 
phospho-transfer steps, first 
from His to Asp, than to a 
His of a transfer protein, and 
the third step is again from 
His to Asp of an effector 
protein. (modified from 
Mitrophanov A.Y. and 
Groisman E.A., 2008) B. 
Scheme of an active 
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receptor histidine kinase. Upon interaction with a target molecule the receptor dimerizes, 
autophosphorylates conserved His residues in the dimerization domain. The response 
regulator translocates the phosphorylation site onto an Asp residue and thereby activates it 
output domain (effector domain). (modified from Attwood P.V. et al., 2007) 
 
To a yet unkown percentage also phosphorylation of arginine is present in bacterial 
proteins. Phospho-arginine is a rarely described protein modification and only one 
mechanism, where phosphorylated arginine is involved in adaptation to stress conditions, has 
been elucidated recently (Fuhrmann J. et al., 2009). Other studies in histones from bovine 
heart also assumed phosphorylation of arginine, but biological meaning and the responsible 
kinase were not identified (Wakim B.T. and Aswad G.D., 1994; Wakim B.T. et al., 1995). 
Furthermore, there are only few studies on phosphoarginine phosphatases, which remove this 
modification to end signalling (Kumon A. et al., 1996). So far only a general protein 
phosphatase has been described to have activity towards arginine phosphorylated peptides and 
the possibility of a dual activity of arginine modifying kinases, similar to histidine kinases in 
two-component systems, cannot be excluded. The limited knowledge makes it difficult to 
select the right phosphatase inhibitors during sample preparation, so that a certain percentage 
of modification is hydrolyzed by residual phosphatase activity.  
Phosphorylation of guanidyl moieties also occurs in eukaryotic cells, where creatine 
and arginine are converted to phosphagens, thereby representing an alternative energy storage 
system (Attwood P.V. et al., 2007, Besant P.G. et al., 2009). While higher eukaryots such as 
mammals, fish, or birds are able to utilize creatine (Curtin N.A. and Woledge R.C., 1978), 
invertebrate organisms phosphorylate the free amino acid arginine on its guanidyl function 
(Padwardhan P. and Miller W.T., 2007). The activity of the corresponding creatine or arginine 
kinases depends on the intracellular ADP and ATP levels. If the ADP level is low and much 
ATP has been produced the cell, the phosphagen kinase transfers a phosphate moiety from 
ATP to the guanidyl function of creatine or arginine, forming one molecule of ADP, which 
then can further be used for ATP production. Under conditions, where ATP is present in low 
levels and high levels of phosphagens exist, the creatine/arginine kinases are able to catalyze 
the reversed reaction from phosphagen to creatine or arginine and form ATP.  
N-phosphorylations on proteins have first been described in the 1960s, where 
biologists discovered phosphorylated proteins that lose the radioactive phosphorylation signal 
upon acidic treatment (Slater E.C. and Kemp A., 1964; Wålinder O., 1969). Localization of 
this modification by different methods pointed towards the amino acids histidine, lysine, and 
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arginine, which could be modified at nitrogen atoms in their side chains. Phosphorylation of 
small chemical molecules like butylamine was used as model system to study such protein 
modifications: the kinetics of pH dependent decay and the reactivity of N-phosphorylations. 
In contrast to arginine and lysine, where only one phosphorylated form exists, chemical 
phosphorylation of histidine leads to two different products, 1-phosphohistidine and 3-
phosphohistidine. Up to now it has not been shown, if only one of the two forms has 
biological relevance or if histidine kinases are able to produce both isoforms.  
All N-phosphorylations and the associated aspartic acid phosphorylation share high 
instability at lower pH values. On the other side, N-bound phospho-moieties are highly stable 
at alkaline conditions, where phospho-esters of serine or threonine can be removed.  
 
I. Chemical Properties of Phospho-Amidates on Biomolecules 
 
In comparison to the acid-stable Ser-, Thr-, Tyr-bound phospho-esters, phosphate 
moieties attached to His, Lys, Arg have a covalent nitrogen-phosphorous bond (figure B_01). 
Interestingly, the nitrogen atoms in the side chains of these amino acids retain their high 
proton affinity upon phosphorylation (Attwood P.V. et al., 2007, Besant P.G. et al., 2009). 
The pKa values for these protonation sites are only slightly lower than that of the unmodified 
side chain (see table B_1). This observation is unusual, because the phosphate moiety is an 
electron withdrawing group, which should be able to delocalize the free electron pair of the 
nitrogen atom into different structures with N=P double bonds (figure B_03). In 
phosphoarginine and phosphohistidine two different electron withdrawing groups compete for 
the lone pair electrons of the sp2-hybridized nitrogen atom.  
 
Table B_1 pKa 
Values for 
Nitrogen-Bound 
Phosphorylations. 
The pKa of the 
phospho-moiety is 
similar to phospho-
esters of Ser,  
Thr, Tyr (pKa1 = 1.2, pKa2 = 4.6). The pKa of the NH-group in the side chain is almost not 
altered in comparison to the unphosphorylated amino acid. Due to structural similarity, 
phospholysine has the same pKa values like phosphoramidate (NH4PO3). 
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Due to stronger withdrawing effect of the guanidyl group and the imidazole ring, they 
show the dominating effects, thereby making formation of N=P bonds unfavourable (Ruben 
E.A. et al., 2005). In case of lysine phosphorylation the nitrogen atom is sp3-hybridized, 
which precludes formation of double bonds. The pKa for the alkylic nitrogen atom is lowered 
from 11.2 to 9.2 in the phosphorylated form. Upon phosphorylation all phosphorous-bound 
nitrogen atoms encounter a reduction of the pKa value, which is predominantly due to 
inductive withdrawing effects. (Besant P.G. et al., 2009). 
 
Figure B_03 Charge Distribution and Mesomeric Structures of Phosphohistidine and 
Phosphoarginine at Neutral pH. Mesomeric structures, having a single positive and two 
negative partial charges, are highly important, whereas the form with a triply negative charged 
phospho-moiety is almost not abundant. 
 
Under acidic pH conditions N-bound phosphorylations rapidly hydrolyze, which can 
be described by an SN2-like mechanism (figure B_04) (Sickmann A. and Meyer H.E., 2001; 
Besant P.G. et al., 2009). In this reaction the phospho-moiety is transferred to a water 
molecule. The N-P bond is weakened in the transition state, leading to a larger distance 
between N and P atom. At this stage, the O-atom of a water molecule is able to interact with 
the P-atom from the other side, since the phospho-moiety adopts a planar structure in the 
transition state. Finally, the modification is eliminated as monohydrogenphosphate. The free 
reaction energy ΔG ْ for the hydrolysis of phosphoarginine is -7.3 kJ/mol, hydrolysis of 
phospholysine has a higher ΔG ْof -42 kJ/mol (Besant P.G. et al., 2009). Dissociation of the 
"low energy" N-P bond is the rate-determining step in this reaction (Besant P.G. et al., 2009). 
In case of phospho-arginine and phospho-creatine, positively charged guanidyl groups interact 
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with the negatively charged phospho-moiety thereby forming an ion pair, which slightly 
increases their resistance towards hydrolysis. Upon hydrolysis this pair has to be disrupted, 
which increases the free energy of the transition state and makes phosphagen molecules ideal 
for energy storage, because the phosphorylated forms are quite stable under physiological 
conditions. While phosphorylated arginine can be stored for quite a long while at pH 7, 
phospho-histidine and phospho-creatine will decay within a few days. 
At basic pH all phosphoamidates have a high stability because the amine anion is 
unsuitable as leaving group. 
 
 
Figure B_04 Acidic Hydrolysis of the Phospho-Amidate of Arginine Follows a SN2-like 
Mechanism.  
 
 
II. Analysis of Nitrogen-bound Phosphorylations on Peptides and Proteins 
 
One of the most sensitive techniques to study protein phosphorylation is the 
introduction of a radioactive phosphorous atom, which can be either 32P or 33P. Detection of 
the radioactive radiation facilitates the identification of phosphoproteins and mutation of 
putatively phosphorylated residues helps to identify a phosphorylation site. The first protein 
phosphorylations, which dissociated upon sample acidification, were discovered in the 1960s. 
Since as previously described serine, threonine and tyrosine phosphorylations are acid-stable, 
other amino acids have to be the targets for this type of kinase modification. Later studies 
revealed that the amino acids histidine, lysine, arginine, and aspartic acid are also phospho-
acceptors (Weller M., 1978; Levy-Favatier F., 1987). Next to mutational studies in 
combination with acidic removal of N-phosphorylations, thin layer chromatography of amino 
acids was used to determine the type of phospho-amino acid (Hoch J.A. and Silhavy T.J., 
2005). Thereby amino acids were released from the proteins after incorporation of a 
radioactive phospho-moiety by alkaline hydrolysis and mixed with unlabeled standard. After 
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one- or two-dimensional separation by thin layer chromatography the localization of the 
radioactive spot revealed the phosphorylated amino acid in the protein. 
Later arginine-phosphorylation was detected by EDMAN-sequencing of the 
unmodified and the phosphorylated peptide. The comparison of both results shows a loss of 
the amino acid signal at the position of the modified residue for the phosphorylated peptide. 
Standard amino acids can be used to validate the finding of an N-phosphorylation and to 
exclude a different type of modification. Unfortunately, the commercial phospho-arginine 
standard is no longer available. 
 
III. Mass spectrometry of protein N-phosphorylations 
 
Due to the acid-lability, detection of peptides with N-phosphorylation is still 
challenging for mass spectrometry. Acidic sample preparation and dilution steps enhance 
hydrolysis of the phospho-amidate. Analysis time seems to be the critical point. Whereas 
normal peptides can be kept in acidic solvents for months or even years, peptides with labile 
modification should be analyzed within one day otherwise the chance to miss the modification 
is quite high (Zu X.L. et al., 2007). Recent studies on phospho-Arg in proteins have not been 
conducted with mass spectrometry since this technique was not jet available (Wakim B.T. et 
al., 1995). First MS-detection of His-phosphorylated peptides was achieved by MALDI MS 
and the acid lability was a good criterion to distinguish histidine phosphorylation from acid-
stable phospho-esters in a hydrolysis step of a second sample (Attwood P.V. et al., 2007, 
Wålinder O., 1969). If peptides with histidine phosphorylation were analyzed by MALDI 
mass spectrometry in positive ion mode, almost exclusively the unphosphorylated form was 
observed. Interestingly, the intact phosphopeptide could be detected in negative ionization 
mode. ESI-MS allowed detection of both peptide forms in positive ionization mode, because 
more protons are transferred to the peptide.  
The first enrichment protocol for peptides with His phospho-modification is based on 
the affinity of the imidazole ring to copper and the negative charge of the phospho-moiety at 
low pH conditions (Ross A.R., 2007). Ross demonstrated that peptides without 
phosphorylation are effectively removed under mild acidic conditions and phosphorylation of 
other amino acids can be washed away by switching to conditions to formation a stable 
imidazole-copper complex of the histidine side chain.   
Sample preparation and mass spectrometric detection of histidine phosphorylated 
protocols has not been intensely investigated so far. Especially the biochemical sample 
 52 
processing requires significant improvement. Since these modifications are labile, the biggest 
difficulty for extensive studies is to accumulate enough peptide. Previously, it was 
demonstrated that low energy CID activation of peptides with phosphorylated histidines leads 
to two different neutral loss products (Medzihradszky K.F. et al., 1997). While a signal at M-
80 Da, which stems from elimination of HPO3, could easily be explained from the chemical 
nature of the histidine phosphorylation, the observed loss of phosphoric acid (M-98 Da) was 
unexpected, because of the nitrogen-phosphorus-bond (Medzihradszky K.F. et al., 1997, Zu 
X.L. et al., 2007). Since the unmodified peptide did not show extensive water elimination, a 
concerted mechanism for the phosphoric acid loss is under discussion. To explain this neutral 
loss behaviour, a phospho-transfer from the histidine side chain to a free OH-moiety within 
the peptide has to take place in the first step, which is followed by the elimination of 
phosphoric acid. In their report, Attwood et al. described an adjacent serine residue as the 
phospho-acceptor (Zu X.L. et al., 2007). Recently, Kleinijenhuis et al. investigated the 
fragmentation behaviour of histidine phosphorylation upon low energy electron activation 
(Kleinijenhuis A.J. et al., 2007). Despite the low stabilty in solution and high tendency to lose 
H3PO4 upon thermal activation no neutral loss is observed in ECD, ETD or EDD processes.  
 
Part 2.  Identification and Characterization of Arginine-Phosphorylated 
peptides and proteins 
 
a the CtsR phospho-switch 
 
Cells encounter a variety of stresses which affect the stability and folding of proteins. 
Bacteria developed therefore highly efficient protein quality systems, which are able to 
remove misfolded or aggregated proteins and often consist of chaperones and proteases. Since 
these degradation complexes can cause problems during normal cellular growths, they are 
only expressed under stress conditions (Hecker M. et al., 1996). Most of these stress factors 
are encoded in a small number of genes and share the same promoters. Therefore, regulation 
is often achieved on the transcriptional level by inhibition of the DNA transcription process, 
for instance by the Class three stress gene regulator (CtsR) protein (Derre I. et al., 1999). 
CtsR is expressed in Gram-positive bacteria and is encoded in the ClpC operon, which 
consists of the genes clpC, ctsR, mcsA and mcsB (Krüger E. et al., 1998; Derre I. et al., 
1999). ClpC is a protein chaperon that is able to unfold misfolded proteins with the help of 
ATP. McsA and McsB (modulator of class three stress gene regulator A and B) are required 
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to phoshorylate CtsR. McsB is the kinase, applying the phosphorylation; McsA is believed to 
act as activator or stabilizer of McsB (Kirstein J. and Turgay K., 2005). This operon is not 
completely conserved, so that few species actually miss the mcsA and mcsB genes.  
The transcription factor CtsR is bound to the promoter region of the gene under normal 
growth, thereby inhibiting the transcription of the upstream genes (Krüger E. et al., 2001; 
Kirstein J. and Turgay K., 2005). When the cell encounters stress CtsR dissociates from the 
DNA and allows expression of the stress genes. To prevent re-association of the complex, the 
DNA-binding domain is phosphorylated by the protein kinase McsB (Kirstein J. and Turgay 
K., 2005; Kirstein J. et al., 2005).  
The protein structure consists mainly of helices (figure B_05), which form two protein 
domains (Fuhrmann J. et al., 2009). The N-terminal domain represents a winged helix-turn-
helix motif, which is a common DNA binding fold and involves many basic amino acids (R, 
K, H). The C-terminus is the protein dimerization domain and consists of a bundle of 4 
helices, to interact with another CtsR molecule via a large hydrophobic surface. Upon 
interaction with DNA, the helix-turn-helix motif (amino acids 2-72) coordinates the 
phosphate backbone of the DNA by ion pair formation with positively charged amino acids 
and interacts with the major groove. The wing domain is a short peptide strand, which is 
stabilized by a ß-sheet structure with other residues in the N-terminal domain and comprises 
the amino acids 57-71. In complex with DNA the tip of the wing (aa 62-66, RGGGG) is fully 
inserted into the DNA minor groove and interacts with the organic bases. The major function 
of this domain is the recognition of the correct DNA sequence in the promoter of the 
regulated genes. A second, yet not fully described function arises from the flexibility of this 
region that is even increased at elevated temperatures. Under such conditions the wing could 
leave the minor groove and thereby initiate the dissociation of the complex. 
Interestingly, both CtsR subunits recognize parallel DNA-sequence repeats, which is 
only possible by a bend of the N-terminal domain of the second subunit. Most dimeric 
transcription factors bind to palindromic DNA-repeats. The flexibility of CtsR lies in the 
linker region (aa 72-78) that is able to turn the second DNA-binding domain by 180°. 
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Figure B_05 CtsR Sequence and Structure of the CtsR Dimer Bound to the DNA 
Recognition Sequence. A. Each CtsR subunit consists of an N-terminal DNA-binding 
domain and a C-terminal dimerization motif. The DNA-binding domain binds to the major 
groove of the DNA and is a “so called” helix-turn-helix motif, comprising amino acids 2-56 
(green). It is extended by a wing domain, which interacts with the minor groove (aa 57-71, 
red). Only the dimer, which it is formed by interaction of the C-terminal helix bundles of two 
CtsR molecules (aa 79-153, highlighted in blue), is stably attached to the DNA. B. The wing 
domain is completely inserted into the minor groove of the DNA where the arginine at the tip 
forms hydrogen bonds with the DNA bases. 
 
To establish the kinase-substrate-protein system which could be studied in vitro with 
high expression rates and protein stability the sequences of CtsR and McsB from bacillus 
stearothermophilus were cloned into a vector. For determination of the phosphorylation state 
and localization of the phosphorylation sites the proteins were constructed with a C-terminal 
His-tag and individually expressed in the bacterium Escherichia coli. Cells were lysed and the 
proteins were purified by Ni2+/NTA chromatography and gel filtration.  
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Phosphorylation Assays and Intact Protein Mass Spectrometry 
The phosphorylation on CtsR was applied by the kinase McsB in an in vitro 
phosphorylation assay and the functionality of the system was validated by autoradiography 
of incorporated radioactive 31P, phosphorylation specific staining of the polyacrylamide 
electrophoresis gel and mass spectrometry of intact protein see figure B_06A+B. For 
phosphorylation, proteins were incubated in 30 mM HEPES pH 8, 50 mM KCl, 5 mM 
MgCl2, 2 mM ATP, 10 mM CtsR, and 5 mM McsB for 10 min at 35°C. After the reaction 
CtsR was separated on a heparin column to remove the reaction components and the kinase. 
Further, reversed phase chromatography was applied on a 200 µm monolithic column, using 
acidic buffer conditions (DVB-PS co-polymer, Dionex, Schley C. et al., 2006), to prepare the 
protein for ESI MS analysis. The CtsR protein was strongly retained on the column and eluted 
at a high percentage of organic solvent, so that the collected elution fraction could directly be 
used for off-line ESI mass spectrometry.  
 
Figure B_06 Detection of CtsR Protein Phosphorylation. A. Autoradiography, which 
detects incorporation of radioactive phosphorous, and phospho-specific gel staining exhibited 
autophosphorylation of the kinase McsB and phosphorylation of the target protein CtsR upon 
incorporation with ATP. B. Unphosphorylated and phosphorylated CtsR can be separated by 
heparin-chromatography, whereof the unmodified form binds stronger to the chromatographic 
resin. MS of the phosphoprotein fraction reveals signals for monophosphorylation and 
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diphosphorylation of CtsR. C. Top down experiments of the monophosphorylated form 
suggest phosphorylation of the wing domain and the N-terminal DNA-binding motif with 
high probabilities, while modification of the C-terminus can be excluded based on the 
obtained results. 
 
The protein was infused into a high resolution Fourier Transform Ion Cyclotron 
Resonance (FT-ICR) mass spectrometer (LTQ-FT, Thermo-Fisher) via static nano-ESI 
ionization. After optimization of the ionization conditions, mass spectra were acquired with a 
resolution of 100000 from 750-850 m/z, including charge states from [M+23H]23+ to 
[M+25H]25+. The final spectrum was averaged from 100 spectra. The spectrum was 
deconvoluted with the Xtract All software tool, which is part of the XCalibur QualBrowser 
software (Thermo-Fisher). The spectrum had evidence that up to two phosphorylations are 
incorporated into the CtsR protein by MscB (figure B_06). To identify the putative 
phosphorylation sites, the full protein was sequenced in the mass spectrometer using a top 
down MS/MS approach, since previous bottom-up LC-MS/MS studies did not lead to the 
detection of a phosphopeptide. For MS/MS analysis the 25fold charged protein ion 
([M+25H]25+) for the unmodified protein and the singly phosphorylated species were isolated 
in a 10 Da window and fragmented by CID, IRMPD and ECD activation. The fragment ion 
spectra (200-1400 m/z) were acquired with resolution of 100000 and 500 spectra were 
averaged for the final spectrum. Fragment ions were extracted from the mass spectrum and 
searched with the ProMass software Vs2.5 SR-1. Fragments, which matched to the 
unmodified protein sequence, were used as basal score. Since no phosphorylation was 
identified in bottom up approaches, all putative phosphorylation targets (Ser, Thr, Tyr, His, 
Arg, Lys, Cys, Asp) were included in the interpretation process. Identified protein fragments 
did not localize the phosphorylation to a specific amino acid. A high probability was found 
for the complete N-terminal domain, since, compared to the basal score, the identification 
score was increased for protein sequences with phosphorylated amino acids in this region. 
Highest scores were observed for the amino acids 55-82 which represent the wing domain. 
These results also excluded the C-terminus since all phosphorylated protein isoforms in this 
area scored lower than the unmodified protein.  
 
New Bottom Up Strategy to Identify Arginine-Phosphorylation 
Since previous attempts to localize the phosphorylation site in CtsR after proteolytic 
cleavage were not successful, the problematic sample preparation step had to be found. Top 
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down analysis clearly localized the phosphorylations to the N-terminal domain but not to a 
specific amino acid. Purified CtsR (20 µM) was mixed with 10 µM McsB, 5mM MgCl2, 1 
mM ATP, 30 mM Tris pH 8.0, and 10 mM β-mercaptoethanol and incubated at 40°C for 30 
min in the presence of 2% glycerol.  CtsR was purified by heparin chromatography to remove 
the reaction components. Cysteines were reduced with DTT and subsequently alkylated with 
iodoacetamide, as described elsewhere. In the first experiment, freshly prepared and 
phosphorylated CtsR protein was proteolytically cleaved by subtilisin, chymotrypsin and 
trypsin, individually. While trypsin produces a well defined cleavage pattern, chymotrypsin 
has a preference for hydrophobic amino acids and subtilisin is able to cleave at any amino 
acid. The peptide mixtures were not acidified to reduce the protease activity, all samples were 
analyzed with MALDI MS within 30 min after proteolytic cleavage and the residual was kept 
at -20°C .  
Since phosphopeptides already eliminate H3PO4 from phospho-Ser, phospho-Thr, and 
phospho-His in MALDI-reTOF-MS experiments, each phosphopeptide gives rise to two 
signals. The major signal represents the intact phosphopeptide, which is accompanied by a 
minor neutral loss signal with a mass shift of -98 Da. The isotopic pattern of the neutral loss 
peptide ion is often not resolved, because the elimination occurs in the reflectron, at an 
analysis step, where high resolution cannot be achieved anymore. This characteristic signal, 
combined with the mass difference of 79.966 Da between unmodified and phosphorylated 
peptide allowed us the identification of phosphorylated peptides in the chymotrypsin and 
trypsin cleaved samples. Analysis of the subtilisin digest by MALDI MS was impaired, 
because of high salt concentration, interfering with crystallization and ionization of peptides. 
The chymotryptic digest had a phosphopeptide with the sequence IVESKRGGGGYIRIM 
(m/z 1715.84, aa 57-71) among the 10 most abundant peptide ions (figure B_07A). 
Phosphorylation of this peptide was further confirmed by MS/MS fragmentation, revealing a 
very intense loss of phosphoric acid. Phosphatase treatment of a fraction of the residual 
peptide digest also resulted in a loss of the phosphopeptide signal and showed an intense 
signal of the unmodified peptide (m/z 1635.89). The peptide sequence was identified from 
both MS/MS spectra of the unmodified and the phosphorylated peptide which clearly showed 
four adjacent glycines. Furthermore, one additional putative phosphopeptide was found in the 
chymotrypsin sample at 2434.22 m/z which also comprised the wing domain, see table TB_2. 
Phosphopeptides were not strongly represented in the trypsin cleaved CtsR sample, but all 
putative phosphopeptides pointed to phosphorylation of the central protein region, the wing 
domain with the block of four glycines (table TB_2). 
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 Table B_2 Phosphopeptides of CtsR detected by MALDI TOF MS. 
MALDI data identified several phosphopeptides in the region of the wing domain. 
Interestingly there was no hint for other phosphorylation sites from these data. 
 
 
After identification of the phosphopeptide we tried to localize the phosphorylation 
within the peptide sequence, which includes one Ser and one Tyr as putative kinase targets. 
Extensive H3PO4 loss in MALDI-MS spectra and MS/MS analysis on the LTQ Orbitrap mass 
spectrometer localized the phosphorylation to Ser4 or Arg6, when arginine was also included 
as putative kinase target. Phosphorylation of Tyr11 was excluded from these data (figure 
B_07B). The sequence of y-ions in MALDI MS/MS pointed to an N-terminal localization of 
the modification.  
Finally, unambiguous localization of the phosphorylation was only possible with a 
peptide fragmentation method, which keeps the modification attached to the amino acid. In 
combination with the high resolving power of FT-ICR MS, electron-capture dissociation 
(ECD) was the method of choice. The chymotryptic digest of freshly phosphorylated CtsR 
protein was separated by nanoRP-HPLC and detected on-line on an LTQ-FT mass 
spectrometer. All peptides with a charge state of 3+ or higher were automatically selected for 
fragmentation by ECD. Database search of the obtained mass spectra identified only the 
unphosphorylated and the phosphorylated form of the previously found peptide 
IVESKRGGGGYIRIM in charge state 3+. Manual interpretation of the phosphopeptide 
spectrum clearly localized the phosphorylation to Arg6 which represents Arg62 of the protein 
sequence. No evidence was found for phosphorylation at Ser4, Lys5, Tyr11, or Arg13 of the 
peptide sequence.  
Next to the modification at Arg62 in the protein sequence, further experiments also 
revealed phosphorylation of Arg28, Arg36, Arg49, and Arg54. Arg28, Arg49, and Arg62 are 
highly conserved in the CtsR variants of different bacteria and are involved in DNA 
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recognition. In the complex with DNA, Arg28 and Arg62 are inserted into the major DNA 
groove. Arg36, Arg49 and Arg54 form salt bridges to the negatively charged phosphate 
backbone and thereby help to localize the DNA strand and stabilize the complex. 
  
 
 
Figure B_07 Identification of the Phosphorylated Arginine in the Wing Domain at 
Position 62. A. MALDI-MS analysis of the chymotryptic digest identifies a phosphopeptide 
at an m/z of 1715.85 (red box) with a neutral loss of H3PO4 at 1617.88 m/z (lilac). The 
unphosphorylated peptide (blue) was also observed at 1635.89 m/z. Phosphatase treatment of 
the peptide mixture with calf intestinal phosphatase removed the signal of the 
phosphopeptides, but residual chymotryptic activity generated fragments of the phosphatase 
(blue triangles). B. Further investigation by ESI-CID MS/MS resulted in ambiguous 
localization of the phosphorylation site within the peptide to S4 or R6. C. Only ECD 
fragmentation was able to reveal the arginine phosphorylation without doubts, since the 
modification is preserved. Fragments, carrying the intact phospho-moiety, are high-lighted in 
blue for z-ions and red for c-ions. 
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Biological Function of the phosphorylation 
As described above, CtsR is a DNA-binding molecule that is removed from the DNA 
under stress conditions to allow stress gene expression. Within the complex the N-terminal 
domain establishes the contact to the DNA, while C-terminal domains of two CtsR molecules 
are fused together to form a stable dimer. MS analysis revealed phosphorylation of the N-
terminal domain and all identified phospho-sites were arginines, which are crucial to maintain 
the protein-DNA interaction. As demonstrated by the blue colour in figure B_08A, many 
basic amino acids are located at the Protein-DNA interface and form ionic interaction with the 
negatively charged phosphate backbone. Structural data imply important interactions of 
Arg28, Arg36, Arg49, Arg54, and Arg62 with the DNA, mostly with the phosphate backbone. 
The location of these arginines in the protein-DNA complex is demonstrated in figure B_08A. 
Phosphorylation inverts the charge of arginine side chains. Therefore, interaction with DNA is 
impaired and the re-association of the complex is inhibited. 
 The tip of the wing domain, which is formed by the amino acids RGGGG (aa 62-66), 
is completely inserted into the minor groove of the DNA (figure B_05B). Together with the 
helix-turn-helix motive, these residues recognize the sequence of the DNA bases to find the 
correct binding side. Arg62, which lies in the wing-domain, interacts with the organic bases 
within the DNA-Helix and favours only two combinations of DNA sequences. Binding assays 
with phosphorylated CtsR or a mutant form of the protein with glutamate in position of 
Arg62, to mimic the phosphorylation, exhibited quantitatively inhibition of DNA binding, 
while mutating Arg62 to Lys results in increased stability of the protein-DNA complex. 
 
Figure B_08 Localization of Phosphorylation Sites in the CtsR2/DNA Structure. Five 
different phosphorylated arginine residues were identified in CtsR, Arg28, Arg36, Arg49, 
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Arg54, and Arg62. All are located in the N-terminal domain of the CtsR subunits (A/B) and 
involved in protein-DNA interactions. Especially Arg62 in the wing domain (see figure 
B_05B) is essential for the stability of the complex. Arg28 and Arg62 interact with the bases 
in the major groove, the other phosphorylation sites coordinate the position of the DNA 
phosphate backbone. Phosphorylation causes electrostatic repulsion of the DNA and thereby 
impairs association of the complex. (red negative charge, blue positive charge, white 
uncharged). B Putative mechanism of CtsR regulation. Upon stress the CtsR2/DNA-complex 
is destabilized and free CtsR is subsequently phosphorylated by McsB. 
 
 
CtsR functions as suppressor of stress-gene transcription under normal growth 
conditions. Upon stress exposure, cells have to adapt quickly and therefore CtsR has to be 
removed from the DNA and re-association of the complex has to be inhibited. In vitro, the 
CtsR dimer requires only one DNA-recognition site to bind short DNA strands with one of the 
two helix-turn-helix domains. The location of the second DNA-binding domain is unknown. 
In a putative biological mechanism (figure B_08B), the CtsR dimer becomes more flexible 
under heat stress conditions and is able to release one helix-turn-helix domain from the DNA, 
which is then phosphorylated by McsB (Fuhrmann J. et al., 2009). This leads to 
destabilization and dissociation of the complex. Free CtsR is further phosphorylated by McsB 
which guarantees inhibition of the re-association of the complex and allows transcription of 
the DNA region. A hint for such a mechanism is provided by NMR studies of a different 
transcription factor, which has a DNA-binding helix-turn-helix motif with a wing domain 
similar to that of CtsR (Derre et al., 2000). This study shows that upon heat shock the highest 
gain of flexibility lies within the wing region. Addition of McsB alone to the CtsR2/DNA 
complex in the absence of ATP is not sufficient to release the CtsR, demonstrating that the 
stress-response is not exclusively mediated by binding of McsB to CtsR.  
 
b Characterization of the Protein Arginine Kinase McsB 
 
Studying the regulation of CtsR activity by phosphorylation revealed the kinase 
activity of McsB towards arginine. Earlier, this protein kinase was reported to have a tyrosine 
specificity that was determined by thin layer chromatography of amino acids (Kirstein J. and 
Turgay K., 2005). For this experiment, amino acids of the purified McsB and CtsR proteins 
were released by acidic hydrolysis and phospho-amino acid analysis was performed by two-
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dimensional thin-layer chromatography. The observed signals overlapped with the phospho-
tyrosine standard (Kirstein J. and Turgay K., 2005). In a second experiment mutation studies 
showed a loss of kinase activity after exchange of specific Tyr residues to Ala in the protein 
sequence. Although both studies pointed towards tyrosine kinase activity, they are not 
sufficient to determine it unambigously. The hydrolysis of proteins and the second dimension 
of chromatographic separation were carried out under strong acidic conditions, which 
undoubtely resulted in the loss of the arginine phosphorylation according to our data. The 
mutation of several tyrosines in the second experiment could interfere with the protein 
structure and stability and therefore lead to loss of the kinase activity. 
 
Peptide Phosphorylation by McsB reveals Arginine Specificity 
To determine the kinase activity of McsB unambiguously, we conducted in vitro 
kinase assays with small synthetic peptides that had sequence similarity to the already 
identified phosphorylation site in CtsR. Peptides (40 µM) were individually mixed with 5 mM 
MgCl2, 1mM ATP, 20 mM Tris pH 8, and 15 µM McsB to final volume of 100 µl. The 
reaction was performed at 40°C for 3 hours. Phosphorylated peptide products were analyzed 
by mass spectrometry and 31P-NMR spectroscopy (figure B_09). Peptides, which revealed 
incorporation of a phospho-moiety, were conducted to MS/MS fragmentation to localize the 
site of modification. 
 
Figure B_09 Schematic Illustration of the Peptide Phosphorylation Assay. After 
incubation of the oligopeptide with McsB and ATP, the incorporation of phosphate is 
measured with MALDI-TOF mass spectrometry and the type of phosphorylation is evaluated 
by 31P-NMR spectroscopy as independent analytical technique. 
 
For phosphorylation, synthetic peptides with different amino acids in position of the putative 
kinase target were incubated with purified McsB kinase from B.stearothermophilus and ATP 
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(peptides see table TB_3). The reaction mixtures were diluted and directly analyzed by 
MALDI mass spectrometry. Synthetic peptide PepR_01, exactly constituting the CtsR amino 
acids 61-73 comprises two arginines that could serve as kinase target. MS/MS analysis 
showed that there was no evidence for a phosphorylation of R69 in the full length CtsR 
protein. Unfortunately, both arginines were phosphorylated by McsB on the synthetic peptide. 
To eliminate such side effects, I optimized the peptide sequence by exchanging the second 
arginine to lysine, resulting in the model peptide ac-KRGGGGYIKIIKV, PepR_02. 
 
Table B_3 Synthetic Peptides for the N-Phosphorylation Study 
 
 
Upon phosphorylation with the purified kinase, I could show that only a single 
phosphorylation is incorporated into this amino acid sequence. Based on this sequence, new 
peptides were synthesized, where the arginine at position two was replaced by other amino 
acids (Ser,Thr,Tyr,Lys,His,Asp), which could be putatively phosphorylated to test, if McsB 
also modifies these residues. Mass spectrometry clearly demonstrates that only the peptide 
with arginine at position 2 (PepR_02) is phosphorylated (figure B_10A+B, spectral range: 
[M+H]-50 Da to [M+H]+150 Da). Furthermore, we studied, if modification of the arginine 
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side chain, for instance by methylation, impairs phosphorylation. Therefore I synthesized a 
peptide with a symmetrically dimethylated arginine in position two ac-KR(Me)2GGGGYIK-
IIKV, PepR_5. MALDI MS demonstrates that this substrate was not modified by McsB in the 
kinase assay (figure B_10A+B). Since tyrosine kinase activity was described for McsB 
previously, we also replaced the Tyr in position 7 of the model peptide with phenylalanine, 
which gave the sequence ac-KRGGGGFIKIIKV. After incubation with McsB and ATP, this 
peptide still revealed incorporation of a phospho-moiety, which would not have been 
observed with a tyrosine-modifying kinase (figure B_10A+B). 
Exchange of other amino acids in the model sequence revealed a preference of McsB 
to phosphorylate basic peptides, while modification of acidic peptides is significantly reduced. 
Peptides ac-KRGGGGYIEIIKV and ac-ERGGGGYIKIIKV exhibited lower signals for the 
phosphorylated form in comparison to the model peptide PepR_2 and the version with three 
glutamic acids in position of the Lys residues could not be phosphorylated at all (figure 
B_10A+B). This observation is in good agreement with the observation that only the basic N-
terminal DNA-binding domain of CtsR is phosphorylated. The identified phosphopeptides of 
CtsR and further studies with synthetic peptides revealed no specific recognition sequence for 
McsB but generally higher activity towards sequences with multiple basic residues.  
 
Detection of Phospho-Arginine by 31P-NMR Spectroscopy 
Since so far only mass spectrometry based methods localized the phosphorylation to 
the side chain of arginine, a second analytical method should be applied to validate this 
finding. For this purpose, 31P-NMR spectroscopy proofed to be the best tool to study this 
modification on small peptides. NMR spectroscopy measures the relaxation of the nuclear 
magnetic spin after perturbation by a radio impulse. Naturally, phosphorous occurs 
exclusively as 31P-isotope, guaranteeing NMR detection of low amounts of phosphopeptide. 
The model peptide ac-KRGGGGYIKIIKV was prepared and purified by RP-HPLC at neutral 
pH with a (NH4)H2PO4 buffer to yield approximately 50-100 µg pure phospho-peptide. The 
phosphate buffer was exchanged by solid phase extraction on C18 cartridges (Phenomenex, 
Germany) to heptafluorobutyric acid at pH 6.8. To exclude the presence of O-
phosphorylations, I also measured the NMR resonance of the chemically synthesized 
phosphopeptides ac-KSGGGGYIKIIKV, ac-KYGGGGYIKIIKV, and ac-KTGGGGYIKIIKV 
that were treated exactly like the arginine-phosphorylated peptide. All NMR analyses were 
carried out by Dr. L. Brecker at the NMR facility of the Organic Chemistry Department of the 
University of Vienna on a 600 MHz NMR instrument (DRX 600, Bruker). The exitation 
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frequency for the phosphorous nuclei was 242.94 MHz. The chemical shift for all four 
phosphorylation types was similar to that reported earlier and the arginine phosphorylation 
was again clearly confirmed and distinguished from phospho-esters (Kumon A. et al., 1996). 
The resonance signals for pSer (+5.04 ppm) and pThr (+4.41 ppm) were shifted downfields in 
comparison to the reference at 0 ppm, the pY resonance (+0.86 ppm) was similar to the 
reference. Only the signal of the arginine phosphorylated peptide ac-KRGGGGYIKIIKV had 
an upfield shift to -2.46 ppm, which is similar to free phospho-arginine (without the peptide 
context) at -2.52 ppm. (figure B_10C)  
 
  
Figure B_10 Protein arginine kinase 
activity of McsB is demonstrated 
by MALDI-MS and NMR 
spectroscopy. A. Mass spectra of 
selected peptide phosphorylation 
assays revealed that only peptides 
with free arginine side chains were 
phosphorylated by McsB. Tyrosine
kinase activity was excluded from 
spectra of PepR_04 and PepR_05 in 
which only the unmodified peptide 
could be observed.
 B. Other putative kinase targets such as Ser, Thr, His, or Lys were also not modified by the 
arginine kinase McsB. The kinase preferred phosphorylation of peptide strands with basic 
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amino acids, while acidic residues have inhibitory function. C. 31P-NMR spectroscopy of 
purified phosphopeptide PepR_02 (enzymatic phosphorylation), PepR_04 and PepR_07 (both 
chemical phosphorylation) reveals different chemical shifts of the phosphorous. The absolute 
values are close to the published chemical shifts of the free amino acids; pArg -2.5 ppm, pTyr 
0.5 ppm, pSer 4.8 ppm.  
 
 
c Stability of the Arginine-Phosphorylation and Enrichment by TiO2-metal oxide 
affinity chromatography 
 
Having the opportunity to selectively modify Arg residues with a phospho-moiety in a 
peptide background and reports about the presence of this modification in living cells, brought 
up the idea to establish an enrichment method that allows detection of these modifications by 
mass spectrometry. Enrichment of Ser, Thr, and Tyr phosphorylated peptides is almost a 
standard technique in proteomics and even His-phosphorylated peptides can be enriched 
(Thingholm T.E. et al., 2009; Ross A.R., 2007). As previous experiments and publications 
revealed, the arginine-bound modification is sensitive to acid treatment and might be also 
unstable under alkaline pH conditions (Sickmann A. and Meyer H.E., 2001). Unfortunately, 
the majority of proteomic separation techniques (C18-RP-HPLC, SCX) and sample 
preparation steps (quenching of the protease activity, MALDI crystallization) are carried out 
at low pH.  
The first step towards selective enrichment was to optimize purification of 
phosphorylated peptides from the kinase assays. These model peptides serve to measure the 
hydrolysis rate at different pH/temperature combinations, to determine the stability of the 
modification. Since Arg represents a putative target for tryptic cleavage, we also evaluated the 
ability of trypsin to cleave a peptide strand at the modified amino acid. Based on these data, 
we established a novel phosphopeptide enrichment protocol that allows purification of Arg-
phosphopeptides and further detection by mass spectrometry. The solid phase for the 
enrichment protocol is TiO2, but in contrast to most TiO2 enrichment protocols the pH value 
is adjusted to approximately 4-5. First, we carefully optimized the method using the standard 
phosphopeptides mix A (table TA_1). Applying the novel protocol to a chymotryptic digest of 
an in vitro kinase assay of CtsR and McsB clearly depleted unmodified peptides and lead to 
the identification of 6 phosphorylation sites in CtsR and 15 phosphorylated arginines in 
McsB.  
Purification of peptides with acid-labile modifications 
To study arginine phosphorylation in proteins more intensely, we first aimed to 
optimize the purification procedure under non-hydrolyzing conditions for standard 
phosphopeptides. In vitro, the activity of the protein arginine kinase McsB is very high 
towards proteins, while small peptides are only poorly phosphorylated. Therefore we required 
high-resolution chromatographic separation of the phosphorylation mixture. Only RP- 
chromatography provides good separation, almost complete recovery of the analyte and has 
been tested under different pH conditions. Initial experiments showed that arginine 
phosphorylation is not hydrolyzed under alkaline pH, moreover, the stability is even 
increased. Therefore we evaluated RP separation at neutral and alkaline pH conditions on 
specific pH resistant silica-based C18 material GeminiNX C18 (Phenomenex, 15 cm x 4.2 
mm).  
The separation step requires a volatile buffer in the HPLC solvents, since these 
peptides will be used in further experiments which should not be influenced by additives from 
the solvents. Several buffer substances were tested for their solubility at high percentage of 
organic modifier (ACN), their UV absorption at 214 nm, and volatility in the freeze-drying 
process, whereof ammonium bicarbonate performed best. This was mainly due to the low 
UV-absorption of the buffer that also allows detection of low levels of phosphopeptides. 
Furthermore, this substance allows 10 mM concentration at 90% organic modifier, where 
phosphate buffers already precipitated. Final HPLC solvents for isolation of standard peptides 
consisted of 10 mM ammonium bicarbonate instead of the acidic modifier. At neutral pH, we 
were able to separate 2 of 3 Arg-phosphoryated peptides sufficiently from their 
unphosphorylated counterparts, whereas the peptide PepR_16 and the histidine-
phosphorylated PepR_8 could not be resolved sufficiently, so that significant amounts of the 
unphosphorypated peptide were found in the phosphopeptide fraction. Shifting the LC 
conditions to pH 9 resulted in baseline resolution for all peptides, with the phosphorylated 
peptide eluting earlier than the unmodified peptide. Peptides with histidine phosphorylations 
were also resolved under these conditions after chemical modification with phosphoric acid 
amidate. Interestingly, for most peptides the phosphorylated form could be detected in a 
single sharp peak, while the unmodified peptide eluted in a broad signal of several minutes or 
was not even distinguished from the background signal. Acidic washing after some separation 
steps, released tightly bound unmodified peptides and thereby reconstituted the capacity of the 
C18-HPLC column. 
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Stability of ARG – phosphorylation 
As basis for an enrichment protocol, I determined the limitations of acidic treatment in 
a simple hydrolysis experiment. Therefore, the arginine phosphorylated model peptide ac-
KRGGGGYIKIIKV was incubated in a phosphate buffered solution at different pH values 
and temperatures. The formation of the unphosphorylated product was detected by LC-MS for 
different time points. All datapoints were measured at least in triplicates to obtain solid 
statistics. Ammonium phosphate was chosen as reaction buffer, since all reactions should be 
carried out with the same chemical background. Furthermore, it was easily removed on the 
trapping column prior to HPLC-MS analysis and provided good buffering capacity over 
almost the complete pH range. On the other side, high phosphate concentration could 
influence the reaction, since phosphate is one of the reaction products so that the obtained 
hydrolysis rates might be lower in comparison to other buffer systems.   
First, contribution of nano-HPLC separation to the hydrolysis was determined by 10 
consecutive injections of freshly purified peptide and separation with the optimized HPLC 
method. The abundances of non-phosphorylated and phosphorylated peptide were determined 
from the mass spectrometric data by their respective peak areas for the doubly and triply 
charged peptide ions. In average, the hydrolyzed peptide was found at approximately 7 % 
intensity with little deviation between all runs. To avoid hydrolyzing HPLC conditions, I also 
studied the elution behaviour of both peptides at pH 4.5 and 7 in comparison to the standard 
separation conditions at pH 2.6. Under standard nanoHPLC conditions both peptides were 
observed as sharp peaks with the phosphopeptide eluting approximately 40 seconds after the 
unmodified form, whereas at pH 4.5 I saw a broadening of both elution profiles and a 
reduction of the elution time difference. This effect could be due to a change in charge states 
of carboxylic acid and phospho-amidate moieties, which then interact differently with the 
solid phase and form broad peaks. At pH 7 the elution order changed, so that the 
phosphorylated peptide eluted before the unmodified form. The unmodified peptide could not 
be detected in the pure phosphopeptide sample, but indvidual injection of this peptide 
revealed a broad elution over more than 5 min even at short gradient times. This behaviour 
agreed with the observation in the purification step, where only the phosphorylated form of 
the model peptide ac-KRGGGGYIKIIKV could be isolated in a distinct fraction. Despite 
small losses due to hydrolysis, we decided to apply the acidic standard nano-HPLC-MS 
conditions to analyze the stability data, since only then both peptide forms were reliably 
detected and the peak shapes allowed quantification on basis of the UV-chromatogram and 
the MS elution profiles. 
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Incubation under strong acidic conditions (pH 1 or 2) led to rapid hydrolysis of the 
phospho-amidate bond at arginine with a half life of approx. 60 min at 25°C (figure B_11A). 
At increased temperature (60 °C) this effect was even more severe, so that the phosphate 
moiety was completely lost within the first 15-25 min (figure B_11B). Furthermore, also 
acidic hydrolysis of the peptide was observed, which led to a slight increase of the curve at 
longer reaction times, while the background signal of the phosphopeptide elution window 
remained stable. Further increase of the temperature to 95°C led to a loss of the phospho-
amidate within the first 5 min and significant peptide hydrolysis for long reaction times. 
Similar experiments with the phospho-Ser peptide ac-KSGGGGYIKIIKV and the  
  
         
Figure B_11 pH/Temperature 
Stability of the Arginine-
Phosphorylation. A. At room 
temperature, the phospho-
amidate bond hydrolyses slowly 
under acidic conditions but is 
completely stable above pH 7. 
Moderate acidic pH (pH 3) 
exhibits significant slower 
hydrolysis rates. B. Elevated 
temperatures accelerate the 
hydrolysis under strong and 
moderate acidic conditions 
dramatically. High stability is 
again observed for neutral and 
alkaline pH conditions. C. 
Acidic hydrolysis over 14 h 
leads to loss of approx. 85% of 
the phosphopeptide at room 
temperature. In contrast, almost 
no hydrolysis is observed for pH 
conditions above pH 7. 
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phospho-Tyr peptide ac-KYGGGGYIKIIKV showed no significant loss of the 
phosphorylation even after 4 h of incubation. Only little hydrolysis was observed at pH 
3/25°C within the first 30 min (figure B_11A). At longer reaction times, the signal of the 
phosphopeptide rapidly decreased, thereby demonstrating also instability under moderate 
acidic conditions. At pH 3/60°C the phospho-amidate bond was hydrolyzed rapidly within the 
first 15 min, similar to pH 1 and pH 2 (figure B_11B). 
Incubation at 25 and 60°C under neutral pH conditions exhibited only basal hydrolysis 
during the HPLC separation (figure B_11A+B), while raising the temperature to 95°C 
increased the hydrolysis rate and resulted in a half life of approximately 150 min (Fuhrmann 
J. et al., 2009). As demonstrated in (figure B_11A+B), highest stability is observed for 
moderate alkaline conditions; at pH 10 or pH 12. The percentage of unmodified peptide did 
not change dramatically over the applied incubation period and was independent from the 
temperature. Incubation of samples at pH 14 impaired HPLC-MS/MS analysis of longer 
timepoints, but the modification was still intact after short reaction times.  
To test the long term stability, as for instance in proteolytic cleavage, we performed 
hydrolysis of the phosphopeptide at 25 °C for 14 h and measured the decay of the 
phosphorylation at pH 3, pH 7, pH 10, and pH 12. In comparison to higher pH values, where 
no significant hydrolysis was detected, the amount of phosphopeptide was significantly 
decreased at pH 3 and the unmodified peptide was present to 85% (figure B_11C). This 
observation explains why samples with phosphorylated arginine should not be stored after 
acidification. Incubation of the sample at pH 7 for 5 days led to no significant formation of 
unmodified peptide, which is in agreement with the literature (Besant P.G. et al., 2009).   
Apart from the abundance, the acidic hydrolysis is one explanation why arginine 
phosphorylation was seldomly detected in recent phospho-proteomic studies, because almost 
all sample separation steps following the enzymatic cleavage were carried out at low pH. 
Strong cation exchange separation, for instance, is commonly performed at pH below 3, while 
for metal oxide-affinity chromatography on TiO2 or ZrO2 even lower pHs are applied in the 
loading and washing steps. As adaptation to this effect, we aborted the enzymatic digest by 
freezing the sample instead of adding formic acid as foreseen by many protocols. Further, we 
changed the HPLC loading buffer on the pre-column for LC-MS/MS analysis to a mixture of 
0.1% TFA, 0.05% HFBA and adjusted the pH to 4 with ammonia, because especially the 
extended sample wash for 40 min after TiO2 enrichment led to undesired hydrolysis. 
Extending the wash on the pre-column was necessary to remove the phosphate buffer, which 
would otherwise impair mass spectrometry by formation of large phosphate clusters.  
 71
Tryptic activity at phosphorylated arginine residues 
Since phosphorylation completely inverts the charge of the guanidyl moiety in the 
amino acid side chain of arginine, tryptic cleavage at the modified residue might be limited. 
For this experiment, we acetylated lysine side chains and the N-terminal amino acid of the 
model peptide YIVESKRGGGGYIKIIK before we set up the kinase reaction, because we 
were not sure, if the arginine phosphorylation is maintained upon acetylation (figure B_12A). 
Phosphorylation with McsB was performed as described to give the peptide ac-
YIVESK(ac)RGGGGYIK(ac)IIK(ac). The phosphorylated peptide was separated from the not 
phosphorylated peptide by RP-separation at pH 9 as described above. A fraction of the 
phosphopeptide and a fraction of the unphosphorylated peptide were incubated with trypsin in 
a 50:1 ratio (peptide/trypsin) at 37°C for 14 h. The efficiency of the tryptic digest was 
determined after LC-MS/MS analysis from the peak areas for the full length peptides and 
respective cleavage products. All peptide forms were identified manually based on their 
fragment ion spectra.  
 
Figure B_12 Trypsin is Not Able to Cleave at Phosphorylated Arginine. A. Strategy to 
study tryptic activity at phosphorylated arginine, other putative targets of trypsin were 
blocked by acetylation prior to phosphorylation with McsB. Phosphorylated and 
unphosphorylated peptide forms were separated and individually incubated with trypsin over 
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night. B. Almost 80% of the phosphorylated precursor remains after tryptic digestion, while 
the unphosphorylated peptide is completely cleaved, demonstrating that trypsin is not able to 
recognize phosphorylated arginines. C. A phosphorylated cleavage product was not identified, 
but low amounts of unmodified cleavage products were observed in the phosphopeptide 
sample. This suggests that trypsin can only cleave after hydrolysis of the phospho-amidate. 
 
Trypsin cleaves the unphosphorylated peptide completely, so that only the N-terminal 
and the C-terminal peptide fragments are detected. The phosphopeptide resists tryptic 
cleavage almost completely (figure B_12B+C). Nevertheless, unphosphorylated tryptic 
fragments were also identified after enzymatic cleavage of the phosphopeptide. These 
fragments resulted from the cleavage of the unmodified peptide, which is present at very low 
amounts or could be formed by phospho-amidate hydrolysis during digestion (figure B_12C). 
Since I did not detect a phosphorylated fragment in any trypsin treated phosphopeptide 
sample, I concluded that trypsin is not able to cleave at the modified arginines. 
 
 Enrichment of ARG-phosphorylated peptide using TiO2-MOAC 
As the stability experiment demonstrated (figure B_11A), strong acidic conditions led 
to a rapid hydrolysis of the phospho-amidate, thereby precluding the application of the 
previously described TiO2 enrichment protocol. To utilize the features of TiO2 enrichment, 
the pH of the loading and wash solvents has to be adjusted carefully, to minimize acidic 
hydrolysis. Moderate acidic conditions revealed higher stability for 30-60 min, which is long 
enough for phosphopeptide enrichment on TiO2.  
The loading buffer was made up from 40% acetic acid (AcOH) that contained 0.4% 
HFBA and was adjusted to pH 4.5 with ammonia. Per 1 ml of loading buffer 600 mg DHB 
were added to the AcOH solution and dissolved by carefully adjusting the pH in a range of 4-
5. This mixture was further diluted by the same volume of ACN to give a 300 mg/ml DHB 
solution in 50% ACN, 20% AcOH and 0.2% HFBA. To remove unphosphorylated peptides in 
the first washing step, ACN was added to the loading buffer up to 65% ACN, 200 mg/ml 
DHB, 13% AcOH and 0.13% HFBA. The second wash solvent contained 75% ACN, 10% 
AcOH and 0.1% HFBA and is required to remove DHB. Phosphopeptide elution was 
achieved with 30 mM (NH4)2HPO4 at a pH of 10.5. To further minimize hydrolysis, the 
sample was mixed with the loading buffer after column preparation and immediately before 
enrichment. First, 1 pmol the previously described standard phosphopeptide mixture A (table 
A_01) was spiked into 4 pmol of a tryptic digest of bovine serum albumin (BSA). This 
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sample was treated with the novel protocol to enrich phosphopeptides and deplete peptides 
from bovine serum albumin. LC-MS/MS analysis of the untreated sample and the eluted 
fractions was performed on an LCQ-XP ion trap mass spectrometer. MS/MS spectra and 
retention times were used to identify the phosphopeptides, since retention times were highly 
reproducible for all samples. Peak areas of the standard peptides in their most abundant 
charge states and 16 highly abundant tryptic BSA peptides were assigned manually after 
filtering for the precursor mass in a 1.6 Da mass window to determine the enrichment 
efficiency.  
For almost all phosphopeptides, we observed higher signal intensities in comparison to 
the untreated standard mixture, which demonstrated strong enrichment by the method (figure 
B_13A). The average signal area of phosphorylated peptides was increased by a factor of 
1.66. This increase is possibly due to reduced ionization suppression in the enriched sample, 
since coeluting unphosphorylated peptides from BSA are removed. Although two 
phosphopeptides had reduced signal areas, peptides with multiple phosphorylations were up 
to 2.5 fold more intense without the BSA background. Depletion of unphosphorylated 
peptides was monitored on peptides NoP1 and NoP2 of mix A and 16 highly abundant BSA 
peptides that were more than 3 times identified by MASCOT in the MS/MS dataset of the 
untreated sample (figure B_13A). Noise peaks significantly contributed to the signal area of 
small signals, as for instance for quantification of BSA peptides after enrichment. In average, 
unphosphorylated peptides were removed to 87% for all BSA peptides, but three peptides 
with more than four acidic amino acids in the sequence remained with relatively high 
intensities of 15-70%. Subtraction of these three acidic peptides reduced the average 
percentage of retained non phosphorylated peptides to 7%.  
To test the protocol for enrichment of arginine phosphorylated peptides 1 pmol of the 
standard peptide ac-KRGGGGYIKIIKV (PepR_02) was added to 2 pmol tryptic BSA digest 
and the TiO2 enrichment was performed. Untreated and TiO2-enriched samples were analyzed 
in triplicates by HPLC-MS/MS on an Ultimate 3000 HPLC system, coupled to an LTQ-
OrbitrapXL mass spectrometer. Peak areas of the eluting phosphopeptide were determined 
with a mass accuracy of 5 ppm and compared for both sample types. These data revealed 
again a slight increase of the phospho-peptide signal after enrichment by a factor of 1.3 
(figure B_13A). Furthermore, these data clearly show that peptides with a very basic sequence 
and arginine-phosphorylation are efficiently trapped on TiO2. The phospho-amidate moiety is 
not extensively hydrolyzed in the loading step, during sample washing, and HPLC separation.  
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Figure B_13 TiO2-Enrichment of Peptides with Acid Labile, N-Bound Phosphorylations. 
A. Feasibility of the novel enrichment protocol. Unphosphorylated peptides from 4 pmol BSA 
are reliably depleted in the loading and washing steps, but peptides with multiple acidic 
groups are still retained (light blue). Standard phosphopeptides (1 pmol) are retained and 
efficiently eluted under alkaline pH conditions. The increase in signal intensity after 
enrichment is mainly due to reduced ionization suppression effects. B. Down-facing bars 
represent peptides that have higher signal intensity after DHB enrichment; up-facing bars are 
better retained in the lactic acid method. Arginine-phosphorylated peptides are equally well 
enriched, when DHB is replaced by lactic acid as masking substance in the washing step, but 
unphosphorylated peptides are more efficiently depleted by the lactic acid protocol. 
 
Comparison of DHB and lactic acid as replacement agents 
Side effects of DHB in the loading buffer were huge background signals in the UV 
chromatogram and in mass spectra, which stem from impurities of DHB and interfere with 
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quantification of phosphopeptide signals. As described above, peptides without 
phosphorylation but many acidic amino acids in their sequence are only poorly depleted upon 
TiO2 enrichment with the DHB method. To circumvent laborious washing of the sample or 
even DHB re-crystallization prior to enrichment, I tested, if lactic acid provides equal 
enrichment quality. This reagent was earlier described as masking reagent for MOAC and is 
also included in commercial phosphopeptide enrichment kits (Jensen S.S. and Larsen M.R., 
2007). In comparison to DHB, lactic acid has a lower potential for crystallization and can be 
effectively removed by the sample washing on the HPLC trapping column. We prepared the 
loading buffer with 300 mg/ml lactic acid instead of DHB as was the washing buffer A and 
performed the TiO2 enrichment with equal amounts (2 pMol) of chymotryptic digest of McsB 
kinase after 30 min autophosphorylation. After LC-MS/MS analysis and database search with 
Protein Discoverer (Vs 1.1.0.242), we filtered the total ion current for mass traces of 
identified phosphopeptides and their unphosphorylated counterparts. By comparing the sum 
of peak areas from different charge states and of individual peptides, I demonstrated that 
lactic acid has a slightly lower efficiency to trap phosphopeptides (FIG B_13B). Interestingly, 
many peptides with a methionine residue in their sequence were found in oxidized form in the 
DHB treated sample, while lactic acid enrichment showed lesser oxidation of methionines. 
This uneven oxidation of both samples lead to the effect that individual peptide species were 
stronger represented in the DHB sample, because the peptide signals were not split over 
different oxidation states. This observation suggests a general oxidation step before 
phosphopeptide enrichment, which completely converts methionine to methionine sulfoxide 
and therefore increases sensitivity for such peptides. Focussing on the detected 
phosphopeptides, the difference of DHB and lactic acid was marginal and both reagents 
guaranteed stability of the arginine-phosphorylation. Moreover, of all identified 
unphosphorylated peptides that were identified by both enrichment methods the signal 
intensity was significantly lower for the lactic acid protocol. Even the strong acidic peptides, 
which were not depleted by DHB, were effectively removed when lactic acid was applied in 
the enrichment step (FIG B_13B). Since lactic acid efficiently prevents binding of acidic 
unphosphorylated peptides and can be effectively removed by washing, it might be the better 
choice for complex samples such as proteolytic digests of cell lysates and tissues. 
 
Phosphosite Assignment on McsB and CtsR 
Earlier publications report autophosphorylation of McsB, next to phosphorylation of its 
target protein CtsR in vitro (Kirstein J. et al., 2005). These studies have been conducted with 
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proteins from B.subtilis, whereas we detected the arginine-phosphorylation in proteins from 
B.stearothermophilus. The amino acid structure of both CtsR variants is highly conserved 
around the previously identified phosphorylation sites, pointing to evolutionary conservation 
of the protein activity. Previous experiments with small model peptides raised the question, if 
autophosphorylation of McsB might have an inhibitory effect on McsB activity. When we 
tried to phosphorylate the small model peptides, only low amounts of the desired product 
were formed and longer incubation times did not significantly increase the percentage.   
Our collaborators established the protein systems from both bacteria, B.subtilis and 
B.stearothermophilus, in vitro. To study the phosphorylation of the proteins we incubated 
CtsR from both bacteria individually with their respective kinase McsB and ATP for 30 min. 
Furthermore, we also tested the phosphorylation of B.subtilis CtsR by McsB from the 
thermophilic organism. After incubation we performed chymotryptic digestion of the reaction 
mixture and enrichment of phosphopeptides from 2 pMol protein on TiO2. Eluted peptide 
fractions were loaded onto a C18 trapping column at pH 4.5, washed for 40 min, and 
subsequently separated by nanoRP-HPLC prior to online detection and fragmentation in the 
mass spectrometer. Peptide fragmentation was performed with three different MS/MS 
methods: multi-stage activation CID (pseudo-MSn), higher-energy collisional dissociation 
(HCD) and electron-transfer dissociation (ETD). For each method two individual 
phosphopeptide samples were prepared. From these three methods, ETD covered the lowest 
number of phospho-sites, which is due to the small peptide size, achieved by chymotryptic 
cleavage (FIG B_14). This leads mainly to peptides with 2+ charge state, of which ETD 
fragmentation often results in low sequence information and therefore such spectra are lost in 
the automated database search. On triply charged ions phospho-sites were assigned very 
accurately by this method, suggesting to repeat the analysis with a different protease. HCD-
MS/MS analysis proved to identify the highest number of phosphopeptides but localized the 
modification site to other amino acid residues in 1/3 of all identified peptides. Wrong 
assignment of phosphorylated amino acids was even amplified upon fragmentation by the 
pseudo-MSn method, where only 1/3 of the hits were assigned to arginine phosphorylation.  
Interestingly, searching ETD spectra with MASCOT led to the lowest identification of 
Arg-phosphorylated peptides, while Sequest reported this modification on almost all 
phosphopeptides. This disagreement of both search engines was only observed with ETD 
data, where MASCOT might have a bias towards identification of phospho-esters. In general, 
Sequest reported slightly more phosphopeptides than MASCOT, but identification scores 
were often quite low, so that manual inspection of the spectra was necessary. 
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Figure B_14 Optimization of the LC-MS/MS Identification Process for Arginine-
Phosphorylated Peptides. Three MS/MS principles were tested for their ability to identify 
arginine phosphorylated peptides from chymotryptic digested CtsR and McsB (B. 
stearothermophilus). The obtained data were searched against an “in house” database with 
MASCOT (blue) and Sequest (red) search algorithms. Multi-stage activation CID and ETD 
MS/MS methods identify less phosphopeptides than HCD. Only 1/3 of all phosphorylations 
were assigned to arginine from multi-stage activation CID-MS/MS data. Since other 
phosphorylations than phospho-Arg can be excluded from the sample preparation, 
identification of Ser, Thr, Tyr, or His modification resulted from ambiguous assignment by 
the search engine. Interestingly, only Sequest reliably identified the Arg-phosphorylation 
from ETD data, while MASCOT was always biased towards phospho-esters. HCD MS/MS 
results in approx. 30% wrong identification of the phosphorylated amino acid. Sequest 
delivers more identified phosphopeptide hits than MASCOT. 
 
Combined results of all analyses revealed similar phosphorylation patterns of the N-
terminal domain of both CtsR variants (Figure B-15), whereas one additional phosphorylation 
site was localized to the B.subtilis CtsR C-terminal domain. All arginines are involved in 
protein-DNA interactions and thus the complex is destabilized upon phosphorylation. Since 
chymotrypsin cleaves at hydrophobic amino acids, often resulting in a complex cleavage 
pattern, most phosphorylation sites were found on at least two overlapping peptide sequences 
(table TB_4). A benefit of the acidic HPLC separation was the formation of unphosphorylated 
peptides that were separately detected and identified. The high sequence coverage of the 
unmodified peptides allowed direct comparison of MS/MS spectra between unphosphorylated 
and phosphorylated peptides and confirmed their identification. We found 15 arginine-bound 
phosphorylations in McsB, representing the majority of arginines in this protein (Figure B-15 
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and table B-04). In comparison to CtsR, where the phosphorylated arginines impair complex 
formation, the phospho-sites of McsB are widespread over the complete protein, which points 
to random phosphorylation. Interestingly, also arginine residues that were predicted to 
mediate the phospho-transfer in the active site or directly bind the ATP were found in 
phosphorylated form, which might be an explanation for the reduced activity at long reaction 
times. 
 
  
 
Figure B_15 Identified Arginine Phosphorylations in CtsR and McsB. Two variants of 
CtsR from B.stearothermophilus and B.subtilis were incubated with the respective McsB 
variants and phosphorylation sites were identified by LC-MS/MS. Most of the 
phosphorylations were found in identical positions of both proteins. Furthermore, cross 
reactivity of McsB (B.stearothermophilus) with CtsR (B.subtilis) revealed the same 
phosphorylation sites, thereby pointing to an evolutionary conserved mechanism of CtsR 
regulation. The kinase itself shows extensive autophosphorylation, which is depicted by 15 
different phosphoarginines. Red arginines are confirmed phosphosites, blue arginines were 
only ambiguously assigned in case of McsB or the spectrum quality was questionable. 
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Table TB_4 Phosphopeptides of McsB after Chymotryptic Cleavage. Peptides in the 
region 329-345 show ambiguous assignment of phosphosites, isoforms of the other peptides 
with two different phosphorylation sites were chromatographically separated and could be 
assigned to one of the two forms.  
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d Fragmentation of peptides with arginine-phosphorylation 
 
In addition to the biochemical properties, also the fragmentation behaviour in MS of 
peptides with arginine phosphorylation differs significantly from that of other phosphorylated 
amino acids. Upon thermal activation, many phosphopeptides undergo a process in which a 
neutral phosphoric acid molecule is eliminated from the peptide (Palumbo A.M. and Reid 
G.E., 2009). Since this process is almost quantitative, MS/MS spectra exhibit only a single 
intense fragment ion of the precursor M-H3PO4. The H3PO4-elimination has been extensively 
studied and for the phospho-esters of Ser and Thr several reaction mechanisms have been 
described on the base of a β-elimination reaction similar to the formation of a dehydro-amino 
acid in solution at high pH (Boersema P.J. et al., 2009). The influence of the position of the 
phosphorylation and charges in the vicinity are not yet fully understood and currently heavily 
discussed. Since this reaction is energetically preferred in comparison to the dissociation of 
the amide bond in the peptide backbone, only few fragment ions are observed upon low 
energy thermal activation such as CID-MS/MS in ion trapping mass spectrometers. In 
contrast, phospho-Tyr is not able to eliminate the H3PO4 molecule, since the aromatic side 
chain impairs β-elimination of hydrogen and formation of a triple bond (Boersema P.J. et al., 
2009). Therefore, peptides with this modification often exhibit fragment ions with the intact 
modification and losses of the phospho-moiety HPO3 (-79.966 Da) are rarely observed. 
Furthermore, this modification can still be detected as immonium ion of tyrosine, which 
allows identification of phospho-Tyr in peptides by screening for a signal at 216.043 Da 
(Steen H. et al., 2001, see figure A_6C). 
Completely surprising was the finding that phospho-His also eliminates H3PO4 under 
low-energy CID conditions, which can not be explained by the chemical structure of a  
nitrogen-attached phospho-moiety (Medzihradszky K.F. et al., 1997, Zu X.L. et al., 2007). 
Detailed MS/MS studies demonstrated that the water molecule stems from a serine residue 
next to the phospho-His in the peptide sequence. The obtained data point to a concerted 
fragmentation mechanism: first, the phospho-moiety is transferred onto the OH-moiety of the 
serine from where it is subsequently eliminated as H3PO4 (Zu X.L. et al., 2007). 
In previously mentioned CID-MS/MS studies of the CtsR protein a similar 
fragmentation was observed, where peptides with arginine phosphorylation are able to 
undergo neutral loss of phosphoric acid. Similar to phospho-His, the chemical structure 
reveals an N-P bond and is therefore not able to explain elimination of H3PO4. Since the 
arginine side chain does not posses further free OH moieties that would support the H3PO4 
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loss, the required OH-groups have to be contributed by other amino acids such as Ser, Thr, 
Asp or Glu. We studied the ability for phosphoric acid loss and backbone fragmentation in 
comparison to other peptide phosphorylations on Ser, Thr, Tyr, and His and implemented 
specific amino acids into the peptide sequence that are able to serve as OH-donors.  
 
Preparation of Peptides with Histidine-Phosphorylation 
In order to compare the fragment ion spectra of peptides with phospho-Arg with 
spectra from other types of phosphorylation, I established chemical phosphorylation of 
histidines with potassium phosphoramidate following the method described by Wei and 
Matthews (Wei Y.-F. and Mattews H.R., 2001). Short, phosphorous oxychloride was 
converted to ammonium phosphoramidate by reaction with an aqueous solution of 15% 
ammonia at 0°C. The pH of the solution was lowered to 6 with acetic acid and the organic salt 
was extracted with acetone. Ammonium phosphoramidate was crystallized at 0°C and 
subsequently crystals were washed with ethanol and diethylether. To expel the ammonia, the 
crystalline product was dissolved in 50% KOH solution and stirred at 60° until ammonia 
formation stopped. The reaction mixture was again acidified and extracted with ethanol and 
crystallized at low temperature. The product was washed again with ethanol and diethylether 
and crystals were dried under vacuum for 24 h. 
The peptide ac-KHGGGGYIKIIKV was diluted in a HEPES buffered solution at pH 8 
and twenty fold excess w/w of phosphoramidate was added to the solution. Phosphorylation 
was carried out at 30°C for 2h and the reaction mixture was directly separated by semi-
preparative HPLC at pH 9. Fractions, containing the phosphopeptide, were acidified and 
directly infused into the mass spectrometer by static nano-electrospray ionization. Since some 
experiments demonstrated significant loss of the modification upon freeze-drying, the exact 
amount of dry phosphopeptide could not be weighed. Storage for 24 h at low temperatures -
80°C, -20°C, or 4°C - did not tremendously affect the stability of the modification, while 
hydrolysis was already observed, when the sample was kept at room temperature. 
 
Fragmentation conditions 
MS/MS fragmentation studies were carried out on an LTQ-Orbitrap XL ETD, an LTQ-
Orbitrap Velos ETD mass spectrometer (both Thermo-Fisher, Bremen), and an 4800 MALDI-
TOF/TOF Analyzer instrument (LifeTechnology, Darmstadt). Peptides were diluted to 10 
mM concentration with H2O and further to 5 µM with 70% ACN, 0.2% FA for offline-
nanoESI experiments or 70% ACN, 0.1% TFA for MALDI ionization. The MALDI samples 
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were co-crystallized on the sample plate with 10mg/ml DHB in 70% ACN, 0.2% TFA, 0.1% 
H3PO4. To avoid extensive acidic hydrolysis, all peptide samples were analyzed by MS within 
30 min after the acidic dilution and crystallization. 
For ESI experiments, peptides were mounted into static nano-ESI-Emitters ES380 
(Proxeon, Denmark) and directly infused into the Orbitrap mass spectrometer with a capillary 
voltage of 800 V. Fragmentation experiments were carried out on the doubly and triply 
charged peptide ions. Low energy CID MS/MS and MS3 experiments were carried out at 
normalized collision energy (CE) of 35% and activation time of 35 ms. For HCD 
fragmentation, conditions were adjusted to leave a precursor ion intensity of 15 - 30 %. 
Peptides PEPR_19 to 23 were fragmented with an activation time of 10 ms and optimized 
collision energy for each peptide, approx. 25-28%. Prior to ETD experiments, the ETD source 
was tuned to optimal emission of fluoranthen anions. All fragment ion spectra were analyzed 
in the Orbitrap mass analyzer at a resolution of 60000 to allow unambiguous identification of 
the respective fragment ions. For MALDI MS 5000-10000 subspectra were recorded and 
summed up for the final mass spectrum and MS/MS spectra were acquired at elevated gas 
pressure in the collision tube. 
Data Interpretation 
All tandem MS spectra were manually evaluated. For ESI MS/MS a mass accuracy of 
0.01 Da was applied, MALDI data were searched with a mass tolerance of 0.1 Da. Fragment 
ions were calculated with the GPMAW software Vs. 7.0 (www.gpmaw.com, Odense, 
Denmark). Fragment ion intensities were used to compare the fragmentation behaviour of 
differently phosphorylated peptides. 
  
Stability of the phospho-amidate in ETD-MS/MS 
The phospho-amidates of His are completely stable during ion-electron reactions in 
ETD processes and previous studies with arginine-phosphorylation also demonstrated the 
stability (Kleinijenhuis A.J. et al., 2007; Fuhrmann J. et al., 2009). This observation makes 
ETD-MS/MS a very important tool for the identification of such modifications. On the other 
side, fragmentation efficiency of this method varies dramatically for different charge states 
and also depends on the amino acid sequence, therefore limiting general application of this 
fragmentation technique. Another limiting factor associated with amino acid phosphorylation 
is the reduced peptide charge, since phospho-moieties add a negative charge to the peptide. 
This effect reduces the occupation of higher charge states, which are required for ETD 
MS/MS. 
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 The ETD spectrum of the model peptide KRGGGGYIKIIKV in figure B_16A is 
obtained from the triply charged precursor at 504.2884 m/z. Apart from the C-terminal valine, 
all amino acids are covered by singly charged c- and z-type fragment ions and for the largest 
ions also doubly charged fragments were detected. None of the fragment or molecular ion 
species reveals a neutral loss of the phospho-moiety. Supplemental activation, an additional 
CID activation at very low energies adjacently to the ETD activation, does not induce neutral 
loss of H3PO4, but improved fragmentation was also not observed.  
Similarly to arginine phosphorylation, the peptide with phospho-His ac-
KHGGGGYIKIIKV formed fragment ions with intact phosphorylation upon ETD activation 
(figure B_16C). Nevertheless, some fragments with low intensity represent a different 
location of the phospho-moiety to the C-terminal lysines (data not shown). This reaction was 
not described in the original publication, but was recently studied by Kowalewska et al. and 
typically requires longer reaction times of approximately 24 h to be quantitative (Kowalewska 
K. et al., 2010). A fraction of the phosphopeptide is modified at a lysine residue in the C-
terminus, whereas it is not possible to distinguish between the two sites. Calculated from the 
signal intensities, less than 5% carry this modification. The contribution of the N-terminal 
lysine residue to the phosphopeptide signal is even more difficult to estimate, since only the 
c1 and the z12 ion are able to distinguish between the lysine and histidine modification. The 
c1 ion was not detected, but the signals of the z12 ion represented only 2% signal intensity of 
the unmodified form. These data show that side reactions have only limited contribution to the 
signal of the histidine phosphorylated peptide and further fractionation to remove the side 
products is not necessary. Shorter reaction times and lowering the pH to pH 7 might further 
suppress the formation of lysine phosphorylated peptides in phospho-His studies.     
 
CID-fragmentation of N-bound phosphorylation on arginine  
Previous reports demonstrated that next to Ser and Thr phosphorylation also phospho-
His containing peptides undergo a nominal loss of H3PO4 upon thermal activation 
(Medzihradszky K.F. et al., 1997). Interestingly, fragments ions exhibit an unmodified 
histidine and water loss from a different location in the peptide, which led to the assumption 
of translocation of the phospho-moiety during the activation process. Since the recently 
described protein arginine phosphorylation reveals similar neutral loss fragments, we tried to 
solve the mechanism of this phosphoric acid loss. Off-line fragmentation experiments with 
phospho-Arg model peptide ac-KRGGGGYIKIIKV demonstrate intense loss of H3PO4 (- 98  
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Figure B_16 MS/MS Analysis of Arg- and His-Phophorylated Model Peptides. A. The 
position of the phosphorylation in PepR_02 is only revealed by ETD MS/MS analysis with 
high sequence coverage. B. CID-MS/MS of the same peptides results in extensive elimination 
of phosphoric acid, whereas formation of sequence specific fragments is suppressed. Further, 
an additional loss of water next to the H3PO4 molecule can be observed ([M(-H5PO5)+2H]2+). 
C. Similarly, ETD MS/MS is required to locate the phosphorylation site to His2 in the model 
peptide PepR_08, which was chemically phosphorylated with phosphoramidate. D+E. Also 
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PepR_14 and PepR_16 undergo extensive neutral loss of H3PO4 in MS/MS analysis upon 
thermal activation. 
 
Da, [M(-H3PO4)+2H]2+ at 706.9405 m/z) in ion trap CID MS/MS spectra (figure 
B_16B) and additional water loss (- 116 Da, [M(-H5PO5)+2H]2+ at 697.9352 m/z) as most 
abundant signals. A similar fragmentation was also observed on other model peptides 
PepR_19 to PepR_23 (figure B_16D+E). Sequence specific fragment ions were only detected 
at low intensity. Since the phospho-moiety is attached to a nitrogen atom and only three 
oxygen atoms are covalently bound, two explanations for the loss of H3PO4 are possible: first, 
as recently described for pHis, the phospho-moiety is involved in a phospho-transfer onto an 
OH-function and subsequently eliminated as H3PO4. Second, the signal is due to extensive 
loss of two individual molecules (HPO3 and H2O) from the peptide that has the sum of 98 Da. 
The additional water loss M-H5PO5 is more likely explained by a concerted mechanism than 
by three independent neutral loss reactions. 
ESI-MS3 analysis of the neutral loss signal M-98Da at 706.9405 m/z demonstrates 
clearly that the loss of H3PO4 is split to two different locations in the peptide. From the 
dominating b-type ion series (b▲) only the previously attached phospho-moiety HPO3 
(79.966 Da) was eliminated, thereby causing a mass shift of this sequence by -79.966 Da 
compared to fragments with intact phosphorylation (figure B_17A+B). Another series of b-
ions (b?), from which H3PO4 was eliminated, was present at very low intensity except for the 
b10 ion (figure B_17B); this fragment had a quite abundant loss of H3PO4. Curiously, the 
series of y-ions (y■) exhibited a water loss (-18.01 Da, figure B_17A+C) and intact y-ions 
were completely absent. Taken together, both losses, -79.966 Da from the b-ions and -
18.0103 Da from the y-ions, exactly represent the elimination of H3PO4 from the whole 
peptide. Since water loss from the C-terminal amino acid is only a minor reaction of the 
unphosphorylated peptide, the observed fragmentation behaviour assumes a concerted neutral 
loss reaction that requires the C-terminal carboxylic acid group to eliminate H3PO4. 
Compared to other phosphorylations on S or H, this fragmentation pattern is more similar to 
that of phosphoHis, where a phospho-transfer mechanism is currently discussed (Zu X.L. et 
al., 2007, figure B_17D). Both spectra exhibit dominant b▲-ion series, whereas pSer 
fragmentation resulted in the b? fragment ions that are associated with β-elimination of 
H3PO4 within the side chain (figure B_17E). Here, b-ions are highly abundant, from which the 
whole H3PO4 molecule was eliminated, and y-ions did not extensively lose water. 
Interestingly, the pArg-peptide shows only a single y-ion series with loss of H2O, while intact 
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y-ions are also present in the pHis-peptide spectrum next to y-H2O. The observation of a less 
intense b-ion series (b?), which had lost H3PO4, and the formation of a [M-
(H3PO4+H2O)+2H]2+ ion points to the presence of a second neutral loss pathway. In this 
pathway different OH moieties are involved to eliminate the H3PO4 molecule. 
 
 
Figure B_17 Fragmentation Analysis of the Neutral Loss Species M-98Da by MS3. A. 
MS3 fragmentation of PepR_02 results predominantly in b-ions that had lost the phospho-
moiety (-80 Da, b▲), which was not expected since the precursor eliminated H3PO4 (-98 Da). 
B. The same fragmentation behaviour was observed on all N-terminal fragment ions (a▲ and 
b▲). The intensity for b-H3PO4 ions (b) was significantly lower. C. The water molecule stems 
from the C-terminal COOH-moiety, as becomes obvious from the y-ion series that was only 
identified with a loss of a water molecule. D. Similar fragmentation behaviour is observed 
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upon fragmentation of phospho-histidine containing peptides, where a phospho-transfer 
reaction is under discussion. E. The β-elimination pathway in the Ser-phosphorylated peptide 
PepR_07 leads to b-98Da fragments, therefore resulting in a completely different fragment 
ion pattern. Intact y-ions are identified in this spectrum (data not shown.) 
 
Formation of neutral loss species depends on activation parameters 
The applied activation parameters (CE 35 and activation time 30 ms) were optimized 
for the fragmentation of unphosphorylated peptides and therefore delivered more energy than 
required for the elimination of H3PO4 alone. To exclude the possibility of a loss of two 
individual neutral molecules due to the high energy level, we screened different collision 
energies to see, if signals from single molecule loss species, either M-H2O or M-HPO3, have 
higher abundance at low collision energies. Interestingly, high resolution data clearly 
demonstrate the formation of the M-98 Da signal (red) even at low CID energies as 
demonstrated in figure B_18A, whereas formation of M-H2O or M-HPO3 (green) was not 
detected. Moreover, parallel to the M-H3PO4 signal, also the species with combined 
water/H3PO4 loss (blue) appeared already at low collision energies, while the precursor 
intensity (black) dropped immediately at CE 17. Since not only the applied energy but also 
the activation time might be of importance for this reaction, we conducted experiments at 
lower activation times with fixed CID energies in which we observed the same fragmentation 
behaviour (figure B_18B).  
Data acquisition was also performed in the ion trap analyzer, since the ion trap requires 
significantly less time but has lower resolution. Acquisition of MS/MS spectra in the ion trap 
is performed in app.100 ms, which would therefore allow us to detect meta-stable ions. The 
orbitrap provides the exact mass and high resolution to determine the elimination products, 
but requires 1-2 seconds acquisition time, so that activated ions can undergo further 
fragmentation. Ion trap fragmentation of the model peptide with 5 ms activation time revealed 
identical results for the formation of neutral loss species (figure B_18C+D). These data 
demonstrate that the observed neutral loss of H3PO4 is not a product of the long detection 
process in the orbitrap analyzer. The M-H3PO4 neutral loss ion reaches a plateau at approx. 
82%, and the M(-H5PO5) signal gains a maximal intensity of 16%. To study the formation of 
other neutral loss species, we applied different CE/activation time combinations. At higher 
collision energy and lower activation times (2 ms), both neutral loss pathways for M-HPO3 
and M-(H3PO4+H2O) were significantly stronger represented (figure B_18D) and the intensity 
of the M-H3PO4 ion reduced. From this data I concluded that different fragmentation 
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pathways exist, which differ by slightly higher collision energy. Although ion trap MS 
provides shorter scan times, fragment ions according to a loss of H2O from the intact 
phosphopeptide were never detected. The M-HPO3 signal at 715.9457 m/z was observed at 
low intensities and required higher CE than elimination of phosphoric acid.  
PSD fragmentation in MALDI-TOF/TOF-MS/MS is measured within very short times 
of usually less than 1 ms but at rather high collision energies. Even under these conditions we 
observed the loss of H3PO4 (M-98Da) as base peak. Loss of HPO3 (M-80Da) had only 4% 
intensity. Interestingly, the combined loss of H3PO4 and H2O (M-116Da), which was quite 
intense in ESI-MS/MS experiments, had less intensity (~2%) than the M-80Da signal in 
MALDI-PSD spectra. This observation assumes that the additional water loss might require 
mobile protons, to form intermediate OH moieties at the amide bonds in the peptide 
backbone.  
 
 
Figure B_18 Formation of Neutral Loss Species Depends on Activation Parameters. A. 
Screening the collision energy at 35 ms activation time and acquisition of fragment ions in the 
orbitrap analyzer leads to elimination of H3PO4 (red) at a minimum CE of 17 for the doubly 
charged precursor. The precursor ion (black) is completely fragmented at CE of 30. B. 
Activation times exceeding 6 ms are required for extensive neutral loss of H3PO4 and H5PO5 
(blue) at collision energy of 35. The data were again acquired in the orbitrap analyzer. C+D. 
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Acquisition of MS/MS spectra in the ion trap provides better investigation of the neutral loss 
process. C. At 5 ms activation time, the loss of H3PO4 is first initiated at CE 16 and gains up 
to 82% relative intensity. Elimination of H5PO5 requires slightly more energy and reaches 
maximal ~16% relative intensity. D. Lower activation times (shown for 2 ms) require higher 
CE to initiate the neutral loss. At higher CE elimination of H5PO5 is significantly increased as 
well as the loss of the phospho-moiety (HPO3, green) alone, which gains little intensity. 
 
MS/MS studies of peptides with amidate- or methylester-blocked OH-moieties 
To substantiate our first idea of the neutral loss mechanism which involves the C-
terminal COOH-moiety of PepR_02, we modified the OH-groups by methyl esters or 
amidation. Thereby, we generated peptides without stable OH-moieties which could undergo 
neutral loss. The remaining OH moiety in the side chain of tyrosine is not able to eliminate 
H3PO4, therefore it is not considered as an acceptor in this neutral loss study. 
ESI-CID-MS/MS of the esterified and arginine-phosphorylated peptide PepR_17 ac-
KpRGGGGYIKIIKV-OCH3 displays again a strong neutral loss of H3PO4 which represents 
the base peak of the spectrum, similar to PepR_02. This fragmentation behaviour was quite 
surprising, since the C-terminal COOH moiety was modified and could not serve as phospho-
acceptor. Upon esterification of the C-terminus, the neutral loss species M-HPO3 (722.9512 
m/z) gained signal intensity by a factor of 27 relatively to the M-H3PO4 (713.9467 m/z) 
neutral loss ion in comparison to PepR_02 (figure B_19A). A similar, but lower increase upon 
esterification of the C-terminus was also observed for peptides with serine or threonine 
phosphorylation (PepR_06 and 07). Further, the combined neutral loss of H3PO4 and H2O (M-
116Da) was significantly reduced in the CID_MS/MS spectrum of PepR_17.  
Fragment ions of the peptide backbone showed around 2-3 times higher signal 
intensities in CID MS/MS compared to the spectrum of PepR_02. To a high percentage the 
phospho-moiety was preserved on identified b-ions during the fragmentation, while the b▲ 
series was dramatically reduced (figure B_19B) in comparison to b and b? ions. Similar to 
PepR_02, strong b-H3PO4 ions were observed starting at b10-H3PO4. CID-MS3 analysis of M-
H3PO4 resulted in a strong loss of methanol from the methylated C-terminus (697.9349 m/z) 
in addition to the H3PO4 loss in the first tandem MS step. Despite loss of H3PO4 in the first 
fragmentation step, MS3 analysis of this species revealed intact y-ions and a less intense y■ 
series, suggesting that a yet unknown functional group acts as phospho-acceptor in the neutral 
loss reaction (figure B_19C). A hint towards the involvement of amide bond carbonyl groups 
is provided by the formation of b?-ions. In MS/MS- and MS3-spectra this b?-ion series that 
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results from elimination of H3PO4 from the N-terminal part, has significantly increased 
intensity in comparison to the peptide with the free COOH-group (figure B_19B). Amidation 
of the C-terminal COOH moiety leads to similar fragmentation behavior of the peptide, which 
further strengthens the hypothesis of different fragmentation pathways for the neutral loss of 
H3PO4 in CID-MS/MS experiments (figure B_19D). 
Interestingly, also peptides with phosphoesters on Ser and Thr and methylesters on the 
C-terminus show increased intensity of sequence specific b- and y-ions but the overall 
intensity gain was lower than for pArg. From MALDI-TOF/TOF MS/MS fragmentation I 
obtained similar fragmentation patterns, but interestingly here the neutral loss species M-
HPO3 gained relative intensity to approximately 80% of the M-H3PO4 peptide ion.  
 
 
Figure B_19 Neutral Loss of Peptides Without Acidic OH-Moieties. A. CID-activation of 
PepR_17 results in extensive elimination of H3PO4 from the precursor, but the intensity of 
other fragments is significantly increased. B. N-terminal fragment ions are present with intact 
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phospho-moieties or exhibit an elimination of H3PO4, which is significantly different from the 
peptide with free C-terminus. Fragments with a loss of the phospho-moiety (-80 Da) have the 
lowest intensity. C. Intact y-ions can be observed with higher intensity than y-ions with water 
loss. D. The amidated peptide PepR_18 leads to a similar fragment ion spectrum like 
PepR_17. 
 
 
Suitability of different OH-moieties for phospho-transfer 
A neutral loss fragmentation pathway, combining the elimination of two molecules 
from different locations in the peptide, raised the question, if other OH-moieties than the C-
terminal COOH can also take part in this mechanism. Therefore we synthesized a new set of 
peptides (table TB_03, PepR_19 to PepR_23), to provide OH-groups at different locations 
within the peptide and of various reactivity: the C-terminus and the side chains of glutamate 
or serine. First, we tested the phosphorylated peptides for their ability to eliminate H3PO4 
upon low energy CID activation and if other neutral loss species can be detected in the 
resulting spectra. A good indicator for a OH moiety to be involved in the neutral loss process 
is the intensity of M-HPO3 ion, which is increased, if the OH group is less suitable to 
eliminate H3PO4 via this pathway, as demonstrated by the esterified and amidated peptides 
above. Furthermore, under such conditions backbone breaks and side reactions are more 
frequently observed.  
Peptides PepR_19 and 20 exhibited lower and upper limits of the neutral loss reaction, 
while the HPO3-loss was almost absent in the peptide with free C-terminus (Peptides 
PepR_19), the C-terminally amidated peptide had the highest percentage of this fragmentation 
type (up to 16%) under the applied conditions (figure B_20A). Replacement of glutamine 
residues by glutamic acid as phospho-acceptor either in position 3 or 12 significantly reduced 
the peptides ability to undergo the H3PO4 loss in comparison to PepR_19, which was 
demonstrated by the higher abundance of [M(-HPO3)+2H]2+. Insertion of Ser at position 12 
resulted in the second strongest loss of HPO3 from the peptide that was almost as intense as 
that of the fully amidated peptide. Therefore, serine had the lowest ability to undergo 
elimination of H3PO4 under the applied conditions. The contribution of Ser- or Thr-directed 
H3PO4-loss from N-phosphorylated peptides to the intensity of the M-98Da signal should be 
very small, if the peptide has a free C-terminal COOH group. 
Fragment analysis of the M-H3PO4 neutral loss species in MS3 spectra demonstrated 
clearly that the neutral loss required an OH-moiety (figure B_20B-K). While the peptide with 
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the free C-terminal COOH (PepR_19) produced exclusively y-H2O ions (y■) and b-ions, 
which had lost HPO3 (b▲), the amidated peptide PepR_20 exhibited also abundant series of 
intact y-ions and b-H3PO4 type ions b? (figure B_20B,C,G,H). This fragmentation pattern 
was similar to PepR_17 and 18 and might be explained by neutral loss from intermediate OH-
groups that were formed by the mobile proton. If the glutamic acid residue was located N-
terminal to the phosphorylation site (PepR_21), then the dominant b-ion series showed 
intensive H3PO4-loss as well as water loss for b-ions before the phosphorylated arginine 
residue, but included the glutamic acid (figure B_20D,I). For this peptide, predominantly 
intact y-ions were observed. PepR_22 had the glutamic acid residue located between the 
phosphosite and the amidated C-terminus at position 12. MS3 analysis of this peptide after 
H3PO4 elimination clearly allowed localization of the reactive OH moiety to this residue. The 
y-ion series exhibited intense water loss starting from the y4 ionm, the first ion with the 
glutamic acid. Further, y-ions which comprise the pArg predominantely lost H3PO4 except for 
y13. The series of b-ions with a loss of HPO3 was dominant from b6 to b11 (figure B_20E,J). 
Starting from b12, at the glutamate, the H3PO4 loss became more intense, which clearly 
revealed that this amino acid is mainly involved in the elimination of H3PO4. Similar 
observations were made for peptide PepR_23 in which the glutamic acid is replaced by serine 
(figure B_20F+H).  
All MS3 spectra of peptides PepR_20 to PepR23 contain NL species that can be 
explained by different NL mechanisms than the phospho-transfer onto the free OH-moiety 
alone. For instance, fragment ions with water losses of b3 or b4 without the N-terminal Glu  
or elimination of H3PO4 from all fragments comprising Arg6. Such fragments can be 
explained by the significantly lower ability of theses peptides, to undergo the phospho-
transfer / H3PO4 elimination with COOH moieties on Glu or hydroxyl groups of Ser instead 
of the free C-terminus. Under these circumstances, the NL pathways that led to the 
elimination of H3PO4 from peptides without free OH groups, gain higher importance in 
comparison to PepR_19, which predominantly eliminated the water from the C-terminus. 
 
Figure B_20 Neutral Loss Fragmentation of Peptides With Different Cleavable OH-
Groups. Peptides PepR_19 to PepR_23 were subjected to different fragmentation methods to 
study the neutral loss products. A. The tendency to eliminate HPO3 instead of H3PO4 is 
higher, if no or other OH groups than the C-terminus are involved. The peptide without OH-
moieties exhibits the highest elimination of HPO3, followed by the Ser-containing peptide. 
B+G. The MS3 spectrum of PepR_19 shows b-HPO3 (b▲) and y-H2O (y■) signals, which 
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were expected after elimination of H3PO4. Y-ions, having the phosphorylated arginine in their 
sequence, exhibit H3PO4 loss. C+H. Fragment analysis of the H3PO4 neutral loss ion of 
PepR_20 exhibits diverse elimination of HPO3 or H3PO4 on the fragment ion level. D+I. In 
PepR_21 the N-terminal Glu residue is involved in the elimination of H3PO4, as demonstrated 
by intense b-H2O and b-H3PO4 signals. E+J. PepR_22 forms b-HPO3 fragments up to A11; 
from E12 H3PO4 is eliminated, which clearly locates the second neutral loss position to this 
amino acid. F+K. Insertion of Ser (PepR_23) at Pos12 results in a similar fragment pattern in 
MS3 spectra as observed for PepR_22 (E+J), with H3PO4 elimination from R6 and S12. 
Interestingly, the b● ions have lower intensity than similar fragments of PepP_22.  
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Revealing the Phospho-Transfer Process upon Thermal Activation of Phospho-Arg-
Containing Peptides 
The great differences for H3PO4-elimination from Arg-phosphorylated peptides 
PepR_19 to 23 with different OH-moieties gives rise to two possible questions: are the 
different OH-moieties less accessible for the phospho-transfer or is the up-following 
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elimination of H3PO4 inhibited. To test, if the second reason explains the fragmentation 
behaviour, we wanted to know, whether we can identify phosphorylated y-type fragment ions 
which do not carry the originally phosphorylated arginine, but an amino acid with free OH-
moiety. Unfortunately, there is only a little chance to detect such fragment ions, which is due 
to the fact that the phospho-transfer does not alter mass or charge state. Keeping these two 
parameters during the transfer process, leads to additional thermal activation of the product 
species by the mass spectrometer, allowing elimination of H3PO4 since activation parameters 
are relatively independent from the type of modification.   
First, exclusive phosphorylation of Arg6 of peptides PepR_19 to 23 was determined by 
intensive investigation of ETD spectra of the 3+ and 4+ charged precursor ions that did not 
exhibit signals for phosphorylation of a different amino acid. Therefore, phosphorylated 
fragment ions in CID-MS/MS spectra, pointing to other residues than Arg5 have to be formed 
upon thermal activation. Low-energy and high-energy CID-MS/MS spectra of peptides 
PepR_22 and PepR_23 revealed signals for putative phosphorylation on y4- and y6-ions, see 
figure B_21ABI+II. In all cases, the mass increase, caused by addition of the phosphorylation 
differed only in the fourth digit from the theoretical value. Y6-ions were quite abundant, since 
they result from an amide bond break N-terminal to praline, which occurs more frequently 
than on other amino acids. The high abundance is due to the rigid ring structure of this amino 
acid, which is not able to release thermal energy by motion or rotation. In case of the 
PepR_22, the signal of the phosphorylated fragment (691.3180 m/z) was only approx. 10% of 
that of the unphosphorylated y6 at 611.3517 m/z, which could be explained by the low 
stability of the formed phospho-anhydride structure in the glutamate side chain. For PepR_23, 
signals of phosphorylated y4 (481.2176 m/z) and y6 (649.3075 m/z) were even more intense 
than that of the unmodified fragment ions (y4 401.2512 m/z, y6 569.3411 m/z) (figure 
B_21ABI+II). All putatively phosphorylated y-fragment ions were absent in CID-MS3 spectra 
of the phosphoric acid neutral loss ion, further pointing to involvement of amino acids in 
these fragments in the phospho-transfer step.  
All respective fragment ion species could be isolated and fragmented in a further 
MS/MS step. CID-MS3 spectra of unphosphorylated y6-fragments confirmed the amino acid 
sequence of the fragment ions. Fragmentation of the phosphorylated y6-fragment of peptide 
PepR_22 with the phospho-anhydride function resulted in excessive loss of phosphoric acid, 
however sequence related fragment ions could not be detected figure B_21CI+II. The y6-
fragment of PepR_23, which contained Ser instead of glutamate allowed identification of the 
amino acids in both unmodified and phosphorylated form. Moreover, in these spectra we 
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found also fragments of y6 which carried the phospho-moiety. Furthermore, MS4 analysis 
after H3PO4 elimination could further be used for sequence validation. 
 
   
 
Figure B_21 CID-Induced Translocation of the Phospho-Moiety Onto Glutamate and 
Serine A. CID-MS/MS spectra of PepR_22 (I) and PepR_23 (II) showed mainly neutral loss 
of H3PO4. B Close inspection of the low mass area revealed presence of phosphorylated y-
ions, which did not comprise the originally phosphorylated arginine. BI PepR_22 exhibited a 
phosphorylated y6 ion (y6+80) next to the unmodified form y6 and that with water loss (y6-
18). BII Two phosphorylated y-ions were identified in the spectrum of PepR_23, y4+80 and 
y6+80. C Fragmentation of the phosphorylated y6-ions of both peptides exhibits strong 
neutral loss of phosphoric acid in both cases, further confirming phosphorylation of the 
respective OH-donors under CID conditions. 
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High energy CID fragmentation in ESI-HCD-MS/MS and MALDI-TOF/TOF-MS/MS 
At elevated collision energy, bond dissociations in the peptide backbone of 
phosphorylated peptides occur more frequently. Although elimination of phosphoric acid is 
the energetically favoured fragmentation pathway, further bond breaks are induced by the 
high energy level. On average, only a single bond should be dissociated in the fragmentation 
reaction, but this also involves a high percentage of fragments with dissociation of two bonds. 
On the other side, a considerable amount of unfragmented precursor is also left in the HCD 
spectrum. In comparison, under low energy CID conditions, the single bond break is achieved 
by longer activation times at lower collision energy.  
Application of higher collision energies to fragment Arg-phosphorylated peptides 
induces the formation of peptide backbone fragment ions with intact modification as well as 
fragments with neutral loss. Higher fragmentation energy and the relatively long detection 
time in the orbitrap analyzer induce subsequent fragmentation reactions and phospho-loss 
from the fragments, which leads to a plethora of fragment ions. Most importantly, fragments 
with intact N-phosphorylation are formed and can be used for identification of the original 
phosphorylation site. Neutral loss of water or phosphoric acid in MSn spectra are often 
ambiguously interpreted for a selected fragment ion, especially if other putative phospho-sites 
such as Ser or Thr are present in the sequence. Due to the high number of observed fragments, 
some fragment ions overlap with their isotopic patterns, often reducing the chance to identify 
the original modification.  
Similar to the low energy fragmentation, under these fragmentation conditions 
predominantly a-HPO3 and b-HPO3 fragments are observed next to that with intact 
modification. In comparison, the phospho-Ser peptide results predominantly in b-type 
fragment ions with a neutral loss of H3PO4. Interestingly, y-ions are observed with highest 
intensity at their expected mass, and the water loss is significantly reduced. 
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Discussion – Part II 
 
Optimization of the protein phosphorylation analysis protocol led to the identification 
of arginine-phosphorylation in the bacterial transcription factor CtsR and first description of a 
protein arginine kinase: McsB (Fuhrmann J. et al., 2009). Both proteins have been targets of 
recent studies, which revealed incorporation of phosphate, but failed at localization of the 
modified amino acids. So far, arginine phosphorylation was only indirectly detected by 
autoradiography of proteins, followed by acidic release of the phosphate, or loss of the signal 
in EDMAN-degradation at the position of putatively modified arginine. By applying electron 
capture dissociation, a special fragmentation method in mass spectrometry, which allows 
detection of labile modifications, we identified several phosphorylated arginines in the 
sequence of CtsR. This dimeric protein is in tight complex with the DNA and thereby inhibits 
transcription of stress-related genes. Upon exposure to stress, the protein is released from the 
DNA and arginines in the DNA-binding motif are phosphorylated by McsB to inhibit re-
association of the CtsR2/DNA-complex. The inhibition is predominantly based on the 
inversion of the charge of arginine side chains upon phosphorylation, leading to electrostatic 
repulsion of the CtsR from the DNA. This model was further strengthened by biochemical 
data on the affinity of several CtsR mutants towards DNA. Interestingly, only arginines in the 
DNA-binding motif were phosphorylated, while the arginine residues in the C-terminal 
dimerization domain were not targeted by McsB. 
McsB was previously described as protein tyrosine kinase, based on phospho-amino 
acid analysis after acidic hydrolysis and tyrosine mutation. Our studies clearly revealed 
specificity towards arginine. To confirm the McsB kinase activity we conducted 
phosphorylation assays on small peptides and measured the incorporation of phosphate by 
MALDI mass spectrometry and 31P-NMR spectroscopy. Peptide phosphorylation assays 
exhibited an additional peptide signal in MALDI mass spectra only when the peptide had an 
unmodified arginine. Other amino acids, which can be phosphorylated, were not modified by 
McsB. The NMR spectrum shows only a single signal, which has a chemical shift close to 
that of free phospho-arginine. Both analyses delivered clear evidence for the arginine 
phosphorylation and excluded modification of tyrosine by McsB. Furthermore, we 
demonstrated that McsB prefers arginine residues in positively charged domains, being often 
associated with DNA-binding proteins.  
Detection of arginine phosphorylation in biological samples is still a challenging task, 
since acidic conditions should be avoided and the knowledge of phospho-arginine 
 99
phosphatases is limited. To establish an enrichment procedure that allows purification of 
arginine-phosphorylated peptides and subsequent detection by mass spectrometry, the 
hydrolysis rate was determined for several pH/temperature combinations. As previously 
described, the hydrolysis is significantly enhanced under acidic conditions but already at pH 3 
the hydrolysis rate is reduced. The modification was completely stable under neutral and 
alkaline conditions. Based on these data, a purification protocol after enzymatic 
phosphorylation of model peptides was established, to prepare pure phosphopeptides for 
fragmentation experiments in the mass spectrometer and optimization of LC-MS/MS based 
identification.  
Using the described protocol we detected 15 different autophosphorylation sites in the 
McsB sequence, which are applied upon incubation with ATP. Some of the identified 
phosphoarginines are required for enzymatic activity. This might explain reduced 
phosphorylation of small model peptides at long reaction times. 
 
 Mechanism of Neutral Loss of Phosphoric Acid Under CID Conditions 
 
Screening of MS activation parameters demonstrated that loss of H3PO4 is the 
preferred fragmentation pathway, which already takes place at lowest fragmentation energies. 
This reaction involves bond breaks at two different positions in the peptide: at an acidic OH 
moiety and the phosphorylated guanidyl side chain. Individual fragmentations from both 
positions are excluded. Since each single molecule loss would require less energy than their 
combination, higher signal intensities of these single loss species should be observed at low 
CE. Nevertheless, elimination of H3PO4 is still preferred under these fragmentation 
conditions. The observed fragmentation mechanism is independent of mobile protons, since it 
also occurs in MALDI MS/MS analysis with high frequency. Elimination of a single water 
molecule from the phosphorylated peptide was never observed and the peptide signal for an 
N-P bond break (M-80Da) alone is not present at low CEs, but gains intensity at higher 
energy levels. This behaviour would account for a high energy fragmentation pathway, which 
is also observed for phospho-esters of Ser and Thr. Furthermore, water loss from the involved 
OH-moiety is not extensively present upon CID MS/MS analysis of the unphosphorylated 
peptide. These observations strengthen the theory of a concerted fragmentation pathway, 
which connects the elimination of HPO3 from the phosphorylated side chain and the water 
loss. This mechanism could be similar to the phospho-transfer described for peptides with 
His-phosphorylation.  
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Interestingly, H3PO4 is also eliminated from peptides that do not have acidic OH 
moieties. This observation is in agreement with a second less intense neutral loss species of 
peptides with acidic OH-moieties. These are able to eliminate an additional water molecule 
next to the H3PO4 loss to form [M(-H5PO5)] ions. At elevated collision energies this type of 
fragmentation is significantly increased upon low and higher energy CID activation. Since 
this fragmentation is significantly suppressed upon fragmentation of singly charged peptide 
ions by MALDI TOF/TOF analysis, maybe the process requires mobile protons. These 
protons are located at the amide bonds and are able to intermediately form OH groups with 
the carbonyl O-atoms. Although the pathway, including the peptides C-terminal COOH 
moiety, seems to require the lowest activation energy under standard fragmentation 
conditions, the resulting tandem MS spectrum is always a mixture of different fragmentation 
pathways. Abundance of mixed fragmentation products increases the complexity to elucidate 
the fragmentation mechanism into detail. A problem of the phospho-transfer mechanism is 
caused by the equal masses of the precursor and intermediate product, a mixed anhydride of 
phosphoric acid and a carbonic acid. If the applied CE initiates the translocation of the 
phospho-moiety from the arginine to the OH group, then the newly formed species is further 
activated and almost immediately fragmented. 
MS/MS spectra of peptides with Ser or Glu as OH donors instead of the C-terminal 
COOH moiety exhibit phosphorylated fragment ion signals, which do not comprise the 
originally phospho-Arg, but the OH-donor. Since phosphorylation and sequence of these 
fragments were confirmed by MSn studies, these signal are the first evidence for the 
translocation of phospho-moieties of N-phosphorylated peptides under thermal activation 
conditions.  
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Outlook – Identification of N-bound Phosphorylations in Cells 
 
The limited knowledge about abundance and biological function of nitrogen-bound 
protein phosphorylations in cells as well as enzymes that apply or remove this modification 
makes this research field highly important and interesting. Especially, since bacteria seem to 
use such modifications more often than eukaryotes, identification of the respective proteins 
might be the basis for the development of novel antibiotics, which will be directed against 
specific bacteria and cause less side effects to eukaryotic cells. The presence of these 
modifications in eukaryotic cells has been demonstrated for phospho-His in yeast and 
phospho-Arg in liver and heart, whereas the latter did not directly identify the modification 
(Wakim B.T. and Aswad G.W., 1994; Levy-Favatier F. et al., 1987).  
Phosphorylation of His, Arg, and Lys leads to charge inversion in the side chains of 
these amino acids which alters the interaction with other molecules. Due to the positive 
charge of the unmodified side chain, these amino acids have often crucial roles in DNA or 
RNA recognition. As demonstrated by the CtsR/McsB regulatory system, especially DNA-
bound transcription factors are effectively removed from the DNA and binding is inhibited. 
Therefore, N-phosphorylations would be highly valuable to adjust the activity of transcription 
factors and could also be present in eukaryotes.  
In bacteria and plants, sensing of extra-cellular conditions is often associated with 
receptor-His-kinases, which demonstrates the importance of this post-translational 
modification. Starting characterization of these modifications in bacteria is also supported by 
the low amount of phospho-esters, being present in these cells (Miller M.L. et al., 2009). 
Since the presented enrichment strategy allows purification of all peptide phosphorylations, a 
large fraction of Ser, Thr, or Tyr phosphorylation would definitely impair identification of N-
bound phosphorylations. So far, approximately 100 phospho-esters have been identified in 
bacteria from rather large sample amounts, demonstrating that this modification is 
underrepresented. Since also other signalling processes might use phosphorylation of arginine 
or histidine, phosphoproteomic studies in bacteria could lead to the identification of novel 
therapeutic targets. Furthermore, this could be the basis to develop strain-specific antibiotics, 
to deal with the rising problem of multi-drug resistant bacteria in hospitals or huge farms.   
Many histidine kinases were also identified in plants that also utilize the two- 
component systems to screen environmental conditions. Since plants have developed both 
phospho-signalling forms, with stable phospho-esters and labile phospho-amidates, this 
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system is not yet optima for proteomic studies. Furthermore, many separation methods and 
sample preparation steps have not yet been adopted to plant samples. 
Animals, in comparison, developed multiple cellular pathways which rely on Ser, Thr, 
and Tyr phosphorylation. O-phosphorylation is found on numerous proteins and should be 
removed before N-phosphorylations are analyzed. Nevertheless, recent publications about 
protein arginine phosphorylations in rat and bovine cells indicate the presence of this 
modification also in higher eukaryotes. Furthermore, it is believed that His-phosphorylation 
occurs approximately 100 times more often in eukaryotic cells than tyrosine phosphorylation 
(Steeg P.S. et al., 2003). A model system for histidine phosphorylation in eukaryotic cells is 
the membrane-bound SLN1 receptor kinase of yeast cells, which is a bacterial-derived 
histidine kinase (Thomason P. and Kay R., 2000). This receptor is the initiating protein of a 
phospho-relay system and involved in osmolarity sensing and represents a second signalling 
mechanism to activate salt stress response. 
   
Figure B_22  
Strategy for 
Identification of 
Peptides With N-
Bound 
Phosphorylations 
from Whole Cell 
Lysates. 
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Appendix 
Chemical Cross-Linking and Mass Spectrometry 
 
Introduction 
 
Protein Structure and Function 
 
After synthesis in the ribosomes, most proteins undergo an extensive process, where 
they receive a specific folding that is often combined with the formation of intracellular 
disulfide bonds. This protein folding is required to guarantee the optimal function of the 
protein and often associated with chaperone function to diminish aggregation of misfolded or 
unfolded proteins. During this process, protein domains are established and contacts between 
different parts of the protein are correctly formed. 
A loss of the specific structure normally leads to replacement and intracellular 
cleavage of the protein, but it can also have severe effects on the cellular health, if large 
aggregates are formed. Folding stresses can be associated with aggregation of the misfolded 
proteins to large particles, so called “inclusion bodies”, which are difficult to remove by 
disaggreases and proteases. Therefore, studying protein structure is a highly important field of 
biochemistry and many methods have been developed to reveal protein folds in different 
levels of resolution. The high-resolution techniques, NMR spectroscopy and X-ray 
crystallography, have resolved many different structures, but they have a significant bias 
towards stable and soluble proteins. Low-resolution methods are often not used to reveal new 
structures but they can deliver important details of structural changes and protein-protein 
interactions. Method such as cryo-electron microscopy or chemical cross-linking that result in 
low resolution structures are often less sensitive to buffer conditions, protein amount, purity, 
and stability. On the other side, data interpretation of distance constrains, which are obtained 
from these methods often require a high resolution structure of the protein of interest or at 
least a related protein or protein domains.   
 
Chemical cross-linking of proteins 
 
In most cases, protein complexes are not stabilized by covalent bonds, so that they 
associate and dissociate depending on intracellular conditions. Such alterations might be due 
to extra-cellular signals, drugs or a changed localization of the protein that could induce 
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structural changes, which favour or diminish complex formation. High-resolution techniques 
for structural investigations can often not be applied to visualize theses changes. This is due to 
the fact that their sample preparation conditions and analysis times are rather unsuitable to 
stabilized transient interactions. 
Chemical cross-linking was introduced in the 1970s to identify specific protein 
complexes and identify putative new binding partners. Since the late 1990s this technique 
evolved from its nichè, when mass spectrometry was available to unambiguously identify 
binding partners as well as putative interaction sides as demonstrated in figure App_01. Since 
then, the combination of chemical cross-linking and mass spectrometry became a popular tool 
to study protein structures and protein-substrate complexes.  
Upon chemical cross-linking, a small organic molecule with two defined reactive 
moieties is added to the protein solution, where it interconnects reactive groups of spatially 
near protein domains in a specific distance. The aim of the method is to maintain the 
structural integrity of the complex, which is achieved by incorporation of a low number of 
cross-links into the protein. Subsequently, this reaction mixture is often separated by gel 
electrophoresis to selectively enrich the cross-linking products that often have different 
electrophoretic mobility (Sinz A., 2003). These products are conducted to enzymatic cleavage 
and analysed by nanoRP-HPLC-MS/MS. Cleavage of such proteins generates up to four 
different types of cross-linking products: peptides, having a cross-linker molecule bound at 
the reactive amino acid side chain, interconnected amino acids within one peptide, and 
products with two connected peptide strands, stemming from the same protein or two 
different proteins (figure App_02A). Subsequent data interpretation is not as straight forward 
as simple peptide identification, since attached peptide sequences can have a high variability 
which is not considered by standard search algorithms.  
Recently, specifically designed cross-linking reagents have been used to facilitate the 
identification process (Sinz A., 2003). For instance, introduction of isotopes in the spacer 
region of the reagent leads to a defined mass shift of ion signals of cross-linking products in 
the mass spectrum. Upon application of a mixture of two isotopically coded reagents for 
chemical cross-linking, peptide signals, which are modified by a cross-linker are easily 
identified by the presence of two peptide isotope patterns in the MS spectrum. Normal 
peptides have only a single isotopic envelope. Implementing a third functional group into the 
cross-linker can help to purify reaction products after enzymatic cleavage, for instance by 
affinity chromatography. This method improves detection of cross-linked peptides that are 
often observed at very low intensity, since all normal peptides are removed from the reaction 
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mixture. Finally, to facilitate identification of the connected peptide strands, cross-linking 
reagents that can be cleaved in a first fragmentation step in the mass spectrometer are 
available. The peptide sequences are than investigated by MS3 fragmentation of the cleavage 
products 
 
Figure App_01 Strategy for Structural Analysis of Protein Complexes by Chemical 
Cross-Linking and Mass Spectrometry. After fixation of the three-dimensional structure by 
incorporation of covalently bound cross-linkers, the reaction mixture is separated according to 
the size of the components. Enzymatic digestion produces small peptides fragments, which 
are analyzed by HPLC-MS/MS. Interpretation of MS data is carried out by a combination of 
automatic and manual interpretation steps. 
 
Analysis and interpretation of cross-linking data in structural context requires at least a 
low resolution structure of the investigated protein or a structural homologue. First cross-
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linked peptides are identified based on their mass. Additionally, a database consisting of all 
putative cross-linking products has to be generated. Therefore, the masses of both peptides 
and an additional mass shift of the cross-linker have to be added for all possible combinations 
of interconnected peptide. Due to the high number of theoretically possible cross-linking 
products, the number of protein entries is often resticted. In the second step candidates are 
evaluated on the basis of their fragment ion spectra. Despite some effort has been put into 
automated analysis of MS/MS spectra of cross-linked peptides in the recent years, data 
processing is still a laborious step and often only manual inspection allows unambiguous 
assignment. This is mainly due to fact that two different peptide sequences are represented in 
the fragment ion spectrum and the modification at the cross-linked amino acid is highly 
variable in its size and composition as the schematic demonstration in figure App_02B shows.  
Next, the identified interconnected regions in the protein have to be matched into a 
structure model with regard to the spacer length of the cross-linker and the flexibility of the 
protein chains. The length of the spacer-region between the two reactive moieties of the cross-
linker defines the maximal distance for this linkage and can be used as a distance constrain to 
map structural features. 
 
 
Figure App_02 Cross-
Linking Products and 
MS/MS Fragmentation. A 
Cross-linking of two 
different proteins gives rise 
to four possible products. B 
Fragmentation analysis of 
cross-linking products leads 
to complex fragment ion 
spectra. This complexity is 
caused by backbone 
fragmentations of both 
interconnected peptide 
strands and the variability 
of the modification for each 
cross-linking product and 
fragment ion.    
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A related method uses mono-reactive reagents of a defined reactivity, for instance 
towards primary amines, to map the surface accessibility of protein domains. These data can 
further be used to refine the topology and to identify localisation of proteins and their domains 
within a complex. Data from protein labeling experiments are more difficult to interpret based 
on the protein or complex structure, but incubation of single proteins and comparison to the 
protein complex can easily reveal the interacting peptide stretches. This technique requires 
significant complex stability and is not applied to study transient protein interactions. 
 
Projects 
 
A In co-operation with Prof. Dr. A. Sinz and M. Müller of the University of Halle 
in Germany we investigated the structural changes of the PPAR2α receptor upon interaction 
with two different inhibitors.  
 
Recently, chemical cross-linking in combination with mass spectrometry was used to 
determine interaction epitopes of proteins with peptides or larger biomolecules such as other 
proteins or DNA. Protein-small molecule interactions can also induce decent structural 
changes but these were believed to be indistinguishable from the natural flexibility of protein 
structures when analyzed with chemical cross-linking. To demonstrate different 
conformational changes in peroxisome proliferator-activated receptors (PPARs) caused by the 
binding of two different antagonists (GW6471, IC50=0.24 µM and YS81, IC50=7 µM), the 
cross-linking protocol and LC-MS/MS analysis were optimized. PPARs are nuclear receptors 
which sense fatty acids and eicosanoids as well as anti-diabetic drugs (Qi C. et al., 2000; 
Plutzky J., 2003). To bind to specific DNA sequences and act as transcription factor, these 
proteins dimerize with retinoic X receptors (Issemann I. et al., 1993). The ligand binding 
domain of PPARα was expressed, purified, and cross-linked in the presence of 10 µM of one 
of the two antagonists. To determine cross-links which are due to conformational changes, 
results were compared to a sample without incubation with inhibitor. The cross-linking 
reagents, bis-sulfosuccinimidyl-glutarate BS2G and bis-sulfosuccinimidyl-suberate BS3, were 
amine reactive and targeted lysine side chains. In individual experiments, cross-linkers were 
added in 50 and 100 molar excess over the purified receptor and incubated for 30 and 60 min. 
Samples were digested “in gel” by combination of trypsin and Asp-N to generate small 
peptide strands which could efficiently be eluted from the polyacrylamide gel. Sample 
analysis was performed by nanoC18RP-HPLC on an Ultimate Dual Gradient system which 
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was directly coupled to an LTQ Orbitrap hybrid mass spectrometer. The mass spectrometer 
was operated in positive ionization mode. 
To improve detection of cross-linking products by mass spectrometry, two different 
fragmentation techniques were applied for fragmentation of eluting peptides. After detection 
of the peptide signals in the survey scan, the three most abundant precursor ions were selected 
for fragmentation by low-energy CID MS/MS in the ion trap part and a second fragmentation 
of the same precursors was carried out in the C-trap under higher collision energy. 
Fragmentation of cross-linked peptides under standard conditions produces often an 
insufficient number of fragments to identify both strands and it is associated with extensive 
neutral losses of small molecules such as water or ammonia. High-energy fragmentation 
induces more backbone fragmentations and provides high resolution and high mass accuracy 
since these scans are measured in the orbitrap analyzer.  
 
Figure App_03 MS/MS spectrum of the identified cross-link NFNMNKVK-KT from 
PPAR2α. After incubation with the inhibitor, cross-linker BS3 was added to the reaction 
mixture. The resulting cross-link sample was enzymatically cleaved with a combination of the 
proteases AspN and trypsin and subjected to HPLC-MSMS analysis. The presented cross-link 
was identified from the fragment ion spectrum and the two isotopic envelopes of the precursor 
signal which resulted from the reaction with isotopic variants of the cross-linker with 0 and 4 
deuterium atoms. 
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 Obtained data for both inhibitors indicate different binding modes of the two 
substances to the PPAR ligand binding domain. While GW6471 induces significant 
conformational changes which are indicated by the newly formed cross-links between 
Lys222/Lys449 and Lys252/Lys449. These cross-links were not found in the free receptor 
form or the sample with YS81 as inhibitor. A possible explanation for the two binding modes 
comes from the size of the inhibitor molecules, while GW6471 is able to fill the binding 
pocket completely, YS81 is too small and will leave higher flexibility. The obtained distance 
constraints were compared to the crystal structure of the ligand binding domain of PPAR2α in 
complex with the antagonist GW6471. 
 
 
B Localization and orientation of protein subunits of the core complex of 
salmonella’s Type III secretion system were studied with acetyl labelling and chemical cross-
linking of lysines in co-operation with Dr. T. Marlovits, O. Schraidt and M. Brunner (Institute 
for Molecular Biotechnology, IMBA, Vienna) 
 
Structural studies of integral membrane proteins and protein complexes is a 
challenging task because these proteins tend to precipitate even at low concentrations which 
often impairs crystallization and NMR analysis. For the investigation of large integral 
membrane protein complexes EM is often the method of choice (Marlovits T.C. et al., 2004). 
Unfortunately, the obtained low resolution structure often misses the protein orientation 
localization of individual proteins and protein domains. By combination of EM and chemical 
cross-linking/labelling we were able to refine the structure of the core complex of the Type III 
secretion system (needle complex) of salmonella thyphimurium.  
The core complex of the type III secretion system is approx. 3 MDa large and consists 
of 5 different proteins which are present in multiple copies (figure App_04, Zhou D. and 
Galán J., 2001). These proteins, InvG, PrgH, PrgK, PrgJ, and PrgI interact with numerous 
other proteins in the cytoplasm such as chaperones which relocate the complex within the 
membrane or prepare the secreted effector proteins. Two proteins PrgH and PrgK form a ring- 
like structure which permeates the inner cell membrane of salmonella. These proteins interact 
with chaperones and disassembled proteins which enter the channel of the needle at this 
position. PrgH is thereby located at the outer rim, while PrgK forms a central ring and the 
entrance to the secretion channel (Marlovits T.C. et al., 2004).  
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Attached to the outer membrane is a second ring which consists of the proteins InvG 
and PrgJ. It is widely accepted that InvG is the major structural component of this ring which 
crosses the outer bacterial membrane, whereas PrgJ is assumed to form the inner basis of the 
outstretching needle. InvG is also involved in protein-protein interactions with proteins in the 
outer membrane which stabilize and localize the needle. Finally, multiple PrgI subunits form 
the needle tip which then interacts with the host cell membrane to transfer the secreted 
proteins.  
 
 
Figure App_04 The Core Complex of the Samonella Type III Secretion System. The so-
called needle complex consists of multiple copies of 5 proteins, InvG, PrgH, PrgI, PrgJ, and 
PrgK. PrgK (orange in left structure) and PrgH (yellow) form the intracellular ring which 
crosses the inner membrane. The outer membrane ring consists of the protein InvG (blue) 
which stabilizes the needle rod which is constructed from PrgJ subunits (red). The needle tip 
which interacts with the host cell membrane is solely made up from PrgI (green) molecules. 
In EM, all structures of the complex can be identified, but localization and orientation of 
individual proteins is elusive. 
 
 
Individual protein species were removed by mutation of the respective gene by our 
coworkers in the laboratory of T. Marlovits. To enlighten the location of the subunits and the 
altered surface accessibility, we set up an acetyl labelling experiment. The wild type (wt) 
complex and the mutant which lacks the InvG protein, and therefore the outer membrane ring 
(figure App_05A EM images, left wt complex, right InvG mutant), were labelled on lysine 
residues by N-sulfosuccinimidyl acetate. Equal amounts of both complexes were digested 
with chymotrypsin and analyzed by nanoRP-HPLC-MS/MS. To quantify the incorporation of 
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the acetyl label, signal areas for identified peptides which posses a lysine residue were 
extracted for the label-free and the acetylated form. By comparing the percentage of acetyl 
incorporation between the two complex forms, we found a significant increase of acetylation 
on all peptides of PrgJ (data not shown) and for Lys168 of PrgK (see figure App05A) in the 
InvG mutant complex. On average, PrgJ peptides showed six times higher acetylation while 
the acetylation of other lysines in the whole complex was not affected by the mutation. The 
first observation confirms the location of the PrgJ to the center of the complex, while it is not 
accessible for the reagent in the wt complex, removal of the surface protein InvG facilitates 
acetylation. Mapping of Lys168 of PrgK into a model of the complex revealed its location to 
the interface between inner membrane ring and outer membrane ring (figure App_05A). 
Removal of the InvG protein brings this residue to the newly formed surface and therefore 
enhances reaction with the acetylation reagent.  
To study such large protein complexes by chemical cross-linking, we had to adapt the 
complete sample preparation procedure and LC-MS/MS method to increase the sensitivity. 
Cross-Linking was attained by addition of BS2G in non-deuterated and fourtimes deuterated 
isotope–coded form to facilitate identification of cross-linking products. Thereby, two isotope 
envelopes are generated in the MS scan which are separated by 4 m/z. Separation of the cross-
linked sample by SDS-Page revealed covalently connected dimers of all components of the 
complex and heterodimers of InvG with PrgI and PrgJ and PrgH with PrgK. SDS-PAGE 
delivers a good resolution of protein but the subsequent enzymatic cleavage has low 
efficiency and especially long polypeptide chains remain in the gel upon elution which 
excluded them from MS analysis. The in-gel processed samples delivered no interconnected 
peptides. Since cross-linking expects the formation of bigger peptide assemblies we decided 
to perform an in solution digest. Due to the nature of the transmembrane domains, the protein 
complex required the presence of a detergent to be stable in solution which reduces enzymatic 
activity of the cleaving protease dramatically. Therefore we chose to add enzyme in a 
sample/enzyme ratio of 15:1 in 4 steps. The second addition was made after 3 h of digestion 
and then every 10 h and the digest was carried out for 35 h (over two nights). Since no 
effective orthogonal separation technique such as strong cation exchange chromatography 
was available for the limited sample amount, we applied a very long gradient on the nano-
C18RP-HPLC separation system to guarantee efficient separation of individual peptide 
species. Mass spectrometric analysis was performed with the double fragmentation method 
(see project 1) which produces two fragment ion spectra for an individual peptide species by 
low-energy CID and high-energy HCD collision. Extended gradient time and the specific 
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detection method increased the size of raw data files to more than 1.5 GB which required data 
reduction before automatic database search with the Xquest software (Rinner O. et al., 2008). 
A second problem of cross-linking is detection and identification of products by mass 
spectrometry. Due to the chemical nature of the deuterium, the heavy peptide form eluted first 
from the column and was therefore more often selected for fragmentation analysis than the 
light form. This underrepresentation of the light isotope is due to limitations of the mass 
spectrometry software to identify such isotope pairs as cross-linking products of the same 
peptide. Normally such signals are excluded, because fragmentation would result in a mixed 
MS/MS spectrum of two different peptide sequences which cannot be interpreted by actual 
MS interpretation algorithms.    
Chemical cross-linking of the Salmonella needle complex revealed interactions of the 
N-terminal domain of InvG with the C-terminal domain of PrgH. Thereby, Lys 38 of InvG 
and Lys368 in the PrgH sequence were covalently connected. This protein-protein interaction 
is quite interesting because it is located in between the two transmembrane rings of the 
complex. Deletion of the PrgH C-terminus by mutation in later experiments was associated 
with higher instability between these domains which lead to detachment of the inner 
membrane ring upon shearing forces during EM sample preparation. Further, the cross-linker 
connected the N-terminal PrgH domain with the C-terminal domain of PrgK at the basis of the 
inner membrane ring. This region faces towards the cytoplasm and is therefore highly 
accessible for modification. Based on these data we were able to determine the orientation of 
three components of the needle complex. Both proteins of the inner membrane ring, PrgH and 
PrgK, face into opposite directions. The N-terminus of PrgH is located in the cytoplasm and 
the C-terminus in the periplasmatic region between inner and outer membrane. The C-
terminus of PrgK is mainly cytoplasmatic and interacts with the PrgH N-terminus, while the 
N-terminus protrudes through the membrane and forms the inner basis of the needle structure. 
The InvG protein adopts the same orientation as PrgH. The N-terminus faces towards the 
inner membrane, while the C-terminal domain perforates the outer cell membrane. 
Cross-linking products were not found for the other two proteins which might be a 
consequence of the location of PrgJ and the amino acid composition of PrgI. PrgJ is found in 
the center of the structure and has no accessible surface area apart from the channel which 
might be to small for the cross-linking reagent to penetrate. Furthermore, it is not known 
which amino acids form this channel.  
Modification of PrgI lysines leads to very hydrophobic peptides after enzymatic digest, 
therefore these peptides might be lost in the RP-separation step.  
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Figure App05 Results for Acetyl-Labelling and Connected Domains Between Different 
Protein Species in the Needle Complex. Acetyl labeling reveals enhanced incorporation of 
the label to Lys168 of PrgK when InvG is deleted from the complex. In the wt complex (left 
EM image) this residue is shielded by the outer membrane domain, whereas in the mutant 
complex (right EM) this residue is located at the newly formed surface. Modelling of the 
PrgK structure and the inner ring formed of PrgK subunits confirms localization of this 
residue to the interface between inner and outer membrane domains of the complex and 
explains higher accessibility in the InvG mutant. B Cross-linking analysis demonstrated 
interaction of the N-terminus of PrgH with the C-terminus of InvG at the interface of the two 
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membrane rings. The PrgH N-terminus and the PrgK C-terminus are located within close 
proximity in the intracellular domain of the needle complex. Gray bars indicate 
transmembrane domains. 
 
 
C Interaction site determination and orientation of Myotilin-IG domains upon 
dimerization were studied in co-operation with Prof. K. Djinovic-Carugo (University of 
Vienna, Vienna) 
 
Immunoglobin (IG)-domains are specific protein-protein interaction domains which 
are very common in proteins of the cytoskeleton. Thereby, two structurally similar domains 
interact with IG-domains of a different protein molecule and form tight complexes. To study 
the dimerization of protein IG-domains of myotilin, these domains were individually 
expressed with an N-terminal His-tag and purified. Dimer formation was monitored by small 
angle X-ray scattering (SAX) and interacting regions of the dimer should be identified by 
chemical cross-linking and mass spectrometry. The preformed complex was incubated with 
two cross-linking reagents in individual experiments. One cross-linker was ethylene glycol 
bis[succinimidylsuccinate] (EGS) which has a spacer length of 16.1 Å and interconnects two 
lysine-ε-amino groups. The second reagent system was EDC/NHS which represents a zero-
length cross-linker that forms an amide bond between spacially close amine and carboxylic 
acid functions of Lys and Asp/Glu. Reaction products were separated by SDS-PAGE, protein 
bands which correspond to monomeric and dimeric forms were excised, tryptically digested, 
and analyzed by HPLC-MS/MS as described previously. 
Both reagents were not isotopically labelled, so the easily recognizable isotopic 
envelopes in MS spectra were missing. Therefore, a different strategy for data interpretation 
and distinction of cross-linking products had to be established. After extraction of peptide 
signals from the survey scans, all signals in the range of 500-5000 m/z were compared to a set 
of theoretical cross-linking products using the GPMAW software (www.gpmaw.com). A 
sample which was not subjected to cross-linking was also matched against the database to 
reveal peptides which have similar mass to putative cross-linking products. Such false 
positives were discarded. Overlapping cross-links of dimeric and monomeric proteins were 
separated from the dimer-only matches since these cross-links define the three-dimensional 
structure within one subunit, but have no information on the interaction epitope. For further 
verification of a dimer specific cross-link, the abundance of the peptide signal was compared 
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between monomeric and dimeric sample. If the same signal was found only in the dimer 
sample, the link would be specific for the interaction of two IG domains.  
Using this strategy we derived a single dimer specific link EHKR-EHK which 
interconnected the same amino acid regions of two IG domains see figure APP_05. The 
number of intramolecular links was significantly higher (table App_1). 
 
Figure App06 Connection of the Same Peptide Strands Identifies the Dimerization 
Region of Myotilin-IG Domains. The fragment ion spectrum clearly identified both peptide 
sequences of the cross-link EHKR-EHK (amino acids sequence A 153-156, sequence B 153-
155) in the IG domain dimer. Sequence α is well identified by many fragment ions, while 
sequence β delivers only a single fragmentation. This ion is verified by two charge states and 
multiple water losses.  
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This cross-link product is exclusively found in the dimeric sample at a retention time of 
approx. 13 min; the same signal is completely absent in the monomeric sample. 
 
 
Table App_1 Identified Cross-Linking Products of Myotilin-IG Domains Cross-Linked 
with EDC/NHS.  
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Appendix 
Detection of Methyltransferase andDemethylase Activity on Small Model 
Peptides by Mass Spectrometry 
 
The project was a co-operation with the laboratory of T. Jenuwein (now MPI for 
Immunology, Freiburg). Protein tagging and purification was performed by the members of 
the TJ-Lab.  
 
Numerous reversible protein modification have been identified in the N-terminal 
domains of histones, the so-called “histone tails”. Since histones are tightly associated with 
DNA, these modifications are essential for the regulation of transcriptional processes and they 
comprise acetylation or methylation of lysines or arginines and phosphorylation of serines. 
Acetylation and phosphorylation are generally associated with transcriptional activation, 
while methylation often causes silencing of the respective DNA region. Furthermore, binding 
of specific transcription factors depends on the modification state of the DNA.  
In most cases methylation and acetylation are antagonistic processes which are found 
on the same amino acids within the histone sequence in different cell states. The field of 
epigenetics is quite young, so that only a limited number of histone modifying enzymes has 
been described so far.  
To test a higher number of putative enzymes with demethylase activity we developed a 
fast assay to detect removal of the methylation mark on small model peptides. These peptide 
sequences perfectly resemble the N-terminal strands of different histone variants (the so-
called “histone tails”). The peptides already carry the respective lysine methylation which 
should be removed by the enzyme. In demethylase assays, candidate proteins are tagged for 
purification and the purified protein is incubated with individual model peptides. Assay 
conditions were optimized with regard to detergents, salt concentration, and buffer 
composition to allow direct MS analysis of the mixture. Therefore, samples were acidified 
and diluted with the matrix substance and directly placed on a MALDI sample plate. 4000 to 
6000 sub spectra were automatically acquired for one MALDI MS spectrum which was then 
investigated for the presence of peptides in lower methylation states. The signals of these 
reaction products should exhibit a mass decrease of 14 Da in comparison to the precursor 
peptide. 
Using this protocol, we confirmed demethylase activity of the proteins Su(var)3-3 and 
JMJD2 as well as methyltransferase activity of SetD6.   
 118
References 
 
 
Agrawal G.K., Thelen J.J., Large scale identification and quantitative profiling of 
phosphoproteins expressed during seed filling in oilseed rape. Molecular and Cellular 
Proteomics 2006, 5, 2044–2059 
 
Alpert A.J. Electrostatic Repulsion Hydrophilic Interaction Chromatography for Isocratic 
Separation of Charged Solutes and Selective Isolation of Phosphopeptides. Analytical 
Chemistry 2008, 80 (1), 62-76 
 
Annan R.S. and Carr S.A., Phosphopeptide analysis by matrix-assisted laser desorption time-
of-flight mass spectrometry. Analytical Chemistry 1996, 68, 3413–3421 
 
Arnott D., Shabanowitz J., Hunt D.F. Mass Spectrometry of Proteins and Peptides: Sensitive 
and Accurate Mass Measurement and Sequence Analysis. Clinical Chemistry 1993, 39 (9), 
2005-2010 
 
Attwood P.V., Piggott M.J., Zu X.L., Besant P.G. Focus on Phosphohistidine. Amino Acids 
2007, 32 (1), 145-156 
 
Bailyes E.M., Bennett D.L., Hutton J.C., Proprotein-processing endopeptidases of the insulin 
secretory granule. Enzyme 1991, 45, 301-313 
 
Bantscheff M., Eberhard D., Abraham Y., Bastuck S., Bösche M., Hobson S., Mathieson T., 
Perrin J., Raida M., Rau C., Reader V., Sweetman G., Bauer A., Bouwmeester T., Hopf C., 
Kruse U., Neubauer G., Ramsden N., Rick J., Küster B., Drewes G. Quantitative chemical 
proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nature 
Biotechnology 2007, 25, 1035-1044 
 
Beausoleil S.A., Jedrychowsky M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., 
Cantley L.C., Gygi S.P. Large-scale characterization of HeLa cell nuclear phosphoproteins. 
Proceedings of the National Academy Sciences 2004, 101, 12130-12135 
 
Besant P.G., Attwood P.V., Piggott M.J. Focus on Phospholysine and Phosphoarginine. 
Current Protein and Peptide Science 2009, 10 (6), 536-550 
 
Blume-Jensen P. and Hunter T. Oncogenic Kinase Signalling. Nature 2001, 411, 355-365 
 
Bodenmiller B., Müller L.N., Müller M., Domon B., Aebersold R. Reproducible isolation of 
distinct, overlapping segments of the phosphoproteome. Nature Methods 2007, 4, 2331-237 
 
Boersema P.J., Mohammed S., and Heck A.J.R. Phosphopeptide fragmentation and analysis 
by mass spectrometry. Journal of Mass Spectrometry 2009, 44, 861-878 
 
Cantin G.T., Shock T.R., Park S.K., Madhani H.D., Yates III J.R. Optimizing TiO2-based 
phosphopeptide enrichment for automated multidimensional liquid chromatography coupled 
to tandem mass spectrometry. Analytical Chemistry 2007, 79, 4666–4673 
 
Cavalli G. and Paro R. Chromo-domain proteins: linking chromatin structure to epigenetic 
regulation. Current Opinion in Cell Biology 1998, 10, 354-360 
 119
 
Chang E.J., Archambault V., McLachlin D.T., Krutchinsky A.N., Chait B.T. Analysis of 
protein phosphorylation by hypothesis-driven multiple-stage mass spectrometry. Analytical 
Chemistry 2004, 76, 4472–4483 
 
Chang F., Steelmans L.S., Lee J.T., Shelton J.G., Navolanic P.M., Blalock W.L., Franklin 
R.L., McCubrey J.A. Signal transduction mediated by the Ras|Raf|MEK|ERK pathway from 
cytokine receptors to transcription factors: potential targeting for therapeutic intervention. 
Leukemia 2003, 17, 1263-1293 
 
Choi H., Lee H., Park Z.-Y., Detection of Multiphosphorylated Peptides in LC-MS/MS 
Analysis under Low pH Conditions. Analytical Chemistry 2008, 80, 3007-3015 
 
Claverol S., Burlet-Schiltz O., Gairin J.E., Monsarrat B. Characterization of Protein Variants 
and Post-Translational Modifications: ESI-MSn Analysis of Intact Proteins Eluted from 
Polyacrylamide Gels. Molecular and Cellular Proteomics 2003, 2, 483-493 
 
Cohen P. The role of protein phosphorylation in neural and hormonal control of cellular 
activity. Nature 1982, 296 (5858), 613-620 
 
Curtin N.A. and Woledge R.C. Energy Changes and Muscular Contraction. Physiological 
Reviews 1978, 58, 690-761 
 
Derre I., Rapoport G., Msadek T. CtsR a novel regulator of stress and heat-shock response 
controls clp and molecular chaperone gene expression in Gram-positive bacteria. Molecular 
Microbiology 1999, 31 (1), 117-131 
 
Fenn J.B., Mann M., Meng C.K., Wong S.F., Whitehouse C.F. Electrospray Ionization for 
Mass Spectrometry of Large Biomolecules. Science 1989, 246, 64-71 
 
Ferri N., Paoletti R., Corsini A. Lipid-modified proteins as biomarkers for cardiovascular 
disease: a review. Biomarkers 2005, 10, 219-237 
 
Ficarro S.B., McCleland M.I., Stukenberg P.T., Burke D.J., Ross M.M., Shabanowitz J., Hunt 
D.F., White F.M. Phosphoproteome analysis by mass spectrometry and its application to 
Saccharomyces cerevisiae. Nature Biotechnology 2002, 20, 301–305 
 
Flora J.W. and Muddiman D.C. Selective, Sensitive, and Rapid Phosphopeptide Identification 
in Enzymatic Digests Using ESI_FTICR_MS with Infrared Multiphoton Dissociation. 
Analytical Chemistry 2001, 73, 3305-3311 
 
Freeman J.A., Lilley B.N., Bassler B.L. A genetic analysis of the function of LuxN: a two-
component hybrid sensor kinase that regulates quorum sensing in Vibrio harveyi Molecular 
Microbiology 2000, 35, 139-149 
 
Fuhrmann J., Schmidt A., Spiess, S., Lehner A., Turgay K., Mechtler K., Charpentier E., 
Clausen T., McsB Is a Protein Arginien Kinase That Phosphorylates and Inhibits the Heat-
Shock Regulator CtsR., Science 2009, 324, 1323-1327 
 
 120
Gao Y., Wang Y. A method to determine the ionization efficiency change of peptides caused 
by phosphorylation. Journal of the American Society for Mass Spectrometry 2007, 18, 1973–
1976 
 
Gassner M., Stehlik D., Schrecker O., Hengstenberg W., Maurer W., Rüterjans H. The 
Phosphoenolpyruvate-Dependent Phosphotransferase System of Staphylococcus aureus. 2. 1H 
and 31P Nuclear-Magnetic-Resonance Studies on the Phosphocarrier Protein HPr, 
Phosphohistidines and Phosphorylated HPr. European Journal of Biochemistry 1977, 75, 287-
296 
 
Ge Y., Lawhorn B.G., ElNaggar M., Strauss E., Park J.-H., Begley T.P., McLafferty F.W. 
Top Down Characterization of Larger Proteins (45 kDa) by Electron Capture Dissociation 
Mass Spectrometry. Journal of the American Chemical Society 2002, 124 (4), 672-678 
 
Ge Y., Lawhorn B.G., ElNaggar M., Sze S.K., Begley T.P., McLafferty F.W. Detection of 
four oxidation sites in viral prolyl-4-hydroxylase by top-down mass spectrometry. Protein 
Science 2003, 12 (10), 2320-2326 
 
Gov Y., Borovok I., Korem M., Singh V.K., Jayaswal R.K., Wilkinson B.J., Rich S.M., 
Balaban, N. Quorum Sensing in Staphylococci is Regulated via Phosphorylation of Three 
Conserved Histidine Residues. The Journal of Biological Chemistry 2004, 279, 14665-14672 
 
Gunawardena H.P., Emory J.F., McLuckey S.A. Phosphopeptide anion characterization via 
sequential charge inversion and electron-transfer dissociation. Analytical Chemistry 2006, 78, 
3788–3793 
 
Hecker M., Schumann W., Völker U. Heat-shock and general stress response in Bacillus 
subtilis. Molecular Microbiology 1996, 19, 417-426 
 
Hicks G.R. and Raikhel N.V. Protein Import into the Nucleus: An Integrated View. Annual 
Reviews of Cell and Developmental Biology 1995, 11, 155-188 
 
Hoch J.A. and Silhavy T.J. Two-component Signal Transduction. ASM Press Washington 
DC, ISBN 1-55581-089-6, 1995 
 
Hunt D.F., Yates III. J.R., Shabanowitz J., Winston S., Hauer C.R. Protein sequencing by 
tandem mass spectrometry. Proceedings of the National Academy of Sciences 1986, 83, 6233-
6237 
 
Hunter T. Signalling – 2000 and Beyond. Cell 2000, 100, 113-127 
 
Issemann I., Prince R.A., Tugwood J.D., Green S., The Peroxisome Proliferator-Activated 
Receptor:Retinoid X Receptor Heterodimer is Activated by Fatty acids and Fibrate 
Hypolipidemic Drugs. Journal of Molecular Endocrinology 1993, 11, 37-47 
 
Janek K., Wenschuh H., Bienert M., Krause E. Phosphopeptide analysis by positive and 
negative ion matrix-assisted laser desorption/ionization mass spectrometry. Rapid 
Communications in Mass Spectrometry 2001, 15, 1593–1599 
 
 121
Jensen S.S., and Larsen M.R. Evaluation of the impact of some experimental procedures on 
different phosphopeptide enrichment techniques. Rapid Communications in Mass 
Spectrometry 2007, 21, 3635–3645 
 
Johnsson A.P. Mass spectrometry for protein and peptide characterization. Cellular and 
Molecular Life Sciences 2001, 58, 868-884 
 
Kalkum M., Lyon G.J., Chait B.T. Detection of secreted peptides by using hypothesis-driven 
multistage mass spectrometry. Proceedings of the National Academy of Sciences 2003, 100, 
2795–2800 
 
Karas M. and Hillenkamp F. Laser Desorption Ionization of Proteins with Molecular Masses 
Exceeding 10,000 Da. Analytical Chemistry 1988, 60 (20), 2299-2301 
 
Keyse S.M. An emerging family of dual specificity MAP kinase phosphatases. Biochimica et 
Biophysica Acta 1995, 1265, 152-160 
 
King R.W., Jackson P.K., Kirschner M.W. Mitosis in Transition. Cell 1994, 79, 563-571 
 
Kirstein J. and Turgay K. A New Tyrosine Phosphorylation Mechanism Involved in Signal 
Transduction in Bacillus subtilis. Journal of Molecular Microbiology and Biotechnology 
2005, 9, 182-188 
 
Kirstein J., Zühlke D., Gerth U., Turgay K., Hecker M. A Tyrosine Kinase and its Activator 
Control the Activity of the CtsR Heat-Shock Repressor in B.subtilis. The EMBO Journal 
2005, 24, 3435-3445 
 
Kjellström S., and Jensen O.N. Phosphoric acid as a matrix additive for MALDI MS analysis 
of phosphopeptides and phosphoproteins. Analytical Chemistry 2004, 76, 5109 
 
Kleinijenhuis A.J., Kjeldsen F., Kallipolitis B., Haselmann K.F., Jensen O.N. Analysis of 
Histidine Phosphorylation Using Tandem MS and Ion-Electron Reactions. Analytical 
Chemistry 2007, 79 (19), 7450-7456 
 
Kochin V., Imanishi S.Y., Eriksson J.E. Fast track to a phosphoprotein sketch – MALDI TOF 
characterization of TLC-based tryptic phosphopeptide maps at femtomolar detection 
sensitivity. Proteomics 2006, 6, 5676–5682 
 
Kowalewska K., Stefanowicz P., Ruman T., Frąnczyk T., Rode W., Szewczuk Z. Electron 
Capture Dissociation Mass Spectrometric Analysis of Lysine-Phosphorylated Peptides. 
Bioscience Reports 2010, published ahead of print 09 Feb 2010 
 
Krüger E. and Hecker M. The first gene of the Bacillus subtilis clpC operon, ctsR, encodes a 
negative regulator of its own operon and other class III heat-shock genes. Journal of 
Bacteriology 1998, 180, 6681-6688 
 
Krüger E., Zühlke D., Witt E., Ludwig H., Hecker M. ClpC-mediated proteolysis in Gram-
positive bacteria is autoregulated by the stability of a repressor. The EMBO Journal 2001, 20, 
852-863 
 
 122
Küster B. and Mann M. Identifying proteins and post-translational modifications by mass 
spectrometry. Current Opinion in Structural Biology 1998, 8 (3), 393-400 
 
Kumon A., Kodama H., Kondo M., Yokoi F., Hiraishi H. Nω-Phophoarginine Phosphatase (17 
kDa) and Alkaline Phosphatase as Protein Arginine Phosphatases. Journal of Biochemistry 
1996, 119, 719-724 
 
Kweon H.K., Hakansson K. Selective zirconium dioxide-based enrichment of phosphorylated 
peptides for mass spectrometric analysis. Analytical Chemistry 2006, 78, 1743–1749 
 
Larsen M.R., Thingholm T.E., Jensen O.N., Roepstorff P., Jorgensen T.J. Highly selective 
enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide 
microcolumns. Molecular and Cellular Proteomics 2005, 4, 873-886 
 
Laub M.T. and Goulian M. Specificity in Two-Component Signal Transduction Pathways. 
Annual Reviews in Genetics 2007, 41, 121-145 
 
Laugensen S., Roepsdorff P. Combination of two matrices results in improved performance of 
MALDI MS for peptide mass mapping and protein analysis. Journal of the American Society 
for Mass Spectrometry 2003, 14, 992–1002 
 
Levy-Favatier F., Delpech M., Kruh J. Characterization of an arginine-specific protein kinase 
tightly bound to rat liver. European Journal of Biochemistry 1987, 166 (3), 617-621 
 
Linding R., Jensen L.J., Pasculescu A., Olhovsky M., Colwil K., Bork P., Yaffe M.B., 
Pawson T. NetworKIN: a resource for exploring cellular phosphorylation networks. Nucleic 
Acids Research, 2008, 36 (Database Issue),D 695-699 
 
Lowery D.M., Mohammad D.H., Elia A.E.H., Yaffe M.B. The Polo-Box Domain – A 
Molecular Integrator of Mitotic Kinase Cascades and Polo-like Kinase Function. Cell Cycle 
2004, 3 (2), 128-131 
 
Marlovits T.C., Kubori T., Sukhan A., Thomas D.R., Galán J.E., Unger V.M. Structural 
Insights Into the Assembly of the Type III Secretion Needle Complex. Science 2004, 306, 
1040-1042 
 
Mazanek M., Mitulović G., Herzog F., Stingl C., Hutchins J.R., Peters J.M., Mechtler K. 
Titanium dioxide as a chemo-affinity solid phase in offline phosphopeptide chromatography 
prior to HPLC-MS/MS analysis. Nature Protocols 2007, 2, 1059–1069 
 
Macek B., Gnad F., Soufi B., Kumar C., Olsen J.V., Mijakovic I., Mann M. Phosphoproteome 
Analysis of E.coli Reveals Evolutionary Conservation of Bacterial Ser/Thr/Tyr 
Phosphorylation. Molecular and Cellular Proteomics 2007, 7, 299-307 
 
Medzihradszky K.F., Phillipps N.J., Senderowicz L., Wang P., and Turck C.W. Synthesis and 
characterization of histidine-phosphorylated peptides. Protein Science 1997, 6, 1405-1411  
 
Miller M.L., Soufi B., Jers C., Blom N., Macek B., Mijakovic I. NetPhosBac – A predictor for 
Ser/Thr phosphorylation sites iin bacterial proteins. Proteomics 2009, 9, 116-125 
 
 123
Mitrophanov A.Y. and Groisman E.A. Signal integration in bacterial two-component 
regulatory systems. Genes & Development 2008, 22 (19), 2601-2611 
 
Mizuno T. Two-Component Phosphorelay Signal Transduction Systems in Plants: from 
Hormone Response to Circardian Rythms. Bioscience, Biotechnology, and Biochemistry 
2005, 69, 2236-2276 
 
Müller M.Q., de Koning L.J., Schmidt A., Ihling C., Syha Y., Rau. O., Mechtler K., Schubert-
Zsilavecz M., Sinz A. An Innovative Method to Study Target Protein-Drug Interactions by 
Mass Spectrometry. Journal of Medical Chemistry 2009, 52, 2875-2879 
 
Nabetani T., Miyazaki K., Tabuse Y., Tsugita A. Analysis of acidic peptides with a matrix-
assisted laser desorption/ionization mass spectrometry using positive and negative ion modes 
with additive monoammonium phosphate. Proteomics 2006, 6, 4456–4465 
 
Nakashima H., Toyoshima-Morimoto F., Taniguchi E., Nishida E. Identification of a 
Consensus Motif for Plk (Polo-like Kinase) Phosphorylation Reveals Myt1 as a PLK1 
Substrate. The Journal of Biological Chemistry 2003, 278, 25277-25280 
 
Nigg E.A. Mitotic Kinases as Regulators of Cell Division and its Checkpoints. Nature 
Reviews 2001, 2, 21-32 
 
Nightingale K.P., O’Neill L.P., Turner B.M. Histone modifications: signalling receptors an 
potential elements of a heritable epigenetic code. Current Opinions in Genetic and 
Development 2006, 16 (2), 125-136 
 
Olsen J.V., Macek B., Lange O., Makarov A., Horning S., Mann M. Higher energy C-trap 
dissociation for peptide modification analysis. Nature Methods 2007, 4, 709–712 
 
Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey M., Mann M. 
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate 
approach to expression proteomics. Molecular and Cellular Proteomics 2002, 1, 376-386 
 
Padwardhan P. and Miller W.T. Processive Phosphorylation: Mechanisms and Biological 
Importance. Cell Signal 2007, 19 (11), 2218-2226  
 
Palumbo A.M. and Reid G.E. Evaluation of Gas-Phase Rearrangement and Competing 
Fragmentation Reactions on Protein Phosphorylation Site Assignment Using Collision 
Induced Dissociation-MS/MS and MS3. Analytical Chemistry 2009, 90, 9735-9747 
 
Parkinson J.S. and Kofoid E.C. Communication Modules in Bacterial Signalling Proteins. 
Annual Reviews Genetics 1992, 26, 71-112 
 
Pinkse M.W., Uitto P.M., Hilhorst M.J., Ooms B., Heck A.J. Selective isolation at the 
femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS 
and titanium oxide precolumns. Analytical Chemistry 2004, 76, 3933–3943 
 
Pinske M.W., Mohammed S., Gouw J.W., van Breukelen B., Vos H.R., Heck A.J. Highly 
Robust, Automated, and Sensitive online TiO2-based Phosphoproteomics Applied to Study 
Endogenous Phosphorylation in Drosophila melanogaster. Journal of Proteome Research 
2008, 7, 687-97 
 124
 
Plutzky J. The Potential Role of Peroxisome Proliferator-Activated Receptors on 
Inflammation in Type 2 Diabetes Mellitus and Atherosclerosis. American Journal of 
Cardiology 2003, 92, 34J-41J  
 
Qi C., Zhu Y., Reddy J.K. Peroxisome Proliferator-Activated Receptors, Coactivators and 
Downstream Targets. Cell Biochemistry and Biophysics 2000, 32, 187-204 
 
Raggiaschi R., Lorenzetto C., Diodato E., Caricasole A., Gotta S., Terstappen G.C. Detection 
of phosphorylation patterns in rat cortical neurons by combining phosphatase treatment and 
DIGE technology. Proteomics 2006, 6, 748–756 
 
Reid G.E., Wu J., Chrisman P.A., Wells J.M., McLuckey S.A. Charge-State-Dependent 
Sequence Analysis of Protonated Ubiquitin Ions via Ion Trap Tandem Mass Spectrometry. 
Analytical Chemistry 2001, 73 (14), 3274-3281 
 
Rinner O., Seebacjer J., Walzthoeni T., Müller L.N., Beck M., Schmidt A., Müller M., 
Aebersold R. Identification of Cross-Linked Peptides from Large Sequence Databases. Nature 
Methods 2008, 5 (4), 315-318 
 
Roepstorff P. and Fohlman J. Proposal for a common nomenclature for sequence ions in mass 
spectra of peptides. Biomedical Mass Spectrometry 1984, 11, 601 
 
Ross A.R. Identification of Histidine Phosphorylation in Proteins Using Mass Spectrometry 
and Affinity-Based Techniques. Methods in Enzymology 2007, 423, 549-72 
 
Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., Khainovski N., 
Pillai S., Dey S., Daniels S., Pukayastha S., Juhasz P., Martin S., Bartlet-Jones M., He F., 
Jacobson A., Pappin D.J. Multiplexed Protein Quantitation in Saccharomyces cerevisiae 
Using Amine-reactive Isobaric Tagging Reagents. Molecular and Cellular Proteomics 2004, 
3, 1154-1169 
 
Rostom A.A. and Robinson C.V. Disassembly of intact multiprotein complexes in the gas 
phase. Current Opinion in Structural Biology 1999, 9 (1), 135-141 
 
Ruben E.A., Chapman M.S., Evanseck J.D., Generalized anomeric interpretation of the “high 
energy” N-P bond in N-methyl-N’-phosphorylguanidine: importance of reinforcing 
stereoelectronic effects in “high energy“ phosphoester bonds. Journal of the American 
Chemical Society 2005, 127, 17789-17798  
 
Ruotolo B.T. and Robinson C.V. Aspects of native proteins are retained in vacuum. Current 
Opinion in Chemical Biology 2006, 10 (5), 402-408 
 
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J. Zhang H., Zha X.M., Polakiewicz 
R.D., Comb M.J. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nature 
Biotechnology 2005, 23 (1), 94-101 
 
Sanders S.L. and Schekman R. Polypeptide Translocation across the Endoplasmatic 
Reticulum Membrane. The Journal of Biological Chemistry 1992, 267 (20), 13791-13794 
 
 125
Sarma K. and Reinberg D. Histone variants meet their match. Nature Reviews Mollecular Cell 
Biology 2005, 6 (2), 139-149 
 
Schley C., Altmeyer M.O., Swart R., Müller R., Huber C.G. Proteome analysis of 
Myxococcus xanthus by off-line two-dimensional chromatographic separation using 
monolithic poly-(styrene-divinylbenzene) columns combined with ion-trap tandem mass 
spectrometry. Journal of Proteome Research 2006, 5, 2760–2768 
 
Schlosser A., Pipkorn R., Bossemeyer D., Lehmann W.D. Analysis of Protein 
Phosphorylation of Elastase Digestion and Neutral Loss Tandem Mass Spectrometry. 
Analytical Chemistry 2001, 73, 170-176 
 
Schmidt A., Kellermann J., Lottspeich F. A novel strategy for quantitative proteomics using 
isotope-coded protein labels. Proteomics 2005, 5 (1), 4-15 
 
Shaw P.E. Peptidyl-prolyl isomerases: a new twist to transcription. EMBO Reports 2002, 3, 
521-526 
 
Sickmann A. and Meyer H.E. Phosphoamino acid analysis. Proteomics 2001, 1, 200-206 
 
Sinz A. Chemical Cross-linking and Mass Spectrometry for Mapping Three-Dimensional 
Structures and Protein-Protein Interactions. Journal of Mass Spectrometry 2003, 38, 1225-
1237 
 
Slater E.C. and Kemp A. Rate Labelling of Mitochondrial Phosphohistidine by Radioactive 
Inorganic Phosphate. Nature 1964, 204, 1268-1271 
 
Sleno L. and Vollmer D.A. Ion activation methods for tandem mass spectrometry. Journal of 
Mass Spectrometry 2004, 39, 1091-1112 
 
Sørensen E.S., Højrup P., Petersen T.E., Post-translational modifications of bovine 
osteopontin: Identification of twenty-eight phosphorylation and three O-glycosylation sites. 
Protein Science 1995, 4, 2040–2049 
 
Steeg P.S., Palmieri D., Ouatas T., Salerno M. Histidine Kinases and Histidine 
Phosphorylated Proteins in Mammalian Cell Biology, Signal Transduction, and Cancer. 
Cancer Letters 2003, 190, 1-12 
 
Steen H., Küster B., Fernandez M., Pandey A., and Mann M., Detection of Tyrosine 
Phosphorylated Peptides by Precursor Ion Scanning Quadrupole TOF Mass Spectrometry in 
Positive Ion Mode. Analytical Chemistry 2001, 73, 1440-1448 
 
Steen H., Jebanathirajah J. A., Rush J., Morrice N., Kirschner M. W., Phosphorylation 
analysis by mass spectrometry: Myths, facts, and the consequences for qualitative and 
quantitative measurements. Molecular and Cellular Proteomics 2006, 5, 172–181 
 
Stensballe A., Jensen O.N., Olsen J.V., Haselmann K.F., Zubarev R.A., Electron capture 
dissociation of singly and multiply phosphorylated peptides. Rapid Communications in Mass 
Spectrometry 2000, 14, 1793–1800 
 
 126
Syka J.E., Coon J.J., Schroeder M.J., Shabanowitz J., Hunt D.F. Peptide and protein sequence 
analysis by electron transfer dissociation mass spectrometry. Proceedings of the National 
Academy of Sciences 2004, 101, 9528–9533 
 
Teis D., Wunderlich W., Huber L.A. Localization of the MP1-MAPK Scaffold Complex to 
Endosomes Is Mediated by p14 and Required for Signal Transduction. Developmental Cell 
2002, 3, 803-814 
 
Theodosiou A. and Ashworth A. MAP kinase phosphatases. Genome Biology 2002, 3 (7), 
reviews3009.1-10 
 
Thingholm T.E., Jensen O.N., Robinson P.J., Larsen M.R., SIMAC – A phosphoproteomic 
strategy for the rapid separation of mono-phosphorylated from multiply phosphorylated 
peptides. Molecular and Cellular Proteomics 2008, 7, 661–671 
 
Thingholm T.E., Jensen O.N., Larsen M.R. Analytical strategies for phosphoproteomics 
Proteomics 2009, 9, 1451-1468  
 
Thomas D., Guthridge M., Woodcock J., Lopez A. 14-3-3 Protein Signalling in Development 
and Growth Factor Responses. Current Topics in Developmental Biology 2005, 67, 285-303 
 
Thomason P. and Kay R. Eucaryotic Signal Transduction via Histidine Aspartate 
Phosphorelay. Journal of Cell Science 2000, 113, 3141-3150 
 
Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L. Comprehansive 
Identification of Phosphorylation Sites in Postsynaptic Density Preparations. Molecular and 
Cellular Proteomics 2006, 5, 914-922 
 
Villen J., Beausoleil S. A., Gerber S. A., Gygi S. P. Large-scale phosphorylation analysis of 
mouse liver. Proceedings of the National Academy of Sciences 2007, 104, 1488–1493 
 
Villen J. and Gygi S.P. The SCX/IMAC enrichment approach for global phosphorylation 
analysis by mass spectrometry. Nature Protocols 2008, 3, 1630-1638 
 
Voet D., Voet J.G., Pratt C.W., dt. Übersetzung Beck-Sickinger A.G., Hahn U. Biochemie, 
ISBN 3-527-30519-X, Wiley-VCH Verlag GmbH & Co KGaA, Weinheim 2002 
 
Wakim B.T. and Aswad G.D. Ca2+-calmodulin-dependent Phosphorylation of Arginine i 
Histone 3 by a Nuclear Kinase from Mouse Leukemia Cells. The Journal of Biological 
Chemistry 1994, 269 (4), 2722-2727 
 
Wakim B.T., Grutoski P.S., Vaughan A.T.M., Engelmann G.L. Stimulation of a Ca2+-
calmodulin-activated Histone 3 Arginine Kinase in Quiescent Rat Heart Endothelial Cells 
Compared to Actively Dividing Cells. The Journal of Biological Chemistry 1995, 270 (39), 
23155-23158 
 
Wålinder O. Protein-bound acid labile phosphate. Isolation of 1-32P-phosphohistidine and 3-
32P-phosphohistidine from some mammalian and microbial cell extracts incubated with 
adenosine triphosphate-32P. The Journal of Biological Chemistry 1969, 244, 1065-69 
 
 127
Wålinder O., Zetterqvist O., Engstöm L. Intermediary phosphorylation of bovine liver 
nucleoside diphosphate kinase. Studies with rapid mixing techniques. The Journal of 
Biological Chemistry 1969, 244, 1060-1064 
 
Wei Y.-F. and Matthews H.R. Identification of Phosphohistidine in Proteins and Purification 
of Protein-Histidine-Kinases. Methods in Enzymology 1991, 200, 388-414 
 
Weller M. Protein-Bound Histidine, As Well As Protein-Bound Serine, Residues Are Sites Of 
Phosphorylation In The Synaptic Plasma Membrane. Biochimica et Biophysica Acta 1978, 
509, 491-498 
 
Weston C.R. and Davis R.J. The JNK signal transduction pathway. Current Opinion in 
Genetics and Development 2002, 12, 14-21 
 
Xu C.F., Wang H., Li D., Kong X.P., Neubert T.A. Selective enrichment and fractionation of 
phosphopeptides from peptide mixtures by isoelectric focusing after methyl esterification. 
Analytical Chemistry 2007, 79, 2007–2014 
 
Yoo C., Patwa T.H., Kreunin P., Miller F.R., Huber C.G., Nesvizhskii A.I., Lubman D.M. 
Comprehensive analysis of proteins of pH fractionated samples using monolithic LC/MS/MS, 
intact MW measurement and MALDI-QIT-TOF MS. Journal of Mass Spectrometry 2007, 42, 
312–334 
 
Zhang X., Ye J., Jensen O.N., Roepstorff P. Highly Efficient Phosphopeptide Enrichment by 
Calcium Phosphate Precipitation Combined with Subsequent IMAC Enrichment. Molecular 
and Cellular Proteomics 2007, 6, 2032-2042 
 
Zhou D. and Galán J. Salmonella entry into host cells: the work in concert of type III secreted 
effector proteins. Microbes and Infection 2001, 3, 1293-1298 
 
Zeng L. and Zhou M.-M. Bromodomain: an acetyl-lysine binding domain. FEBS Letters 
2002, 513, 124-128 
 
Zu X.L., Besant P.G., Imhof A., and Attwood P.V. Mass spectrometric analysis of protein 
histidine phosphorylation. Amino Acids 2007, 32, 347-357 
 128
Figures 
 
Part I 
 
A_01 Phosphoamino acids           002 
A_02 Signalling cascades in cells          003 
A_03 Kinase Activity and Phosphatase Activity        004 
A_04 Proteomics workflows for Protein Identification       009 
A_05 Enrichment Techniques for Phosphopeptides       012 
A_06 Schematic Overview of MS/MS Methods        016 
A_07 Properties of Peptides with Multiple Phosphorylations      021 
A_08 Optimization of MALDI Detection of Phosphopeptides      026 
A_09 MS/MS Spectrum of the Singly Phosphorylated Peptide (aa 33–48) from 
Tryptically Digested β-casein                    029 
A_10 Enrichment Strategy on TiO2          030 
A_11 Results TiO2 optimization          032 
A_12 Improved Phosphopeptide Separation in RP-Chromatography     035 
A_13 Improved Identification of Phosphopeptides from Osteopontin with MALDI-
MS/MS            038 
A_14 Comparison of MALDI-MS/MS analysis with ETD fragmentation of 
Phosphopeptides           042 
 
Part II 
 
B_01 Nitrogen-Bound Phosphorylations in Living Cells       045 
B_02 Receptor Histidine Kinases in Bacteria and Plants       047 
B_03 Delocalization of pArg and pHis         050 
B_04 Hydrolysis Mechanism          051 
B_05 Structure of the CtsR Homodimer in Complex with DNA      055 
B_06 Intact Protein MS and Top Down Analysis        056 
B_07 Identification of Phosphorylation at R62 of CtsR       060 
B_08 Localization of Phosphorylated Arginine Residues       061 
B_09 McsB Catalyzed Phosphorylation of Peptides       063 
B_10 Arginine-Specificity of McsB demontrated MS and 31P-NMR     066 
B_11 Stability of Phospho-Arginine         070 
B_12 Tryptic Activity at Arginine-Phosphorylation       072 
B_13 TiO2-based Enrichment of Peptides with Acid-Labile Phosphorylations    075 
B_14 Comparison of MS/MS Methods for the Identification of Arginine-
Phosphorylated Peptides          078 
B_15 Identified Phosphorylation Sites of CtsR and McsB       079 
B_16 MS/MS Analysis of Peptides with Phospho-Arg and Phospho-His     085 
B_17 Neutral Loss from two Different Positions Revealed by ESI-MS3     087 
B_18 H3PO4-Eliminiation is the Lowest Energy Neutral Loss Pathway     089 
B_19 Different Fragmentation of Peptides without free OH-Moieties     091 
B_20 Acidic Amino Acids Partially Substitute the Function of the C-terminal 
COOH-Group               094-095 
B_21 CID-Induced Translocation of the Phospho-Moiety Onto Glutamate and Serine 
               097 
B_22 Analysis of N-Phosphorylations in Living Cells – Strategy      103 
 
 
 129
Appendix Cross-Linking 
 
App_01 Strategy for Structural Analysis of Protein Complexes by Chemical 
Cross-Linking and Mass Spectrometry         106  
App_02 Cross-Linking Products and MS/MS Fragmentation           107 
App_03 MS/MS spectrum of the identified cross-link NFNMNKVK-KT from 
PPAR2α           109 
App_04 The Core Complex of the Samonella Type III Secretion System    111 
App_05 Results for Acetyl-Labelling and Connected Domains Between 
Different Protein Species in the Needle Complex      114  
App_06 Connection of the Same Peptide Strands Identifies the Dimerization 
Region of Myotilin-IG Domains        116 
 
 
Tables 
 
Part I 
 
TA_1  Synthetic phosphopeptides for method optimization.      027 
TA_2  Removal of sequence-unspecific neutral loss ion signal improves automatic 
database identification of highly phosphorylated peptides.      037 
TA_3 Mascot Phosphosite Determination          039 
 
Part II 
 
TB_1  pka values for pHis, pArg and pLys        049 
TB_2  Phosphopeptides of CtsR from B.stearothermophilus     059 
TB_3  Synthetic Peptides for Investigation of N-Bound Phosphorylations   064 
TB_4  Autophosphorylation sites of McsB        080 
 
Appendix – Cross-Linking 
 
TApp_1 Identified Cross-Linking Products of Myotilin-IG Domains Cross-
Linked with EDC/NHS         117  
 130
Abbreviations 
 
ACN  acetonitrile 
AcOH  acetic acid 
ADP  adenosine diphosphate 
ATP  adenosine triphosphate 
BSA  bovine serum albumin 
BS2G   bis-sulfosuccinimidyl-glutarate 
BS3  bis-sulfosuccinimidyl-suberate 
CE  collision energy 
CHCA  α-cyano-4-hydroxycinnamic acid 
CID  collision-induced dissociation 
ClpC, clpC class three stress response-related ATPase, small gene name 
CtsR, ctsR class three stress response regulator, small gene name 
Da  Dalton  
DHB  2,5-dihydroxybenzoic acid, gentisic acid 
DNA  Desoxyribonucleic acid 
DTT  dithiothreitol 
DVB  divinylbenzole 
ECD  electron-capture dissociation 
EDC  1-ethyl-3-(N,N-dimethylaminopropyl) carbodiimide hydrochloride 
EDD  electron-detachment dissociation 
EGS  ethylene glycol bis[succinimidylsuccinate] 
EM  electron microscopy 
ERLIC  electrostatic repulsion, hydrophilic interaction chromatograpy 
ESI  electrospray ionization 
ETD  electron-transfer dissociation 
FA  formic acid 
FT  Fourier-transform 
FT-ICR Fourier-transform ion cyclotron resonance 
GPMAW general protein mass analysis for Windows 
HCD  higher-energy collisional dissociation 
HFBA  Heptafluorobutyric acid 
HPLC  high performance liquid chromatography 
IG  immunoglobulin 
iTRAQ isobaric tag for relative and absolute quantificantion 
LC  liquid chromatography 
ICPL  isotope coded protein labeling 
IMAC  immobilized metal ion-affinity chromatogrpahy 
IMP  institute for molecular pathology 
IRMPD infra-red multiphoton dissociation 
LTQ  Linear trap-quadrupole 
MALDI matrix-assisted laser desorption/ionization 
MAP  mitogen-activated protein 
MAPK  mitogen-activated protein kinase 
McsA, mcsA modulator of class three stress response A, small gene name 
McsB, mcsB modulator of class three stress response B, small gene name 
MOAC metal oxide-affinity chromatography 
MS  mass spectrometry 
MS/MS tandem mass spectrometry 
MSn  multiplexed tandem mass spectrometry, for instance MS3 
 131
m/z  mass to charge 
NHS  N-hydroxysuccinimide 
NL  neutral loss 
NMR  nuclear magnetic resonance 
OcSNa  octylsulfonate sodium salt 
PAGE  polyacrylamide gel electrophoresis 
PPAR  peroxisome proliferator-activated receptors 
phospho-, p- phosphorylated 
ppm  parts per million 
PS  polystyrole 
PSD  post-source decay  
PTM  post-translational modification 
RNA  Ribonucleic acid 
RP  reversed phase 
RPC  reversed phase chromatography 
SAX  small angle X-ray scattering 
SCX  strong cation exchange 
SDS  sodium dodecylsulfate 
SILAC  stable isotope labelling of amino acids in cell culture 
TOF  time of flight 
 TFA  trifluoroacetic acid 
UV  ultra-violet 
WAX  weak anion exchange 
wt  wild type  
 
Amino  acids 
 
amino acid 3 
letter 
code 
1 
letter 
code 
amino acid 3 
letter 
code 
1 
letter 
code
amino acid 3 
letter 
code 
1 
letter 
code 
alanine Ala A cysteine Cys C aspartate Asp D 
glutamate Glu E phenyl-
alanine 
Phe   F glycine Gly G 
histidine His H isoleucine Ile I lysine Lys K 
leucine Leu L methionine Met M asparagine Asp N 
proline Pro P glutamine Gln Q arginine Arg R 
serine Ser S threonine Thr T valine Val V 
tryptophane Trp W tyrosine Tyr Y    
 
 132
List of Publications 
 
First author publications 
 
1: Proteomics. 2008 Oct 29;8(21):4577-4592. 
Enhanced detection and identification of multiply phosphorylated peptides using TiO(2) 
enrichment in combination with MALDI TOF/TOF MS. 
Schmidt A., Csaszar E., Ammerer G., and Mechtler K.  
 
2: Science. 2009 Jun 5;324(5932):1323-7. 
McsB is a protein arginine kinase that phosphorylates and inhibits the heat-shock regulator 
CtsR. 
Fuhrmann J., Schmidt A., Spiess S., Lehner A., Turgay K., Mechtler K., Charpentier E., and 
Clausen T.  
 
3: J Am Soc Mass Spectrom. 2006 Aug;17(8):1100-13. Epub 2006 Jun 5. 
Isotope-Labeled Cross-Linkers and Fourier Transform Ion Cyclotron Resonance Mass 
Spectrometry for Structural Analysis of a Protein/Peptide Complex  
Ihling C, Schmidt A., Kalkhof S, Schulz D.M., Stingl C., Mechtler K., Haack M., Beck-
Sickinger A.G., Cooper D.M.F., and Sinz A.  
 
Contributions 
 
1: BMC Bioinformatics. 2007 Jun 13;8:197. 
MASPECTRAS: a platform for management and analysis of proteomics LC-MS/MS data 
Hartler J., Thallinger G.G., Stocker G., Sturn A., Burkard T.R., Körner E., Rader R., Schmidt 
A., Mechtler K., and Trajanoski Z. 
 
2: Mol Cell. 2007 Apr 13;26(1):103-15. 
Heterochromatin Formation in Drosophila Is Initiated through Active Removal of H3K4 
Methylation by the LSD1 Homolog SU(VAR)3-3 
Rudolph T., Yonezawa M., Lein S., Heidrich K., Kubicek S., Schäfer C., Phalke S., Walther 
M., Schmidt A., Jenuwein T., and Reuter G.  
 
3: J Biol Chem. 2009 Mar 27;284(13):8395-405. Epub 2009 Jan 13. 
Dynamic histone H1 isotype 4 methylation and demethylation by histone lysine 
methyltransferase G9a/KMT1C and the Jumonji domain containing JMJD2/KDM4 proteins 
Trojer P., Zhang J., Yonezawa M., Zheng H., Schmidt A., Perez-Burgos L., Lobel P., 
Jenuwein T., Reinberg D. 
 
4: PLoS Pathogens, accepted 2010 Feb 01, published April 2010 
Topology and organization of the Salmonella typhimurium type III secretion needle complex 
components 
Schraidt O., Lefebre M., Brunner M, Schmied W.H., Schmidt A., Radics J., Mechler K, 
Galan J.E., and Marlovits T.  
 
5: Proteins. 2007 Nov 1;69(2):254-69. 
Annexin A2/P11 interaction: New insights into annexin A2 tetramer structure by chemical 
crosslinking, high-resolution mass spectrometry, and computational modeling 
Schulz D.M., Kalkhof S., Schmidt A., Ihling C., Stingl C., Mechtler K., Zschörnig O., and 
Sinz A. 
 133
6: J Med Chem. 2009 May 14;52(9):2875-9. 
An innovative method to study target protein-drug interactions by mass spectrometry. 
Müller M.Q., de Koning L.J., Schmidt A., Ihling C., Syha Y., Rau O., Mechtler K., Schubert-
Zsilavecz M., and Sinz A.  
 
Further Publication 
 
Mapping protein interfaces by chemical cross-linking and Fourier transform ion cyclotron 
resonance mass spectrometry: application to a calmodulin/adenylyl cylase 8 peptide complex 
Schmidt A., Kalkhof S., Ihling C., Cooper D.M.F., and Sinz A. 
  
Planned Publications 2010 
Detection of N-bound phosphorylations in bacteria after TiO2 enrichment 
Fragmentation of peptides with Arginine Phosphorylation 
 
Presentations at Conferences 
Posters 
IMSC 2006, Prague 
Multidimensional Chromatography and Quantitative Mass Spectrometry Based Approach for 
Identification of Differentially Expressed Proteins in Mice Livers 
Schmidt A., Pichler P., Mitulovic G., Hasselblatt P., Stingl C., Ammerer G., Wagner E.F., and 
Mechtler K. 
ASMS 2008, Denver 
MALDI TOF/TOF Is a Convenient Tool for the Identification and Quantification of Multiply 
Phosphorylated Peptides from Low Complexity Samples 
Schmidt A., Csaszar E., Mitulovic G., Ammerer G., and Mechtler K. 
ASMS 2009 
Arginine-Phosphorylation as Post-Translational Modification of Proteins 
Schmidt A., Fuhrmann J., Stingl C., Brecker L., Clausen T., and Mechtler K. 
 
Talks 
Phospho-Proteomics Seminar – 13th and 14th October 2008, IMP Vienna 
Analysis of multiphosphorylated peptides with Maldi TOF/TOF 
(Andreas Schmidt) 
 
 134
 135
Curriculum Vitae 
 
Personal Details 
 
Last Name: 
First Name: 
 
Current address: 
 
 
Date of Birth: 
Place of Birth: 
 
 
 
Nationality: 
 
Parents: 
 
 
 
Brother: 
 
 
Schmidt, birth name Schreiter 
Andreas 
 
Laxenburgerstrasse, 59/6, Vienna, A-1100, 
Austria 
 
4th April 1981 
Annaberg-Buchholz (Federal Republic of 
Germany) 
(former German Democratic Republic) 
 
German 
 
Annelie Schmidt, birth name Schreiter 
(29th June 1957),  
Ralf Schmidt (18th October 1959),  
 
Norbert Schmidt (24th March 1984), 
married 
 
 
Degrees and Education 
 
1st January 2006 -  PhD student at the Christian-Doppler.Laboratory for Proteome 
Analysis, Vienna  
   research projects: 
A phosphoproteome analysis of multiple phosphorylated peptides 
and N-phosphorylations - focus on method developement for 
reliable detection and quantification (N-phosphorylation 
analysis in cooperation with Dr. Tim Clausen, Strucural 
Biology, IMP Vienna, Austria) 
B cross-linking studies for the identification of protein 
conformation changes upon small molecule binding and 
localization and relative structure of protein subunits in large 
assemblies (with Prof. Dr. A. Sinz, University of Halle, Dr. 
Thomas Marlovits, IMBA Vienna, Austria, and Prof. Dr. 
Kristina Djinović-Carugo, University of Vienna, Vienna, 
Austria) 
C detection/localization and relative quantification of methylation 
and demethylation processes by protein histone methylases and 
demethylases (in cooperation with Prof. Dr. Thomas Jenuwein, 
now MPI for Immunology, Freiburg, Germany) 
 
1st August 2005 - research assistent at Prof. Dr. Dermot M.F. Cooper's Laboratory 
30th December 2005 at the University of Cambridge (Cambridge, UK) 
Introduction to microbiology to study effect of mutations in the 
adenylyl cyclase 8 calmodulin binding motif on its activation by 
Ca2+/calmodulin. 
 
31st May 2005 Diploma thesis: Studying the AC8/calmodulin interaction with chemical 
cross-linking and high resolution mass spectrometry 
Introduction to chemical cross-linking methods and application 
to a calmodulin/peptide complex.  
   Degree: Diploma Chemist (Univ.), equivalent to MSc (Chemistry) 
   Mark: very good 
 
October 2000 -  Study of chemistry at the University of Leipzig 
May 2005   July 2002 Pre-Diploma  
main study (2003-2005) focus on analytical chemistry, 
biochemistry and organic chemistry 
 
September 1999 - military service (Osterode/Harz) 
July 2000 
 
10th July 1999  Senior High School Graduation 
September 1992 -  school for higher education (Landkreisgymnasium Schlettau) 
July 1999   examination marks:  Chemistry, 2.3 
       Mathematics, 2.9 
 
September1990-  "polytechnical school" in Cranzahl 
August 1992 
 
September 1987 -  elementary school in Cranzahl ("Wolfgang Goeftel Oberschule") 
August 1990 
 137 
 
RESEARCH ARTICLE
Enhanced detection and identification of multiply
phosphorylated peptides using TiO2 enrichment in
combination with MALDI TOF/TOF MS
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The analysis of PTMs such as phosphorylation has become an important field in MS because
they can directly indicate protein states and interactions. Whereas the characterization of singly
and doubly phosphorylated peptides has almost become routine, identifying phosphorylation
events at multiple residues within a small region of a protein is still problematic. The identifica-
tion of multiple modifications can be further hampered by low sequence information due to
multiple neutral losses from phosphorylated side chains. Here we present a strategy for the
analysis of complex phosphopeptides that combines peptide enrichment by titanium dioxide,
separation by RP separation on monolithic columns and MS using high energy HE-CAD in a
MALDI TOF/TOF analyser. Using synthetic phosphopeptides our approach is compared to
multistage activation (MSA) MS/MS and the recently described electron transfer dissociation
(ETD) method using an ESI-LTQ mass spectrometer.
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1 Introduction
PTMs such as phosphorylation, glycosylation and peptide-
conjugation are vital for function of proteins and cellular
pathways. Phosphorylation, a reversible modification that
practically occurs in all cellular compartments is viewed as a
key regulator of protein activity as well as a major mediator of
protein–protein interactions. The extent of the modification
depends on dynamic interactions of specific protein kinases,
of which more than 500 different forms are supposed to be
expressed in human cells [1] and a smaller number of pro-
tein phosphatases. Misregulation at the step of modification
or dephosphorylation is often associated with severe physio-
logical consequences for the organism. In recent years, MS
gained a key role in the identification of phosphorylation
sites and the cellular pathways and signalling networks
behind them. For example, large-scale experiments designed
towards identification of phosphopeptides led to a high
number of newly described phosphorylation sites on many
proteins [2, 3]. This situation triggered increased efforts to
test the physiological relevance of these modification using
combinations of molecular biology methods, of biochemistry
and of bioinformatics [4]. Although there are now numerous
cases for which the functional and regulatory role of phos-
phorylation on selected protein sites has been worked out,
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there is still a vast area of events that have either escaped
detection or whose relevance could not be resolved due to the
complexity of the system. One of the remaining problems is
also the question of how to attain complete sequence cover-
age by MS for proteins in question. Among the difficulties to
resolve this problem area is the fact that proteins are some-
times phosphorylated by the same or even different kinases
within small regions. Although considerable progress has
been made in the identification of phosphopeptides in gen-
eral, thereby allowing the confident assignment of single or
double phosphorylation events, the analysis of multiple
phosphorylated peptides is still a major challenge that has
not yet attracted a large amount of attention [5, 6]. After pro-
teolytic digestions of proteins a major problem is the trace-
ability of a complex modification due to either low stoichio-
metry compared to the unphosphorylated or singly phos-
phorylated peptides. Yet other factors cause poor
identification of these peptides by any mass spectrometric
method whereof the ionization efficiency is the most impor-
tant [7, 8]. Finally, the chromatographic properties of multi-
ply phosphorylated peptides can also have a detrimental
effect within routine purification protocols.
Development of enrichment methods has given a big
boost to the characterization of phosphorylated peptides, be-
cause it solved the problem of signal suppression by unpho-
sphorylated peptides. Enrichment can be achieved either by
using the physico-chemical properties of the phosphate
moiety, by chemical derivatization or by the affinity to anti-
bodies or metal ions [9–23]. Today’s affinity methods are
predominantly based on metal ions with immobilized metal
affinity chromatography (IMAC) as the most widespread
approach [21]. IMAC allows affinity enrichment of phospho-
peptides based on the affinity of acidic groups to trivalent
metal atoms such as iron or gallium. The early problem that
strong acidic peptides also show high affinity for the IMAC
resin was solved by esterification of the free carboxy groups
found at the C-terminus as well as the side chains of gluta-
mate and aspartate [14]. A second method that has become
quite popular throughout the last years is the enrichment of
phosphopeptides on the surface of metal oxides such as tita-
nium or zirconium. Theoretical arguments had suggested a
specifically strong attraction of the phosphate moiety to-
wards titanium dioxide (TiO2) compared to other acidic
functions like carboxyl groups or other anions such as halo-
gens or acetate [17]. One advantage of this method is that
selective enrichment of phosphorylated peptides does not
depend on prior esterification procedures and is therefore
not affected by side reactions or incomplete esterification.
Earlier experiments revealed a significant loss of multiply
phosphorylated peptides upon TiO2 enrichment because of
this effect, IMAC is currently favoured for the analysis of
multiply phosphorylated peptides [19].
The final separation of phosphopeptide mixtures before
MS analysis is routinely accomplished on C18 columns be-
cause the applied separation conditions allow easy coupling
to ESI-MS. Although chromatographical behaviour of multi-
ply phosphorylated peptides has not been investigated in
depths, it has been speculated that their separation on C18
column can have major drawbacks such as a low recovery or
broad retention width. Since ESI is the most commonly used
ionization technique for phosphopeptides any bias of the
C18 chromatographic method would also influence the gen-
eration of MS data. ESI mass spectrometers have an advan-
tage as they offer high throughput and a wide range of frag-
mentation methods that can be successfully applied to
phosphopeptides. However, early MS/MS experiments on
phosphopeptides also exhibited the inadequacy of thermal or
vibrational exitation to generate daughter ions with high
amount of sequence information. This inadequacy is due to
lower stability of the phosphate moiety in contrast to the
bonds in the peptide backbone. This phenomenon of neutral
phosphate loss is mainly connected to phosphoserine and
phosphothreonine (in case of phosphotyrosine strong neu-
tral loss ions are normally not observed).
One solution was fragmentation of the precursor in so-
called MSn or multistage activation (MSA) methods applied
on IT instruments which gave significantly improved results
for the identification [24–26]. During the MS/MS steps the
precursor is dephosphorylated and in the final step frag-
mented, which often results in higher yields of backbone
fragment ions. A recently described method fragments
phosphorylated peptides at elevated energy levels in the so-
called C-trap of linear IT-Orbitrap hybrid instruments which
is believed to improve fragmentation of the peptide backbone
in MS/MS analysis in comparison to low energy collisional
fragmentation in normal ion trapping instruments [27].
A different fragmentation mechanism, electron capture
dissociation (ECD), was introduced especially for the
enhanced analysis of post-translationally modified peptides.
This mechanism relies on the uptake of a single low energy
electron followed by dissociation. Chemical bonds are
cleaved prevailingly in the peptide backbone at the N–Ca
bond as a result from a radical reaction cascade [28]. ECD
provides MS/MS analysis of phosphopeptides without
excessive loss of phosphoric acid (PA) from the precursor, so
that the formed daughter ions still carry the intact phosphate
moiety which benefits the assignment of the phosphosite
within the amino acid sequence [29]. Since this technique is
only available on Fourier transform ICR (FT-ICR) instru-
ments excellent mass accuracy and resolution are achieved
also for MS/MS data. While ECD works nicely for direct MS,
the coupling to HPLC is still difficult.
Quite recently electron transfer dissociation (ETD) was
described as a method where electron uptake and fragmenta-
tion takes place in the IT [30, 31]. Thereby electrons are deliv-
ered in the form of aromatic anions, while the positively
charged peptides are trapped, during interaction of precursor
ions with the anions electrons can be transferred leading to
neutralization of the anion and a single charge of the peptide
ion.Bothmethodshave thedisadvantage that fragmentation is
only effective with multiply charged ions as precursors, typi-
cally three- or four-fold charged ions give the best results [28].
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MALDI is rarely used for phosphopeptide analysis [32–
35]. The major disadvantage is the immense signal suppres-
sion of phosphorylated peptides during ionization, when
there are also unphosphorylated peptides present in the
crystallized peptide mixture [35, 36]. A higher number of
phosphate moieties in the peptide sequence significantly
increases signal supression. Literature describes the inver-
tion of this effect in negative ionization mode, which could
be used to identify phosphopeptides from difficult mixtures,
e.g. after in gel digest by comparing the signal intensities
from both experiments [34].
MALDI analysis before and after phosphatase treatment
provides another possibility to identify phosphorylated pep-
tides, because they can be easily identified by the mass shift
to the unmodified counterpart in the phosphatase treated
sample. This method proved to be efficient with MALDI
instruments, because only singly charged peptides have to be
taken into account [37, 38]. Unfortunately both methods
cannot answer the question of the localization of the phos-
phate moiety within the observed peptide unless only one
single putatively phosphorylated amino acid is present.
In the case of serine or threonine phosphorylation, PSD
fragments which belong to ions with a neutral loss of H3PO4
are observed in reflector TOF (reTOF) spectra as unresolved
peak 98 Da below of the expected peptide mass. These sig-
nals are normally observed at low intensity levels but they
can be easily detected because of their characteristic unre-
solved structure. In the case of multiphosphorylated peptides
also a second peak may occur at [M 1 H]1 minus 196 Da.
The massive signal suppression of phosphopeptide signals
in the presence of unphosphorylated peptides is the stron-
gest argument against MALDI ionization for the direct anal-
ysis of protein phosphorylations. This is due to complex for-
mation of the phosphate moiety on the metal surface of the
MALDI target which is often stainless steel and its low pro-
ton affinity and therefore applied negative charge. Another
handicap is the predominant formation of singly charged
ions, which cover a quite broad mass range which is unsui-
table for trapping instruments. The quality of MS/MS spec-
tra upon CID fragmentation is also lower for singly charged
peptides compared to multiply charged which are formed in
ESI.
To obtain structural information of phosphorylated pep-
tides, PSD fragmentation analysis is not often the method of
choice, because of its low fragmentation efficiency. Although
signals which are related to the neutral loss of the phosphate
moiety dominate the resulting MS/MS spectra, many back-
bone fragments of low intensity are observed [32].
Today MALDI ionization is commonly used with a TOF/
TOFmass analyser which provides MS/MS using either PSD
alone or in combination with collisional activation of the ions
in a short CID-tube. PSD is suitable to generate high mass
daughter ions, while activation in the collision cell (up to
361026 bar) mainly promotes the formation of low mass
ions such as ammonium ions or small internal fragments.
This approach is quite powerful, because it is applicable over
a broad mass range in MS from 800 to over 4000 amu and a
high mass accuracy can be achieved in tandem mass spectra.
Our study presents an alternative method for identifica-
tion of multiply phosphorylated peptides which initially
become purified on TiO2 particles. Following the enrichment
we introduce a fast monolithic chromatography which pro-
vides high recovery and effective separation and MALDI
TOF/TOF MS/MS analysis. Using this approach we cannot
only identify multiply phosphorylated proteins and their
phosphosites but in combination with the iTRAQ chemistry
we are also able to obtain quantitative data [39, 40].
2 Materials and methods
2.1 Materials
All organic solvents and ammonia were from VWR-Merck
(Vienna, Austria) in chromatographic grade. Trypsin was
purchased from Promega (Mannheim, Germany) and all
chemicals for the tryptic digest, DTT, ammonium hydro-
gencarbonate (NH4HCO3), ammonium dihydrogenphos-
phate (NH4H2PO4) and iodoacetamide, were from Sigma
(Vienna, Austria) at highest available purity. MALDI matrix
CHCA was purchased in 98% purity (Sigma) and recrys-
tallized following the protocol from Bruker (Bremen, Ger-
many). 2,5-Dihydroxybenzoic acid (DHB, 98% purity;
Sigma–Aldrich, Vienna, Austria) for TiO2 enrichment and
octylsulphonate sodium salt (OcSNa, highest purity) were
also from Sigma. MALDI matrix DHB was from Bruker. PA
and heptafluorobutyric acid (HBFA) were from Fluka
(Sigma–Aldrich), glacial acetic acid (AcOH) was from J.T.
Baker (Griesheim, Germany), and TFA from Pierce (THP,
Vienna, Austria). Osteopontin from bovine milk without
BSA matrix was from R&D Systems (Minneapolis, USA) and
b-casein from Sigma. Peptides were in-house synthesized
using the FMOC strategy on a peptides synthesizer ABI
433A (Applied Biosystems, Darmstadt, Germany).
2.2 Enzymatic protein cleavage
A 100 mg/mL solution of b-casein was prepared with freshly
prepared 50 mM NH4HCO3 solution. A 100 mL aliquot was
used for tryptic cleavage. Osteopontin was dissolved in
freshly prepared 50 mM NH4HCO3 in H2O to a final protein
concentration of 1 mg/mL and sonicated for 2 min. A pH of
7.7 was applied and aliquots of 10 mg were prepared and kept
at 2807C. Prior to trypsination osteopontin was mixed with
50 mM NH4HCO3 solution to a final volume of 50 mL. Two
microlitres of DTT (6.5 mM, in 50 mM NH4HCO3) were
added to aliquots of b-casein and osteopontin and the mix-
tures were incubated at 567C for 35 min. After cooling to
room temperature 2 mL of iodoacetamide solution (27 mM,
in 50 mM NH4HCO3) were applied and the sample was kept
in the dark for 35 min to ensure a quantitative blocking of
cysteines. Excess of iodoacetamide was removed afterwards
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by adding 10 mL of the previously mentioned DTT solution.
Trypsin was dissolved in 50 mM acetic acid and diluted to a
final concentration of 500 ng/mL and kept at 2807C until
use. An aliquot of 1 mg was diluted with 50 mM NH4HCO3 to
a concentration of 50 ng/mL. Trypsin solution (4 mL) was
added to each aliquot and after 4 h at 377C additional 4 mL of
the trypsin solution was added. The cleavage was carried out
for 14 h at 377C and the reaction was stopped after 14 h by
addition of 10% TFA to a final concentration of 0.5%.
2.3 TiO2 enrichment of phosphorylated peptides
TiO2 packed into small tips (Glygen, Columbia, USA) was
washed with 40 mL of ACN, 60 mL of 0.2% HFBA in 70%
ACN and 100 mL of diluted loading buffer (200 mg/mL
DHB, 33.3 mM OcSNa in 20% AcOH, 45% ACN, 0.1%
HFBA). Tryptic digests from osteopontin (4.3 mM) and b-
Casein (5.8 mM) were diluted to 2 mM solutions using 0.1%
TFA and further dilution to 0.2 mM peptide concentration
was accomplished by adding 50% ACN with 10% AcOH.
Twenty microliters were mixed with 40 mL concentrated
loading buffer (300 mg/mL DHB (Sigma), 50 mM OcSNa in
40% AcOH, 40% ACN, 0.2% HBFA) to a final DHB con-
centration of 200 mg/mL. Aliquots according to 1 and
3 pmol of each protein respectively were loaded onto four
TiO2 columns over a time span of 30 min. In order to remove
unphosphorylated peptides, 60 mL of diluted loading buffer
and 100 mL of 70% ACN (with 0.2 HFBA) were used as wash
solvents. The complete liquid was removed from the TiO2
tips before the elution buffer was applied. NH4H2PO4
(50 mM) was prepared with H2O and the pH was set to 11
with concentrated ammonia solution (25%). Over 20 min
phosphopeptides were eluted with 25 mL of the NH4H2PO4
solution in steps of 5 mL. The resulting sample was acidified
with 5 mL of 5% H3PO4 to give a pH of 2–3. Enrichment effi-
ciency was tested by MALDI reTOF MS spectra of treated
and untreated sample.
2.4 HPLC separation coupled to MALDI detection
Separation of phosphorylated peptides was carried out using
an Ultimate Plus HPLC system (Dionex, Germany) which
was equipped with FAMOS autosampler, Switchos column
switching device, UV detector (detection at 214 nm) and
Probot fractionation device (all Dionex). Comparison of
separation efficiencies of C18 and monolithic columns was
carried out using PA in all HPLC solvents. In case of
separation with C18 column, 0.1% H3PO4 was used as load-
ing solvent and transport liquid, solvent A was 5% ACN with
0.1% H3PO4 and solvent B 80% ACN with 0.08% H3PO4
(flow rate 0.280 mL/min). The C18 column (PepMap C18,
30 cm675 mm63 mm, 100 Å, Dionex) was operated at ele-
vated temperature of 407C in combination with a trap col-
umn (PepMap C18, 5 mm6300 mm65 mm, 100 Å, Dionex)
to remove salts. Phosphopeptide separation on C18 material
was performed after 10 min washing with a linear gradient
from 0 to 60% B in 40 min and sample collection (15 s/frac-
tion) started 5 min after precolumn switching. Separation on
the monolithic column was performed with 0.05% H3PO4 as
solvent A and transport liquid and 80% ACN with 0.04%
H3PO4 in solvent B at a flow rate of 2.5 mL/min. Monolithic
separation (5 cm6200 mm, Dionex) was performed in direct
injection mode with temperature of the column oven set to
607C. A two step linear gradient from 3 to 15% B in 6 min
and 15–65% B in 8 min followed by 0.5 min 65%B and 4 min
95% solvent B was applied 2 min after injection and samples
were collected every 7 s, starting 1 min after injection.
2.5 MALDI MS
Acquisition parameters, resolution and laser energy were
optimized prior to MS analysis on the 4800 MALDI TOF/
TOF Analyser (Applied Biosystems) using the 14 peptide
mixture from Table 1 (peptides 1–14) with 1 pmol/peptide.
MS/MS optimization was performed on peptides 1 for
determination of key acquisition parameters (x2 and y2 volt-
age) and 14 was used as a control for multiply phosphorylat-
ed peptides. The instrument was operated in positive ioni-
zation mode unless otherwise stated. Samples crystallized
with CHCA were analysed in MS mode with 2000 shots/spot
to ensure good S/N quality for precursor selection. DHB
crystallized samples gave high spectral quality after 1500
laser shots. MS/MS was done with varying number of laser
shots in the case of directly spotted samples, for LC-MALDI
analysis 4000 laser shots were applied for each selected pre-
cursor. Enhanced fragmentation was achieved by applying
an increased pressure (261026 bar) in the collision cell.
Obtained MS/MS data were smoothed automatically
using a Savitsky–Golay function of 4th order with 7 points/
peak. Generation of MASCOTgeneric files (mgf) was carried
out with the implemented PEAKStoMASCOT tool from the
4000 Explorer software version 3.5.1 (Applied Biosystems).
Spectral images for manual validation were prepared with
the Data Explorer Software version 4.9 (Applied Biosystems).
2.6 Online nano-RP-HPLC/nano-ESI MS
For online nano-RP-HPLC/nano-ESI MS/MS measure-
ments, the HPLC system Ultimate Plus (Dionex) was direct-
ly coupled to the nano-ESI source (Proxeon, Odense, Den-
mark) instead of the Probot device. It was operated with 0.1%
TFA as loading solvent, 5% ACN with 0.1% formic acid (FA)
was solvent A and solvent B consisted of 80% ACN and
0.08% FA. After sample load, salts were removed on the trap
column (PepMap C18, 5 mm6300 mm63 mm, 100 Å, Dio-
nex) for 40 min at a flow rate of 20 mL/min. For separation on
a 15 cm C18 column (PepMap C18, 15 cm675 mm63 m,
100 Å, Dionex), a gradient from 0 to 35% B in 25 min and to
60% B in 5 min (flow rate 0.275 mL/min) was applied. MS
detection was carried out either on an LTQ-Orbitrap hybrid
mass spectrometer (Thermo Fisher, Bremen) or LTQ mass
spectrometer equipped with ETD (Thermo Fisher).
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Table 1. Synthetic peptides
No. Name Mr Sequence [M 2 H]
1
1 NoP_1 1569.6696 EGVNDNEEGFFSAR 1570.6769
2 NoP_2 1263.6208 APPDNLPSPGGSR 1264.6281
3 OneP_1 963.3587 SVSDYEGK 964.3660
4 OneP_2 1137.5292 NSVEQGRRL 1138.5365
5 OneP_3 1302.5493 LIEDNEYTAR 1303.5566
6 OneP_4 1313.5990 RSDGGHTVLHR 1314.6063
7 OneP_5 1343.5871 APPDNLPSPGGSR 1344.5944
8 OneP_6 1758.7938 SVENLPEAGITHEQR 1759.8011
9 OneP_7 1931.8296 ENIMRSENSESQLTSK 1932.8369
10 OneP_8 2026.0176 THILLFLPKSVSDYEGK 2027.0249
11 OneP_9 2093.8613 TASDTDSSYAIPTAGMSPSR 2094.8686
12 TwoP_1 2229.9807 QLGEPEKSQDSSPVLSELK 2230.9880
13 ThreeP_1 2309.9471 QLGEPEKSQDSSPVLSELK 2310.9544
14 ThreeP_2 1792.6471 FGSSNTDSAGALGTLR 1793.6544
15 OneP_10 1655.6842 WWGSGPSGSGGSGGGKR 1656.6915
16 OneP_11 1792.7431 HWWGSGPSGSGGSGGGKR 1793.7504
17 TwoP_2 1735.6505 WWGSGPSGSGGSGGGKR 1736.6578
18 TwoP_3 1872.7094 HWWGSGPSGSGGSGGGKR 1873.7167
19 ThreeP_3 1815.6169 WWGSGPSGSGGSGGGKR 1816.6241
20 ThreeP_4 1952.6758 HWWGSGPSGSGGSGGGKR 1953.6830
21 FourP_1 1895.5832 WWGSGPSGSGGSGGGKR 1896.5905
22 FourP_2 2032.6421 HWWGSGPSGSGGSGGGKR 2033.6494
23 FourP_3 2863.1732 RELLNVPGESIVESLSSEESITR 2864.1805
Peptides that were used for optimization of MALDI MS/MS and chromatographic separation. Phosphorylated
amino acids are in bold and underlined; peptides 1 and 2 are not phosphorylated.
2.7 Nano-ESI-MSA MS
The LTQ-Orbitrap mass spectrometer was operated in posi-
tive ionization mode and MS survey scans were carried out in
the orbitrap. Survey scans were internally calibrated using a
lock mass at 445.120024 m/z, and up to six signals were
selected for MS/MS analysis in the IT part of the instrument
in a single cycle. Neutral loss masses of 32.6, 49 and 98 m/z
were set to perform MSA of phosphorylated peptides [29].
Signals with charge state one were completely rejected from
MS/MS analysis whereas peptide masses which already have
been fragmented were put onto an exclusion list for 180 s.
Monoisotopic precursor selection (MPS) was activated be-
cause earlier experiments showed improved identification of
peptides with this feature.
2.8 Nano-ESI-ETD MS
The LTQ instrument was operated in positive ionization
mode and the nanospray source of Proxeon was used with
off-line borosilicate emitters of the same company. The
instrument was offline calibrated and optimization of ETD
fragmentation resulted in an activation time of 90 ms. A
2.5 pmol/mL solution of peptide FourP_2 was directly inject-
ed with a flow rate of ,50 nL/min. The electrospray voltage
was set to 850 V, fragment ion spectra were manually
recorded in the mass range of 180–2000 Da for doubly and
triply charged peptide ions. Ions were selected from a 1 Da
mass window with automatic gain control. One microscan
was acquired for each mass spectrum.
2.9 Data analysis
Analysis of MALDI MS data was accomplished using either
MASCOT (version 2.2.1, Matrixscience, London, UK;
www.matrixscience.com) orProtein Pilot (AppliedBiosystems,
Foster City, USA) [41]. Interpretation of all results ofMALDI or
ESIMSdata viadatabase searchingwasaccomplishedusing an
in-house database and all identified MS/MS spectra of phos-
phorylated peptides were manually confirmed. The in-house
database consists of approximately 500 entries of several
standardproteinsused forLC-MSoptimization, allMSrelevant
synthetic peptides of our laboratory and proteins which were
analysed by LC-MS/MS in different other experiments. Using
this database it was possible to perform MASCOTsearches of
MS optimization experiments with synthetic standard pep-
tides. For identification of nonphosphopeptides, a general
MASCOT score of 30 was applied. Phosphopeptides with
scores above 15were manually interpreted, if theymatch to the
‘in silico’ digest of osteopontin. The significant similarity of ESI
andMALDI data forCIDactivation washelpful to annotate low
scoring ESI spectra of multiply phosphorylated peptides.
© 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
4582 A. Schmidt et al. Proteomics 2008, 8, 4577–4592
MASCOT search parameters were 0.1 Da mass error for
precursor ions and 0.3 Da for fragment ion signals, in case of
tryptic digests carbamidomethylation was selected as fixed
modification. Phosphorylation of S, Tor Y was set as variable
modification, loss of water during sample preparation was
also considered as well as methionine oxidation. Four missed
cleavages were allowed with trypsin as enzyme. Precursor
charge state was set to 1 and MALDI TOF/TOF was selected
as instrument type.
Data analysis of MSA results of osteopontin was per-
formed with the MASCOT Daemon software (Matrixscience,
GB). Parameters for database search were equal to MALDI
experiments except of charge state which was automatically
assigned, MS tolerance of 3 ppm and MS/MS tolerance of
0.6 Da. In this search, the instrument type was set to LCQ.
Acquired ETD data were analysed with MASCOT with
following parameter settings: MS tolerance 2 Da, fragment
mass tolerance 0.8 Da, maximal missed cleavages 1, instru-
ment type ETD-trap and phosphorylation of S or Tas variable
modification.
3 Results
3.1 Optimization of crystallization conditions for
detection of phosphorylated peptides
A crucial first step for obtaining reliable identification of
complex phosphopeptides with MALDI MS was to establish
a suitable protocol for matrix crystallization. In previous
studies, several different matrices have been advertized as
suitable for phosphopeptide analysis by MALDI, however, so
far there exists no commonly accepted protocol. One impor-
tant aspect in matrix selection is the composition and con-
centration of the crystallization mixture as the eventual crys-
tal structure and size play an important role in the ionization
efficiency of peptides. Commonly, best results are obtained
from sample spots with homogeneously dispersed small
crystals. With regard to phosphopeptide analysis another
important point is the use of PA in the matrix solvent to
prevent phosphopeptide binding to the stainless steel surface
of the MALDI sample plate [42]. We expected that the addi-
tion of PA would be particularly important for a low detec-
tion limit of multiply phosphorylated peptides.
Our initial optimization experiments were carried out
using a mixture of peptides that were in a low phosphoryla-
tion state consisting of peptides 1–13 (13PPMix) of Table 1
with 10 pmol of each peptide in 0.1% TFA from peptide
stock solutions (1 mg/mL in water). This mixture was fur-
ther diluted with 0.1% TFA to obtain a series of peptide con-
centrations from 10 nM to 10 mM. Four different MALDI
matrices were chosen to test the ionization efficiency of
phosphopeptides: CHCA, DHB, indolylacrylic acid (IAA)
and 2,5-dihydroxyacetophenone (DHAP) [9]. CHCA crystal-
lization was performed with a solution of 2 mg/mL in 70%
ACN containing 0.1% TFA, the other matrices were dis-
solved to 10 mg/mL in 50% ACN, 0.1% TFA. We found that
IAA (hint from ABRF forum) or DHAP showed good results
for high amounts of phosphopeptides (.2 pmol/spot, data
not shown) but yielded unsatisfactory and irreproducible
detection at low amounts (,200 fmol/spot). For IAA, we
surmise that this deficiency is due to a polymerization prod-
uct that limits the number of useful laser shots that can be
applied to the sample.
In further optimization experiments, we therefore
focussed on the use of CHCA and DHB. CHCA was used at a
concentration of 2 mg/mL in 70% ACN, 0.1% TFA and
crystallization with DHB was performed with a 10 mg/mL
solution in 50% ACN 0.1% TFA. Both matrices turned out to
be sufficient for detection and identification of pure phos-
phopeptides at low amounts (10 fmol/spot). Although we
could not detect multiphosphorylated peptides spiked into a
nonsphophorylated peptide sample at such low concentra-
tions using CHCA matrix. We were able to identify them at
least at the concentrations of 200 fmol/spot. Comparable
ionization efficiencies were observed for not phosphorylated
and monophosphorylated peptides in samples of 50 fmol/mL
synthetic phosphopeptides that were mixed with 50 fmol/mL
of a tryptic digest of cytochrome c (Fig. 1) to simulate the
conditions of biological samples. Only samples that were
crystallized with DHB exhibited signals of multiply phos-
phorylated peptides at this concentration. Although these
signals were not intense they were reproducibly detected in
repeat measurements on ten sample spots. In a mixture
containing exclusively phosphorylated peptides (peptides
15–22), signal suppression of multiply phosphorylated pep-
tides was reduced only with DHB as matrix (data not shown),
when CHCA and DHB were compared from the analysis of
equal samples. It was described earlier that mixtures of both
matrices provide better results than the pure substances
alone [43]. CHCA (10 mg/mL) and DHB (10 mg/mL) were
combined in different ratios, and ionization efficiency of the
matrix mixtures was compared to pure matrix substances. In
contrast to published evidence, we observed no significant
improvements from these experiments (data not shown). We
therefore chose pure DHB as matrix substance in all further
experiments.
3.2 Optimization of DHB crystallization
For further improvement of our procedure, the signal inten-
sity of phosphopeptides was used as a parameter. The 13
PPMix was crystallized with different amounts of DHB
(from 50 to 1 mg/mL) and each mixture was analysed in tri-
plicates. As expected high peptide concentrations
(10 pmol2800 fmol/spot) work very well with higher
amount of DHB (50 mg/mL) but formation of multiple lay-
ers of big crystals was observed. In the case of low peptide
amounts and high DHB concentration, huge background
signals were present especially in the low mass area (900–
1300 m/z) affecting the detection of phosphorylated pep-
tides.
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Figure 1. Ionization of multiply
phosphorylated peptides with
different matrices. Two reTOF
mass spectra of a mixture of 13
phosphopeptides (Table 1, pep-
tides 1–13) with a tryptic digest
of horse heart cytochrome c
(CC) (50 fmol/mL of each peptide)
are shown (mass range 900–
2400 Da). Peptides are indicated
in reference to Table 1 in the
case of peptides from CC they
are named CC. The upper spec-
trum is taken from a mixture
crystallized with HCCA (2 mg/
mL) and the lower spectrum
shows the sample with DHB
(10 mg/mL). Multiply phospho-
rylated peptides TwoP_1 and
ThreeP_1 are only detected in
the DHB sample.
If low matrix concentrations (2 and 1 mg/mL) were
applied two effects were quite obvious. On one hand, low re-
producibility of crystallization was achieved. The crystal spot
varied in size and showed a ring of thin DHB needles which
surrounded a surface of small crystals. On the other hand,
only a low number of spectra could be acquired because of
the high consumption of matrix during ionization. Matrix
concentrations in the range of 5–20 mg/mL did not tre-
mendously differ in their ionization behaviour for peptide
amounts of 5 pmol220 fmol/spot, while lower sample
amounts performed better with 10 and 5 mg/mL DHB.
DHB dissolved in a mixture of 80% ACN v/v, 1% TFA v/v
and 0.2% H3PO4 v/v gave the best ionization results and was
used in a concentration of 10 mg/mL in all following experi-
ments. Optimized matrix conditions for offline experiments
were also tested in their LC-MALDI compatibility, where the
conditions from offline experiments (10 mg/mL DHB in
80% ACN, 1%TFA, 0.1% H3PO4) also proved to be optimal
for LC-MALDI experiments (comparison of ionization
modes see Supporting Information).
3.3 Affinity enrichment of phosphorylated peptides
In order to effectively detect phosphopeptides in low com-
plexity samples of purified proteins or protein complexes, an
enrichment step using TiO2 was introduced into the proto-
col. The first affinity purification demonstrated that the pre-
viously published method from Mazanek et al. [22] is not
compatible with MALDI MS without further purification of
the eluted phosphopeptide fraction. Dominating signals of
octylsulphonate multimers were observed with their char-
acteristic mass difference of 194 Da and suppressed all pep-
tide signals completely. To prove enrichment efficiency, it
was necessary to adapt this protocol for direct detection of
enriched phosphopeptides by MALDI MS.
A major change was applied for sample loading were the
previously described loading buffer was replaced by 200 mg/
mL DHB (Sigma), 35 mM OcSNa, 23% AcOH, 40% ACN and
0.1 HFBA. Peptide samples were diluted with 50% ACN (con-
taining 10% AcOH) to ensure a high amount of organic
solvent which promotes phosphopeptide binding to TiO2.
Additionally volumes for washing were increased to 60 mL of
diluted loading buffer and 100 mL of 70% ACN containing
0.2% HFBA. For effective elution of 50 mM NH4H2PO3,
pH 11adjustedwithNH3,was applied to the titaniumcolumn.
Protein digests (300 fmol) of b-casein and osteopontin
were treated according to the new protocol and the enrich-
ment is displayed in Fig. 2 in comparison to the untreated
sample. In case of b-casein, the signal of the monopho-
sphorylated peptide FCSEEQQQTEDELQDK (amino acids
33–48, m/z 2061.83) which is nearly lost in the spectral
background without enrichment represents the base peak
after TiO2 enrichment (black star). The four-fold phospho-
rylated peptide of beta casein at m/z 3122.26 (amino acids 1–
25, RELEELNVPGEIVESLSSSEESITR) which was not
detected in the untreated digest is greatly enriched and two
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Figure 2. Efficiency of TiO2 enrichment of tryptic digests of b-
casein and osteopontin. MALDI reTOF MS spectra (mass range
900–4000 m/z) are shown for tryptic digest of b-casein (A) and
osteopontin (B) before TiO2 enrichment (A I and B I) and the
eluted phosphopeptide fraction (A II and B II). White circles indi-
cate single phosphorylated peptides, multiply phosphorylated
peptides are indicated with black circles.
adjacent signals of unphosphorylated peptides are com-
pletely removed. The seldom observed signal at m/z 2966.16
which belongs to the four-fold phosphorylated peptide with-
out the N-terminal arginine residue is detected, but it has
only low intensity because trypsin is not able to cleave this
protein N-terminus effectively.
The MS spectrum of the osteopontin digest contains few
major peaks with up to four sodium adduct signals, because
the protein was purchased with a sodium containing buffer
substance. Signals of phosphorylated peptides are not detec-
ted (Fig. 2) in this spectrum. After enrichment almost all
major signals are related to phosphorylated peptides of
osteopontin and most of them have multiple phosphosites
(black circles). The base peak corresponds to the three-fold
phosphorylated C-terminal peptide IRISHELDSASSEVN
(m/z 1896.72).
To get more insight how the new protocol improves
enrichment of multiply phosphorylated peptides, we set up
an experiment to determine the recovery from TiO2 in the
elution step. Eight synthetic peptides of different phospho-
rylation state and hydrophobicity were mixed and two equal
fractions were labelled with the iTRAQ reagents 114 and 115.
2 pmol/TiO2 column of the 115 fraction were treated accord-
ing to the described protocol in five individual enrichment
experiments. Sample 114 was mixed to the eluted fractions
in equal amount to the loaded sample 115. The resulting
mixture was crystallized with DHB as matrix and iTRAQ
ratios were determined in MS/MS experiments. The
obtained ratios are shown in Fig. 3, the area of signal 114 was
used as reference and is therefore set to 1. Almost all phos-
Figure 3. Recovery of phosphopeptides after TiO2 enrichment.
Eight synthetic peptides were mixed and split into two parts
which were labelled with iTRAQ reagents 114 and 115, respec-
tively. The 115 labelled fraction was treated according to the
described TiO2 enrichment protocol and sample 114 was added
to the elution fractions in equal amount to loaded sample 115.
The iTRAQ ratios were determined by MALDI TOF/TOF MS/MS
MS and averaged over five individual enrichment steps.
phopeptides are recovered to about 90% from the titanium
column and there are no differences between singly (pep-
tides A, B, C) and multiply phosphorylated peptides (two
phosphates D, E, three phosphates F, G, four phosphates H)
visible. Only peptide C which has strong hydrophobicity has
a lower recovery from the column which can be due to a
higher solubility in the washing solution compared to the
other peptides.
3.4 HPLC fractionation of phosphorylated peptides
Experiments with mixtures of unphosphorylated, singly and
multiply phosphorylated peptides showed a tremendous
suppression of signals of multiply phosphorylated peptides
in the MALDI ionization step (Fig. 1 and Supporting Infor-
mation Fig. S1). Separation of phosphorylated peptides is
necessary to reduce suppression and therefore enhance
identification of multiply phosphorylated peptides. RP-
HPLC is capable of separating complex peptide mixtures
according to their hydrophobicity as well as phosphorylated
peptides with different number and positions of phospho-
rylated amino acids, even if they share the same amino acid
sequence. Unfortunately, low recovery rates are often
observed for highly phosphorylated peptides upon separa-
tion on C18 columns under standard conditions. TFA as well
as FA which are widely used for RP-HPLC separations lead
to broad peaks which are also a reason why the detection
limit of multiply phosphorylated peptides is quite high.
Integrating H3PO4 as acidic component of the solvent system
significantly improves peak shapes of multiply phosphoryl-
ated peptides on C18 columns because undesired interac-
tions of the phosphate moiety with metal parts of the HPLC
system, e.g. titanium valves are suppressed. Unfortunately,
even low amounts of PA cannot be combined with online
ESI MS detection.
Two separation systems were compared for their resolv-
ing power and recovery of multiply phosphorylated peptides
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from simple peptide mixtures. Phosphopeptides from 1 and
3 pmol osteopontin tryptic digest were enriched on TiO2
using the new protocol and the sample was split for separa-
tion on a monolithic column and an in-house packed C18
column. Samples representing 300 fmol and 1 pmol of the
TiO2 elution fraction were injected on each HPLC system
and eluting fractions were spotted on a MALDI sample plate.
The monolithic system was operated in direct injection mode
to ensure high recovery of weakly binding peptides. A frac-
tionation time of 7 s for the monolith was applied which
resembled roughly the double peak width at half height and
ensures small sample droplets. For C18 chromatography, the
fraction time was set to 15 s which is about one and a half
peak widths and was optimized in earlier experiments.
Interestingly, the order of the eluting peptides was dif-
ferent between monolithic and C18 column (Fig. 4). Highly
phosphorylated peptides showed significantly increased
retention times on C18 material compared to peptides in
lower phosphorylation state. This becomes quite obvious
from the selected ion chromatograms (SICs) of peptides
OneP_8 and ThreeP_2 in Fig. 4, where the strongly hydro-
phobic monophosphorylated peptide OneP_8 elutes earlier
from the C18 column than the triply phosphorylated peptide.
Also peptides which share the same amino acid sequence but
have a different number of phosphate moieties became
separated while the peptide with less phosphoamino acids
eluted earlier than the higher phosphorylated form (see
TwoP_1 and ThreeP_1).
However this strong retention of multiply phosphorylat-
ed peptides could not be observed in the monolithic separa-
tion, but hydrophobicity of the peptide backbone is the driv-
ing force for retention of peptides which is demonstrated by
comparing peptides OneP_8 and ThreeP_2. Peptides with
high backbone hydrophobicity elute later from the mono-
lithic column. Phosphopeptides with same amino acid
sequence but different phosphorylation state eluted in
reversed order to the C18 column from monolithic columns
as shown for peptides TwoP_1 and ThreeP_1. This effect was
also observed for multiply phosphorylated peptides from
osteopontin. Some late eluting highly phosphorylated pep-
tides did not show a sharp elution profile on C18 columns,
for example peptide osteopontin B. In contrast, monolithic
Figure 4. Elution profiles of phosphorylated peptides on C18 or monolithic column. SICs for several phosphopeptides, including two
osteopontin peptides are displayed for separation on either C18 or monolithic column. Interestingly all highly phosphorylated peptides
have significantly increased retention times on the C18 column compared to single phosphorylated peptides (OneP_8) or can even not be
eluted in a sharp signal (osteopontin_B). Earlier elution of highly phosphorylated peptides (ThreeP_2) compared to singly phosphorylated
ones is observed from the monolithic fractionation.
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separation leads to a sharp elution profile and a high recovery
rate. This peptide is three-fold phosphorylated SNVQSPDA-
TEEDFTSHIESEEMHDAPK ([M 1 H]1 3286.18 Da, amino
acids 155–181, MSO at M22). Although spot time for the
monolithic separation was only half of that of the C18 sys-
tem, peptides were often detected only in a single spot or in
two adjacent spots whereof one contained more than 80% of
the peptide.
These observations lead to the impression that C18
chromatography contributes to higher detection limits for
multiphosphorylated peptides because of a stronger reten-
tion compared to monophosphorylated peptides and unde-
fined broad elution. Monolithic columns on the other hand
do not have the peak capacity of C18 columns but allow fast
and highly reproducible separations with sharp peak shapes.
Based on our data we suggest the use of monolithic column
for the analysis of enriched phosphopeptides from low com-
plexity samples.
3.5 Phosphosite determination of osteopontin
Fractions of 500 fmol of TiO2 enriched phosphopeptides
from tryptic digest of osteopontin were analysed using either
LC-ESI MSA MS/MS or LC MALDI TOF/TOF MS/MS. The
enriched phosphopeptides were fractionated by nano-RP-
HPLC using the standard set-up with C18 column and
online MS was carried out with MSA which combines the
quality of MSn spectra with improved scan speed. A second
phosphopeptide fraction was separated using the monolithic
HPLC system and fractions were spotted every 7 s on a
MALDI target sample plate, which was prespotted with
12 mg/mL DHB. Two hundred fractions were collected
starting from 1 min after injection of the samples to ensure
that also nonbinding peptides are found in the early frac-
tions. Both approaches identified 15 phosphosites out of 28
predicted phosphosites of osteopontin with MASCOT scores
above 20 (Fig. 5). To evaluate the obtained data, phospho-
peptides were compared to the theoretical phosphorylation
state according to the Swiss-Prot database entry for PTMs of
osteopontin [5].
Interestingly, identified phosphopeptides from MSA
showed a very high diversity of phosphorylation states for
peptides with multiple phosphorylations and often mono-
phosphorylated species scored highest. Peptides in expected
phosphorylation states did not receive good identification
results. One reason for poor identification of these peptides
was that the final separation step was carried out on a C18
column with solvents containing FA as acidic component
which resulted in peaks eluting over a broad time span thus
decreasing the number of ions available for a single spec-
trum. This effect led to the acquisition of up to ten individual
MS/MS spectra of a single peptide.
MALDI TOF/TOF MS/MS analysis showed a different
picture herein almost all identified phosphopeptides were in
there expected phosphorylation state or missed only one
phosphate moiety. Signals for lower phosphorylation states
Figure 5. Identified phosphosites on osteopontin. Phosphorylat-
ed amino acids of bovine osteopontin which were identified by
ESI-MSA and MALDI TOF/TOF MS/MS (bold red letters), black
upfacing triangles mark phosphosites exclusively identified with
ESI-MS/MS (MASCOT score .20), red downfacing triangles
stand for phosphoamino acids only found in MALDI TOF/TOF
data (score .30). All phosphopeptide spectra were manually
interpreted to avoid false positive identification.
were less intense and often not selected for MS/MS analysis.
Their abundance was elucidated by their mass traces which
had up to 20 times lower intensity compared to the identified
phosphopeptide species.
Significantly higher scores for multiphosphorylated pep-
tides were achieved with the MALDI approach. This might
be due to a lower number of background signals because
maximal 200 masses per MS/MS spectrum were extracted for
the mgf-file. Additionally the upper mass area, where signals
of different neutral losses of phosphate moieties occur, was
deleted manually for each peptide before database search.
This significantly improved identification, because MAS-
COT is not able to recognize signals of neutral losses from
the intact peptide (Supporting Information Fig. S2 ). Two
major criteria were applied for manual deletion of this mass
area, first the most intense signals of MS/MS data were
related to neutral loss of H3PO4 or HPO3 which was
determined by manual inspection of the spectrum. As sec-
ond criterion a database search in MASCOTwith the original
mgf-file was performed to decide if multiple phosphoryla-
tions were present which was used to determine the minimal
range of masses that was deleted.
3.6 Phosphosite assignment
Although MSA leads to the observation of series of b- and y-
ions, while in MALDI TOF/TOF spectra often only one type
of fragment ions was predominantly present, exact pin-
pointing of the phosphorylation site was more successful
with MALDI data (Table 2). This aspect is shown for three
highly phosphorylated peptides of osteopontin which have
been identified with ESI and MALDI.
MALDI data yield higher identification scores for multi-
ply phosphorylated peptides compared to ESI so that the N-
terminal peptide LPVKPTSSGSSEEK (MR 1764.61) as well
as the C-terminus IRISHELDSASSEVN (MR 1895.71) of
osteopontin do not even receive a score of 30 for the highest
scoring spectrum from ESI data see Table 2. Manual inter-
pretation was done on each phosphopeptide with score above
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Table 2. Automatic annotation of phosphorylation sites by
MASCOT
Phosphosite distribution MASCOT score
ESI MALDI
Sequence A
A-1 LPVKPTSSGSSEEK 5.9 50.5
A-2 LPVKPTSSGSSEEK 17.8 45.0
A-3 LPVKPTSSGSSEEK 11.4 32.3
A-4 LPVKPTSSGSSEEK 8.8 29.2
A-5 LPVKPTSSGSSEEK 8.8 27.5
Sequence B
B-1 IRISHELDSASSEVN 16.4 54.2
B-2 IRISHELDSASSEVN 10.2 44.1
B-3 IRISHELDSASSEVN 9.3 35.1
B-4 IRISHELDSASSEVN 3.2 22.1
Sequence C
C-1 SNVQSPDATEEDFTSHIESEEMHDAPK 34.4 70.8
C-2 SNVQSPDATEEDFTSHIESEEMHDAPK 15.7 50
C-3 SNVQSPDATEEDFTSHIESEEMHDAPK 6.5 50
C-4 SNVQSPDATEEDFTSHIESEEMHDAPK 20.8 46.4
C-5 SNVQSPDATEEDFTSHIESEEMHDAPK 34.4 45
C-6 SNVQSPDATEEDFTSHIESEEMHDAPK 10.3 39.6
C-7 SNVQSPDATEEDFTSHIESEEMHDAPK 4.4 39.6
C-8 SNVQSPDATEEDFTSHIESEEMHDAPK 19.2 22.5
C-9 SNVQSPDATEEDFTSHIESEEMHDAPK 2.7 22.2
C-10 SNVQSPDATEEDFTSHIESEEMHDAPK n.a. 22.2
C-11 SNVQSPDATEEDFTSHIESEEMHDAPK 6.1 n.a.
MASCOT scores for different phosphosite distributions of three
peptides of osteopontin (A, B, C) are listed in the table. Putatively
identified phosphosites are underlined and in bold. From the
Swiss-Prot database entry predicted distribution has a grey
background. All peptides contain at least one additional T or S
residue next to the phosphoamino acids, which is not phospho-
rylated. Only MALDI data lead to the identification of the expect-
ed phosphosite distribution with the highest score.
15. Interestingly, a high similarity on the fragment ion level
was found between both activation mechanisms. Exact iden-
tification of the phosphorylated amino acid is often only
achieved from MALDI data, because although fragment ions
do not have high intensity relevant signals are only detected
in MALDI MS/MS spectra. ESI spectra yield also a high
number of neutral loss fragment ions which do not allow an
unambiguous phosphosite alignment especially in the case
of peptides containing other putative phosphoamino acids.
The score difference between first and second hit of the
MALDI data is quite small for peptide LPVKPTSSGSSEEK.
This result is due to the fact that almost all identified signals
overlap between the two possible peptides because one
phosphate is ambigously assigned to two adjacent amino
acids. Only fragments at T6 or S7 are responsible for the
identification. Assignment of the first phosphate moiety to
S7 is difficult because of a neutral loss signal of water from
the threonine side chain which is present next to the signal
for the unmodified amino acid. The signal which includes
the intact phosphoamino acid does not exist. Also two signals
are observed for the first serine at position 7, one with intact
phosphate moiety and one with neutral loss of H3PO4, no
signal for the unmodified serine is present which deter-
mines the first phosphorylation to S7. The result of the cor-
responding ESI spectrum leads to the assumption of a dif-
ferent phosphate distribution. The phosphosites of the C-
terminal peptide of osteopontin are correctly assigned for
ESI and MALDI data but the ESI spectrum obtained a low
score and was even not in the list of identified peptides for
osteopontin. The third peptide SNVQSPDATEEDFT-
SHIESEEMHDAPK (MSO at M22) presents another short-
coming of ESI data, where automatic interpretation does not
always lead to a single distribution, but two or more forms
receive the same score. The identification from MALDI data
is quite unambiguous with a score difference of 20 between
first and second hit (for annotated spectra see Supporting
Information).
3.7 Relevance of the method in contrast to novel
fragmentation techniques
To evaluate the viability of our method, MS/MS spectra
of the four-fold phosphorylated peptide HWWGSG-
PSGSGGSGGGKR (FourP_1) were compared for either
MALDI TOF/TOF PSD fragmentation or ETD in an LTQ IT
instrument (Figs. 6 and 7). For MALDI TOF/TOF experi-
ments, 100 fmol peptide was crystallized with 0.8 mL of 12
mg/mL DHB matrix and 8000–12 000 shots were summed
up for one MS/MS spectrum. Peaks were exported using the
PEAKStoMASCOT tool from the 4000 Explorer Software
(Applied Biosystems) and the upper mass region where
neutral losses of H3PO4 and HPO3 occur was manually
removed from the mgf-file.
Base peak of theMALDIMS/MSspectrum (Fig. 6)was the
neutral loss of a single H3PO4 molecule but also species with
two or three neutral losseswere identified with high intensity.
Interestingly no signal for the loss of one molecule HPO3
from the intact peptide was observed, but evidence of this loss
was taken from backbone fragments carrying a phosphoryl-
ated amino acid. Nearly the complete y-ion series was identi-
fied in the spectrum, which suggests that the basic residues at
the C-terminus are predominantly charged. Next to the origi-
nal y-ion series, many y-ions with either loss of H3PO4 (trian-
gles) or HPO3 were detected with lower signal intensity. This
series started at the first phosphorylated amino acid. Some
fragment signals showed even more than a single neutral loss
(circle or square). Interestingly all y-ions, resulting from the
break N-terminally to phosphorylated amino acids, have low
intensity, while fragments of the following unphosphorylated
amino acids where significantly stronger.
ETD spectra were acquired on an LTQ-ETD instrument
by direct infusion of a 2.5 pmol/mL solution of the peptide.
Two- and three-fold charged precursors were selected for
MS/MS experiments to reveal the influence of the charge
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Figure 6. MALDI TOF/TOF tandem mass spectrum of peptide
FourP_2. The MS/MS spectrum of the peptide was summed up
from 12000 shots. The upper spectrum shows the complete MS/
MS spectrum, and the grey region is enlarged in the bottom. The
spectrum is dominated by several neutral loss signals of either
loss of H3PO4 or HPO3 or combinations. A high number of y-type
fragment ions could be identified in the spectrum (blue intact y-
ions, red y-ions with loss of phosphate 16m, 26d, 36n ). Spec-
tral data were analysed by MASCOTand y-80 and y-98 ions were
added to the fragment table manually. The mass accuracy of the
MS/MS spectrum is 0.2 Da.
state on the applied fragmentation settings. The spectrum of
the doubly charged precursor did not show formation of
fragment ions, whereas the triply charged precursor was
suitable for MS/MS analysis (Fig. 7). Base peak of the spec-
trum of FourP_1 is the radical ion [M 1 3H]21? the second
intense signal represents the precursor. Although fragment
ions have only small intensity high sequence coverage is
obtained for this peptide. Interestingly, a significant number
of y-ions are present in the spectrum which was not expected
from the underlying fragmentation mechanism.
As Figs. 6 and 7 show our method yields at least equal
identification results as ETD fragmentation at low peptide
amounts. Almost the complete peptide sequence with intact
phosphate moieties was identified and y-ions that were not
annotated by MASCOT can easily be assigned manually in
the TOF/TOF MS/MS spectrum upon manual inspection.
The set of c-ions, y-ions, z 1 1-ions and z 1 2-ions from the
ETD spectrum cover also the whole peptide.
3.8 Isotopic labelling
Yet another benefit of our identification strategy is combina-
tion with multiple stable isotope labelling strategies for pro-
tein quantification, which is demonstrated in Fig. 8. The
peptide FourP_1 was labelled with 4-plex iTRAQ reagents
(isotopes 114 and 116) and mixed to give a 1:1 ratio. The
spectrum is not severely altered by the addition of the iTRAQ
moiety, all identified fragment ions carry a single intact
iTRAQ label at the e-amino function of K17. Signals of frag-
ments with loss of the iTRAQ moiety are not detected. The
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Figure 7. ESI-IT ETD tandem mass spectrum of peptide FourP_2.
2.5 pmol/mL of FourP_2 peptide were injected using a static
nanospray and ETD fragmentation was carried out on the triply
charged precursor ion with optimized parameters. Enlarging the
low intensity area below 7% of the base peak (grey box) reveals
the fragment ions of c-, z- and y-type. Spectral data were ana-
lysed with MASCOT which led to an almost complete identifica-
tion of all amino acids by combining the observed c-, y- and z-
type ions. The mass accuracy of the MS/MS spectrum is 0.8 Da.
label is beneficial for fragment ions with a mass which is
near to the area of H3PO4 losses from the complete peptide
because this area is shifted further by two iTRAQ labels at
the N-terminus and K17, while the corresponding fragment
ions carry only a single iTRAQ modification. Identified y-
ions are also almost complete for this spectrum, unfortu-
nately two fragments at phosphorylated residues were not
considered by MASCOT.
4 Discussion
Although a large number of tools exists that help in the
identification of phosphorylation sites of peptides by MS,
the analysis of multiply phosphorylated peptides has
remained a difficult task. In this work, we have estab-
lished a strategy that should help to overcome the limita-
tions inherent in some of the more classical approaches.
We developed a method consisting of three steps, enrich-
ment, separation and detection/identification that allows
analysis of highly phosphorylated peptides from digests of
phosphoproteins and exact determination of the phos-
phorylated amino acids. Although our TiO2 protocol is not
designed and therefore not quite suitable for large-scale
analysis of phosphorylation sites from whole cells, it
yields excellent data for enriched phosphoproteins or
protein complexes. As such it might be a valuable addi-
tion to our arsenal for determining complicated mod-
ification patterns.
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Figure 8. MALDI TOF/TOF MS/MS spectrum of iTRAQ-labelled
FourP_2. The MALDI TOF/TOF MS/MS spectrum of 100 fmol
iTRAQ-labelled peptide FourP_2 displayed in the figure. Again
dominating peaks result from neutral losses of H3PO4 or HPO3
and fragment ions as well as iTRAQ reporter ions have lower
intensity. Interestingly y-type fragments with high intensity have
an intact label and phosphorylation. In comparison to the unla-
belled peptide not significant implication occurs upon labelling
and the spectrum shows only small alterations such as the intact
iTRAQ labels at H1 and K17.
Concerning the enrichment step, we opted for a purifi-
cation protocol using TiO2. In our opinion, TiO2 has some
advantages over the common IMAC method. First of all,
acidic amino acid side chains must not necessarily be ester-
ified which is a source of increased sample complexity if the
reaction is not complete. Secondly, our protocol provides
good recovery for multiple phosphorylated peptides also at
variable sample amounts, thus allowing easy upscaling and
downscaling of the enrichment procedure. In our experi-
ence, IMAC purification is sometimes sensitive to changes
in the sample amount. Another important improvement in
our procedure is the low phosphate concentration in the
elution buffer, which on one hand ensures almost complete
elution of multiple phosphorylated peptides from the TiO2
surface and on the other hand allows direct and efficient
analysis of the eluted fraction by MALDI MS.
With regard to the final separation step, monolithic
HPLC proved to be an excellent alternative for separation of
enriched phosphopeptide mixtures compared to HPLC on
C18 columns [44, 45]. Advantages are reduced time require-
ment for chromatography combined with sharp elution pro-
files. Whereas separation on C18 material often results in
broad peaks for multiply phosphorylated peptides. This det-
rimental effect is not only caused by the column material
itself, but also by the solvent composition that might alter the
retention behaviour of such peptides. We showed that PA as
acidic component gave the best performance, but it cannot
be used in combination with ESI ionization.
In contrast to ESI MS, MALDI is not affected by small
amounts of phosphate in the HPLC solvent. It even proved to
be necessary to prevent phosphopeptides from binding to the
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surface of the steel target. Another benefit of the presence of
phosphate in MALDI MS is the suppression of matrix cluster
signals that can be formed during ionization. Interestingly,
MALDI TOF/TOF MS/MS spectra of multiply phosphorylat-
ed peptides had a high number of fragment ions with intact
phosphosites. These fragments were also observed in ESI
MSA spectra which demonstrates high similarity between
both activation methods for multiphosphorylated peptides.
Concerning sensitivity problems which were discussed with
MALDI MS, we found that our mass spectrometer had com-
parable sensitivity to common ESI approaches. Another
benefit of the TOF/TOF analyser is high mass accuracy both
in MS and MS/MS which allowed us unambiguous identifi-
cation of phosphorylation sites. Excellent results could be
obtained from off-line analysis low sample amounts with
MALDI MS or ESI-ETD MS, demonstrating that our method
is at least equally successful in the identification of complex
phosphorylation patterns.
Finally, our approach is also compatible with relative
quantification between two samples, if an isotope label is
introduced. Almost all published labelling techniques can be
applied because they are stable during the enrichment and
separation process. We demonstrated the viability of the
iTRAQ strategy to yield quantification data from MS/MS
spectra of low sample concentrations. This method cannot be
combined with other strategies for phosphopeptide identifi-
cation like ETD or ECD because the isobaric label will not be
fragmented to give the characteristic reporter ions which are
necessary for quantification. Since identification and quantifi-
cation is accomplished from a single LCrun, slight differences
which result from the separation conditions itself and fromthe
crystallization step do not affect the quantification result.
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the profile from Hoxd9 to Hoxd1 was compara-
ble to wild type. The robust gain in H3K4me3
marks overHoxd12was not scored in older wild-
type tail buds (fig. S2) and did not match any
transcriptional activity, neither for Hoxd12 nor
for Hoxd11 (Fig. 3B). In this case, both Hoxd11
andHoxd12were ready to be transcribed (28), yet
they remained silent because they were moved
away from the required enhancer sequence lo-
cated telomeric to the breakpoint. In contrast, in-
creased H3K4 trimethylation on the other side of
the breakpoint (Fig. 3C) matched the premature
activation of Hoxd10.
The DNA interval decorated by H3K27me3
marks in invmutants was virtually identical to wild
type (Fig. 3C), indicating that an integral cluster is
not necessary to define the initial extent of the re-
pressive domain; H3K27me3 marks were posi-
tioned over posterior genes even though these genes
were disconnected from the rest of the cluster, thus
ruling out the existence of a spreading mechanism
sensu stricto for the implementation of this repres-
sion. In addition, the overall density of these marks
on both sides of the break point was considerably
below the wild-type situation (Fig. 3C). In the pos-
terior half-cluster, H3K27me3 marks were distrib-
uted almost as in wild type over Evx2 andHoxd13,
whereas a decrease was scored over the Hoxd12 to
Hoxd11 intergenic region and 3′ to Hoxd11 (Fig.
3C). In the anterior half-cluster, a similar reduction
was detected at theHoxd10 locus, consistentwith its
premature activation and, to a lesser extent, over
Hoxd9 (Fig. 3C). This weakening in H3K27me3
signal over Hoxd10 was not observed at the wild-
type locus, even in older tail buds (fig. S2). The gen-
eral decrease in H3K27 trimethylation around the
break point suggests that a dense coverage of the
HoxD cluster by this histonemodification requires an
intact clustered configuration. Whereas isolated parts
of the gene cluster can be trimethylated at H3K27
independently ofone another, these various partsmay
cooperate and synergize tomediate a dense pattern of
methylation, potentially through local cis interactions.
These results shed light on the general regulatory
strategy implemented by Hox gene loci during the
earliest steps ofmouse trunk development.Unlike in
Drosophila, mammalian Hox gene loci appear re-
fractory to transcription before transcription initiates,
as indicated by high levels of H3K27me3 marks
covering the HoxD locus early on. This likely re-
flects the necessity to prevent the premature activa-
tion of posterior genes at a time when anterior
structures are being determined, which would be
deleterious to the embryo. During gastrulation, this
repression is counteracted by an activity progressing
from the telomeric to the centromeric extremity of
the cluster, illustrated by both an elevation of
H3K4me3 level and the demethylation of
H3K27me3. The region of transition between these
two states of chromatin corresponds to the dynamic
windowwhereinHoxd genes become transcription-
ally active. Alternatively, Hox genes could be ac-
tivated from a persisting pool of nonexpressing stem
cells. In this view, the chromatin modifications ob-
served in our samples reflect the average of suc-
cessive waves of transcriptional activation rather
than a dynamic process occurring in the same cells.
We do not favor this possibility because such a pool
of Hox-negative cells would constitute a large
fraction of the tissue sample, yet it has never been
observed in gastrulating tail buds. Also, the nucleo-
somes of these stem cells would lack the repressive
marks over theHoxD cluster, unlike inESC. Finally,
Hox genes are activated in cells already expressing
more anterior combinations thereof.
We have shown that gene clustering is not nec-
essary for the initial definition of the H3K27me3
landscape. However, clustering is required for a full
repression to be consolidated and/or maintained
over the cluster, which suggests a synergistic effect
due to Hox genes’ density. Likewise, whereas an
integral cluster appears dispensable for selecting the
sites of H3K4 trimethylation, gene clustering helps
the coordination of this general transition in
chromatin status because split clusters displayed
premature H3K4me3 marks on either side of the
breakpoint. Although the gain of H3K4me3 and the
concurrent weakening of H3K27me3 at the mutant
Hoxd10 locus coincided with its early ectopic
transcription, similar imbalances at the inverted
Hoxd11 and Hoxd12 loci did not elicit the same
transcriptional response. From this, we conclude
that H3K4me3 chromatin modification is necessary
but not sufficient for properHox gene transcriptional
control and that remote enhancer sequences must
have contributed to the maintenance of clustered
organization during animal evolution.
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McsB Is a Protein Arginine Kinase
That Phosphorylates and Inhibits the
Heat-Shock Regulator CtsR
Jakob Fuhrmann,1* Andreas Schmidt,2* Silvia Spiess,3 Anita Lehner,1 Kürşad Turgay,4
Karl Mechtler,1,5 Emmanuelle Charpentier,3,6 Tim Clausen1†
All living organisms face a variety of environmental stresses that cause the misfolding and
aggregation of proteins. To eliminate damaged proteins, cells developed highly efficient stress
response and protein quality control systems. We performed a biochemical and structural
analysis of the bacterial CtsR/McsB stress response. The crystal structure of the CtsR repressor, in
complex with DNA, pinpointed key residues important for high-affinity binding to the promoter
regions of heat-shock genes. Moreover, biochemical characterization of McsB revealed that McsB
specifically phosphorylates arginine residues in the DNA binding domain of CtsR, thereby
impairing its function as a repressor of stress response genes. Identification of the CtsR/McsB
arginine phospho-switch expands the repertoire of possible protein modifications involved in
prokaryotic and eukaryotic transcriptional regulation.
One of the most intensely studied stress-response pathways is the bacterial heat-shock response. In the Gram-positive model organism Bacillus subtilis, the heat-shockresponse is mediated by a complex regulatorynetwork (1, 2) that is under control of at least four
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major transcriptional regulators, including the al-
ternative sigma factor sB (3), the two-component
response regulator CssR (4), and the repressors
HrcA (5) and CtsR (6, 7). The latter factor, CtsR,
controls the expression of genes encoding the
HSP100/Clp chaperones and the protease ClpP
(6, 8) that constitute the core of the bacterial
protein quality control system (9, 10). CtsR is
encoded by the first gene of the clpC operon that
includes ctsR, mcsA, mcsB, and clpC (6). The
dimeric repressor consists of an N-terminal do-
main with a helix-turn-helix (HTH) motif and a
C-terminal domain of unknown function (11). In
B. subtilis, CtsR represses transcription of the clpC
heat shock operon and the clpE and clpP genes
by binding specifically to a seven-nucleotide
direct repeat sequence located upstream of the
transcriptional start sites (7). Stress-induced tran-
scription of the clp genes depends on the in-
activation of CtsR by McsB (12). McsB shows
pronounced homology to phosphagen kinases
(PhKs) and has been reported to exhibit tyrosine
kinase activity (12, 13). Under normal growth
conditions, McsB is captured and inhibited by
ClpC. However, when bacteria are exposed to
stress situations, the ClpC chaperone preferen-
tially interacts with misfolded proteins. It is as-
sumed that the released McsB can now form a
complex with CtsR, thereby displacing it from
DNA and inducing the expression of heat-shock
genes (14). Alternatively, the phosphorylation of
CtsR by McsB may be critical for the release of
the repressor from DNA (12). To clarify and de-
lineate the precise function of CtsR and McsB in
the bacterial stress response, we screened the re-
spective proteins fromvariousGram-positive bac-
teria for recombinant production and succeeded in
reconstituting the Bacillus stearothermophilus
CtsR/McsB system in vitro.
To uncover how McsB modulates the re-
pressor activity of CtsR, we performed electro-
phoretic mobility shift assays (EMSAs) (Fig. 1A).
Addition of CtsR to the 258–base pair (bp) clpC
promoter containing three ctsr half sites led to a
substantial band shift caused by the formation
of a CtsR4/DNA complex. Addition of McsB
yielded two lower migrating bands that repre-
sent CtsR2/DNA and free DNA. The McsB-
dependent release of CtsR was observed only in
the presence ofMg/adenosine triphosphate (ATP),
whereas addition of EDTA or phosphatase coun-
teracted the effect of McsB. Because no protein-
protein interaction could be detected by native
gel analysis or size exclusion chromatography,
we speculated that McsB and CtsR interact tran-
siently and that phosphorylation of CtsR by
McsB abolishes its binding to DNA. To test this
hypothesis, CtsR was incubated with McsB in
the presence of ATP, and subsequently, phos-
phorylated CtsR (CtsR-P) was separated from
nonphosphorylated CtsR by heparin affinity
chromatography (Fig. 1B). Mass spectrometry
(MS) analysis of CtsR-P revealed two protein
species with either one or two phosphate moieties
per protomer (Fig. 1B). In contrast to unmodified
CtsR, the isolated CtsR-P cannot bind to its target
DNA, as deduced from isothermal titration calo-
rimetry (ITC) and gel-shift experiments (Fig. 1, C
and D). Removal of the phosphate group by
alkaline phosphatase fully restored the DNA
binding capability of CtsR. Thus, phosphoryl-
ation of CtsR by McsB is sufficient to inhibit the
repressor function of CtsR.
To understand how phosphorylation of
CtsR affects DNA binding, we determined the
crystal structure of CtsR bound to a 26-bp DNA
derivative of the clpC promoter (table S1). The
CtsR2/DNA structure revealed that the CtsR
protomer is composed of two distinct domains:
(i) an N-terminal DNA binding domain that
adopts the winged HTH fold (residues 2 to 72)
and (ii) a C-terminal dimerization domain (resi-
dues 79 to 153) that consists of four a helices
organized in a four-helix bundle (Fig. 2A). The
DNA reading heads of the major and minor
groove comprise the recognition helix of the
HTH motif and the extended b-hairpin wing,
respectively. Key residues for recognizing and
binding the ctsr consensus sequence are indicated
in Fig. 2A and fig. S3. After obtaining a molecular
model of the CtsR/DNA complex, we usedMS to
pinpoint individual phosphorylation sites. Our
initial analyses of “in-solution” and “in-gel” di-
gested CtsR-P were not successful; thus, we at-
tempted to sequence mono-phosphorylated CtsR
in a “top-down” MS experiment (Fig. 2B).
Purified CtsR-P was directly infused into the mass
spectrometer and fragmented by different tech-
niques including electron-capture dissociation
(ECD), collisionally activated dissociation (CAD),
and infrared multiphoton dissociation (IRMPD).
Mapping of the resulting modified protein frag-
ments to the CtsR amino acid sequence revealed
that the phosphorylation sites reside in the
winged HTH domain. Furthermore, the broad
distribution of modified fragments pointed to the
existence of product isoforms with different phos-
phorylation sites. The highest probability for a
phosphorylation event was observed for the region
1Research Institute of Molecular Pathology, Dr. Bohrgasse 7,
A-1030 Vienna, Austria. 2Christian Doppler Laboratory for
Proteome Analysis, University of Vienna, Dr. Bohrgasse 3,
A-1030 Vienna, Austria. 3Max F. Perutz Laboratories, University
of Vienna, Dr. Bohrgasse 9, A-1030 Vienna, Austria. 4Institute
for Biology–Microbiology, Freie Universität Berlin, Königin-
Luisé-Str. 12-16, 14195 Berlin, Germany. 5Institute for
Molecular Biotechnology–IMBA, Dr. Bohrgasse 3, A-1030
Vienna, Austria. 6The Laboratory for Molecular Infection
Medicine Sweden, Umeå University, S-90187 Umeå, Sweden.
*These authors contributed equally to the work.
†To whom correspondence should be addressed. E-mail:
clausen@imp.univie.ac.at
Fig. 1. Phosphorylation of CtsR impedes DNA binding. (A) EMSA analysis of the DNA binding
capability of CtsR in the presence of McsB. CtsR was incubated with a clpC promoter fragment, McsB
(+, 2 mM; ++, 8 mM), EDTA, and phosphatase (P-ase), as indicated. The promoter fragment, which was
visualized by ethidium bromide staining of the native polyacrylamide gel, was either bound to one
(CtsR2/DNA) or two (CtsR4/DNA) CtsR dimers. (B) Schematic presentation of the separation of CtsR-P
from CtsR and McsB by heparin chromatography (left) and deconvoluted MS spectra of CtsR (average
mass of 19047.2 daltons) and CtsR-P (19127.2 and 19207.1 daltons for mono- and di-
phosphorylated isoforms, respectively) (right). (C) ITC analysis of CtsR2/DNA complex formation.
The 26-bp DNA duplex containing the ctsr box was injected into the sample cell containing either
CtsR or CtsR-P (inset). The area under each peak was integrated and plotted against the molar ratio
DNA/CtsR inside the sample cell. Thermodynamic values of CtsR/DNA complex formation are Kd =
22.2 T 3.0 nM and n = 0.53 (reflecting the stoichiometry of bound DNA per CtsR protomer), whereas
DNA binding of CtsR-P could not be detected by ITC. (D) EMSA analysis of the DNA binding capability
of CtsR and CtsR-P, before and after phosphatase treatment.
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Tyr55 toAsp82, making up the b-hairpinwing (Fig.
2A). A lower, albeit still substantial, number of
modified fragments matched the N-terminal
segment from Ser18 to Tyr55.
To identify individual CtsR phosphorylation
sites, we established a modified protocol for
sample preparation and MS analysis (15). Most
importantly, we implemented ECD andCAD frag-
mentation in two parallel MS/MS experiments.
Only the ECD MS/MS spectrum of the phospho-
rylated CtsR peptide I57VESKpRGGGGYIRIM71
(16) allowed the unambiguous identification of
Arg62 as the site of modification (Fig. 2C). Both
c- and z-fragment ion series unveiled a fragment
of 236.067 daltons, reflecting the addition of a
phosphate moiety (79.966 daltons) to an Arg res-
idue (156.101 daltons). Moreover, CADMS/MS
of the I57VESKpRGGGGYIRIM71 phospho-
peptide resulted in a discrete mass shift of 98
daltons, indicating the loss of phosphoric acid
(fig. S1). This fragmentation behavior argues
against a tyrosine kinase activity of McsB be-
cause phospho-tyrosine is stable upon CAD frag-
mentation (17). Further MS analysis led to the
identification of two additional phosphoryla-
tion sites, Arg28 and Arg49 (fig. S2). Consistent
with the results of the top-down approach, these
amino acids are located within the winged HTH
domain. Moreover, all Arg residues are strictly
conserved in the CtsR protein family and play a
crucial role in DNA binding, as predicted by our
crystal structure. Arg62 is a residue within the b
wing and deeply invades the minor groove of the
DNA duplex. In addition to undergoing exten-
sive van der Waals contacts, the guanidinium
group of Arg62 forms hydrogen bonds with the
DNA backbone and with one of the thymine
pyrimidine carbonyls (Fig. 2A). Similarly, in the
major groove of the CtsR consensus site, Arg28
and Arg49 bind to purine bases and coordinate
the sugar-phosphate backbone, respectively
(fig. S3).
To explore the functional relevance of the
identified phosphosites, we conducted a muta-
tional analysis of full-length CtsR by introducing
various Arg-to-Lys mutations. Mutating the tar-
get sites in position 28, 49, and 62 (3RK) did not
completely abolish, but did substantially reduce
the phosphorylation of CtsR by McsB (Fig. 3A).
Moreover, a mutant protein (8RK), in which the
eight Arg residues located in the DNA binding
region were replaced by Lys residues, was com-
pletely unsusceptible to McsB modification. Re-
introduction of Arg62 (7RK) markedly restored
the phosphorylation potential. To study the direct
effect of CtsR phosphorylation on DNA bind-
ing, we replaced Arg62 by a phosphomimicking
Glu residue. EMSA experiments clearly demon-
strated that the Arg62→ Glu62 (R62E) mutant lost
its capability to bind DNA (Fig. 3B), thus cor-
roborating our finding that phosphorylation of
CtsR alone is sufficient to inhibit its repressor
activity. Conversely, replacing Arg62 by Lys62
did not alter the DNA binding ability of CtsR in
band-shift assays. To test which state of CtsR is
targeted by McsB, we incubated the kinase with
DNA-bound and -unbound CtsR. Following the
interaction with DNA over time revealed that
McsB preferentially phosphorylates free CtsR,
thereby preventing DNA complex formation
(fig. S4).We conclude that the selective introduc-
tion of a negatively charged phosphate moiety
functions as a molecular switch regulating DNA
binding. Whereas the unphosphorylated CtsR
binds with high affinity to its DNA consensus site
and inhibits transcription of downstream genes,
the McsB-phosphorylated CtsR repressor is not
able to bind to DNA, thus allowing heat-shock
gene expression.
Fig. 2. Identification of arginine phosphorylation sites of CtsR. (A) Ribbon diagram showing the CtsR
dimer (gray, with labeled domains) bound to the DNA direct repeat motif (green). The identified CtsR
phosphopeptide I57VESKpRGGGGYIRIM71, which constitutes the b-hairpin of the winged HTH domain
penetrating the DNAminor groove, is highlighted in orange. The lower panel illustrates the binding mode
of Arg62 (orange), the main phosphorylation site, at the floor of the DNA minor groove (green). (B)
Phosphosite mapping with top-down MS. The mono-phosphorylated isoform of full-length CtsR was
sequenced by three different fragmentation techniques. The blue line represents the average (ave) value
of the three experimental setups and refers to the number of fragments additionally identified in CtsR-P,
relative to unmodified CtsR. The residue with the highest phosphorylation score was Arg62. (C) ECD-MS/MS
spectrum of the major phosphopeptide I57VESKpRGGGGYIRIM71 obtained after chymotryptic cleavage of
phosphorylated CtsR. Individual fragments are labeled according to the c- or z-ion nomenclature. The
characteristic mass difference of the phosphorylated Arg62 is highlighted, and the threefold charged
precursor ion is marked with an asterisk. m/z, mass/charge ratio.
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To verify our finding that McsB is a protein
arginine kinase, we established an in vitro phos-
phorylation assay (Fig. 3C) using synthetic oli-
gopeptides that resembled the CtsR sequence
(residues 61 to 73). To avoid side effects during
sample preparation that would preclude quantifi-
cation of the phosphorylation reaction, we re-
placed one potential oxidation site (Met71) and
one arginine (Arg69), yielding the 13-residue
model substrate K61RGGGGYIKIIKV73. Sys-
tematic incorporation of potential phosphoryl-
ation sites (Tyr, Ser, Thr, His, Asp, and Lys) in
position 62 revealed that only peptides with an
Arg moiety are modified by McsB (Fig. 3C).
Moreover, modification of the guanidinium
group of Arg62 by asymmetric dimethylation
prevented McsB-mediated modification. Addi-
tionally, we analyzed the purified phospho-
peptide K61RGGGGYIKIIKV73 by
31P nuclear
magnetic resonance (NMR) spectroscopy (fig. S5).
The chemical shift of about –2.4 parts per million
(ppm) fits well to the measured NMR spectrum
of free phospho-arginine (–3.0 ppm) (18), sug-
gesting that the phosphate is attached via a phos-
phoramidate N-P linkage. Corresponding spectra
of O-P linked phosphor compounds (as, for ex-
ample, phospho-tyrosine, -serine, and -threonine)
exhibit markedly higher chemical shifts of ~ 0.7
to 4.0 ppm (18). Thus,McsB is a protein kinase that
acts exclusively on Arg residues, phosphorylating
one of the amine nitrogens of the guanidinium
group.
Phosphorylation of the free amino acid
L-arginine by eukaryotic PhKs yields a chem-
ically labile compound (19). We studied the
CtsR/McsB system of a thermophilic organism
living at ~55°C and thus explored the thermo-
stability of a phosphorylated Arg residue present
in a peptide context. For this purpose, we phos-
phorylated the K61RGGGGYIKIIKV73 peptide
with McsB, incubated the purified phospho-
peptide at different temperatures, and quantified
the stability of the phosphorylation signal by
high-performance liquid chromatography–MS
analysis. The results clearly showed that peptide
arginine phosphorylation is surprisingly stable
up to 60°C. Dephosphorylation of the phospho-
peptide occurred only at 95°C, with a half life t1/2
of ~130 min (fig. S6). Therefore, phosphoryl-
ation of protein arginine residues should repre-
sent a relevant biological signal.
Sequence analysis indicated that the McsB
protein arginine kinase exhibits no substantial ho-
mology to known Ser, Thr, Tyr, or His kinases.
However, the catalytic domain of McsB is highly
homologous to the catalytic domain of PhKs
(12, 13), which are involved in maintaining en-
ergy homeostasis but not in intermolecular sig-
naling (20). Mutational analyses revealed that
McsB and PhKs use a common mechanism to
phosphorylate the terminal guanidinium group of
substrates (fig. S7) (14). However, in contrast to
PhKs where substrate specificity is primarily de-
termined by the N-terminal domain, McsB har-
bors a distinct C-terminal domain that may re-
direct the substrate specificity from free Arg to
protein-incorporated Arg residues.
McsB appears to be the founding member of
a new class of protein kinases acting specifically
on Arg residues. It should be noted that protein
arginine phosphorylation has been reported pre-
viously (21). Remarkably, histone H3 was iden-
tified as a potential eukaryotic target (22),
implying that Arg phosphorylation activity might
be relevant for epigenetic regulation. However,
these analyses failed to identify the corresponding
kinase and obtained only indirect evidence for
Arg modification. The thorough characterization
of a protein arginine kinase presented in this work
should provide the experimental tools to directly
address the impact of Arg phosphorylation in
prokaryotic and eukaryotic signaling pathways.
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Rhes, a Striatal Specific Protein,
MediatesMutant-Huntingtin Cytotoxicity
Srinivasa Subramaniam, Katherine M. Sixt, Roxanne Barrow, Solomon H. Snyder*
Huntington’s disease (HD) is caused by a polyglutamine repeat in the protein huntingtin (Htt) with
mutant Htt (mHtt) expressed throughout the body and similarly in all brain regions. Yet, HD
neuropathology is largely restricted to the corpus striatum. We report that the small guanine
nucleotide–binding protein Rhes, which is localized very selectively to the striatum,
binds physiologically to mHtt. Using cultured cells, we found Rhes induces sumoylation of mHtt,
which leads to cytotoxicity. Thus, Rhes-mHtt interactions can account for the localized
neuropathology of HD.
Huntington’s disease (HD), a geneticallydominant neurodegenerative disorder, re-flects expansion of a polyglutamine re-
peat in the protein huntingtin (Htt) (1). Mutant
Htt (mHtt) occurs uniformly throughout the brain
and peripheral tissues. Yet, HD is brain-specific
with profound abnormal movements related to
selective, gross degeneration of the corpus stri-
atum and lesser damage to the cerebral cortex
eliciting dementia (2, 3). Molecular mechanisms
causingmHtt cytotoxicity are unclear. mHtt forms
protein aggregates, whichmay be neuroprotective
with soluble mHtt linked to cytotoxicity (4–7).
mHtt is sumoylated, which increases the soluble
form of mHtt and elicits cytotoxicity and neu-
rotoxicity in a Drosophila model of HD (8).
Rhes (Ras homolog enriched in striatum) is
a small guanine nucleotide–binding protein (G
protein) very selectively localized to the
striatum (9). To determine whether Rhes binds
to Htt, we overexpressed Rhes in HEK293
cells where it bound to both wild-type (wt) Htt
and mHtt (Fig. 1A) (10). In conditionally
immortalized Htt knock-in striatal neuronal cells
(11), which lack endogenous Rhes (fig. S1C),
overexpressed Rhes bound robustly to endoge-
nous mHtt (Fig. 1B). In HD transgenic mice (12),
endogenous striatal mHtt coprecipitated with
Rhes (Fig. 1C). In the presence of purified Rhes
and Htt, Rhes bound much more to mHtt than
wtHtt protein (fig. S1A). Rhes did not bind to
ataxin (fig. S1B), a polyglutamine-repeat protein
involved in another neurodegenerative disorder,
spinocerebellar ataxia.
To ascertain whether Rhes influences mHtt
cytotoxicity, we used several cell lines. In
The Solomon H. Snyder Department of Neuroscience, Johns
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Fig. 1. Rhes binds Htt and affects cell survival. (A)
Rhes interacts with N-terminal Htt. HEK293 cells were
transfected with glutathione S-transferase (GST) or
GST-Rhes together with Flag-tagged Htt or the N-
terminal fragment containing 171 amino acids and 18
glutamines (wtHtt) or 82 glutamines (mHtt). After 48
hours, cell lysates were glutathione (GSH) precipitated
and immunoblotted (IB) for Flag. (B) Rhes interacts
with full-length Htt. Striatal cells expressing wild-type
Htt (STHdhQ7/Q7) or mutant Htt (STHdhQ111/Q111) were
transfected with GST or GST-Rhes. After 48 hours, cell
lysates were GSH-precipitated and immunoblotted for
Htt. Htt and GST inputs are shown. (C) Rhes interacts
with mHtt in striatum. Striatum of transgenic mice
expressing mHtt was lysed and immunoprecipitated
with Rhes antibody or immunoglobulin IgG alone
(bead control). Immunoprecipitates were probed with
an N-terminal–specific Htt antibody (N-Htt). (D) Rhes
reduces cell survival. HEK293 cells were transfected
with Myc/Myc-Rhes and wtHtt–mHtt constructs. ***P <
0.005 versus mHtt alone. (E) Wild-type (STHdhQ7/Q7) or
mutant (STHdhQ111/Q111) striatal cells were transfected
with Myc/Myc-Rhes. ***P < 0.005 versus Myc. (F)
Depletion of Rhes prevents PC12 cell death. Control
short hairpin–mediated (shRNA) or Rhes shRNA 1 to 4
were cotransfected with mHtt. Only shRNA4 was
significantly cytoprotective (**P < 0.01 versus control
shRNA). After 48 hours, cell survival was measured by
MTT.
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Isotope-Labeled Cross-Linkers and Fourier
Transform Ion Cyclotron Resonance
Mass Spectrometry for Structural Analysis
of a Protein/Peptide Complex
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For structural studies of proteins and their complexes, chemical cross-linking combined with mass
spectrometry presents a promising strategy to obtain structural data of protein interfaces from low
quantities of proteins within a short time. We explore the use of isotope-labeled cross-linkers in
combination with Fourier transform ion cyclotron resonance (FTICR) mass spectrometry for a
more efficient identification of cross-linker containing species. For our studies, we chose the
calcium-independent complex between calmodulin and a 25-amino acid peptide from the
C-terminal region of adenylyl cyclase 8 containing an “IQ-like motif.” Cross-linking reactions
between calmodulin and the peptide were performed in the absence of calcium using the
amine-reactive, isotope-labeled (d0 and d4) cross-linkers BS
3 (bis[sulfosuccinimidyl]suberate) and
BS2G (bis[sulfosuccinimidyl]glutarate). Tryptic in-gel digestion of excised gel bands from covalently
cross-linked complexes resulted in complicated peptide mixtures, which were analyzed by
nano-HPLC/nano-ESI-FTICR mass spectrometry. In cases where more than one reactive func-
tional group, e.g., amine groups of lysine residues, is present in a sequence stretch, MS/MS
analysis is a prerequisite for unambiguously identifying the modified residues. MS/MS experi-
ments revealed two lysine residues in the central -helix of calmodulin as well as three lysine
residues both in the C-terminal and N-terminal lobes of calmodulin to be cross-linked with one
single lysine residue of the adenylyl cyclase 8 peptide. Further cross-linking studies will have to be
conducted to propose a structural model for the calmodulin/peptide complex, which is formed in
the absence of calcium. The combination of using isotope-labeled cross-linkers, determining the
accurate mass of intact cross-linked products, and verifying the amino acid sequences of
cross-linked species by MS/MS presents a convenient approach that offers the perspective to
obtain structural data of protein assemblies within a few days. (J Am Soc Mass Spectrom 2006,
17, 1100–1113) © 2006 American Society for Mass SpectrometryPublished online June 5, 2006
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doi:10.1016/j.jasms.2006.04.020Tremendous progress has been made during thepast few years in mapping interface regions be-tween interacting proteins, which is crucial for
understanding signal transduction pathways and regu-
lation of proteins. Currently, X-ray crystallography and
NMR spectroscopy are the primarily applied analytical
methods to structurally characterize protein complexes.
Yet, both techniques possess inherent insufficiencies:
NMR spectroscopy requires rather large quantities of
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1101J Am Soc Mass Spectrom 2006, 17, 1100–1113 ISOTOPE-LABELED CROSS-LINKERS AND FTICR-MSisotope-labeled (13C and 15N) pure protein in a specific
solvent, and for X-ray studies the protein has to be
crystallized. An alternative strategy consists in subject-
ing the complex constituents to chemical cross-linking
reactions, followed by a mass spectrometric analysis of
the created cross-linked products [1–3]. The procedure
is fast, requires only low amounts of material, and
offers the opportunity to gain insight into three-
dimensional structures of protein complexes in solu-
tion. Matrix-assisted laser desorption/ionization time-
of-flight (MALDI-TOF) [4] and electrospray ionization
(ESI) [5] mass spectrometry are the methods of choice
for cross-linking studies because of their high sensitiv-
ity enabling rapid analysis of the complex mixtures
obtained after enzymatic digestion of the cross-linking
reaction mixtures. One major shortcoming of chemical
cross-linking approaches, however, is the tremendous
sample complexity attributable to the wide variety of
cross-linked products that can be created during the
cross-linking reaction. To circumvent this disadvantage,
a number of different strategies have been developed
that have in common to facilitate identification of
cross-linker containing species, e.g., by employing iso-
tope-labeled cross-linkers [6, 7], isotope-labeled pro-
teins [8], cleavable cross-linkers [9], fluorogenic cross-
linkers [10], or cross-linkers creating a characteristic
marker ion during MS/MS analysis [11]. Another strat-
egy to selectively enrich cross-linker containing species
by using trifunctional cross-linkers containing a biotin
moiety has been described recently [12–14].
In the present study, we utilize isotope-labeled cross-
linkers, which are employed as 1:1 mixtures of nondeu-
terated and four-times deuterated derivatives. Thus,
interpretation of mass spectra is greatly facilitated as
cross-linker containing species are easily detected based
on their characteristic isotope patterns. We are imple-
menting FTICR mass spectrometry, which offers dis-
tinct advantages for the analysis of complex biological
samples, such as excellent mass resolution, ultra-high
mass measurement accuracy, and high sensitivity [15,
16] to evaluate its use in the area of cross-linking.
Top-down approaches employing FTICR-MS for ana-
lyzing cross-linked products have been described by
other groups [17–19] but, so far, that strategy has been
exclusively employed to determine low-resolution
three-dimensional structures of proteins from intramo-
lecular cross-linking experiments. Our aim is to analyze
the cross-linked species in a bottom-up approach, in
which the cross-linked products are enzymatically or
chemically digested before an FTICR-MS analysis is
performed on the peptide mixtures [20, 21]. Therefore,
the approach has the potential to be applied to investi-
gate even large protein assemblies—given that the
cross-linked species can easily be discriminated from
underivatized peptides, e.g., by isotope-labeling. In the
present study, we are making use of an FTICR mass
spectrometer equipped with a linear ion trap in front of
the ICR cell, which offers the possibility to conveniently
acquire MS/MS data during LC/MS analysis.As a model system to demonstrate the feasibility of
our approach, we chose the complex between calmod-
ulin and a peptide derived from the C-terminal region
of adenylyl cyclase 8 (AC8) that is created in the absence
of calcium. CaM is an acidic protein comprised of 148
amino acids, which belongs to the family of EF-hand
proteins, and is found ubiquitously in animals, plants,
fungi, and protozoa [22]. CaM/peptide complexes have
been used frequently in our group for developing and
improving chemical cross-linking strategies [12, 20, 21],
as a wealth of structural data is available for the various
CaM/target complexes (http://calcium.uhnres.utoronto.
ca/ctdb/).
AC8 belongs to the family of adenylyl cyclases,
which are important signalling proteins, possessing two
distinct CaM binding sites [23]: one calcium-dependent
binding site is located at its N-terminus, whereas a
so-called “IQ-like motif” is located at its C-terminus.
“IQ-like motifs” are well known to bind to CaM in a
Ca2-dependent as well as a Ca2-independent manner
[24]. Therefore, we chose the complex between CaM,
and a peptide derived from the C-terminal region of
AC8, to be well suited for demonstrating our strategy
using isotope-labeled cross-linkers combined with
high-resolution mass spectrometry.
A 25-amino acid peptide with amidated C- terminus
comprising the “IQ-like motif” of AC8 was synthesized
and subjected to chemical cross-linking with CaM using
the two amine-reactive, isotope-labeled cross-linkers
BS3 (bis[sulfosuccinimidyl]suberate) and BS2G (bis[sul-
fosuccinimidyl]glutarate) in the absence of calcium. In a
previous publication, we had conducted structural
studies on the CaM/AC8 peptide complex that is cre-
ated in the presence of calcium using isotope-labeled
cross-linkers and FTICR mass spectrometry [25]. How-
ever, in this earlier study, we did not perform MS/MS
experiments, which are essential for pinpointing the
cross-linked amino acids as well as for verification of
the amino acid sequences of the created cross-linked
products. In that respect, the present study extends our
initial studies using isotope-labeled cross-linkers and
high-resolution mass spectrometry for a structural anal-
ysis of protein complexes.
The combination of using isotope-labeled cross-
linkers, determining the accurate mass of the intact
cross-linked products, and verifying the amino acid
sequences of cross-linked species by MS/MS presents a
convenient approach that offers the perspective to ob-
tain structural data of protein assemblies within a few
days.
Experimental
Materials
Bovine brain CaM was obtained from Calbiochem
(Schwalbach am Taunus, Germany) and used without
further purification. The purities of CaM and the AC8
peptide were checked by HPLC, ESI-FTICR and
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isotope-labeled (d0 and d4) cross-linkers BS
3 and BS2G
were a generous gift from Pierce (Rockford, IL). Trypsin
(sequencing grade) was obtained from Roche Diagnos-
tics (Mannheim, Germany). LHRH (luteinizing hor-
mone releasing hormone), 2,5-dihydroxybenzoic acid,
and proteins for MALDI-TOF-MS calibration were pur-
chased from Sigma (Taufkirchen, Germany). Chemicals
were obtained from Sigma at the highest available
purity. Nano-HPLC solvents were spectroscopic grade
(Uvasol, VWR, Darmstadt, Germany). Water was puri-
fied with a Direct-Q5 water purification system (Milli-
pore, Eschborn, Germany).
AC8 Peptide Synthesis
The AC8 peptide was synthesized by solid-phase pep-
tide synthesis using the automated multiple peptide
synthesizer Syro II (MultiSyntech, Witten, Germany).
The peptide chain was synthesized by Fmoc/tert-butyl
strategy applying a double coupling procedure with a
ten-fold excess of amino acid, HOBt, and DIC in DMF
for 40 min twice. N-Fmoc-protected amino acids and
Rink amid resin (polymer) were purchased from Nova-
biochem (Läufelfingen, Switzerland), HOBt and DIC
from Iris Biotech (Marktredwitz, Germany), and DMF
from BioSolve (Valkenswaard, The Netherlands). Fmoc
deprotection was accomplished by 40% piperidine in
DMF for 3 min, followed by 20% piperidine in DMF for
7 min, and finally by 40% piperidine in DMF for 5 min.
Removal of the amino acid side-chain protecting groups
and cleavage of the peptide from the resin were accom-
plished simultaneously by using TFA/thioanisole/thio-
cresol (90/5/5, vol/vol) for 3 h. The deprotected pep-
tides were allowed to precipitate for 15 min in ice-cold
diethyl ether. The suspension was centrifuged at 5 °C,
the diethyl ether was decanted, and the peptide was
suspended in fresh diethyl ether. The peptide was
washed by repeated centrifugation, decanting, and sus-
pending the peptide in diethyl ether. Finally, the pep-
tide was dissolved in tert-butyl alcohol/water (1:3,
vol/vol) and lyophilized. Piperidine, tert-butyl alcohol
as well as the chemicals for cleavage were purchased
from Fluka (Taufkirchen, Germany).
Cross-Linking Reactions
For cross-linking experiments with the homobifunc-
tional cross-linking reagents BS3-d0/d4 and BS
2G-d0/d4,
an aqueous CaM stock solution (1 mg/ml) was diluted
with 20 mM Hepes buffer (pH 7.5) containing 1 mM
EGTA to give solutions containing CaM at a concentra-
tion of 10.6 M (volume 964 l). After an incubation
time of 10 min, 28 l of an AC8 peptide solution (1
mg/ml) were added. The mixture was incubated at
room temperature for 30 min. The cross-linking reac-
tions were started by adding 8 l of solutions contain-
ing either BS3-d0/d4 or BS
2G-d0/d4 (each in a 1:1 mixture
of d0 and d4 reagent at concentrations of 62.5 mM, 125mM, or 250 mM in DMSO), thus yielding 50-, 100-, and
200-fold molar excesses of cross-linker over the pro-
tein/peptide concentration. One solution was prepared
without adding cross-linker solution, but 8 l of DMSO
were added instead. The reaction mixtures were incu-
bated at room temperature, and 200-l aliquots were
taken after 5 min, 15 min, 30 min, 60 min, and 120 min.
The reactions were terminated by adding 20 l of a 220
mM NH4HCO3 (final concentration 20 mM) solution to
each aliquot. The solutions were desalted using
Microcon-YM-3 filters (Millipore) and stored at 20 °C
before MALDI-TOF-MS and SDS-PAGE were con-
ducted.
SDS-PAGE and Enzymatic Proteolysis
Following separation of the reaction mixtures by one-
dimensional SDS-PAGE (15%, Coomassie staining [26]),
the bands of interest were excised and in-gel digested as
described previously [27]. Trypsin (50 ng/L) was used
as digestion enzyme for all samples. Depending on the
volume of the gel pieces, between 6 and 8 l of enzyme
solution were added. The gel pieces were covered with
50 mM NH4HCO3 solution and incubated at 37 °C for
16 h.
MALDI-TOF Mass Spectrometry
MALDI-TOF mass spectrometry of the cross-linking
reaction mixtures was performed on a Voyager DE RP
Biospectrometry Workstation (Applied Biosystems,
Foster City, CA) equipped with a nitrogen laser (337
nm). The instrument was run in positive ionization
mode and measurements were performed in the linear
mode (detection range m/z 13,000 to 45,000) using
2,5-dihydroxybenzoic acid as matrix. A saturated ma-
trix solution was prepared in 30% (vol/vol) acetonitrile,
69.9% (vol/vol) water, and 0.1% (vol/vol) TFA. Sam-
ples were prepared using the dried droplet method by
spotting 0.5 l of matrix solution and 0.5 l of sample
solution onto the target. Spectra from 100 to 300 laser
shots were accumulated to one spectrum. The in-
strument was calibrated using cytochrome c
([M  H]average at m/z 12,361) and myoglobin
([M  H]average at m/z 16,952). Data acquisition and
data processing were performed using the Voyager
software version 5.1 and the Data Explorer software
version 4.0 (Applied Biosystems).
Nano-HPLC/Nano-ESI-FTICR Mass Spectrometry
Peptide mixtures from enzymatic digests were sepa-
rated by nano-HPLC on an Ultimate Nano-LC system
(Dionex, Idstein, Germany) equipped with a Switchos II
column switching module and a Famos Micro Au-
tosampler with a 20-l sample loop. Samples were
injected by the autosampler and concentrated on a
trapping column (PepMap, C18, 5 mm 300 m, 3 m,
100 Å, Dionex, Idstein, Germany) with water containing
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for desalting, the peptides were eluted onto the separa-
tion column (PepMap, C18, 150 mm 75 m, 3 m, 100
Å, Dionex), which had been equilibrated with 95% A
(Solvent A: water containing 0.1% formic acid). Pep-
tides were separated using the following gradient: 0–30
min: 5–50% B, 30–31 min: 50–95% B, 31–45 min: 95% B
(Solvent B: acetonitrile containing 0.1% formic acid) at
flow rates of 200 nl/min and detected based on their
UV absorptions at 214 and 280 nm.
The nano-HPLC system was coupled on-line to an
APEX II FTICR mass spectrometer equipped with a 7
tesla superconducting magnet (Bruker Daltonics, Bil-
lerica, MA) and a nano-electrospray ionization source
(Agilent Technologies, Waldbronn, Germany). For
nano-ESI-MS, coated fused-silica PicoTips (tip ID 8 m,
New Objective, Woburn, MA) were applied. The capil-
lary voltage was set to -1400 V. Mass spectral data were
acquired in the broadband mode over an m/z range of
400 to 2000 with 256 k data points, four scans were
accumulated per spectrum, and 400 spectra were re-
corded for each LC/MS run. MS data acquisition was
initialized with a trigger signal from the HPLC system
7 min after initiation of the LC gradient. Data were
acquired over 34.5 min. Calibration of the instrument
was performed with CID fragments (capillary exit volt-
age 200 V) of the LHRH peptide. Data acquisition and
data processing were performed using the XMASS
software, version 7.0.2 (Bruker Daltonics). Before Fou-
rier transformation the time-domain signals were dou-
bly zero filled, followed by apodization with a sine
function. Four hundred single spectra were projected
into one final mass spectrum using the “Projection” tool
in the XMASS software [28]. The obtained spectra were
internally recalibrated using autolytic peptide signals
from trypsin. The XMASS software, version 7.0.2, was
used for manual generation of peak lists containing the
neutral monoisotopic peptide masses. An in-house soft-
ware (“IsoFind”) was employed to search for signals
exhibiting a mass difference of 4 u and to calculate the
ratios of the respective signal intensities.
MS/MS Analysis
Products of the cross-linking reactions conducted with
BS2G (gel bands D, 30, 60, 120 min reaction times,
Figure 2), were additionally analyzed by MS/MS exper-
iments. The peptide mixtures resulting from the tryptic
in-gel digests were separated by C18-RP-chromatogra-
phy on a nano-HPLC system (Ultimate 3000, Dionex;
pre-column: PepMap, C18, 5 mm  300 m, 3 m, 100
Å, Dionex; separation column: PepMap, C18, 150 mm
75 m, 3 m, 100 Å, Dionex; solvents A: 5% acetonitrile,
0.1% formic acid in water, B: 80% acetonitrile, 0.08%
formic acid in water) using a gradient from 0% B to 60%
B in 90 min followed by isocratic elution with 90% B for
3 min. An LTQ-FT mass spectrometer (Thermo Elec-
tron, Bremen, Germany) with a 7 T magnet, equipped
with a nano-ESI source (Proxeon Biosystems, Odense,Denmark; emitter: distal coated PicoTips, tip ID 15 m,
New Objective) was on-line coupled to the nano-HPLC
system. MS data were acquired over 100 min in data-
dependent MS2 mode: each high-resolution full scan
(m/z 300 to 2000, resolution at m/z 400 was set to
100.000) in the ICR cell was followed by 10 product ion
scans in the linear trap for the 10 most intense signals in
the full-scan mass spectrum (isolation window 3 u).
Dynamic exclusion (exclusion duration 20 s, exclusion
window5 ppm) was enabled to allow detection of less
abundant ions. Data analysis was performed using the
SEQUEST search algorithm (BioWorks 3.2, Thermo
Electron).
Identification of Cross-Linked Products
Cross-linked products were identified using the
GPMAW (General Protein Mass Analysis for Windows)
software, versions 6.01 and 6.2 (Lighthouse Data,
Odense, Denmark) (available at: http://welcome.to/
gpmaw) [29] and the ExPASy Proteomics tools in the
Swiss-Prot Database (available at: www.expasy.ch).
Proteolytic cleavages at modified amino acids, such as
the trimethylated K115 in CaM as well as amino acids
modified by cross-linking reagents were excluded. The
N-terminus of CaM was excluded from possible cross-
linking as it is acetylated (Figure 1).
Structure of Calcium-Free CaM
The NMR structure of apo Cam (Ca2-free CaM) is
deposited in the RCSB Protein Data Bank (http://
www.rcsb.org/pdb/) under the entry “1DMO”. The
structure was visualized using the VMD-XPLOR visu-
alization package (available at: http://vmd-xplor.cit.
nih.gov).
Results and Discussion
Characterization of CaM and AC8 Peptide
A prerequisite for successfully conducting cross-linking
  1ADQLT   6EEQIA  11EFKEA  16FSLFD  21KDGDG  26TITTK
 31ELGTV  36MRSLG  41QNPTE  46AELQD  51MINEV  56DADGN
 61GTIDF  66PEFLT  71MMARK  76MKDTD  81SEEEI  86REAFR
 91VFDKD  96GNGYI 101SAAEL 106RHVMT 111NLGEK 116LTDEE
121VDEMI 126READI 131DGDGQ 136VNYEE 141FVQMM 146TAK
  1YSLAA 6VVLGL 11VQSLN 16RQRQK 21QLLNE-NH2
(a)
(b)
Figure 1. Amino acid sequences of (a) CaM and (b) AC8 peptide.
CaM is N-acetylated (Ac-Ala) and contains a trimethylated lysine
in position 115 (the modified amino acids Ala-1 and Lysine 115 are
underlined). The “IQ-like motif” in the AC8 peptide comprises
amino acids 11–16 (VQSLNR underlined).experiments consists in an in-depth characterization of
1104 IHLING ET AL. J Am Soc Mass Spectrom 2006, 17, 1100–1113the proteins regarding their post-translational modifi-
cations, splice variants, or amino acid exchanges. The
characterization of CaM has been described in detail in
previous publications of our group [20, 21]. Exact mass
measurements, after spectral deconvolution, of the in-
tact protein and peptide performed by ESI-FTICRMS
yielded a most abundant mass of 16,790.921 u for CaM
(simulated: 16,790.884 u, m  0.037 u, 2.1 ppm) and a
monoisotopic mass of 2838.650 u for the AC8 peptide
(calculated: 2838.619 u, m  0.031 u, 10.9 ppm). The
amino acid sequences of CaM and AC8 peptide are
presented in Figure 1.
Cross-Linking Reactions
Cross-linking experiments between CaM and the AC8
peptide were conducted as described in the Experimen-
tal section. The homobifunctional, amine-reactive cross-
linking reagents BS3-d0/d4 and BS
2G-d0/d4 (Table 1)
were used for cross-linking experiments. Homobifunc-
tional cross-linking reagents contain two identical func-
tional groups on either side of the molecule that are
separated by a spacer bridging a defined distance [30].
The homobifunctional sulfo-NHS esters BS3 and BS2G
are highly reactive towards primary amine groups, but
are also susceptible to hydrolysis. Upon cross-linking,
BS3 and BS2G produce amide bond cross-linked mole-
cules causing mass shifts of 138.077 u (BS3-d0) and
96.030 u (BS2G-d0), respectively, whereas peptides mod-
ified with partially hydrolyzed cross-linkers exhibit
mass increases of 156.092 u (BS3-d0) and 114.045 u
(BS2G-d0), respectively. 1:1 mixtures of nondeuterated
(d0) and four-times deuterated (d4) reagents were em-
ployed to facilitate identification of cross-linker contain-
ing species based on their characteristic isotope doublet
with a mass difference of 4.025 u in the deconvoluted
Table 1. Chemical structures and spacer lengths of the amine–r
cross–linking reagents BS3 and BS2GESI-FTICR mass spectra.SDS-PAGE
After the cross-linking reactions, reaction mixtures were
separated by one-dimensional SDS-PAGE and the gels
were stained with Coomassie Brilliant Blue. CaM exhib-
ited three bands on the gel (one intense and two faint
bands, Figure 2). We assume that— despite using EGTA
as calcium-complexing agent—a minor part of CaM
molecules are present in different calcium-loaded
states, exhibiting different mobilities on the gel. As
shown for the cross-linking reaction mixture obtained
with BS2G-d0/d4 (Figure 2), an intense band at 17 kDa
probably represents intramolecularly cross-linked CaM
(Band C, Figure 2). Bands of nonreacted CaM (Band B,
e, homobifunctional, and isotope–labeled (d0 and d4)
15
20
25
37
50
75
100
250
St    CaM AC 8  AC 8 5     15 30 60 120 St
CaM/
Reaction time in min
kDa
A
B
C
D
E
F
Figure 2. SDS-PAGE of CaM/AC8 peptide cross-linking reaction
mixture with BS2G-d0/d4 (100-fold excess, 1 mM EGTA), reaction
times 5 to 120 min. St: molecular weight standard. Band A:
intramolecularly cross-linked AC8 peptide; Band B: CaM; Band C:
intramolecularly cross-linked CaM; Bands D and E: CaM/AC8eactivpeptide complexes (1:1); Band F: CaM/AC8 peptide (1:2) complex.
1105J Am Soc Mass Spectrom 2006, 17, 1100–1113 ISOTOPE-LABELED CROSS-LINKERS AND FTICR-MSFigure 2) and intramolecularly cross-linked AC 8 pep-
tide (Band A, Figure 2) are also visible on the gel. Two
bands migrating at 19 and 20 kDa were assigned to
CaM/AC8 peptide (1:1) complexes (Bands D and E)
exhibiting different mobilities on the gel due to the
presence of differently cross-linked species (Figure 2).
Also, formation of a CaM/AC8 peptide (1:2) complex
was observed (Band F, Figure 2) as was visualized by
the presence of a faint gel band migrating at 25 kDa.
Aggregation of proteins caused by excessive cross-
linking was not observed for any of the cross-linking
reagents, as no gel bands were visible in the higher
mass range.
MALDI-TOF Mass Spectrometry
MALDI-TOF-MS was employed to estimate the extent
of chemical cross-linking over the course of the cross-
linking reaction. For BS2G, formation of a CaM/ AC8
peptide (1:1) complex atm/z19,900 was observed with
the signal intensity slightly increasing with increasing
reaction time (Figure 3). From the 300 u-mass shift of
the CaM signal (signal at m/z 17,100 instead of m/z
16,790 for noncross-linked CaM), the incorporation of
three BS2G molecules per CaM molecule was estimated
(Figure 3). The broadness of the signal for intramolecu-
larly cross-linked CaM gives a first hint on the variety of
intramolecular modifications that have been created in
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Figure 3. MALDI-TOF mass spectra of CaM/AC8 peptide cross-
linking reaction mixtures obtained with BS2G (100-fold excess
over protein / peptide concentration), 1 mM EGTA.the course of the cross-linking reaction.Analysis of Cross-Linked Products
Following SDS-PAGE separation of the cross-linking
reaction mixtures, bands of the cross-linked CaM/AC8
peptide (1:1) complexes (Bands D and E, Figure 2) as
well as bands originating from intramolecularly cross-
linked CaM (Band C, Figure 2) were excised from the
gel and subjected to enzymatic in-gel digestion with
trypsin. CaM/AC8 peptide (1:2) complexes that were
observed in SDS-PAGE (Band F, Figure 2) were as-
sumed to be artifacts and were not investigated further.
Now, we cannot rule out that CaM/AC8 peptide (1:2)
complexes are also created in vivo. The band corre-
sponding to intramolecularly cross-linked CaM could
either originate from unbound CaM or, alternatively, it
represents the CaM conformation within the complex,
which dissociates during SDS-PAGE separation as it is
not covalently attached to its binding partner by a
cross-linker molecule. The intricate peptide mixtures
resulting from in-gel digestion were analyzed by nano-
HPLC/nano-ESI-FTICR mass spectrometry with re-
spect to the presence of intra- and intermolecular cross-
linked products as well as peptides, which are modified
by a partially hydrolyzed cross-linker.
Cross-Linked Products Obtained with BS2G-d0/d4
BS2G was employed for conducting cross-linking reac-
tions as a 1:1 mixture with its deuterated derivative (d4)
(Table 1). Thus, an additional criterion for the identifi-
cation of cross-linked products is introduced, as every
species containing one cross-linker molecule should
exhibit a doublet with a distance of 4.025 u in the
deconvoluted ESI-FTICR mass spectra. One intermolec-
ular cross-linked product was identified during our first
set of experiments from band E (Figure 2), in which
amino acid sequence 75–86 (central -helix) of CaM is
connected with amino acids 17–25 of AC8 peptide
(Table 2). Lys-20 is the exclusive reaction site in the
respective AC8 sequence that has reacted with Lys-75
or Lys-77 of CaM. For clarification, which of the lysine
residues at position 75 or 77 in CaM had reacted,
MS/MS experiments were conducted (see below). The
deconvoluted ESI-FTICR mass spectrum, from which
this cross-linked product was identified, is presented in
Figure 4 with the inset showing the magnified signal of
the identified intermolecular cross-linked product. The
doublet of isotope patterns with a mass difference of
4.025 u caused by using a 1:1 mixture of d0- and
d4-cross-linker greatly facilitates identification of cross-
linker-containing species.
Cross-Linked Products Obtained with BS3-d0/d4
As in the case of BS2G, BS3 was employed as 1:1 mixture
with its fully deuterated derivative (d4). With a 100-fold
excess of BS3-d0/d4 over protein/peptide, one intermo-
lecular cross-linked product was identified between
CaM and AC8 pointing to amino acids 75–86 of CaM
b
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1106 IHLING ET AL. J Am Soc Mass Spectrom 2006, 17, 1100–1113and the complete AC8 peptide being connected (Table
3). In the AC8 peptide, either the N terminus or, more
likely, the -amino group of the lysine in position 20 has
reacted with one of the lysine residues in position 75 or
77 of the CaM central -helix.
Peptides Modified by Hydrolyzed Cross-Linker
In addition to inter- and intramolecularly cross-linked
products, we observed a large number of peptides that
had been modified by partially hydrolyzed BS3 or BS2G
(Tables 2, 3, and 4).The modified amino acids do not
yield direct information on the interface between CaM
and AC8; however, they provide valuable information
on the surface topology of the complex. As is readily
visible from Figure 6, these residues are solvent-
exposed in calcium-free CaM and thus, are quite easily
modified by the cross-linker.
Identification of Cross-Linked Amino Acids
by MS/MS
To unambiguously identify the amino acids that had
actually been cross-linked, additional MS/MS experi-
ments were conducted on the tryptic peptides of Band
D (Figure 2), derived from cross-linking reaction mix-
tures that had been created using a 100-fold molar
excess of BS2G-d0/d4. MS/MS experiments yielded a
wealth of information on the various cross-linked prod-
ucts that had been created in one single cross-linking
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Figure 4. Deconvoluted ESI-FTICR mass spectrum of a tryptic
digest of a cross-linking reaction mixture (CaM/AC8 peptide (1:1)
complex created with 100-fold excess BS2G-d0/d4, 1 mM EGTA,
reaction time 60 min). Signals of the identified cross-linked prod-
uct between amino acids 75–86 of CaM and amino acids 17–25 of
AC8 peptide (Table 3) are shown enlarged. Please note that
neutral monoisotopic masses are given. The signal intensities of
the characteristic isotope doublet are not equal, as the BS2G-d0/d4
mixture was not exactly 1:1. Signals originating from CaM pep-
tides (diamond), AC8 peptides (triangle), cross-linked products
(open star), and autolytic peptides of trypsin (filled circle) are
indicated; n.a.: signal not assigned.reaction (Table 4). As far as intermolecular cross-linkingTa tim Ca 75 75 Ca
— — — —
Table 3. Intermolecular cross–linked products between CaM and AC8 peptide as well as peptides that are modified by partially hydrolyzed cross–linker using BS3G–d0/d4. Reaction
times and molar excess of cross–linking reagent are indicated, labeling of gel bands according to Figure 2. MSO: oxidized methionine
Intermolecular cross-linked products
CaM AC8 peptide Reacted amino acids [M  H] calc. [M  H] exp. m [ppm] Detected in SDS-PAGE band
75–86 1–25 K75, K77 (CaM)-Y1, K20 (AC8) 4457.382
(BS3-d0)
4457.426
(BS3-d0)
10 Band E, 100-fold excess, 60 min
75–86 1–25 K75, K77 (CaM)-Y1, K20 (AC8) 4461.407
(BS3-d4)
4461.411
(BS3-d4)
1 Band E, 100-fold excess, 60 min
Peptides Modified by Partially Hydrolyzed Cross-Linker
CaM AC8 Peptide Reacted amino acids [M  H] calc. [M  H] exp. m [ppm] Detected in SDS-PAGE band
1–37 — K13, K21, K30 4348.106
(BS3-d0)
4348.143
(BS3-d0)
1 Band C, 100-fold excess, 60 min
1–37 — K13, K21, K30 4352.131
(BS3-d4)
4352.143
(BS3-d4)
3 Band C, 100-fold excess, 60 min
91–126 — K94 4293.105
(BS3-d0)
4293.108
(BS3-d0)
1 Band C, 100-fold excess, 60 min
91–126 — K94 4297.130
(BS3-d4)
4297.149
(BS3-d4)
5 Band C, 100-fold excess, 60 min
91–126 — K94 4293.105
(BS3-d0)
4293.076
(BS3-d0)
7 Band E, 50-fold excess, 60 min
91–126 — K94 4297.130
(BS3-d4)
4297.105
(BS3-d4)
6 Band E, 50-fold excess, 60 min
91–126 — K94 4309.100,
(MSO, BS3-d0)
4309.070
(MSO, BS3-d0)
7 Band E, 50-fold excess, 60 min
91–126 — K94 4313.125 MSO
(BS3-d4)
4313.093
(MSO, BS3-d4)
7 Band E, 50-fold excess, 60 min
91–126 — K94 4309.100
(MSO, BS3-d0)
4309.108
(MSO, BS3-d0)
2 Band C, 100-fold excess, 60 min
91–126 — K94 4313.125
(MSO, BS3-d4)
4313.110
(MSO, BS3-d4)
3 Band C, 100-fold excess, 60 min
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Table 4. MS/MS data of cross–linked products between CaM and AC8 peptide as well as peptides that are modified by partially hydrolyzed cross–linker BS2G–d0/d4. Reaction time: 30
min, 100–molar excess of BS2G–d0/d4, 1mM EGTA, band D (see Figure 2). Species containing two cross–linker molecules (one cross–link plus one partially hydrolyzed cross–linker) are
printed in shaded areas
Cross-linked sequences Cross-linked residue
Theoretical
precursor
mass
Experimental
precursor
mass Cross-linker BS2G Identified fragment ions
CaM AC8 peptide CaM AC8 peptide [M  H] [M  H] b ion series CaM
AC 8
peptide y ion series CaM
AC8
peptide
14–30 19–25 K21 K20 2811.404 2811.412 d0 3–9,11,12,14,16 — 3–8,11–16 —
2815.429 2815.434 d4 3–7,9–16 — 3–12,14–16 —
22–30 19–25 K30 K20 1873.950 1873.939 d0 3,4,6–8 — 1–3,5–8 —
1877.975 1877.934 d4 3,4,6,8 — 1–3,5–8 —
75–86 19–25 K77 K20 2447.208 2447.204 d0 1–4,6–11 — 2–11 —
2451.233 2451.228 d4 2–11 — 2–11 —
Oxidation at M76
75–86 19–25 K77 K20 2463.207 2463.212 d0 4,6,8–11 2,4–6 2–11 2–6
2467.232 2467.239 d4 3–11 — 2–10 —
Ammonia loss and oxidation at M76
75–86 19–25 K77 K20 2446.180 2446.174 d0 2–11 — 2–11 —
2450.205 2450.210 d4 2–11 — 2–10 —
Two cross-linkers
75–86 19–25 K75 K20 2561.240 2561.244 2x d0 1–8,10,11 — 2–11 —
75–86 19–25 K77 K20 2561.240 2561.244 2x d0 1–3,5,6,8–11 — 2–11 —
75–86 19–25 K75 K20 2565.265 2565.272 d0 K75,d4 K77 1–11 — 2–11 —
75–86 19–25 K75 K20 2565.256 2565.272 d4 K75,d0 K77 1–11 — 2–11 —
75–86 19–25 K77 K20 2565.256 2565.272 d4 K75,d0 K77 2–11 — 2–10 —
75–86 19–25 K77 K20 2565.256 2565.272 d0 K75,d4 K77 1–11 — 2–11 —
75–86 19–25 K75 K20 2569.281 2569.280 2x d4 1,3–10 — 2,4–9,11 —
75–86 19–25 K77 K20 2569.281 2569.280 2x d4 2–8,10,11 — 2–11 —
76–86 19–25 K77 K20 2319.113 2319.115 d0 2–8,10 — 2–10 —
2323.238 2323.157 d4 2–4,6,7,9,10 — 2–10 —
Oxidation of M76
76–86 19–25 K77 K20 2335.112 2335.118 d0 2–8 — 3–10 —
2339.137 2339.143 d4 2–8 — 2–10 —
91–106 19–25 K94 K20 2721.384 2721.397 d0 3–5,7–13,15 — 2–14 —
2725.409 2725.411 d4 3–15 2–15 —
Ammonia loss
91–106 19–25 K94 K20 2704.357 2704.367 d0 4–15 — 2–12,15 —
2708.382 2708.387 d4 4–15 — 2–12 —
Peptides modified by hydrolyzed cross-linker
CaM modified residue 1958.923 1958.929 d0 2–16 — 2–16 —
14–30 K21 1962.948 1962.951 d4 2–16 — 2–16 —
(Continued)
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Table 4. Continued
Modified sequence Modified residue
Theoretical
precursor
mass
Experimental
precursor
mass Cross-linker BS2G Identified fragment ions
CaM AC8 peptide CaM AC8 peptide [M  H] [M  H] b ion series CaM
AC 8
peptide y ion series CaM
AC8
peptide
14–37 — K21 — 2745.329 2745.322 d0 3–10,12–14,16–23 — 16,18,19,21 —
2749.354 2749.361 d4 3–23 — 2–7,9–15,17–21,23 —
— — K30 — 2745.329 2745.322 d0 3–7,9–11,13–23 — 2–11,13–16,18,19,21 —
2749.354 2749.361 d4 3–7,9–23 — 2–8,10–21,23 —
Ammonia loss
14–37 — K21 — 2728.302 2728.315 d0 4–10,11,13–23 — 2–23 —
2732.327 2732.347 d4 6,6,7,9–23 — 2–10,12,14–23 —
— — K30 — 2728.302 2728.315 d0 4–12,14,15,17–23 — 2–23 —
2732.327 2732.347 d4 3,6–10,12–23 — 2–7,9,11–15,16,18–23 —
Oxidation of M36
14–37 — K21 — 2761.328 2761.334 d0 3,5–10,12–23 — 2–7,9–12,15–22 —
2765.353 2765.351 d4 3–10,12,14–23 — 2–7,10,12,14,17–23 —
— — K30 — 2761.328 2761.334 d0 3,5–23 — 2–12,14,16–18,20,21 —
2765.353 2765.351 d4 3–11,13–23 — 2–7,9–14,16–18,20–22 —
Oxidation of M36 and ammonia loss
14–37 — K21 — 2744.301 2744.321 d0 3–6,8–10,12,14,16–23 — 2–7,10–21,23 —
2748.326 2748.344 d4 3–6,9,10,12,15–23 — 2–7,9–22 —
— — K30 — 2744.301 2744.321 d0 3–23 — 2–13,15–23 —
2748.326 2748.344 d4 3–6,8–14,17–23 — 2–8,10,11,13–22 —
Oxidation of M36, two cross-linkers
14–37 — K21, K30 — 2875.360 2875.334 2x d0 5,7,9–16,2 9–17,19 —
2879.385 2879.386 d0 K21,d4 K30 3–10,12–23 2–21 —
2879.385 2879.386 d4 K30,d0 K21 3–23 2–13,15,17–21 —
2883.410 2883.419 2x d4 3–9,11–23 2–15,17–23 —
22–37 — K30 — 1807.874 1807.880 d0 3–15 2–11,13,14 —
1811.899 1811.904 d4 3–15 2–15 —
Oxidation of M36
22–37 — K30 — 1823.873 1823.874 d0 3–15 — 2–15 —
1827.898 1827.896 d4 4–15 — 2–15 —
75–86 — K75 — 1594.727 1594.730 d0 1–11 — 2–11 —
1598.752 1598.755 d4 1–11 — 2–11 —
— — K77 — 1594.727 1594.730 d0 2–11 — 2–11 —
1598.752 1598.755 d4 2–11 — 2–11 —
(Continued)
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Table 4. Continued
Modified sequences Modified residue
Theoretical
precursor
mass
Experimental
precursor
mass Cross-linker BS2G Identified fragment ions
CaM AC8 peptide CaM AC8 peptide [M  H] [M  H] b ion series CaM
AC 8
peptide y ion series CaM
AC8
peptide
Oxidation of M76
75–86 — K75 — 1610.725 1610.726 d0 1–3,6–11 — 1–11 —
1614.751 1614.751 d4 1–11 — 1–11 —
— K77 — 1610.726 1610.726 d0 2–11 — 2–11 —
1614.751 1614.751 d4 2–11 — 2–11 —
Two cross-linkers
75–86 — K75, K77 — 1708.758 1708.763 2x d0 2–8 — 1–6,8–11 —
1712.783 1712.787 d0 K75,d4 K77 2–11 — 2–11 —
1712.783 1712.789 d4 K75,d0 K77 2–11 — 2–11 —
1716.808 1716.813 2x d4 2–11 — 2–11 —
Oxidation of M76
75–86 — K75, K77 — 1724.757 1724.759 2x d0 2–11 — 2–11 —
1728.782 1728.785 d0 K75,d4 K77 2–11 — 2–11 —
1728.782 1728.785 d4 K75,d0 K77 2–11 — 2–11 —
1732.807 1732.811 2x d4 2–11 — 2–11 —
76–86 — K77 — 1466.632 1466.632 d0 2–10 — 2–10 —
1470.657 1470.660 d4 2–10 — 2–10 —
Oxidation of M76
76–86 — K77 — 1482.631 1482.634 d0 2–10 — 2–10 —
1486.656 1482.653 d4 2–10 — 2–10 —
Oxidation of M76
76–90 — K77 — 1985.880 1985.883 d0 2–9,11,12,14 — 2–14 —
1989.905 1989.901 d4 2,3,5,7–10,12–14 — 3,5–8,10–14 —
91–106 — K94 — 1868.903 1868.910 d0 3–6,9–15 — 2–14 —
1872.928 1872.932 d4 3–7,9–15 2–15 —
— 19–25 — K20 985.531 985.533 d0 — 2–6 — 1–5
989.556 989.558 d4 — 2–6 — 1–6
Ammonia loss
— 19–25 — K20 968.502 968.506 d0 — 2,4–6 — 1–6
972.527 972.532 d4 — 2–6 — 2–6
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data pointed to lysine residues at positions 75 and 77 in
the central -helix of CaM, Lys-21, and Lys-30 in the
N-terminal lobe of CaM, and Lys-94 in the C-terminal
lobe of CaM to be cross-linked with Lys-20 in the AC8
peptide (Table 4). In Figure 5, the product ion spectrum
of the triply charged ion of the cross-linked product
between CaM (amino acids 75 to 86, Met-76 oxidized)
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Figure 6. NMR structure of calcium-free CaM (pdb entry 1DMO)
with the side chains of lysines indicated that were found to be
cross-linked with the AC8 peptideand AC8 peptide (amino acids 19 to 25), is presented.
For both peptides comprising the cross-linked product,
nearly complete y type ion series and a number of b
type ions were observed, with the fragmentation pat-
terns unambiguously identifying Lys-77 of CaM as the
amino acid to be cross-linked with Lys-20 of the AC8
peptide. In total, MS/MS information was obtained for
six intermolecular cross-linked products, with a num-
ber of cross-linked products being also present as
oxidized species (Met-76 oxidized). Moreover, ammo-
nia loss from the precursor ion was frequently observed
in the product ion spectra. Three of the six intermolec-
ular cross-linked products revealed cross-links between
Lys-75 or Lys-77 of CaM with lysine 20 of the AC8
peptide (Table 4). One cross-linked product was found
for each of the CaM lysine residues at positions 21, 30,
or 94 with Lys-20 of the AC8 peptide. MS/MS analysis
of peptides that had been modified by a partially
hydrolyzed cross-linker revealed the same lysines that
had already been found to be involved in intermolecu-
lar cross-linking (Lys-21, Lys-30, Lys-75, Lys-77, and
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linked products had been created, in which two cross-
linker molecules are present (Table 4, shaded areas)—
thus making the complexity of created cross-linked
species even more fascinating. For these species, the
isotope pattern obviously is 1:2:1. Here, the first cross-
linker molecule connects two amine groups of the
binding partners, whereas the second cross-linker mol-
ecule is partially hydrolyzed due to the absence of a
suitable amine group in the correct cross-linking dis-
tance. In the present case, either Lys-75 or Lys-77
reacted with Lys-20 in the AC8 peptide, whereas the
second cross-linker molecule reacted at the remaining
free lysine on one site and was hydrolyzed at its other
reactive site (Table 4). All possible combinations of
cross-linked species with incorporated nondeuterated
and four-times deuterated cross-linkers were observed.
Structure of the Calcium-Free CaM/AC8 Peptide
Complex
In Figure 6, an NMR structure of calcium-free CaM
(apo-CaM) is presented, in which the side chains of
these lysines are indicated that have been found to be
involved in intermolecular cross-linking between CaM
and the AC8 peptide based on MS/MS experiments.
The intermolecular constraints found for the homobi-
functional amine-reactive cross-linkers BS2G and BS3
(spacer lengths 7.7 and 11.4 Å, Table 1) point conclu-
sively to Lys-75 or Lys-77 of the central -helix of CaM
as well as Lys-21 and Lys-30 in the N-terminal lobe, and
Lys-94 in the C-terminal lobe of CaM to be cross-linked
with Lys-20 of the AC8 peptide. One drawback of the
present study consists in that only a few reactive sites
(N-terminus and Lys-20) are present in the AC8 pep-
tide, thus reducing the number of possibly created
cross-linked products. For future studies, cross-linking
reagents with different specificities, such as photo-
reactive cross-linkers, should be evaluated [13]. With-
out conducting further cross-linking studies, we are
presently unable to propose a structural model of the
CaM/AC8 peptide complex. From the calcium-free
structure of CaM (Figure 6), one could envision that
Lys-20 of the AC8 peptide is in the correct distance to
CaM lysines at positions 21, 30, 75, and 77 to be
cross-linked by BS2G and BS3. However, the observed
cross-linked product between Lys-94 of CaM and
Lys-20 of the AC8 peptide is not in agreement with the
proposed arrangement. Further cross-linking studies
will reveal if the AC8 peptide might even bind to CaM
in different orientations.
Conclusions
The combination of employing isotope-labeled cross-
linkers and a mass spectrometric technique yielding
data with high mass accuracy has proven to be ex-
tremely powerful in rapidly identifying cross-linkercontaining species from the complex peptide mixtures
created from enzymatic digestion of the cross-linking
reaction mixtures. In case more than one reactive func-
tional group, e.g., -amine groups of lysine residues, is
present in a sequence stretch, an in-depth MS/MS
analysis is essential for unambiguously identifying sites
of modification. Further cross-linking studies will have
to be conducted to propose a structural model for the
CaM/AC8 peptide complex, which is formed in the
absence of calcium.
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Abstract
The correct organization of single subunits of multi-protein machines in a three dimensional context is critical for their
functionality. Type III secretion systems (T3SS) are molecular machines with the capacity to deliver bacterial effector proteins
into host cells and are fundamental for the biology of many pathogenic or symbiotic bacteria. A central component of T3SSs
is the needle complex, a multiprotein structure that mediates the passage of effector proteins through the bacterial
envelope. We have used cryo electron microscopy combined with bacterial genetics, site-specific labeling, mutational
analysis, chemical derivatization and high-resolution mass spectrometry to generate an experimentally validated
topographic map of a Salmonella typhimurium T3SS needle complex. This study provides insights into the organization
of this evolutionary highly conserved nanomachinery and is the basis for further functional analysis.
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Introduction
One of the most exciting recent developments in the field of
bacterial pathogenesis is the discovery that many bacterial
pathogens utilize supramolecular nanomachines to deliver bacte-
rial proteins into eukaryotic cells. These proteins, which are
collectively referred to as effectors, have the capacity to modulate a
variety of cellular functions including cytoskeleton dynamics,
vesicle traffic, cell cycle progression and transcription. At least four
types of machines capable of transporting effectors have been
identified. They are known as type II, type III, type IV, and type
VI protein secretion systems [1–5]. Arguably the best understood
of these machines are the type III secretion systems (T3SS), which
are essential for the virulence of several important bacterial
pathogens including Salmonella enterica, Shigella spp., Yersinia spp.,
enteropathogenic strains of E. coli, and Vibrio cholerae. A central
component of T3SS is the needle complex, a multiprotein
structure that mediates the passage of the effector proteins through
the bacterial envelope. Although this structure was initially
identified in Salmonella enterica serovar typhimurium (S. typhimurium)
[6], it has been shown to be conserved in other bacteria encoding
T3SSs [7,8]. The cylindrically shaped needle complex is composed
of a multi-ring base (,25nm in width and ,30nm in length),
associated to the bacterial envelope, and a needle-like extension
that protrudes several nanometers (,20–50nm) from the bacterial
surface. The needle is anchored to the base through another
substructure, the inner rod, which together with the needle
filament forms a ,3nm wide channel that serves as conduit for the
proteins that travel this secretion pathway [9]. Assembly of the
needle complex occurs in discrete steps that first lead to the
assembly of the base substructure [10]. Once assembled, the base
begins to work as a secretion machine although exclusively
devoted to the secretion of the proteins required for the assembly
of the inner rod and the needle. Only upon complete assembly, the
secretion machine changes substrate specificity and becomes
competent for the secretion of effector proteins destined for
delivery into eukaryotic target cells [5]. This functional repro-
gramming is believed to involve significant conformational
changes in the needle complex itself [11].
S. typhimurium encodes two different T3SS within its pathoge-
nicity island 1 (SPI-1) and 2 (SPI-2), which in a coordinated
fashion mediate bacterial uptake into and replication within
epithelial cells. Previous biochemical and genetic studies have
established that the SPI-1-encoded S. typhimurium needle complex is
composed of the bacterial proteins PrgH, PrgK, and InvG, which
make up the base substructure, and PrgI and PrgJ, which
constitute the needle and inner rod substructures, respectively
[6,12]. Cryo electron microscopy and single particle analysis have
provided a ,17A˚ resolution density map of the S. typhimurium SPI-
1-encoded needle complex [9]. Recently, atomic structures of
soluble domains of protein components from needle complexes
from various bacterial species have become available [13–15].
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These studies have revealed the presence of a conserved domain
within the main components of the base, which in the S.
typhimurium SPI-1 T3SS are InvG, PrgH and PrgK. Given the
fact that these three proteins apparently organize themselves in a
ring-like fashion, it has been proposed that this domain may
mediate the formation of these rings. Attempts have been made to
dock these protein domains into the needle complex structure.
However, the relatively low resolution of the available electron
microscopy density map does not allow the confident placement of
the atomic structures of the different protein domains without
additional experimental verification. Consequently, different, and
in some case mutually incompatible, locations have been proposed
for various protein domains [15,16].
In this study, we have used a combination of methods including
bacterial genetics, biochemistry, mass spectrometry and cryo
electron microscopy/single particle analysis to experimentally
assign specific protein domains to different substructures of the
needle complex. In addition, we have identified specific interaction
sites among components of the needle complex, which are critical
for its stable assembly. Combined, this analysis provides the first
experimentally validated topographic map of different components
of the needle complex of the S. typhimurium SPI-1 TTSS.
Results
InvG forms the outer rings and neck region and PrgH and
PrgK form the inner rings of the needle complex
The S. typhimurium needle complex component InvG belongs to
the secretin family, which is composed of outer membrane
proteins that are associated with several secretion systems in
Gram-negative bacteria. These include proteins associated with
type II (e.g. Klebsiella pneumoniae PulD) [17] and type III (e.g. Yersinia
spp. YscC) protein secretion systems [18], type IV pilus assembly
(e.g. Neiseria PilQ) [19] and filamentous bacteriophage secretion
(e.g. filamentous bacteriophage pIV) [20]. Secretins form higher-
ordered ring-like structures, which in the case of PulD are
organized in the form of two rings connected by a central disc.
This basic architecture creates two chambers of different size, one
of which extends with its N-terminal domain into the periplasmic
space as visualized by cryo electron microscopy of the trypsin
resistant core of the PulD complex [21]. Comparison of the PulD
structure with the needle complex shows striking similarities
between the PulD rings and the outer rings of the base
substructure of the needle complex. The similarities also extend
to regions of the neck of the needle complex, which connect the
outer rings with the inner rings (Fig. 1A). These similarities
strongly suggest that InvG forms the outer rings of the needle
complex of the SPI-1 T3SS base. However, this has not been
formally demonstrated and the extent to which InvG may form
the neck region of the needle complex has not been experimentally
determined. In order to ascertain what needle complex substruc-
tures are specifically formed by InvG, we purified needle
complexes from a DinvG mutant strain and analyzed their structure
by cryo electron microscopy and single particle analysis (Fig. 1).
Western blot analysis of the structures isolated from the DinvG
mutant showed the presence of PrgH and PrgK at equivalent
stoichiometry to that found in needle complexes isolated from wild
type (Fig. 1B). Structures isolated from this mutant strain showed
the presence of the inner ring 1 (IR1) and 2 (IR2) and an extending
needle-like structure but lacked the upper rings and the neck
region (Fig. 1C, E). Subtraction of two-dimensional class averages
of samples obtained from a DinvG mutant strain (Fig. 1E) from a
wild-type needle complex structure (Fig. 1D) revealed that InvG is
localized at the apical side of the needle complex forming the outer
ring structures and neck region (Fig. 1F). In comparison to PulD,
InvG extends further into the periplasmic space reaching the
largest inner ring (IR1) of the needle complex, presumably
anchoring the outer rings and thus stabilizing the base substruc-
ture.
The secondary structural features of PrgH and PrgK strongly
suggest that they form the inner rings of the needle complex base
although no direct evidence for this hypothesis has been presented.
Subtraction of two-dimensional class averages of samples obtained
from a DinvG mutant strain from the wild-type needle complex
structure also revealed that the ring structures from this mutant
strain are virtually identical to the inner rings of the wild type
needle complex (Fig. 1F). Since, beside PrgH and PrgK, the
needle and inner rod proteins are the only main structural
components of the DinvG substructure, these results formally
demonstrate that PrgH and PrgK make up the inner rings of the
base substructure. Taken together these results demonstrate that
InvG is the main component of the outer rings and connecting
neck of the needle complex while PrgH and PrgK are the main
components of the inner rings.
Localization and topology of PrgH within the base
substructure of the needle complex
Secondary structure prediction analysis indicates that PrgH
contains a transmembrane domain (from amino acid 142 to 162),
which would separate the protein into two soluble domains of
roughly equivalent size but distinct secondary structures (Fig. S1,
S2). The N-terminal domain is predicted to be rich in beta-sheets,
whereas the recently solved crystal structure of the major part of
the C-terminal domain (amino acids 170–362) showed that it has a
modular arrangement of similar a/b domains [15]. The
localization of the two soluble domains of PrgH relative to the
assembled needle complex, however, is still unclear. This
information is essential to guide the potential placement of the
recently solved atomic structure of a soluble domain of PrgH
within the protein density map of the needle complex. In order to
determine the topology of PrgH within fully assembled complexes
we constructed S. typhimurium strains expressing N- or C-terminal
Author Summary
Many Gram negative pathogens such as Salmonella,
Yersinia, or Shigella use the type III secretion system
(T3SS) to initiate infection in eukaryotic cells, resulting in
well known clinical symptoms ranging from mild head-
aches and diarrhea to life-threatening diseases such as
typhoid fever or bubonic plague. The T3SS is a highly
developed macromolecular system that serves as a
platform to make physical contact between host cells
and pathogens and mediates the translocation of bacterial
toxins (effector proteins) into eukaryotic cells. Central to
the T3SS is the mega-dalton sized membrane associated
needle complex, which is composed of several soluble and
membrane proteins; however, their organization within
the needle complex critical for proper assembly and
function is unclear. Here, we use an integrated experi-
mental approach that combines cryo electron microscopy
with bacterial genetics, site-specific labeling, mutational
analysis, chemical derivatization and high-resolution mass
spectrometry in order to determine the topographic
organization of individual components of the Salmonella
typhimurium needle complex and define sites critical for its
stability. Our study provides insights into the organization
of this evolutionary highly conserved system and is the
basis for further functional analysis.
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poly-histidine tagged PrgH. Addition of the peptide tag did not
affect the functionality of the needle complex as assayed by its
ability to secrete the effector proteins SipB and SptP (Fig. 2A).
Needle complexes isolated from these strains were labeled with Ni-
NTA nanogold and analyzed by cryo electron microscopy and
single particle analysis. Class-averages showed that the labeled N-
and C-termini are located far away from each other, consistent
with the bioinformatic prediction that the different termini of
PrgH are topologically located on opposite sides of the inner
membrane (Fig. 2B and 2E). Classification of gold-labeled needle
complexes isolated from a strain expressing N-terminal poly-
histidine tagged PrgH showed additional density exclusively on the
cytoplasmic side of the base substructure suggesting that the N-
terminus of PrgH faces the cytoplasm (Fig. 2B). Moreover, in side
views of classified particles, the nanogold label can be seen at
various vertical and horizontal positions below IR2, presumably
due to a flexible tag and/or the existence of multiple copies of
PrgH that are organized in a cylindrical fashion and that are not
uniformly labeled by Ni-NTA nanogold. This observation is
consistent with the diffuse appearance of the additional ‘‘density’’
observed below IR2 in a class average of all the labeled particles
(Fig. 2C and D). In contrast, labeled needle complexes isolated
from a strain expressing C-terminal poly-histidine tagged PrgH
showed additional density above IR1 in close proximity to the
neck region (Fig. 2E–G). In this case, the labeling was visualized
as a distinct density, even in the class average of all particles
suggesting a more rigid conformation of this domain of PrgH.
Taken together, these results indicate that the amino terminus of
PrgH faces the bacterial cytoplasm while its carboxy terminus is
located within the periplasm of the bacterial envelope.
Localization of PrgK within the base substructure of the
needle complex
PrgK is a lipoprotein with a canonical sec-dependent
transport signal sequence that is processed upon secretion [6],
and a predicted single transmembrane domain (AA 207–227)
close to its carboxy terminus. Consequently, the large N-
terminal domain of PrgK (starting from Cys-18) is predicted to
be localized in the periplasm and anchored to the inner
membrane via its transmembrane domain. The atomic
structure of the PrgK homologue EscJ, which lacks a
transmembrane domain, revealed that this protein is organized
in two independent domains linked by a flexible linker [13,14]
(Fig. S1). Although EscJ carries a ‘ring forming’ motif similar
to that of PrgH and EscC (InvG) [15], EscJ rings have so far
never been isolated and/or visualized. To investigate the
topology of PrgK within the needle complex, we constructed S.
typhimurium strains expressing N- or C-terminal poly-histidine
tagged PrgK. Addition of the tag at the amino terminus
resulted in a loss of type III dependent protein secretion (data
not shown). In contrast, addition of the tag to the carboxy
terminus did not negatively affect needle complex function as
measured by SipB and SptP secretion (Fig. 3A). Needle
complexes isolated from this strain, labeled with Ni-NTA and
Figure 1. InvG forms the outer rings and neck region of the needle complex. (A) Cut-away view and description of individual substructures
of the needle complex from S. typhimurium. (OR outer ring; IR inner ring) Bar = 10nm. (B–F) Analysis of complexes obtained from a S. typhimuirum
DinvG strain: Western blot analysis (B), cryo electron microscopy images (C), and class averages of non-tilted complexes, (D, E) isolated from wild type
and DinvG mutant S. typhuimurium strains, respectively. (F) Density difference between averaged images of wild type needle complexes and DinvG
mutant complexes (1F=1D-1E), indicates the position of the outer ring substructure.
doi:10.1371/journal.ppat.1000824.g001
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examined by cryo electron microscopy and single particle
analysis showed additional density exclusively on the cytoplas-
mic side of the base substructure (Fig. 3B). These results
indicate that the carboxy terminal domain of PrgK faces the
cytoplasm. Comparison of the position of the nanogold label on
the C-terminus of PrgK (Fig. 3C) with that of the N-terminus
of PrgH (Fig. 2C) by subtracting the total class averages from
wild type (Fig. 1D) showed a more distinct localization of the
nanogold label in PrgK (Fig. 3D, 2D). This observation
suggests that the C-terminus of PrgK is less flexible than the N-
terminus of PrgH and positioned closer towards the cup region
of the needle complex (Fig. 1A, 3E).
Localization of PrgH and PrgK within IR1 and IR2
In order to refine the relative position of PrgH within the inner
rings we constructed a strain of S. typhimurium that expresses a
PrgH mutant in which we introduced a poly-histidine insertion
linker after amino acid 267 (PrgH-267his) (Fig. S3). The resulting
strain expressed a functional T3SS system as shown by its ability to
secrete the effector proteins SipB and SptP (Fig. 4A). Needle
complexes isolated from this strain were labeled with Ni-NTA-
nanogold and examined by cryo electron microscopy and single
particle analysis. Additional density at the widest part of the IR1
(Fig. 4B, 4C, Fig. S4) was readily observed, indicating that PrgH
is located at the periphery of IR1.
Figure 2. The N- and C-terminus of PrgH are located far away from each other within the needle complex. (A) N- and C-terminally poly-
histidine tagged PrgHs are functional. Culture supernatants of a wild type S. typhimurium (w.t.), PrgH-deficient (DprgH), and mutant strains encoding
either N- (his-PrgH) or C-terminally (PrgH-his) poly-histidine tagged PrgH were analyzed for the presence of the type III secreted proteins SipB and
SptP by Western immunoblot. (C: whole cell lysates; S: culture supernatants). (B, E) Representative class averages obtained by single particle analysis
of cryo electron microscopy images of Ni-NTA-labeled needle complexes derived from strains expressing either N-terminally (B) or C-terminally (E)
tagged PrgH. (C, F) The total class averages (average of all particles) from the respective data set are shown in (C) (N-terminally labeled PrgH) and (F)
(C-terminally labeled PrgH). The diffuse appearance of density at the basal side in (C) indicates that the Ni-NTA-nanogold (Au) label is present in
various positions below IR2, but is more restricted above IR1 in C-terminally labeled complexes (F) (IR1 and IR2= inner ring 1 and 2). (D, G) Density
difference between the total averages of the labeled particles and unlabeled wild type complexes (panel D: w.t. needle complexes subtracted from
labeled N-terminally tagged complexes (2D=2C-1D); panel G: w.t. needle complexes subtracted from labeled C-terminally tagged complexes
(2G=2F-1D)).
doi:10.1371/journal.ppat.1000824.g002
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PrgK has been proposed to exist as an inner ring enclosed by
an outer ring formed by PrgH [15]. This model was based on the
crystallographic analysis of the PrgK homolog EscJ, which
crystallized in a superhelical fashion. Subsequent modeling led
to an approximately 180A˚ wide ring structure, which was
proposed to be anchored to the inner membrane by the lipidated
N-terminal cysteine of EscJ/PrgK. In this model, the EscJ/PrgK
ring would be located on top of the outer leaflet of the inner
membrane projecting into the periplasmic space [14]. An
alternative model proposed for MxiJ, the Shigella spp. homolog
of PrgK, positions this protein as radial spikes enclosed by an
outer ring [16]. To gain insight into the organization of PrgK
within the needle complex, we sought to obtain top views of the
inner rings of the needle complex by electron microscopy for
subsequent single particle analysis, which required the removal of
the InvG rings. The proximity of the C-terminus of PrgH to InvG
suggested the possibility that truncating the C-terminus of PrgH
could weaken the interaction between these two proteins. We
therefore constructed a S. typhimurium strain that expresses a PrgH
mutant lacking its last 4 amino acids (PrgHD4). The resulting
strain expressed a functional T3SS as shown by its ability to
secrete effector proteins (Fig. 4A) and the presence of intact
needle complexes (Fig. 4D). However, when subjected to high
pH treatment, the needle complexes not only disassembled the
needle filament over time [9], but, in contrast to wild type, upon
negative staining the complexes obtained from this mutant strain
could be further disassembled to generate intact inner rings (IR1/
IR2) separated from the smaller outer rings (Fig. 4D). We
analyzed the inner rings (IR1/IR2) thus obtained by electron
microscopy without imposing any symmetry or introducing any
potential model bias. This analysis showed the presence of several
concentric rings with different staining intensities (Fig. 4E). The
two concentric rings with the larger diameter (,250A˚ and
,180A˚) exhibited repeating subunits separated every 15 degrees
thus resulting in a 24-fold symmetry. The accessibility of PrgH-
267his to surface labeling and the appearance of additional
density on the outermost surface of IR1 strongly suggested that
the largest ring visualized in the inner ring particles must be made
up by PrgH. On the other hand, the size, configuration, and
density distribution of the second largest ring with an approx-
imate diameter of 180A˚ are consistent with the hypothesis that
this ring is formed by PrgK (Fig. 4E, G, Fig. S6). If this were
the case, most of PrgK would be buried by the presence of InvG
(top) and PrgH (outside). Consequently, this model would also
predict that removal of InvG should expose otherwise buried
residues. To test this hypothesis, we compared the ratio of
accessibility of lysine residues of PrgK in complexes isolated from
wild type or DinvG S. typhimurium strains (which exposes the apical
side of IR1, see Fig. 1) by subjecting the isolated particles to
acetylation using NHS-acetate and subsequent analysis by mass
spectrometry. Lysine 168 from PrgK was found to be more
frequently (.15 times) acetylated in tryptic peptides derived from
PrgK obtained from complexes from a DinvG mutant strain than
in PrgK peptides obtained from wild type needle complexes
(Fig. 4F, Table S1). Consistent with this observation, modeling
of PrgK using the EscJ structure as a template (see below) showed
that the side chain amino group of K168 would be surface
exposed in the absence of InvG (Fig. 4G).
Figure 3. The C-terminus of PrgK is located at the basal (cytoplasmic) side of the needle complex. (A) Carboxy terminally poly-histidine
tagged PrgK is functional. Culture supernatants of wild type S. typhimurium (w.t.), PrgK-deficient (DprgK), and a mutant strain encoding C-terminally
(PrgK-his) poly-histidine tagged PrgK were analyzed for the presence of the type III secreted proteins SipB and SptP by Western immunoblot. (C:
whole cell lysates; S: culture supernatants). (B) Representative class averages obtained by single particle analysis of cryo electron microscopy images
of Ni-NTA-labeled needle complexes derived from strains expressing C-terminally poly-histidine tagged PrgK. (C) Total class average of Ni-NTA-
labeled needle complexes obtained from a S. typhimurium strain expressing C-terminally poly-histidine tagged PrgK. The location of the density
observed at the basal side (Au) is similar to the diffuse density observed in Ni-NTA-labeled needle complexes obtained from strains expressing N-
terminally poly-histidine tagged PrgH (see Fig. 2C) (IR1 and IR2= inner ring 1 and 2). (D) Resulting difference in density after subtraction of w.t.
needle complexes from labeled C-terminally poly-histidine tagged PrgK complexes (3D=3C-1D). (E) Subtraction of the total averages of labeled
complexes obtained from a strain expressing N-terminally-tagged PrgH from a strain expressing C-terminally-tagged PrgK (3E=3D-2C).
doi:10.1371/journal.ppat.1000824.g003
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Figure 4. Organization of PrgH and PrgK within the lower ring of the needle complex. (A) Insertion of a poly-histidine linker at amino acid
267 of PrgH (267his) or removal of four amino acids from its C-terminus (D4) does not alter its function. Culture supernatants of wild type S.
typhimurium (w.t.), PrgH-deficient (DprgH), and mutant strains encoding a poly-histidine linker at amino acid 267 of PrgH (267his) or a PrgH lacking the
terminal four amino acids (D4) were analyzed for the presence of the type III secreted proteins SipB and SptP by Western immunoblot. (C: whole cell
lysates; S: culture supernatants). (B) Representative class average obtained by single particle analysis of cryo electron microscopy image of Ni-NTA-
labeled needle complexes obtained from a S. typhimurium strain expressing PrgH with a poly-histidine tag inserted at amino acid 267. A prominent
gold label (Au) is seen at the widest side of the periplasmic face of the IR1 (IR1 and IR2= inner ring 1 and 2). Bar = 10 nm. (Additional results of the
analysis are shown in Fig. S4). (C) Resulting difference in density after subtraction of unlabeled w.t. needle complexes from labeled complexes
isolated from strains expressing a poly-histidine insertion following amino acid 267 in PrgH. (D) Mutant needle complexes carrying truncated PrgH
can be selectively disassembled into larger and smaller rings by shifting pH to 10.5 and subsequent negative staining, whereas wild type (w.t.) needle
complexes maintain the integrity of the base. (E) En face class-average derived from single particle analysis from negatively stained electron
microscopy images of inner rings substructures. The substructures were obtained by selective disassembly of needle complexes isolated from a
mutant strain encoding for a C-terminally, four amino acid truncated PrgH. The ring substructure is organized in two larger concentric rings with
different diameters (,180A˚ and,250A˚). Bar = 10nm. Rotational cross-correlation analysis revealed that the maximum of the cross-correlation peak is
repeatedly obtained every 15u, demonstrating that the larger concentric rings of the inner ring structure from the prgHD4 mutant strain exhibit 24
fold symmetry. (F) Surface accessibility of lysine K168 is increased in complexes obtained from a S. typhimurium DinvG strain. Primary amines of wild
type and DinvG mutant complexes were acetylated with Sulfo-NHS-Acetate and the ratio of modified to non-modified peptides was determined by
mass spectrometry. Each bar represents the ratio of acetylation of lysines between specific PrgK peptides obtained from the DinvG mutant and the
same peptides obtained from a wild type complex (Table S1). The ratio of peptide acetylation is an average of two independent mass spectrometry
measurements. (G) Lysine 168 is surface exposed in modeled PrgK rings. A monomeric PrgK structure was modeled using EscJ as a template and
protein-protein contacts present in the EscJ crystal structure were used to form a PrgK ring (top and side view). Lysine 168 is located on top of the
ring and its side group nitrogen is surface exposed as highlighted in blue in the surface view of the cut-out segments of individual monomers. The
cut-out segment shows two PrgK molecules in surface representation (yellow and light-yellow) followed by one neighboring molecule on each side
but displayed in ribbon style.
doi:10.1371/journal.ppat.1000824.g004
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Taken together these results indicate that the inner rings are
composed of two larger concentric rings: a peripheral ring formed
by PrgH enveloping an inner ring formed by PrgK, which is
shielded by PrgH (on the sides) and InvG (on the top).
Domain interactions among components of the type III
secretion needle complex characterized by cross-linking
and mass spectrometry
In order to refine the spatial relationship between the domains
of the different proteins that make up the needle complex and to
gain insight into the nature of potential domain-domain
interactions, we used chemical cross-linking combined with high-
resolution mass spectrometry. Purified needle complexes were
incubated with the bi-functional cross-linking agent BS2G (d0/d4),
which is able to covalently link primary amino groups at a distance
up to ,8A˚. Particles in which two or more complexes were cross-
linked were separated from individual ones by re-purification on
sucrose gradients, and tryptic fragments generated from these
complexes were analyzed by mass spectrometry after protease
digestion in solution. Several cross-links were identified between
the different domains of InvG, PrgH, and PrgK (Fig. 5A,
Table 1). A single cross-link between InvG (K38) and PrgH
(K367) was found, establishing that the N-terminal domain of
InvG and the C-terminal domain of PrgH are in close contact.
This is also consistent with the observation that truncation of four
amino acids from the carboxy terminal end of PrgH resulted in the
destabilization of the needle complex (Fig. 4D) and supports the
notion that the interaction of PrgH with InvG is very important for
the linkage of these two substructures. From strains with longer
truncations at the C-terminus of PrgH only complexes similar to
those obtained from a DinvG mutant strain could be purified (data
not shown), further demonstrating the importance of this domain
for needle complex assembly.
We found two clusters of residues of the amino terminus of
PrgH that cross-linked to the C-terminal end of PrgK (Table 1
and Fig. 5A). In addition to the primary amino group at the N-
terminal end of the protein, lysine residues at position 5, 132, and
133 of PrgH were found to cross-link to lysine residues at position
239, 246 and 248 of PrgK. The linkages found exclusively between
the N-terminal domain of PrgH and the C-terminal tail of PrgK
are in full agreement with the results obtained from the nanogold
labeling experiments. The absence of any cross-links from the
large N-terminal domain of PrgK is also consistent with the
proposed concentric arrangement of PrgK shielded by PrgH and
InvG.
Topology model of the S. typhimurium needle complex
components
To construct a model for the topological arrangement of the
components of the S. typhimurium needle complex, we used the
available crystal structure of PrgH and modeled InvG and PrgK
using the structures of their close homologues EscC and EscJ,
respectively (Text S1). In addition, we incorporated in such model
all of our experimental findings described above. The model shows
that the N-terminal domain of PrgH and the short C-terminal
domain of PrgK are in close contact at the cytoplasmic face of the
needle complex (Fig. 5B). Furthermore, the N-terminal domain of
InvG is localized at the lowest part of the neck-region oriented in
such a way that allows its interaction with the C-terminal domain
of PrgH (Fig. 5B, Fig. S7). This arrangement is supported by the
finding of cross-linked peptides [IPVTGSGFAVK38DDSLR]-
[DDWLK367G] encompassing these two domains (Table 1).
The C-terminal PrgH peptide, however, is not visible in the
atomic structure, hence this interaction can not be incorporated
into a high-resolution model building (Fig. 5D).
Several models involving 12 or 14 fold symmetries have been
proposed for the N-terminal region of the InvG homologue EscC.
These ring models were placed at different positions within the
needle complex depending on the proposed symmetries and
correlating different volumes and diameters [15]. Our data
indicate that the amino terminus of InvG should face the inner
rings, which provides an unambiguous orientation to the InvG
ring that is incompatible with some of the previously proposed
models [15,16]. However, our data cannot clarify the issue of the
differing symmetries in the proposed models, which would require
experimental data at a sufficiently high resolution to show
individual subunits within the outer ring and neck region.
PrgH and PrgK are the main constituents of the inner rings.
Nanogold labeling of a needle complex isolated from strain
expressing a PrgH mutant derivative with a his-tag after position
267 resulted in an additional density on the outer perimeter of the
IR1. This observation led us to manually position the C-terminal
domain of PrgH in such a way that amino acid 267 would be
located at the periphery of IR1 (Fig. 5C, E, Fig. S7). The
positioning of PrgK in our model takes into account the
crystallographic contacts between the monomers observed in its
homologue EscJ, resulting in a ring of roughly the same diameter
to that proposed for EscJ. In our model we have also positioned
the PrgK ring in such a way that PrgK K168 faces the periplasm,
to account for our observation that K168 becomes accessible for
derivatization in the absence of InvG (Fig. 5C, E, Fig. S7).
Discussion
The atomic structures of several soluble domains of needle
complex components have become available. Attempts have been
made to place those domains within the available structures of the
entire needle complex to begin to generate an atomic model of the
entire structure. However, the low resolution of the available needle
complex structure has significantly hampered this objective and has
prevented the unambiguous assignment of specific domains to specific
protein densities within the needle complex. The cylindrical
architecture of the needle complex further complicates the docking
since, depending on the assumed stoichiometry or subunit number,
modeled ring-like structures can be placed at different positions
within the needle complex. Consequently, different studies have
proposed incompatible locations for different proteins and/or protein
domains within the needle complex [15,16]. We have used a multi-
pronged approach to generate data allowing us to place domains of
different protein components of the needle complex at specific sites of
its structure. We have experimentally shown that InvG forms the
outer rings. Although widely predicted from secondary structure
analysis as well as the organization of homologues in other secretion
systems (e.g. PulD family of proteins), this is the first experimental
demonstration of this organization. Furthermore, our data demon-
strated that InvG reaches deep into the periplasmic space making up
the entire neck region and making direct contact with the inner rings,
and in particular, the carboxy terminal domain of PrgH. Although
the C-terminus of PrgH is not visible in the atomic structure therefore
hindering high-resolution model building, the interaction between
this domain and the amino terminus of InvG appears to be critical for
the stability of the entire complex.
Our data also demonstrates that PrgH and PrgK are the main
constituents of the inner rings. Our results indicate that the C-
terminal domain of PrgH is localized at the periphery of IR1, as
supported by the nanogold label of a tag introduced between
amino acid 267 and 268, Fig. 4B and 4C). As previously
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proposed [15], our results suggest that PrgK is organized in a
smaller diameter ring structure engulfed by the PrgH ring on the
side and covered by the InvG neck region on top.
Multicomponent macromolecular complexes are central to
many fundamental processes in biology. To gain insight into
mechanistic details, knowledge not only of the atomic structure of
the different subunits, but also their orientation relative to one
another is essential. Therefore, our studies offer an essential view
of the architecture of this remarkable bacterial nanomachine and
will be the basis for further functional studies.
Materials and Methods
Bacterial strains and plasmids
All strains were derived from the non-flagellated S. enterica
serovar typhimurium strain SJW2941. The invG, prgH, and prgK
mutant alleles were introduced into this strain by P22HTint-
mediated transduction as described elsewhere [22]. The needle
complexes lacking InvG were purified from the strain SB1171 (all
‘‘SB’’ strains are described elsewhere) [10]. PrgH modified needle
complexes were obtained by complementing the strain SB906,
which harbors a chromosomal deletion of prgH, with plasmids
expressing C-terminal truncated PrgH, an 18x-C-terminal, a 6x-
N-terminal, or a 6x internal (after M267) poly-histidine tagged
PrgH. A longer C-terminal poly-histidine tag was chosen because
a 6xhistidine-tag yielded a poor Ni-NTA-NanoGold label. All
plasmids were based on the low copy vector plasmid pWSK29 and
expressed the tagged PrgH under its natural promoter (500bp
upstream sequence). The w.t. strain SB905 was used as a negative
control for the Ni-NTA-NanoGold labeling experiments and for
the detection of adjacent epitopes by mass spectrometry. An allele
of PrgK with a C-terminal 6x-poly-hisitidine tag was introduced
into SB905 by homologous recombination as described previously
[22]. Plasmids expressing the hilA positive transcriptional regulator
Figure 5. Domain interactions and relative orientations of needle complex components. (A) Proximity of specific domains of the base
proteins, InvG, PrgH, and PrgK within the needle complex. The block diagrams shows the three major base proteins, InvG, PrgH, and PrgK and
covalent cross-links of peptides obtained from chemically derivatized needle complexes at primary amino groups. Amino acid position are indicated
for the full length proteins prior signal peptide cleavage (processed InvG starts at Ser-25, and processed PrgK starts at Cys-18 [6]) protein-cross-links
found are indicated with amino acid position and with crossing lines between proteins. While the position of non-derivatized lysines (presumably due
to lack of surface exposure) is shown as vertical lines within the block diagram, the positions of derivatized lysines (surface accessible) is indicated as
vertical lines extending from the block diagram (Table S2). Note that lysines within the N-terminal domain of PrgK are not derivatized, suggesting
that the majority of PrgK within fully assembled needle complexes is not surface exposed. (B–E) Topographic model of the needle complex:
Localization of InvG, PrgH, and PrgH within the base of the needle complex. The N-terminal domain of InvG (blue-grey) reaches far down into the
neck region and is in close contact with the C-terminal domain of PrgH (white and grey), which resembles the larger of the two concentric rings.
Insertion of a poly-histidine tag between amino acid 267 (yellow) and 268 (orange) and subsequent Ni-NTA nanogold labeling further determines the
position of this domain within the complex. Sites of interaction found by cross-linking and mass spectrometry, for which in the case of PrgH and EscJ/
PrgK no atomic structure is available, are labeled as red dots. The N-terminal domain of PrgH is pointing to the cytoplasmic side of the complex, and
interacts with the C-terminal domain of PrgK. For both, no high resolution structure is available as of yet. The N-terminal domain of PrgK is located
within the complex and is therefore packed into its position by PrgH from the side and InvG from the top. (C) Top and side view of the modeled PrgH
(white/grey alternating) and PrgK (yellow/bright yellow alternating), as well as sites accessible for nanogold labeling (267/268) and chemical
derivatization (K168). (D) Proposed relative position of protein domains from PrgH, InvG, and PrgK. The side group nitrogen of K38 (InvG) and K168
(PrgK) are highlighted in blue. (E) Top-view of three PrgK and PrgH monomers extracted from the modeled inner ring structure highlighting sites for
chemical derivatization (PrgK (K168, blue)) and Ni-NTA nanogold labeling of a poly-histidine insertion at position 267/268 (yellow/orange) within
PrgH.
doi:10.1371/journal.ppat.1000824.g005
Table 1. List of hetero-cross-linked peptides determined by chemical derivatization and mass spectrometry.
Crosslinked proteins Crosslinked lysines Peptide1 Peptide2 Mass Error (ppm) xQuest Score
InvG-PrgH K38—K367 IPVTGSGFVAKDDSLR DDWLKG 2.1 17.7
PrgH-PrgK N-Term-K239 METSK KGITADDK 1.3 25.8
PrgH-PrgK N-Term-K246 METSK GITADDKAK 1.3 26.7
PrgH-PrgK N-K248 METSK KGITADDKAK 0.7 19.1
PrgH-PrgK N-K248 METSK AKSSNE 1.1 20.5
PrgH-PrgK K5-K239 METSKEK KGITADDK 0.5 21.4
PrgH-PrgK K5-K246 METSKEK GITADDKAK 1.0 18.4
PrgH-PrgK K5-K248 METSKEK AKSSNE 0.0 15.4
PrgH-PrgK K132-K239 LETSAKK KGITADDK 1.4 23.4
PrgH-PrgK K132-K246 LETSAKK GITADDKAK 0.9 15.2
PrgH-PrgK K132-K248 LETSAKK AKSSNE 1.0 22.4
PrgH-PrgK K133-K239 KNEPR KGITADDK 1.1 21.2
PrgH-PrgK K133-K246 KNEPR GITADDKAK 1.3 24.7
PrgH-PrgK K133-K248 KNEPR AKSSNE 1.7 17.8
Only peptides with an xQuest score of higher than 15 are displayed as those cross-linking results are likely to be reliable [25] (Text S1). The respective modified amino
acid is displayed in bold. Under ‘‘Crosslink’’ listed positions are the absolute positions of the respective protein (including signal peptides), ‘‘Error’’ the deviation of
measured precursor ion mass from theoretical precursor ion mass in parts per million, and ‘‘Score’’ the xQuest score.
doi:10.1371/journal.ppat.1000824.t001
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gene under the control of PBAD promoter (pSB667 or pSB1418)
were used to over-express the SPI-I TTSS regulon as described
elsewhere [23].
Bacterial secretion assay
The preparation and analysis of cultured supernatant proteins
was conducted as described elsewhere [22].
Needle complex expression and purification
Needle complex purification was based on the purification
protocol previously published [9]. Needle complexes were
purified from 2 L of bacterial culture. For the strain SB1171
the protocol was up-scaled to 18 L of bacterial culture to obtain
a yield comparable to the other strains. Details are provided
under Text S1. To further improve purity of the sample or to
separate inter-particularly cross-linked particles from single
particles, a sucrose gradient centrifugation was performed. A
continuous 10–25% sucrose gradient in thin-wall tubes of the
Sorvall TH-660 rotor was made with a 0.1% LDAO, 10 mM
sodium phosphate (pH 7.4), 0.5 M NaCl buffer. The sample
was applied to the top of the gradient and centrifuged for
3.5 hours at 50 krpm. Two 1.1 ml and four 0.45 ml fractions
were collected from the top of the tube and were diluted in
sucrose-free buffer and pelleted at 90 krpm for 30 minutes in a
Sorvall S100-AT4 rotor. The pellets were re-suspended in
0.1 ml 0.1% LDAO, 10 mM sodium phosphate (pH 7.4), 0.5 M
NaCl. Integrity and purity of the sample was verified by
negative stain EM and SDS-PAGE.
Disassembly of needle complexes to inner and outer
rings
The needle filament was removed by incubating purified needle
complexes in 10 mM sodium phosphate (pH 10.4), 0.5 M NaCl,
0.1% LDAO for 15 min at 37uC. Subsequently the pH was re-
adjusted by purifying the sample by sucrose gradient centrifuga-
tion as described above. The sample was observed by negative
stain electron microscopy as described below.
Ni-NTA-NanoGold labeling of poly-histidine-tagged
needle complexes
Samples tending to aggregate (His-PrgH, PrgK-His) were
purified in presence of 10mM imidazol. Free thiols of sucrose
gradient purified needle complexes were blocked by incubating the
sample with 1 mM N-ethylmaleimide at 4uC over night.
Subsequently, imidazole was added to a concentration of
20 mM and the sample was incubated with 5 mM nickel-
nitrilotriacetic acid (Ni-NTA) NanoGold (Nanoprobes, Stony
Brook, NY) at room temperature for 10 minutes. The sample
was gel-filtrated with a Sephacryl 300 column to remove unbound
Ni-NTA-NanoGold and analyzed by cryo-electron microscopy.
Chemical derivatization, mass spectrometry (MS) and MS
data analysis
Chemical derivatization was performed by incubating sucrose
gradient purified sample (about 1mg/ml) on ice with 600 mM
Sulfo-NHS Acetate (Pierce, Rockford, USA) for 60 minutes or
200 mM BS2G-d0/d4 (Pierce, Rockford, USA) for either 30 or
60 minutes.. Details about chemical derivatization and subsequent
MS analysis are provided in Text S1.
Electron microscopy and image processing
Samples were applied to glow-discharged carbon-coated 400
mesh hexagonal Cu/Pd-grids. For negative stain images 5 ml of
sample was applied to the grid and subsequently stained with 2%
PTA (phosphotungstate), pH 7.0 (Fig. 4D) or NanoVan (Nanop-
robes, Stony Brook, NY) (Fig. 4E, Fig. S5). Overview images
were acquired at 44,000-fold magnification in a Morgani TEM
(FEI Company, Hillsboro, USA) at 80kV using an 11 megapixel
CCD camera. High-resolution data was collected with a FEI
Tecnai Polara at 300kV using a Gatan Ultrascan 4000 UHS CCD
camera (16 mega-pixel, 4k64k, 15 micron pixel size). Images were
acquired at 112,968-fold magnification, which corresponds to
1.33 A˚/pixel at the level of the specimen, with underfocus values
ranging from 1.2–3.5 mm.
For cryo electron microscopy 5 ml sample was applied to glow-
discharged grids before vitrification by plunge freezing in liquid
ethane. Low-dose data was collected with a FEI Tecnai Polara at
300kV using a Gatan Ultrascan 4000 UHS CCD camera (16
mega-pixel, 4k64k, 15 micron pixel size). Images were acquired at
71,949-fold magnification (2.08 A˚/pixel) with under focus values
ranging from 1.2–3.5 mm.
Individual particle projections were extracted, combined into a
dataset and processed by IMAGIC-5 (Image Science Software
GmbH, Germany). The contrast reversals imposed by the contrast
transfer function (CTF) of the objective lens were corrected for
each particle projection using the mean under focus value of the
respective CCD-images as determined by the program
CTFFIND3 [24].
Supporting Information
Text S1 Supplementary Information Protocols
Found at: doi:10.1371/journal.ppat.1000824.s001 (0.05 MB RTF)
Figure S1 Block diagram of the three major base proteins, InvG,
PrgH, and PrgK of the needle complex and region of atomic
structures of PrgH and the homologues EscC (InvG) and EscJ
solved. Vertical lines extending from the block diagram are
positions of lysines that can be chemically derivatized and are
presumably surface exposed. Remaining non-derivatizable (and
probably not surface exposed) lysines are indicated as vertical lines
within the block diagram.. Amino acid position for InvG, PrgH,
and PrgK are indicated for the full length proteins prior signal
peptide cleavage (processed mature InvG starts at Ser-25, and
PrgK starts at Cys-18, respectively).
Found at: doi:10.1371/journal.ppat.1000824.s002 (2.84 MB TIF)
Figure S2 Sequence alignment and secondary structure predic-
tion of the major part of the N-terminal domain of PrgH (1–122)
from various species (S. typhimurium (PrgH), E. coli (EprH), Y.
enterocolitica (Ye3550), S. flexneri (MxiG)). The N-terminal
domain of PrgH is predicted to be mostly composed of beta-
strands. Highly conserved and similar residues are indicated in
red.
Found at: doi:10.1371/journal.ppat.1000824.s003 (0.47 MB TIF)
Figure S3 Ribbon diagram of PrgH (177–362) and position for
insertion of a poly-histidine tag following amino acid 267 for Ni-
NTA-nanogold labeling.
Found at: doi:10.1371/journal.ppat.1000824.s004 (0.23 MB TIF)
Figure S4 Single particle analysis of Ni-NTA labeled needle
complexes with a poly-histidine insertion following position 267 in
PrgH. Representation of various views of class-averages, variance-
images, and individual particles of PrgH-267his labeled needle
complexes show the presence of the nanogold label at the
outermost perimeter of the inner rings. The highest variance was
observed at the position of the nanogold label, which indicates that
the individual particles are not uniformly labeled. This is also
evident, when individual particles are visualized.
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Found at: doi:10.1371/journal.ppat.1000824.s005 (4.35 MB TIF)
Figure S5 PrgK resembles the smaller concentric ring of the
PrgHD4 inner ring substructure. En face view of the most
prominent class-average derived after hierarchical clustering from
images of negatively stained inner rings substructures from
PrgHD4 complexes. The smaller concentric ring shares similarity
in dimension (,180A˚) and organization to the modeled PrgK ring.
In order to allow a comparison between the class average of the
inner ring substructure and the modeled PrgK ring, only a
segment of the latter is shown.
Found at: doi:10.1371/journal.ppat.1000824.s006 (0.53 MB TIF)
Figure S6 Ribbon diagram of modeled InvG and PrgK
domains. The structure of InvG (white) and PrgK (yellow) were
obtained by structure homology-modeling based on EscC (blue)
and EscJ (blue) templates, using the SWISS-MODEL server
(http://swissmodel.expasy.org/). Note that in EscJ Asn134 to
Gln139 is not resolved in the X-ray structure, however, the
corresponding amino acids in PrgK (Asp133 to Lys144) have been
modeled using the the SWISS-MODEL server, indicating a
possible conformation of this amino acid stretch (marked with an
*). This domain (also marked with an *) is shown with a 70%
transparency setting in Fig. S7.
Found at: doi:10.1371/journal.ppat.1000824.s007 (0.43 MB TIF)
Figure S7 Overview of needle complex substructures and
organization. Side view of half-sectioned base and location of
individual protein domain. (* indicates to a possible confirmation
of amino acids 133–144 in PrgK based on modeling using the
SWISS-MODEL server (Fig. S6). Concentric ring-organization of
IR1/2 revealed from top-viewed disassembled complexes and ring
models of PrgH and PrgK.
Found at: doi:10.1371/journal.ppat.1000824.s008 (1.48 MB TIF)
Table S1 Comparison of surface accessibility in wild type and
DinvG mutant complexes. Peptides from NHS-acetate derivatized
complexes were identified by MS/MS sequencing and semi-
quantified by MS peak integration (Text S1). The table displays
the modified lysine (Lysine), the identified corresponding peptide
(Peptide) and the degree of NHS-acetate modification for the wild
type (%w.t.) and the DinvG mutant (%DinvG). The ratio of
peptide acetylation is an average of two independent mass
spectrometry measurements. To highlight which lysines get
stronger modified in the DinvG mutant (and are most likely more
surface exposed) the ratio of DinvG mutant and wild type
acetylation is determined (%DinvG/%w.t.). Due to the presence
of several lysines within the peptides ‘‘K48, K53’’ and the C-
terminally located peptides (‘‘C-term’’ = K238, K239, K246,
K248) the exact position of the derivatization could not be
distinguished.
Found at: doi:10.1371/journal.ppat.1000824.s009 (0.07 MB RTF)
Table S2 List of mono-links and loop-links determined by
chemical derivatization and mass spectrometry. In order to specify
all lysines being accessible for derivatization, hetero-cross-links
(cross-link between two different proteins, see Table 1), mono-links
(modified peptides that reacted with only one functional group of
the bivalent cross-linker (BS2G (0/d4))) and loop-links (cross-links
within one polypeptide chain or between homo-proteins) were
determined. Only peptides with an xQuest score of higher than 15
are displayed as those cross-linking results are likely to be reliable
(see Text S1). The respective modified amino acid is displayed in
bold. Under ‘‘Monolink/Looplink’’ listed positions are the
absolute positions of the respective protein (including signal
peptides), ‘‘Error’’ the deviation of measured precursor ion mass
from theoretical precursor ion mass in parts per million, and
‘‘Score’’ the xQuest score.
Found at: doi:10.1371/journal.ppat.1000824.s010 (0.10 MB RTF)
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Epigenetic indexing of chromatin domains
by histone lysine methylation requires the bal-
anced coordination of methyltransferase and
demethylase activities. Here, we show that
SU(VAR)3-3, the Drosophila homolog of the
human LSD1 amine oxidase, demethylates
H3K4me2 and H3K4me1 and facilitates sub-
sequent H3K9 methylation by SU(VAR)3-9.
Su(var)3-3 mutations suppress heterochro-
matic gene silencing, display elevated levels of
H3K4me2, and prevent extension of H3K9me2
at pericentric heterochromatin. SU(VAR)3-3
colocalizes with H3K4me2 in interband regions
and is abundant during embryogenesis and in
syncytial blastoderm, where it appears concen-
trated at prospective heterochromatin during
cycle 14. In embryos of Su(var)3-3/+ females,
H3K4me2 accumulates in primordial germ cells,
and the deregulated expansion of H3K4me2
antagonizes heterochromatic H3K9me2 in
blastoderm cells. Our data indicate an early
developmental function for the SU(VAR)3-3 de-
methylase in controlling euchromatic and het-
erochromatic domains and reveal a hierarchy
in which SU(VAR)3-3-mediated removal of acti-
vating histone marks is a prerequisite for sub-
sequent heterochromatin formation by H3K9
methylation.
INTRODUCTION
Covalent modifications of histone N termini control chro-
matin structure and define epigenetic marks for transcrip-
tional competence during development. Methylation of
histone H3 lysine 9 (H3K9) is a hallmark of constitutive het-
erochromatin (Rea et al., 2000; Nakayama et al., 2001;MolePeters et al., 2002; Schotta et al., 2002), whereas methyl-
ation of H3K4 is associated with actively transcribed chro-
matin (Zhang and Reinberg, 2001; Bernstein et al., 2002;
Kouzarides, 2002). In eukaryotes, a large fraction of the
genome is in an inaccessible heterochromatic state.
Factors defining heterochromatin were first identified in
Drosophila by genetic dissection of gene silencing in posi-
tion-effect variegation (PEV) with the help of dominant
modifier mutations (Schotta et al., 2003), so-called sup-
pressors of variegation or Su(var) genes. The currently
characterized Su(var) genes encode either heterochroma-
tin components or factors that impair spreading of het-
erochromatin into euchromatin (Ebert et al., 2006). For
example, the H3K9 methyltransferase SU(VAR)3-9, its
associated H3K9 methyl binder HP1, and the Zn-finger
protein SU(VAR)3-7 (Jaquet et al., 2002) work together in
a complex tomaintain stable gene silencing in heterochro-
matin (Ebert et al., 2006).
At the end of embryonic development, which is syn-
cytial in Drosophila, the transition of cleavage chromatin
into somatic and germline chromatin occurs during or
shortly before blastoderm formation. Heterochromatin
first becomes visible at the apical pole of early blastoderm
nuclei as an intensely staining region when chromosomes
are organized in a typical Rabl conformation (Foe et al.,
1993). Themolecular mechanisms that initiate heterochro-
matin formation during early development are currently
unknown.
Based on its thermodynamic stability, histone lysine
methylation has been regarded as a very robust histone
modification that would be ideally suited to impart more
long-term epigenetic information. With the discoveries of
histone lysine demethylases (Shi et al., 2004; Tsukada
et al., 2006), the epigenetic stability of histone lysinemeth-
ylation has to be reconsidered by comparing the activities
of methyltransferases (HMTase) and demethylases that
either target activating (e.g., H3K4) or repressive (e.g.,
H3K9) histone modifications (Bannister and Kouzarides,
2005). For example, the human amine oxidase LSD1
catalyzes removal of methyl groups from H3K4me1 and
H3K4me2 (Shi et al., 2005) and, when complexed withcular Cell 26, 103–115, April 13, 2007 ª2007 Elsevier Inc. 103
Molecular Cell
H3K4 Demethylation and Heterochromatin Formationother factors, also destabilizes H3K9me2 (Metzger et al.,
2005). LSD1 function is present in unicellular organisms,
and highly related genes are conserved throughout multi-
cellular genomes. However, with the exception of knock-
down studies in C. elegans (Shi et al., 2004) and a recent
study in S. pombe (Nicolas et al., 2006), no in vivo analysis
for H3K4 demethylation during metazoan development
has been described.
Here,weshow that thedominantPEVmodifierSu(var)3-3
encodes the Drosophila homolog of LSD1 and is an H3K4
demethylase that associates with prospective heterochro-
matin in early embryonic development. The SU(VAR)3-3
enzyme directly restricts the extent of H3K4me2 at hetero-
chromatic sequences in somatic cells and safeguards
transcriptional silence in primordial germ cells. Loss of the
SU(VAR)3-3 demethylase indirectly impairs the full expan-
sion of H3K9me2 marks at heterochromatin. SU(VAR)3-3
is an abundant nuclear protein at cleavage stage embryos.
In syncytial blastoderm, it is restricted to heterochromatic
regions and complexes with other silencing factors in-
cluding the SU(VAR)3-9 HMTase, HP1, and the histone
deacetylase RPD3. Analysis ofSu(var)3-3mutant embryos
and flies suggests a function for SU(VAR)3-3 in the protec-
tion of heterochromatic domains against antagonistic
H3K4 methylation. Together, our data define an early
developmental role for the SU(VAR)3-3 demethylase in
initiating heterochromatin formation and gene silencing in
Drosophila.
RESULTS
The Drosophila Homolog of LSD1 Is the Dominant
PEV Modifier Su(var)3-3
Su(var)3-3 mutations belong to the strongest dominant
suppressors for white gene silencing in the wm4 PEV rear-
rangement (Wustmann et al., 1989). Su(var)3-3 mutations
are characterized by a number of interesting phenotypic
effects. Homozygousmutant females produce no oocytes
(agametic), whereas in males only immobile sperms are
found (Szabad et al., 1988). These mutations are also bu-
tyrate sensitive and display recessive lethal interactions
with additional heterochromatin, such as an extra copy
of the Y chromosome in XXY females or in XYY males
(Reuter et al., 1982).
Wemapped Su(var)3-3 to polytene chromosome region
77A3 by male recombination and complementation analy-
sis examining recessive female and male sterility with a
series of deletions (Ryder et al., 2004; see Figure S1 in
the Supplemental Data available with this article online).
This region contains the two genes CG17147 and
CG17149 (Crosby et al., 2007). Genetic analysis proves
that CG17149 is identical with Su(var)3-3. The PiggyBac
insert PBac{WH}f00678 in CG17149 (Parks et al., 2004)
is allelic to Su(var)3-3. Su(var)3-3 encodes a gene product
that shows high amino acid conservation to the human de-
methylase LSD1, including 71% identity in the SWIRM do-
main and 75.3% in the amine oxidase domain (Figure 1A).104 Molecular Cell 26, 103–115, April 13, 2007 ª2007 Elsevier IAll 22 Su(var)3-3 mutations were isolated as dominant
suppressors of white variegation in wm4, and 15 alleles
displayed mutational lesions in the protein-coding se-
quences (Figure 1A). In the remaining seven alleles, no
transcript is detected by RT-PCR. Phenotypic rescue of
the dominant suppressor effect of Su(var)3-3 heterozy-
gotes is restored by an extra gene copy of a wild-type al-
lele of Su(var)3-3 (Figure 1C). Genetic crosses demon-
strate that the Su(var)3-3 mutations also strongly
suppress heterochromatic PEV in other rearrangements
(Figure 1B), such as brown, Stubble, yellow, or a lacZ
transgene (Sinclair et al., 1992; Le et al., 1995; Lu et al.,
1998). The general suppressor effect of Su(var)3-3 muta-
tions in PEV illustrates its crucial requirement for hetero-
chromatic gene silencing.
H3K9 methylation catalyzed by the evolutionarily con-
served HMTase SU(VAR)3-9 is a hallmark for constitutive
heterochromatin in all eukaryotic cells (Rea et al., 2000;
Nakayama et al., 2001; Schotta et al., 2002). The strength
and extent of gene silencing in PEV are directly correlated
with the dosage of the heterochromatin-associated fac-
tors SU(VAR)3-9, HP1, and SU(VAR)3-7 (Ebert et al.,
2004). Additional genomic copies of all three genes cause
strong enhancement of white gene silencing in wm4
(Figure 1C). Su(var)3-3 mutations dominate in their sup-
pressor effect the PEV enhancement induced by addi-
tional Su(var)3-9, Su(var)2-5 (HP1), and Su(var)3-7 gene
copies. Even in wm4;Su(var)3-3/+ flies carrying two addi-
tional wild-type copies of Su(var)3-9, enhancement of
white gene silencing is strongly suppressed (Figure 1C).
This epistatic effect of Su(var)3-3 mutations on PEV en-
hancement suggests that SU(VAR)3-3 functions upstream
of the SU(VAR)3-9 H3K9 methyltransferase in control of
heterochromatin formation.
SU(VAR)3-3 Is an H3K4 Demethylase that Also
Affects H3K9 Methylation
Histone demethylase activity of SU(VAR)3-3 and of the
mouse LSD1 homolog was studied using baculovirus-
expressed proteins and calf thymus histones by western
blot with methyl-lysine-specific histone antibodies. Like
LSD1 (Shi et al., 2004), recombinant SU(VAR)3-3 specifi-
cally reduces H3K4me1 and H3K4me2, but not H3K9 (Fig-
ure 2) or any of the other knownmethylation sites (data not
shown). No enzymatic activity is detected for a point mu-
tant protein (G316R) that impairs the amine oxidase do-
main. This mutation is identical to the Su(var)3-309mutant,
which is a strong silencing suppressor in vivo. We next
confirmed the demethylase activity bymass spectrometry
using recombinant SU(VAR)3-3 and histone H3 peptides
(1–20) which were either mono-, di-, or trimethylated at
H3K4.SU(VAR)3-3demethylatesH3K4me1andH3K4me2
but, as expected, cannot convert H3K4me3 andH3K9me1
or me2 (Figure 2D). These enzymatic data demonstrate
that Drosophila SU(VAR)3-3 and mammalian LSD1 are
functionally conserved histone H3K4 demethylases.
To address the function of SU(VAR)3-3 in vivo, we first
examined the chromosomal distribution of the proteinnc.
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H3K4 Demethylation and Heterochromatin FormationFigure 1. The Drosophila Homolog of Histone Demethylase LSD1 Is the PEV Suppressor SU(VAR)3-3
(A) Protein structure of SU(VAR)3-3 and positions of the molecularly characterized mutations. SU(VAR)3-3 shows high identity with the human LSD1
protein, with 71% in the SWIRM and 75.3% in the amine oxidase domain. Yellow lozenge indicates the FAD binding domain.
(B) SU(VAR)3-3 is required for heterochromatic gene silencing. All Su(var)3-3mutations were isolated as dominant suppressors of white variegation in
wm4. They also suppress gene silencing in other PEV rearrangements (brown, Stubble, yellow, lacZ).
(C) Genomic extra copies of Su(var)3-9, Su(var)2-5, and Su(var)3-7 display enhanced silencing of the white gene in In(1)wm4 (upper row), which is im-
paired in the presence of the strong PEV suppressor mutantSu(var)3-3 (lower row). Rescue of the dominant suppressor effect of Su(var)3-3mutations
is found in wm4 flies heterozygous for a Su(var)3-3 mutation and a duplication (second column).along polytene chromosomes using a SU(VAR)3-3-
specific antibody (Figure 3A). In salivary gland chromatin,
SU(VAR)3-3 is exclusively found at euchromatin and pref-
erably associates with interband regions that also accu-
mulate H3K4me2 (Ebert et al., 2006). Our immunocytology
indicates significant colocalization of SU(VAR)3-3 and
H3K4me2 at interbands (Figure S2). Immunocytology in
Su(var)3-3 null larvae revealed elevated H3K4me2 levels
and reduction in heterochromatic H3K9me2 (Figure 3B).
Western blot analysis proved elevated H3K4me2 and re-
duced H3K9me2 levels (Figure S3). The apparent inter-
dependent shift between increased H3K4me2 and de-Molecreased H3K9me2 in Su(var)3-3 null larvae suggests that
SU(VAR)3-3 not only directly regulates H3K4me2 but
also indirectly affects dimethylation of H3K9. In addition,
an interesting change in the distribution of H3K9me3 is
detected in Su(var)3-3 null larvae, which, compared to
wild-type larvae, display many sites of H3K9me3 along
all chromosomes (Figure 3B).
We also generated transgenic lines expressing
SU(VAR)3-3 under control of the yeast UAS promotor.
Forced expression of SU(VAR)3-3 in development was
controlled by different GAL4 driver elements, including
tubulin-GAL4 for global and SGS3-GAL4 for salivarycular Cell 26, 103–115, April 13, 2007 ª2007 Elsevier Inc. 105
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H3K4 Demethylation and Heterochromatin FormationFigure 2. SU(VAR)3-3 Demethylates In Vitro Mono- and Dimethyl H3-K4
Western blot analysis with a-mono-, a-di-, and a-trimethyl H3K4; a-mono- and a-dimethyl H3K9; and a-H3, a-HA, a-LSD1, and a-SU(VAR)3-3.
(A) Histone demethylation assays on bulk histones without enzyme and with mLSD1, mLSD K612A, SU(VAR)3-3, and SU(VAR)3-3 G316R recombi-
nant protein.
(B) Western blot analysis of serial dilutions of the reaction products from HDM assays on bulk histones with SU(VAR)3-3 wild-type and G316Rmutant
protein. About 80% of H3K4me1 and H3K4me2 is removed from bulk histones upon incubation with SU(VAR)3-3. 1 corresponds to 4.5 ml of reaction
products.
(C) Concentration-dependent H3K4 demethylation activity of SU(VAR)3-3 on bulk histones. 1x corresponds to 2 mg of SU(VAR)3-3 protein.
(D) Mass spectrometric analyses of H3K4me1, -me2, and -me3 and H3K9me1 and -me2 levels in synthetic H3 peptides after incubation without
enzyme and with mLSD1, mLSD K612A, SU(VAR)3-3, and SU(VAR)3-3 G316R.gland-specific overexpression. Forced expression of
SU(VAR)3-3 in salivary glands results in reduction of
H3K4me2 at interbands in polytene chromosomes (Fig-
ure 3C), whereas the level of H3K4me3 is not changed
(data not shown). Interestingly, we also detected reduced
staining for H3K9me2 and H3K9me3 in chromocenter het-
erochromatin after overexpression (Figure 3C). Although
SU(VAR)3-3 cannot be detected at the heterochromatic
chromocenter of wild-type polytene chromosomes,106 Molecular Cell 26, 103–115, April 13, 2007 ª2007 Elsevierforced overexpression results in weak association of
SU(VAR)3-3 with this domain (Figure 3C).
We next examined these global changes in H3K4 and
H3K9 methylation on gene silencing in PEV. Since all
transgene constructs contain the mini-white marker, we
studied the effect of ectopic SU(VAR)3-3 expression on
PEV in the T(2;3)Sbv rearrangement by measuring fre-
quency of Stubble (Sb) mutant gene inactivation (Sinclair
et al., 1992). Reduction of H3K9 methylation after ectopicInc.
Molecular Cell
H3K4 Demethylation and Heterochromatin FormationFigure 3. SU(VAR)3-3 Is a H3K4 Demethylase that Shows Ectopic Effects on In Vivo H3K9 Methylation
(A) Salivary gland polytene chromosomes from wild-type larvae stained with a-SU(VAR)3-3, a-dimethyl H3K4, and a-mono-, a-di-, or a-trimethyl
H3K9.
(B) Histone methylation marks in Su(var)3-3 null polytene chromosomes. A loss of SU(VAR)3-3 causes chromosomewide increase in H3K4me2 and
decreases the amount of H3K9 di- and trimethylation in chromocenter heterochromatin. Immunostaining with a-SU(VAR)3-3, a-dimethyl H3K4, and
a-mono-, a-di-, or a-trimethyl H3K9.
(C) Ectopic effect on histone methylation after SU(VAR)3-3EGFP overexpression using a GAL4-SGS3 driver element results in heterochromatin as-
sociation of SU(VAR)3-3EGFP, strong reduction of H3K4me2, and H3K9me2, and -me3. H3K9monomethylation is not affected. Immunolabeling with
a-SU(VAR)3-3, a-dimethyl H3K4, and a-mono-, a-di-, or a-trimethyl H3K9. DNA was stained with DAPI (red). Arrows point to chromocenter region.SU(VAR)3-3 overexpression coincides with significant
suppression of PEV in T(2;3)Sbv, which is reflected by an
increase in the number of Stubble mutant bristle to
83.3% as compared to 51.7% in control flies. In contrast
to forced SU(VAR)3-3 overexpression, controlled expres-
sion by additional genomic copies of Su(var)3-3 results
in weak enhancement of PEV. Strong suppression of PEV
is the typical loss-of-function phenotype of Su(var)3-3
(Figure 1C). Therefore, a dose-dependent activity of
SU(VAR)3-3 is required for establishment of heterochro-
matic gene silencing.
Heterochromatin Formation during Embryonic
Development Depends on SU(VAR)3-3
To investigate the function of SU(VAR)3-3 in heterochro-
matin formation during early embryonic development,Molewe first studied nuclear distribution of the protein in wild-
type embryos and in embryos produced from females
carrying either the loss-of-function Su(var)3-312 allele
or a deletion of the gene. We analyzed distribution of the
H3K4me2, H3K9me2, and H3K9me3 marks during
embryonic development in somatic as well as in germline
precursor cells (Figure 4). In early cleavage, SU(VAR)3-3
displays a uniform nuclear distribution (Figure 4A). During
the cleavage divisions, the protein becomes redistributed
(Figure 4B). At metaphase, a significant amount of
SU(VAR)3-3 is detected at the chromosome periphery,
whereas it localizes between the chromosomes during
anaphase. A rather uniform interphase chromatin asso-
ciation of SU(VAR)3-3 is detected until syncytial blasto-
derm (Figure 4A). When cellular blastoderm is formed
(cycle 14), SU(VAR)3-3 becomes preferably associatedcular Cell 26, 103–115, April 13, 2007 ª2007 Elsevier Inc. 107
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H3K4 Demethylation and Heterochromatin FormationFigure 4. Chromatin Association of SU(VAR)3-3 and Distribution of Histone Modification Marks at Cleavage and during Develop-
ment of Somatic and Germline Precursor Cells
(A) During cleavage, SU(VAR)3-3 shows a uniform chromatin association until cycle 12. H3K4 dimethylation first becomes visible at the end of cleav-
age (cycle 12) and is excluded from the heterochromatic compartment and pole cells, the primordial germ cells ofDrosophila. At cycle 14, SU(VAR)3-3
becomes enriched at prospective heterochromatin and remains uniformly associated with pole cell chromatin. H3K4 dimethylation is excluded from
heterochromatin and pole cell chromatin.
(B) Redistribution of SU(VAR)3-3 during cleavage mitosis. The protein becomes accumulated at the chromosomal periphery during metaphase,
whereas only weak uniform staining is detected during anaphase.
(C) H3K4me2, H3K9me2, and H3K9me3 staining in wild-type embryos and embryos produced bySu(var)3-3/+ females. Increase of H3K4me2 in blas-
toderm cells and significant H3K4me2 staining in pole cells of mutant embryos. Concomitant reduction of heterochromatic H3K9 di- and trimethy-
lation in somatic and pole cell nuclei is observed. Arrowheads point to pole cells.with pericentric heterochromatin (Figures 4A and 5) that is
located in a typical Rabl conformation as DAPI bright
material situated at the apical pole of blastoderm nuclei
(Foe et al., 1993). Later in development, SU(VAR)3-3 is
only found over euchromatin. In the germline precursor
pole cells, SU(VAR)3-3 remains uniformly distributed
within the nucleus (Figure 4A).
Heterochromatin association of SU(VAR)3-3 in blasto-
derm nuclei coincides with the appearance of H3K4meth-
ylation. H3K4methylation is first visible at syncytial blasto-
derm (cycle 12) in a speckled distribution (Figure 4C). At
cycle 14, H3K4 methylation becomes restricted to the
euchromatic compartment of the nuclei. At this time,
SU(VAR)3-3 is enriched at pericentric heterochromatin,108 Molecular Cell 26, 103–115, April 13, 2007 ª2007 Elsevierand all H3K9 methylation states appear in this domain.
In contrast to later stages of Drosophila development
(Ebert et al., 2004), early heterochromatin shows more
intense staining for H3K9me3 (Figure 5B). In pole cells,
intense staining for H3K9me2 was found (Schaner et al.,
2003). Indeed, all H3K9 methylation states can be
detected in pole cells (Figure 4 and data not shown).
To study the role of SU(VAR)3-3 in heterochromatin
formation during early embryonic development and in par-
ticular at cycle 14, we analyzed embryos produced after a
cross of females and males heterozygous for a Su(var)3-3
null mutation. In most of these embryos, the amount of
SU(VAR)3-3 over heterochromatin is significantly reduced
(Figure 5A). These embryos show a more extendedInc.
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H3K4 Demethylation and Heterochromatin FormationFigure 5. High-Resolution Analysis of SU(VAR)3-3, HP1, and RPD3 Binding and Histone Modifications in Early Blastoderm Cells
(A) Immunostaining of wild-type (left panel) and embryos of Su(var)3-3/+ females (right panel) with a-SU(VAR)3-3, a-HP1, a-RPD3, and a-acetyl
H3K9. SU(VAR)3-3 distribution is shown for cycles 13–15 as indicated. All other photos represent cycle 14 embryos. In wild-type embryos,
SU(VAR)3-3 is uniformly distributed during cycle 13, becomes enriched in heterochromatic regions during cycle 14, and afterwards is accumulated
at the boundary region between eu- and heterochromatin (cycle 15). SU(VAR)3-3 and HP1 staining is significantly reduced in mutant embryos. RPD3
binding is almost uniform along the apicobasel axis of blastoderm nuclei in both wild-type and mutant embryos. In contrast, extended acetyl H3K9
staining toward heterochromatin is found in mutant embryos.
(B) Compared to wild-type (left panel) in Su(var)3-3 mutant embryos (right panel), the euchromatic mark H3K4me2 is elevated and spreads into the
heterochromatic compartment. In mutant embryos, the heterochromatic trimethyl H3K9 is significantly reduced. No effects are found on mono- and
trimethyl H3K4 and monomethyl H3K9. H3K9me2 appears only weakly reduced in Su(var)3-3 mutant embryos.staining of H3K4me2 at the prospective heterochromatin
compartment (Figure 5B). Conversely, H3K9me2 and
staining for HP1 appear to be reduced. Distribution of
H3K9me3 is markedly affected and now shows foci
throughout the nuclei. The amount of H3K9me1 appears
not to be affected. Western blot analysis of 0–4 hr old em-
bryos also revealed increase in global H3K4me1 and
H3K4me2 levels. In these collections, which contain
only a fraction of cycle 13–14 embryos, reduction of
H3K9me3 but no obvious global change in H3K9me2 is
detected, suggesting that mainly local concentration of
these marks at prospective heterochromatin in early em-
bryos controls heterochromatin formation (Figure S3B).
Furthermore, immunostaining for H3K9 acetylation in cy-
cle 14 embryos shows expansion of H3K9ac distribution
toward heterochromatin. These data indicate that both
demethylation of H3K4 by SU(VAR)3-3 and deacetylation
of H3K9 by RPD3 are coordinated during chromatin differ-
entiation in early embryogenesis.
In Drosophila, the primordial germ cells become sepa-
rated from the soma at the posterior end of the embryo
as pole cells at the end of cleavage (cycle 10). Pole cell
nuclei are devoid of any H3K4me2 (Schaner et al., 2003)
and show intense staining for H3K9me2 and H3K9me3
(Figure 4C). In Su(var)3-3 mutant embryos, significant
H3K4methylation is found. Appearance of H3K4 methyla-
tion coincides with significant reduction of H3K9me2 andMolecH3K9me3 (Figure 4C). This demonstrates that SU(VAR)3-3
also plays an essential role in establishment of transcrip-
tional silence in pole cells. Together, this mutant analysis
suggests a developmentally regulated function for
SU(VAR)3-3 in protecting heterochromatic regions against
expansion of H3K4 methylation during early stages of
Drosophila development.
SU(VAR)3-3 Associates with Other Silencing Factors
and Controls Heterochromatin Spreading in PEV
Histone H3K4 andH3K9methylation represent antagonis-
tic indexing marks. Similar to mammalian SUV39H1 (Nish-
ioka et al., 2002), Drosophila SU(VAR)3-9 HMTase activity
is inhibited by pre-existing methylation of H3K4, as ob-
served in in vitro methylation assays with H3K4me1 and
H3K4me2 histone H3 peptides (1–20) (Figure 6A). Addition
of recombinant SU(VAR)3-3 relieves this inhibition (Fig-
ure 6A). To examine if the SU(VAR)3-3 demethylase
may associate with the SU(VAR)3-9 HMTase in vivo, we
analyzed extracts from early embryos by coimmunopreci-
pitation using a protein A Sepharose-coupled SU(VAR)3-
3-specific antibody. Together with SU(VAR)3-3, three
proteins, SU(VAR)3-9, HP1, and RPD3, are coimmuno-
precipitated (Figure 6B). These data indicate the existence
of a silencing complex, in which the SU(VAR)3-3 demethy-
lase and the RPD3 histone deacetylase can provide activ-
ities in resetting pre-existing chromatin modificationsular Cell 26, 103–115, April 13, 2007 ª2007 Elsevier Inc. 109
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H3K4 Demethylation and Heterochromatin FormationFigure 6. SU(VAR)3-3 Abolishes the Inhibitory Effect of K4-Methylated H3 Substrates on SU(VAR)3-9 Lysine 9Methylation Activity,
Associates with SU(VAR)3-9/HP1 Heterochromatin Complexes, and Impairs Heterochromatin Spreading in PEV
(A) HMTase assay with SU(VAR)3-9 and H3K4-methylated peptides (1–20) after incubation with SU(VAR)3-3. The amount of incorporated label was
measured by scintillation counting after 20 min (error bars indicate minimum and maximum values).
(B) Affinity purification of SU(VAR)3-3 complexes from early (0–3 hr) embryos using a covalently Sepharose A-coupled SU(VAR)3-3 antibody. Immu-
noblotting of copurified proteins with a-SU(VAR)3-3, a-SU(VAR)3-9, a-HP1, and a-RPD3.
(C) Su(var)3-3 mutations impair heterochromatin spreading. ChIP analyses along the white-roughest euchromatic region juxtaposed in wm4 to peri-
centric heterochromatin.
In wm4;+/+ flies, a gradient of H3K9me2 along the white-roughest region is found (gray bars), whereas no H3K9 dimethylation is detected over this
region at its normal position in the X chromosome (white bars). In Su(var)3-9 null mutant flies, H3K9me2 is not induced (black bars), whereas in
Su(var)3-3 null flies, spreading of H3K9me2 is blocked (gray shaded bars). Error bars indicate standard deviation.for the subsequent methylation and binding of H3K9
by SU(VAR)3-9 andHP1. A requirement for H3K9 deacety-
lation by HDAC1 in a sequential H3K9 methylation by
SU(VAR)3-9 to establish heterochromatic gene silencing
was already shown (Czermin et al., 2001).
SU(VAR)3-3 association with SU(VAR)3-9 indicates that
spreading of H3K9methylation along euchromatic regions
depends on the activity of SU(VAR)3-3. To analyze this in
more detail, we performed chromatin immunoprecipita-110 Molecular Cell 26, 103–115, April 13, 2007 ª2007 Elsevietion (ChIP) for H3K9me2 across the euchromatic region
flanking the wm4 rearrangement. In wm4, the white-rough-
est region is located next to pericentric heterochromatin,
and heterochromatization results in variable silencing of
the genes located in this euchromatic region. The ChIP
analysis was done with chromatin material prepared
from adult fly heads and using the heterochromatic 395
bp satellite and euchromatic b-tubulin gene sequences
as controls. In the wm4 rearrangement, a gradient ofr Inc.
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H3K4 Demethylation and Heterochromatin FormationFigure 7. Coordinated Histone Demethylation and Methylation Define the Boundary between Eu- and Heterochromatin in Early
Embryonic Development
SU(VAR)3-3, the Drosophila homolog of human LSD1, associates in early embryonic development with heterochromatin. Protection of heterochro-
matin against the active histone methylation marks H3K4me1 and -me2 by the H3K4 demethylase SU(VAR)3-3 is a prerequisite for heterochromatin
formation and establishment of heterochromatic H3K9 methylation by SU(VAR)3-9. The H3K4 demethylase SU(VAR)3-3 associates with the
SU(VAR)3-9 complex for coordinated function in determination of the boundary between heterochromatic and euchromatic chromatin domains.H3K9me2 along the white-roughest region is detected,
whereas no significant H3K9me2 is present across this
region in its wild-type chromosomal configuration (Fig-
ure 6C). H3K4 methylation could not be detected within
the white-roughest region in adult heads and salivary
glands (data not shown), suggesting that the genes
located in this region are not expressed in the majority
of cells within the analyzed tissues. The amount of
H3K9me2 in thewhite-roughest region withinwm4 strongly
depends on SU(VAR)3-9. In Su(var)3-9 null mutant flies, no
spreading of H3K9me2 is found (Figure 6C), whereas in
flies with additional Su(var)3-9 gene copies, regional ex-
pansion of H3K9me2 is significantly enhanced (data not
shown). Importantly, in Su(var)3-3 null flies, spreading of
heterochromatin is impaired and no H3K9me2 is detected
along the white-roughest region in wm4 (Figure 6C). This
finding indicates that SU(VAR)3-3 is required to allow
extended decoration of H3K9me2 into the flanking
euchromatic region.
Early Initiation and Maintenance of Heterochromatic
Gene Silencing in PEV
In early embryos, SU(VAR)3-3 associates with RPD3,
SU(VAR)3-9, andHP1.We therefore investigated by clonal
analysis whether initiation of heterochromatic gene silenc-
ing specifically occurs early in development. In wm4
Su(var)3-9/+ heterozygotes, Su+/Su+ cell clones were in-
duced with the flipase/FRT mitotic recombination system
(Xu and Rubin, 1993), and their phenotype was inspected
in adult flies for restoredwhite variegation. Flipase expres-
sion under the control of the eyeless promotor (Newsome
et al., 2000) results in eye clones whose size depends on
the timing of their induction (Figure S4). Although in all
Su+/Su+ clones two wild-type copies of Su(var)3-9 are
present, white variegation is restored only in large clones,
which were induced early in development (Figure S4A). AllMolsmaller clones, which are induced at later developmental
time points, show a suppressor phenotype. Their indica-
tive brownish color is due to homozygosity of the red
eye marker mutation (Figure S4B). The size of the white
mottled clones corresponds to the size of clones induced
by X-ray treatment of w+/w embryos or early first-instar
larvae (Becker, 1966), suggesting that suppression of
heterochromatic gene silencing by a Su(var)3-9 mutation
in wm4 is established early and then stably maintained.
Reversionof suppressedsilencingcould alsodependon
the number of cell divisions.We therefore inducedSu+/Su+
clones in Su(var)3-9/+ heterozygotes carrying a dominant
Minutemutation [M(3)w124] on the Su(var)3-9mutant chro-
mosome. The Su+/Su+ clones automatically convert to
Minute+ (Figure S4) and overgrow larger territories, since
M/+ neighboring cells are significantly delayed in develop-
ment (Garcia-Bellido et al., 1973). Late-induced Su+/Su+
clones frequently occupy the entire eye. Because these
late clones still manifest a suppressor phenotype, addi-
tional cell divisions do not interfere with maintenance of
the established suppressor effect (Figures S4C and S4D).
The size of the Su+/Su+ clones reverting back to a white
mottled phenotype suggests that heterochromatic gene
silencing in wm4 is already defined at embryogenesis or
first larval instar stage and than remains stablymaintained.
DISCUSSION
Our data support a model in which heterochromatin for-
mation and gene silencing in PEV are defined during early
embryonic development of Drosophila. A dynamic bal-
ance between HMTases and demethylases controls
establishment of the functionally antagonistic histone
H3K4 and H3K9 methylation marks at the border region
of euchromatin and heterochromatin (Figure 7). In trans-
criptionally silent cleavage nuclei, chromatin is in a naiveecular Cell 26, 103–115, April 13, 2007 ª2007 Elsevier Inc. 111
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completely missing. A dramatic transition of chromatin
structure occurs during blastoderm formation and cellula-
rization by establishing H3K4 and H3K9 methylation. In
contrast to H3K9 acetylation, which is already found in
cleavage chromatin, H3K4 methylation at prospective eu-
chromatin appears first at the end of cleavage in cycle 12.
In parallel, di- and trimethylation of H3K9 and HP1 binding
establish heterochromatin. Pole cells, which are the pri-
mordial germ cells of Drosophila, are in a transcriptionally
silent state and show extensive H3K9me2 and H3K9me3.
During the definition of the euchromatin-heterochromatin
boundaries in blastoderm cells and for the establishment
of repressive H3K9 methylation marks in primordial germ
cells, the SU(VAR)3-3 demethylase plays an early and
inductive regulatory role. SU(VAR)3-3 might also be in-
volved in control of early transcriptional activities within
Drosophila pericentromeric sequences preceding hetero-
chromatin formation, as suggested by a model of hetero-
chromatin formation that depends on the RNAi pathway
(Pal-Bhadra et al., 2004).
A Mechanistic Hierarchy for the Establishment
of Heterochromatin in Somatic Cells
Genetic analysis revealed that SU(VAR)3-3 functions up-
stream of the H3K9 HMTase SU(VAR)3-9 and the hetero-
chromatin-associated proteins HP1 and SU(VAR)3-7 in
control of gene silencing in PEV. Combined with earlier
studies of epigenetic interactions (Schotta et al., 2002),
heterochromatic gene silencing is established by a se-
quential action of SU(VAR)3-3, SU(VAR)3-9, the amount
of Y heterochromatin, HP1, and SU(VAR)3-7. RPD3 also
acts upstream of SU(VAR)3-9, because Rpd3 mutations
dominate the dose-dependent PEV enhancer effect of
SU(VAR)3-9 (Czermin et al., 2001). Additional genomic
copies of Su(var)3-3 are epistatic to a Rpd3 mutation
(Figure S5) placing the H3K4 demethylase SU(VAR)3-3
together with RPD3 at the top of a mechanistic hierarchy
controlling heterochromatic gene silencing in Drosophila.
Such a role is in agreement with the enriched association
of SU(VAR)3-3 to prospective heterochromatin in early
blastoderm nuclei. In Su(var)3-3 null embryos, there is
an extension of H3K4me2 and concomitant reduction of
H3K9me3 at prospective heterochromatin, suggesting
that SU(VAR)3-3 has a protective function at heterochro-
matic regions to restrict expansion of H3K4 methylation.
Similarly, H3K9 acetylation becomes expanded toward
heterochromatin. H3K4 methylation precedes H3K9
methylation in blastoderm nuclei, and both SU(VAR)3-3
and SU(VAR)3-9 are abundant proteins within cleavage
chromatin. A developmentally regulated silencing com-
plex between SU(VAR)3-3, RPD3, and SU(VAR)3-9 (Fig-
ure 5B) is therefore likely to dictate the distinction between
euchromatic and heterochromatic domains during early
embryogenesis. A comparable functional crosstalk be-
tween human LSD1 and HDAC1/2, which depends on
nucleosomal substrates and the CoREST protein, was
currently shown (Lee et al., 2006). The interaction between112 Molecular Cell 26, 103–115, April 13, 2007 ª2007 Elsevier ISU(VAR)3-3 and RPD3 could also explain butyrate sensi-
tivity of Su(var)3-3 mutations (Reuter et al., 1982). The ef-
fect of SU(VAR)3-3 on heterochromatin formation during
blastoderm could involve both maternal and zygotic pro-
tein. Association of SU(VAR)3-3 with cleavage chromatin
is dependent on maternal sources. In contrast, all other
effects on gene silencing are zygotically determined, and
no maternal effects on PEV were found in any of the
Su(var)3-3 mutations. This is also supported by clonal
analysis showing early onset and stable maintenance of
gene silencing in PEV (Figure S5).
SU(VAR)3-3 Controls Transcriptional Silence
in Primordial Germ Cells
Transcriptional silence in primordial germline cells of Dro-
sophila is regulated by nanos (nos), pumillio (pum), and
germ cell-less (gcl), since mutations in these genes result
in premature activation of transcription in germ cells
(Asaoka-Taguchi et al., 1999; Deshpande et al., 1999;
Leatherman et al., 2002). However, in nos null embryos,
only about 50% display H3K4 methylation signals (Scha-
ner et al., 2003), suggesting that several other factors
contribute to establishment andmaintenance of transcrip-
tional silence. SU(VAR)3-3 is likely to be a main compo-
nent in this control because every pole cell nucleus in
Su(var)3-3mutants displays H3K4 methylation and signif-
icant reduction of H3K9me2 and H3K9me3. Homozygous
Su(var)3-3 mutant females are completely sterile and do
not develop oocytes in their egg chambers, which show
a spectrum of developmental abnormalities and become
arrested already at stage three to four (Szabad et al.,
1988). This suggests that SU(VAR)3-3 is also required dur-
ing oogenesis in Drosophila. In mammals, two of the three
nos homologs are required for female fertility. For nanos-3,
a function in primordial germ cell specification was dem-
onstrated in knockout mice (Tsuda et al., 2003). Based
on our data, a likely function for LSD1 during germline
specification in mammals is predicted.
Su(var)3-3mutant males are sterile and produce immo-
bile sperm, and in primary spermatocytes of Su(var)3-3
males, crystals are frequently found (G.R., unpublished
data), a phenotype typical for X0 males or XY males carry-
ing a deletion for the crystal (cry) locus (Tritto et al., 2003).
Whether or not SU(VAR)3-3 also interferes with control of
activation of Y chromosomal genes in the male germline
remains to be studied. Furthermore, alleles of Su(var)3-3
increase crossover in pericentric regions (Westpahl and
Reuter, 2002), suggesting that SU(VAR)3-3 is also in-
volved in control of heterochromatin packaging in female
meiosis. All these phenotypic effects indicate that the
H3K4 demethylase SU(VAR)3-3 is an important regulator
in protecting chromatin functions in germline cells.
EXPERIMENTAL PROCEDURES
Drosophila Cultures, Stocks, and Genetic Analysis
Flies were reared on standard medium at 25C. Chromosomes and
mutations not noted here are described in Crosby et al. (2007).nc.
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fect on white variegation of In(1)wm4 in the background of E(var)muta-
tions after EMS (2.5mM)mutagenesis (Reuter et al., 1986). The general
effect of Su(var)3-3 on gene silencing was studied in Dp(1;f)g238
(Le et al., 1995) variegating for yellow, T(2;3)BL1 showing P[(w+),
HS-lacZ] transgene silencing (Lu et al., 1998) and T(2;3)SbV (Sinclair
et al., 1992). Su(var)3-312-dependent compensation of PEV enhance-
ment was studied in genotypes with one or two additional genomic
copies of Su(var)3-9 and one additional copy of HP1 or Su(var)3-7.
Immunostaining of Polytene Chromosomes and Embryos
Preparation and staining of polytene chromosomeswere performed as
described (Schotta et al., 2002). Chromosomes were incubated with
rabbit polyclonal a-mono-, a-di-, and a-trimethyl H3K4 or H3K9, re-
spectively (Upstate; 1:50/5% dry milk) or a-SU(VAR)3-3 (1:300/5%
dry milk) overnight at 4C, followed by incubation with Alexa Fluor
488 (Molecular Probes) conjugated secondary antibody for 2 hr at
37C (1:100/5% dry milk). Preparations were examined with confocal
laser scanning microscopy (LSM 510; Zeiss). Drosophila embryos
were fixed with the boiling fix method as described (Rothwell and
Sullivan, 2000). SU(VAR)3-3-specific rabbit antibodies were raised
against purified bacterial 63 HIS–SU(VAR)3-3 (amino acids 1–150)
antigen.
Molecular Cloning of Su(var)3-3 and Constructs
Su(var)3-3was mapped to the genomic region 76D-77B by P-transpo-
sase-induced male recombination using a series of P element inser-
tions. After a cross of +/Y; CyO, H{w+mC = P2-3}HoP2.1/+; Ly
Su(var)3-303 Sb/P element males, wm4h;+/+, Ly+, and +Sb recombi-
nant chromosomes were selected and tested for the presence of
Su(var)3-303 by a cross to Su(var)3-312/TM3, Sb Ser flies (sterility
test). For molecular analysis of Su(var)3-3 mutations, genomic DNA
from Su(var)3-3x/Df(3L)TR2 heterozygotes was used.
Full-length ORFs of Su(var)3-3 (GenBank accession number
AY094837) and mLSD1 (GenBank accession number BC059885)
were amplified by PCR and cloned into expression vectors. Point mu-
tations were introduced by site-directed mutagenesis. All constructs
were verified by sequencing.
Immunoaffinity Purification of SU(VAR)3-3 Complexes
Nuclear extract from Drosophila embryos (0–3 hr) was incubated with
crosslinked SU(VAR)3-3 antibody for 4 hr at 4C. The antibodies were
coupled to protein A Sepharose (Amersham) using standard tech-
niques. The beads were washed with buffer A (50 mM Tris [pH 7.5]/
150 mM NaCl/0.1% NP-40) followed by a wash with buffer A plus
250 mM KCl. The proteins were eluted with 0.1 M glycine (pH 2.5)
and neutralized with 1:10 volume of 1 M Tris (pH 8.0). a-RPD3
(ab1767; 1:1000), a-HP1 (ab24726; 1:3000), a-SU(VAR)3-9 (Schotta
et al., 2002; 1:1000), and a-SU(VAR)3-3 (1:3000) were used for western
blotting. The detection was done according to manufacturer’s instruc-
tions (Amersham; ECL-Kit).
In Vitro Histone Demethylase Assays
N-terminally FLAG-HA-tagged SU(VAR)3-3 and mLSD1 were baculo-
virally expressed in Sf9 cells and purified with M2 agarose (Sigma).
Typically, 1 mg of recombinant protein was incubated with 11.25 mM
histone H3 peptides (1–20) or 2.5 mg of calf thymus bulk histone
(Roche) for 4 hr at 25C in HDM buffer (10 mM HEPES (pH 7.9),
60 mM KCl, 1% glycerol) in a final volume of 20 ml. Histones were
analyzed by western blot using methyl-specific antibodies (Peters
et al., 2003). a-HA (sc-805; 1:1000), a-LSD1 (ab17721; 1:1000), and
a-SU(VAR)3-3 (1:2000) were used to evaluate enzyme concentration.
For mass spectrometry, peptide samples were acidified by adding
1 ml of 10% (v/v) TFA followed by purification using ZipTip C-18 micro-
columns (Millipore). Peptides were eluted with 50% (v/v) ACN, 0.1%
(v/v) TFA, and 5 ml was mixed with an equal volume of 10 mg/ml
4-hydroxy-a-cyanocinnamic acid (HCCA, Sigma, in 70% [v/v] ACN,Mole0.1% [v/v] TFA), of which 1 ml was placed on a MALDI sample plate.
Spectra were acquired on a MALDI-TOF/TOF mass spectrometer
4800 Analyzer (Applied Biosystems, Darmstadt) with 8000 shots per
spectrum. In HMTase assays, 3 mg of recombinant SU(VAR)3-3 and
1 mg histone H3 peptides were incubated overnight at 25C in
16.7 mM HEPES-KOH (pH 7.9), 100 mM KCl, and 1.7% glycerol in a
final volume of 20 ml. Then, 2.5 ml 103 HIM buffer (Czermin et al.,
2001), 1 ml of 1.25 M glycine, 0.5 ml of SAM (1 mCi/ml; Amersham),
and 1 mg of recombinant SU(VAR)3-9 were added and incubated for
20 min at 25C. Reactions were stopped and incorporated radioactiv-
ity was measured according to Czermin et al. (2001).
Chromatin Immunoprecipitation
Fly heads and salivary glands were fixed with 1.8% formaldehyde for
30 min at room temperature, resuspended in RIPA buffer (140 mM
NaCl, 10 mM Tris-HCl [pH 8.0], 1 mM EDTA, 1% Triton X-100, 0.1%
SDS, 0.1% DOC), and lysed by sonication. The lysate was cleared
by centrifugation, preabsorbed by incubation with protein G Sephar-
ose beads (Amersham), and incubated with 7 mg a-dimethyl H3K9
(Upstate) overnight at 4C. Antibody complexes were bound to protein
G Sepharose beads. DNA was recovered and dissolved in 150 ml
water. Control mock immunoprecipitations were done in parallel with-
out antibodies. Real-time PCR analysis was performed according to
Dellino et al. (2004) and DNA from 5 ml of each sample amplified in
20 ml reactions with 23 SYBR Green Super Mix (Bio-Rad). Primer
sequences are available upon request.
Supplemental Data
Supplemental Data include five figures and can be found with this ar-
ticle online with this article at http://www.molecule.org/cgi/content/
full/26/1/103/DC1/.
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